data_2k27_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k27 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.032 -0.359 . . . . 73.239999999999995 110.032 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.439999999999998 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 72.239999999999995 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 73.140000000000001 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 70.519999999999996 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 63.009999999999998 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 65.549999999999997 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 75.299999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 72.319999999999993 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 74.030000000000001 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp . . . . . 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 109.122 -1.145 . . . . 74.109999999999999 109.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 70.340000000000003 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 73.439999999999998 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 73.239999999999995 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 73.519999999999996 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 73.209999999999994 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 62.43 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 73.099999999999994 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 73.530000000000001 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 71.25 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 74.239999999999995 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 74.409999999999997 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 74.310000000000002 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 73.5 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 70.099999999999994 110.134 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.242 0.83 . . . . 75.109999999999999 113.242 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 70.109999999999999 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 73.0 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 74.329999999999998 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 74.540000000000006 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 73.319999999999993 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.549999999999997 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 64.420000000000002 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 73.349999999999994 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 73.420000000000002 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 74.420000000000002 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 74.030000000000001 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 72.400000000000006 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 55.140000000000001 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 75.510000000000005 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 74.140000000000001 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 70.150000000000006 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 71.430000000000007 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.349999999999994 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 72.230000000000004 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 74.129999999999995 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 72.239999999999995 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 75.329999999999998 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 74.519999999999996 112.05 -178.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.675 -0.491 . . . . 74.230000000000004 109.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 72.329999999999998 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 75.209999999999994 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 63.32 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 61.439999999999998 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.319999999999993 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 61.25 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 75.120000000000005 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 75.040000000000006 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 74.209999999999994 109.477 -179.135 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 N-CA-C 109.498 -1.001 . . . . 72.340000000000003 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 74.430000000000007 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 72.420000000000002 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 63.520000000000003 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 73.230000000000004 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 72.150000000000006 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 73.140000000000001 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 71.010000000000005 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 73.099999999999994 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 73.430000000000007 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 61.240000000000002 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 75.299999999999997 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 75.120000000000005 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 74.430000000000007 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 71.329999999999998 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 74.329999999999998 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 74.5 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 65.239999999999995 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 119.44 -0.314 . . . . 73.040000000000006 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 74.120000000000005 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 75.430000000000007 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 74.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 73.230000000000004 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 75.109999999999999 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 71.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 64.140000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 75.530000000000001 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 72.409999999999997 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 75.200000000000003 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 73.310000000000002 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 62.409999999999997 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 71.25 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 73.109999999999999 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 70.299999999999997 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 72.109999999999999 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 74.329999999999998 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 74.439999999999998 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 75.439999999999998 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 73.230000000000004 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 52.130000000000003 111.658 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.007 -0.738 . . . . 73.319999999999993 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 75.219999999999999 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 73.099999999999994 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 62.119999999999997 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 74.150000000000006 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.450000000000003 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 71.439999999999998 108.522 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 108.586 -1.352 . . . . 62.109999999999999 108.586 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 75.450000000000003 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 71.040000000000006 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 72.219999999999999 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 74.030000000000001 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 74.239999999999995 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 53.399999999999999 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 74.109999999999999 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 53.229999999999997 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 74.420000000000002 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 73.120000000000005 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 73.239999999999995 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 62.5 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 74.340000000000003 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 71.400000000000006 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 74.340000000000003 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 52.130000000000003 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 64.010000000000005 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 72.120000000000005 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 64.319999999999993 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 63.340000000000003 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 74.239999999999995 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 111.755 0.279 . . . . 74.120000000000005 111.755 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.420000000000002 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 74.109999999999999 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 72.25 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 73.400000000000006 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 75.219999999999999 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 73.439999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 74.239999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 74.140000000000001 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 52.119999999999997 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 73.230000000000004 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 65.129999999999995 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 74.420000000000002 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 75.439999999999998 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 74.329999999999998 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 73.430000000000007 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 74.209999999999994 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 75.450000000000003 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 71.230000000000004 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 61.310000000000002 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 73.5 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 72.310000000000002 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 73.109999999999999 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.420000000000002 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 64.109999999999999 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 72.5 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.430000000000007 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 73.409999999999997 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 71.219999999999999 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 74.129999999999995 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 74.519999999999996 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 74.25 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 110.569 -0.159 . . . . 75.150000000000006 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 54.530000000000001 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.450000000000003 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 75.540000000000006 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 71.420000000000002 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 73.430000000000007 108.852 -178.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.539 0.773 0 N-CA-C 110.389 -0.658 . . . . 72.329999999999998 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 74.25 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 75.439999999999998 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.540000000000006 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 73.209999999999994 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 73.019999999999996 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 72.420000000000002 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 74.329999999999998 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 71.209999999999994 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.230000000000004 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 73.040000000000006 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 75.209999999999994 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 75.400000000000006 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.549999999999997 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 73.519999999999996 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 75.450000000000003 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 75.5 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 54.399999999999999 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 75.549999999999997 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 75.150000000000006 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 75.420000000000002 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.519999999999996 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 75.0 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 65.150000000000006 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 72.400000000000006 111.431 170.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.753 0.279 . . . . 64.510000000000005 111.753 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 74.219999999999999 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 71.140000000000001 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 75.120000000000005 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.299999999999997 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 73.150000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 63.520000000000003 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 75.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 75.209999999999994 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.109999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 71.040000000000006 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 75.120000000000005 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.530000000000001 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 74.109999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 72.510000000000005 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 73.439999999999998 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.349999999999994 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 75.109999999999999 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 63.439999999999998 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 65.239999999999995 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 73.349999999999994 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 75.450000000000003 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 75.299999999999997 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.510000000000005 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 73.150000000000006 112.661 -179.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.265 -0.643 . . . . 75.239999999999995 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 71.439999999999998 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 73.340000000000003 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.439999999999998 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 74.450000000000003 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 74.129999999999995 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 71.329999999999998 110.35 -175.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 N--CA 1.455 -0.742 0 N-CA-C 109.396 -1.04 . . . . 64.019999999999996 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 73.319999999999993 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 74.239999999999995 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 64.140000000000001 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.319999999999993 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 74.200000000000003 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 74.409999999999997 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 73.439999999999998 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 72.019999999999996 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 73.519999999999996 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 72.040000000000006 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.319999999999993 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.420000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 60.340000000000003 111.678 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.618 0.599 . . . . 74.329999999999998 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 70.439999999999998 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 73.329999999999998 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 73.109999999999999 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 73.409999999999997 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 74.120000000000005 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 61.25 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 74.230000000000004 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 74.239999999999995 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 73.299999999999997 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 74.310000000000002 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 74.209999999999994 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 74.209999999999994 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 61.530000000000001 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 75.140000000000001 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 60.340000000000003 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 73.340000000000003 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 45.329999999999998 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 73.200000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 65.409999999999997 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 75.040000000000006 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 75.010000000000005 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 74.219999999999999 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 73.219999999999999 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 74.120000000000005 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 74.129999999999995 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.29 -0.633 . . . . 71.519999999999996 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 73.209999999999994 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 64.219999999999999 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 72.209999999999994 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 75.209999999999994 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 109.844 -0.868 . . . . 73.340000000000003 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 65.329999999999998 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 61.130000000000003 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 75.230000000000004 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 74.409999999999997 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 62.100000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 74.140000000000001 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 74.239999999999995 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 74.319999999999993 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 64.219999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 75.319999999999993 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 74.329999999999998 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 72.439999999999998 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 74.219999999999999 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 75.239999999999995 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 74.5 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.450000000000003 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.319999999999993 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.93 0.715 . . . . 75.219999999999999 112.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 72.519999999999996 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 74.340000000000003 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 74.010000000000005 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 73.439999999999998 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 74.530000000000001 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 73.230000000000004 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.439999999999998 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 74.420000000000002 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 73.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 60.329999999999998 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 75.439999999999998 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 70.420000000000002 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 75.200000000000003 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 75.040000000000006 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 64.0 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 73.219999999999999 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 74.219999999999999 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 72.120000000000005 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 74.129999999999995 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 75.319999999999993 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 72.430000000000007 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 74.439999999999998 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 74.5 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 74.230000000000004 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 63.219999999999999 109.569 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 75.109999999999999 109.657 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 74.349999999999994 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 73.0 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 74.349999999999994 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 72.319999999999993 109.998 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 CA--C 1.539 0.769 0 N-CA-C 111.426 -0.259 . . . . 74.230000000000004 111.426 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 71.140000000000001 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 74.010000000000005 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.540000000000006 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.209999999999994 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 74.340000000000003 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 72.420000000000002 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 74.420000000000002 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 75.420000000000002 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 65.409999999999997 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 72.150000000000006 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 75.310000000000002 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 75.129999999999995 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 74.0 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.491 0.552 . . . . 72.319999999999993 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 74.140000000000001 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 74.400000000000006 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.120000000000005 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 63.5 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 74.439999999999998 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 65.540000000000006 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 61.109999999999999 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 71.140000000000001 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 65.140000000000001 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 74.209999999999994 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 73.430000000000007 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 73.329999999999998 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 73.340000000000003 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 62.210000000000001 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 75.209999999999994 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 44.030000000000001 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.510000000000005 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.43 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 75.310000000000002 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 72.150000000000006 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 72.030000000000001 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 71.430000000000007 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 72.549999999999997 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 75.519999999999996 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 75.209999999999994 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 74.439999999999998 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 75.120000000000005 112.598 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.272 0.558 . . . . 75.420000000000002 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 62.530000000000001 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 72.319999999999993 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 74.319999999999993 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 109.754 -0.902 . . . . 63.0 109.754 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 74.329999999999998 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 64.140000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 75.319999999999993 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 73.400000000000006 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.5 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 71.310000000000002 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 75.340000000000003 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 73.030000000000001 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 74.430000000000007 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 73.310000000000002 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 72.329999999999998 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 74.430000000000007 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 74.439999999999998 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 75.349999999999994 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 74.439999999999998 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 73.430000000000007 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 74.230000000000004 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 75.120000000000005 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 74.5 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 72.209999999999994 109.573 -174.067 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 113.086 0.773 . . . . 75.25 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 65.129999999999995 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 71.129999999999995 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 72.420000000000002 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 74.420000000000002 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 71.219999999999999 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 74.430000000000007 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 73.109999999999999 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 73.019999999999996 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 74.450000000000003 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 74.239999999999995 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 74.400000000000006 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 74.219999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.450000000000003 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 75.340000000000003 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.430000000000007 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 72.200000000000003 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 73.540000000000006 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 73.540000000000006 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 73.109999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 72.049999999999997 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 72.25 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 64.099999999999994 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 74.340000000000003 111.66 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 110.58 -0.156 . . . . 75.349999999999994 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 75.349999999999994 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 54.409999999999997 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 72.409999999999997 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 75.0 109.623 -174.459 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 N-CA-C 111.422 -0.261 . . . . 73.150000000000006 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 72.120000000000005 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 71.340000000000003 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 65.319999999999993 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 73.230000000000004 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 74.219999999999999 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 75.25 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 75.120000000000005 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 74.230000000000004 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 73.310000000000002 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 71.340000000000003 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 75.109999999999999 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 73.010000000000005 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 73.409999999999997 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 72.230000000000004 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 73.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 73.129999999999995 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 72.040000000000006 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 75.209999999999994 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 72.400000000000006 111.221 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.676 0.621 . . . . 75.450000000000003 112.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 65.019999999999996 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 75.030000000000001 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 74.340000000000003 110.586 165.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.210000000000001 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 71.420000000000002 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 71.340000000000003 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 73.510000000000005 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 71.129999999999995 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 73.439999999999998 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 73.019999999999996 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 75.209999999999994 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 72.140000000000001 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 70.409999999999997 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 74.129999999999995 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 72.310000000000002 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 72.219999999999999 112.235 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 71.420000000000002 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 71.239999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.095 -0.706 . . . . 73.340000000000003 109.095 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 75.239999999999995 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 73.109999999999999 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 74.209999999999994 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 74.25 108.923 176.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 110.26 -0.708 . . . . 71.209999999999994 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 74.0 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 73.120000000000005 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 73.340000000000003 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 71.349999999999994 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 75.519999999999996 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 75.319999999999993 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 71.239999999999995 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 74.209999999999994 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 74.420000000000002 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 73.219999999999999 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 75.329999999999998 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.420000000000002 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 74.310000000000002 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 74.209999999999994 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 70.430000000000007 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 75.329999999999998 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 75.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 71.319999999999993 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 51.210000000000001 111.049 -170.542 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 75.140000000000001 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 75.540000000000006 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 72.140000000000001 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 73.219999999999999 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 75.439999999999998 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 75.439999999999998 109.48 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 73.219999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 74.040000000000006 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 74.430000000000007 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 74.540000000000006 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.209999999999994 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 74.340000000000003 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 75.040000000000006 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 63.0 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 74.310000000000002 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 65.329999999999998 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 75.040000000000006 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 74.140000000000001 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 63.109999999999999 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 72.409999999999997 111.984 -176.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.047 -0.723 . . . . 72.230000000000004 109.047 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 70.5 106.464 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.450000000000003 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 73.430000000000007 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 70.129999999999995 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 74.420000000000002 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.420000000000002 110.252 -165.041 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 N-CA-C 111.318 -0.301 . . . . 74.140000000000001 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 72.510000000000005 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 75.129999999999995 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 65.230000000000004 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 73.549999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 73.310000000000002 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 75.150000000000006 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 74.030000000000001 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 75.409999999999997 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 75.450000000000003 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 72.319999999999993 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 75.409999999999997 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 75.019999999999996 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 73.349999999999994 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 71.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 63.020000000000003 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 74.299999999999997 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.25 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 75.349999999999994 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.430000000000007 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 71.129999999999995 111.664 -173.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.876 0.695 . . . . 73.310000000000002 112.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 73.439999999999998 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 74.409999999999997 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 75.219999999999999 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 74.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 74.129999999999995 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 71.239999999999995 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 62.109999999999999 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 72.540000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 61.030000000000001 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.329999999999998 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 74.200000000000003 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 75.129999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 73.329999999999998 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 75.200000000000003 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 74.430000000000007 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 75.120000000000005 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 64.129999999999995 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 74.140000000000001 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 75.510000000000005 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 64.150000000000006 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 72.030000000000001 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 108.668 -0.864 . . . . 75.299999999999997 108.668 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 72.450000000000003 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 64.310000000000002 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 72.329999999999998 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 N-CA-C 110.63 -0.565 . . . . 70.329999999999998 110.63 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 74.340000000000003 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 72.409999999999997 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 74.129999999999995 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 64.310000000000002 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 64.439999999999998 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 75.519999999999996 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 72.120000000000005 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 74.0 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 73.340000000000003 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 61.210000000000001 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 74.519999999999996 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 75.010000000000005 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 71.219999999999999 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 75.310000000000002 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.510000000000005 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.209 0.448 . . . . 73.109999999999999 112.209 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 71.129999999999995 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 71.420000000000002 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 73.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 74.329999999999998 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 71.430000000000007 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 75.099999999999994 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 75.409999999999997 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 73.340000000000003 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 61.219999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 75.519999999999996 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 73.150000000000006 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 72.129999999999995 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 71.120000000000005 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 63.439999999999998 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 71.120000000000005 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 72.099999999999994 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 74.010000000000005 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 71.299999999999997 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 74.510000000000005 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.540000000000006 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 75.0 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 74.319999999999993 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 75.219999999999999 112.093 -178.133 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.474 -0.195 . . . . 73.310000000000002 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 73.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 73.549999999999997 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 44.240000000000002 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 75.030000000000001 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 N-CA-C 109.691 -0.927 . . . . 64.510000000000005 109.691 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 75.349999999999994 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 72.439999999999998 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 74.319999999999993 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 75.219999999999999 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 75.400000000000006 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 70.099999999999994 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 73.409999999999997 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 65.450000000000003 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 64.129999999999995 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 74.409999999999997 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 75.120000000000005 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 73.109999999999999 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 71.099999999999994 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 63.009999999999998 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 65.400000000000006 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 75.549999999999997 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 72.209999999999994 110.452 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.579 0.585 . . . . 72.109999999999999 112.579 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 63.109999999999999 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 75.030000000000001 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 75.420000000000002 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 75.230000000000004 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 72.129999999999995 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 74.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 75.239999999999995 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 74.310000000000002 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 74.129999999999995 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 71.150000000000006 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 75.019999999999996 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 72.329999999999998 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 71.239999999999995 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 74.420000000000002 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 75.120000000000005 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 65.409999999999997 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 75.129999999999995 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 75.019999999999996 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 73.409999999999997 112.061 -179.196 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.61 -0.885 . . . . 70.430000000000007 108.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 71.549999999999997 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 60.100000000000001 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 73.129999999999995 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 75.549999999999997 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 72.540000000000006 112.49 179.249 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 109.752 -0.903 . . . . 75.439999999999998 109.752 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 74.120000000000005 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 74.209999999999994 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 75.040000000000006 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.099999999999994 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 73.120000000000005 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.230000000000004 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 74.409999999999997 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 75.450000000000003 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 72.450000000000003 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 75.209999999999994 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 72.099999999999994 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 74.510000000000005 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 73.109999999999999 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 71.409999999999997 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 71.340000000000003 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 75.209999999999994 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 75.420000000000002 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 74.439999999999998 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.099999999999994 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 72.109999999999999 108.912 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.696 0.628 . . . . 61.439999999999998 112.696 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 72.510000000000005 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 75.150000000000006 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 53.109999999999999 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 73.319999999999993 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 73.540000000000006 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 74.019999999999996 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 75.230000000000004 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 72.150000000000006 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 72.319999999999993 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 73.530000000000001 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 72.329999999999998 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 73.409999999999997 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 73.150000000000006 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 73.319999999999993 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 74.129999999999995 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 75.150000000000006 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.420000000000002 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.032 -0.359 . . . . 73.409999999999997 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 63.43 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 72.549999999999997 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 74.430000000000007 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 75.209999999999994 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 74.549999999999997 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 55.409999999999997 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 75.010000000000005 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.5 109.189 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 108.915 -1.225 . . . . 73.140000000000001 108.915 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 75.409999999999997 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 75.409999999999997 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 73.299999999999997 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 74.099999999999994 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 72.219999999999999 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 73.430000000000007 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 74.310000000000002 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 74.349999999999994 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 74.510000000000005 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 64.310000000000002 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 73.319999999999993 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 73.299999999999997 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.230000000000004 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 75.109999999999999 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 60.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 71.519999999999996 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 70.450000000000003 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 71.420000000000002 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 74.420000000000002 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 75.430000000000007 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.829 0.307 . . . . 75.239999999999995 111.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 74.299999999999997 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 74.129999999999995 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 75.439999999999998 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 74.319999999999993 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 75.239999999999995 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 71.349999999999994 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 75.219999999999999 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 74.439999999999998 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 74.129999999999995 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 64.209999999999994 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 70.510000000000005 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 61.140000000000001 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.349999999999994 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 74.150000000000006 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 70.420000000000002 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 74.540000000000006 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 74.019999999999996 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 73.430000000000007 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 73.129999999999995 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 74.109999999999999 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 73.420000000000002 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 73.519999999999996 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.969 -0.752 . . . . 74.530000000000001 108.969 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 63.340000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 74.129999999999995 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 72.409999999999997 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 73.040000000000006 111.659 -172.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 110.805 -0.498 . . . . 73.400000000000006 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 73.140000000000001 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 73.319999999999993 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 73.109999999999999 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 60.140000000000001 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 74.239999999999995 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 71.340000000000003 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 75.340000000000003 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 72.109999999999999 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 70.430000000000007 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 73.109999999999999 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 71.409999999999997 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 75.150000000000006 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 74.129999999999995 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 60.100000000000001 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 74.540000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 73.319999999999993 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 72.219999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 72.310000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 72.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.420000000000002 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 72.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.154 0.428 . . . . 74.129999999999995 112.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 75.400000000000006 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 74.549999999999997 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 74.299999999999997 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 63.310000000000002 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 75.540000000000006 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 75.239999999999995 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 74.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 75.150000000000006 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 73.109999999999999 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 74.230000000000004 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 74.299999999999997 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 75.230000000000004 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 74.310000000000002 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 75.439999999999998 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 74.540000000000006 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 72.450000000000003 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 73.109999999999999 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 72.010000000000005 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 71.239999999999995 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 73.549999999999997 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 73.519999999999996 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 73.319999999999993 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 74.420000000000002 111.879 -176.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.932 0.396 . . . . 74.319999999999993 111.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 75.239999999999995 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 72.040000000000006 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 73.129999999999995 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 53.109999999999999 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 75.219999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.439999999999998 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 65.340000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 110.128 -0.759 . . . . 73.030000000000001 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 74.120000000000005 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 73.219999999999999 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 70.109999999999999 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 74.239999999999995 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 72.420000000000002 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 74.0 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 74.319999999999993 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 74.319999999999993 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 71.099999999999994 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 65.209999999999994 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 75.549999999999997 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 72.030000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 64.409999999999997 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 75.109999999999999 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 74.450000000000003 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 72.049999999999997 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 74.140000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.5 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.756 0.28 . . . . 74.409999999999997 111.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 71.209999999999994 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.409999999999997 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 75.150000000000006 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 71.439999999999998 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 71.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 63.530000000000001 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 75.239999999999995 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 64.540000000000006 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 75.129999999999995 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 75.129999999999995 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 73.109999999999999 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 75.329999999999998 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 75.109999999999999 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 71.409999999999997 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 73.299999999999997 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 73.310000000000002 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 72.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 74.310000000000002 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.22 -0.289 . . . . 72.349999999999994 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 74.420000000000002 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 73.519999999999996 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 73.0 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 64.409999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 70.439999999999998 111.153 -172.631 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 109.778 -0.893 . . . . 71.120000000000005 109.778 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 74.219999999999999 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.400000000000006 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 75.439999999999998 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 75.310000000000002 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 64.200000000000003 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 62.43 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 75.120000000000005 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 64.319999999999993 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 74.219999999999999 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 73.129999999999995 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 74.230000000000004 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 72.120000000000005 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 73.25 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 74.430000000000007 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 73.540000000000006 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.219 0.822 . . . . 73.430000000000007 113.219 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 75.319999999999993 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 73.099999999999994 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 71.319999999999993 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 72.310000000000002 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 73.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 74.310000000000002 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 74.549999999999997 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 74.519999999999996 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 71.239999999999995 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 75.129999999999995 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 71.25 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.519999999999996 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 73.239999999999995 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 63.329999999999998 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 75.010000000000005 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 74.519999999999996 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 73.209999999999994 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 71.409999999999997 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 73.319999999999993 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 75.25 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 75.040000000000006 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 74.420000000000002 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 63.200000000000003 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 72.340000000000003 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 74.019999999999996 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 74.010000000000005 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 64.25 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 74.109999999999999 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 74.230000000000004 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 64.430000000000007 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 72.129999999999995 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 72.549999999999997 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.439999999999998 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 73.120000000000005 108.063 -175.245 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 CA--C 1.539 0.748 0 N-CA-C 110.431 -0.642 . . . . 74.25 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 70.540000000000006 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 75.040000000000006 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 72.439999999999998 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.219999999999999 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 71.310000000000002 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 71.299999999999997 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 71.230000000000004 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 61.119999999999997 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 65.540000000000006 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 74.430000000000007 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 73.510000000000005 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 74.319999999999993 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 71.439999999999998 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 71.310000000000002 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 75.299999999999997 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 72.549999999999997 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 74.230000000000004 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 72.129999999999995 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.171 0.434 . . . . 75.200000000000003 112.171 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 73.040000000000006 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 71.420000000000002 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.510000000000005 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 74.420000000000002 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 70.439999999999998 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 74.120000000000005 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 74.420000000000002 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 72.209999999999994 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 72.409999999999997 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 75.439999999999998 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.540000000000006 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 75.430000000000007 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 75.450000000000003 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 62.340000000000003 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 72.409999999999997 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 74.239999999999995 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 71.450000000000003 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 73.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 72.140000000000001 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 72.120000000000005 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 75.439999999999998 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 73.340000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.516 -0.549 . . . . 72.109999999999999 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 74.540000000000006 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.319999999999993 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.5 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 64.099999999999994 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 71.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 72.310000000000002 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 73.209999999999994 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 72.430000000000007 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.310000000000002 110.293 -174.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 N-CA-C 108.842 -1.253 . . . . 70.140000000000001 108.842 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 74.319999999999993 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 74.329999999999998 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 72.409999999999997 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 74.510000000000005 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 75.099999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 74.25 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 73.400000000000006 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 41.340000000000003 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 75.430000000000007 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 64.209999999999994 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.409999999999997 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 75.530000000000001 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 71.420000000000002 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.420000000000002 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 74.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 72.439999999999998 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 72.530000000000001 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 72.019999999999996 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 75.299999999999997 109.37 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.617 0.599 . . . . 75.319999999999993 112.617 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 73.409999999999997 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 74.349999999999994 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 75.040000000000006 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 74.109999999999999 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 71.129999999999995 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 73.219999999999999 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 73.329999999999998 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 73.109999999999999 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.400000000000006 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 74.319999999999993 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 75.019999999999996 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 71.319999999999993 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 73.209999999999994 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 74.519999999999996 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 74.040000000000006 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 72.099999999999994 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 64.109999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 75.430000000000007 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 64.219999999999999 112.547 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 118.684 -0.674 . . . . 70.299999999999997 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.77 104.29 1.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.664 2.242 . . . . 72.329999999999998 109.676 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -78.28 78.65 4.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.798 0.839 . . . . 73.239999999999995 110.032 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.439999999999998 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 72.239999999999995 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 73.140000000000001 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 70.519999999999996 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 63.009999999999998 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 65.549999999999997 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 75.299999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 72.319999999999993 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 74.030000000000001 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp 70.9 141.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.69 33.2 75.51 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.39 0.519 . . . . 73.010000000000005 112.671 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.47 83.82 1.49 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.615 -1.794 . . . . 72.299999999999997 108.615 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.26 89.61 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.996 1.318 . . . . 75.299999999999997 111.466 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 53.75 45.43 27.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.881 1.272 . . . . 73.239999999999995 111.034 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.2 t -112.05 -83.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 108.2 -1.037 . . . . 74.230000000000004 108.2 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -169.8 153.02 4.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.677 1.191 . . . . 70.439999999999998 108.344 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.53 55.3 29.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.334 -1.106 . . . . 75.540000000000006 110.334 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -117.76 96.35 49.34 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.932 1.293 . . . . 73.230000000000004 109.42 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.0 136.01 14.42 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.117 2.544 . . . . 73.329999999999998 110.486 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.1 mt 46.23 63.07 10.28 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.339 1.456 . . . . 74.340000000000003 111.681 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.9 93.44 1.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.341 2.694 . . . . 74.109999999999999 109.122 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 70.340000000000003 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 73.439999999999998 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 73.239999999999995 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 73.519999999999996 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 73.209999999999994 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 62.43 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 73.099999999999994 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 73.530000000000001 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 71.25 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 74.239999999999995 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 74.409999999999997 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 74.310000000000002 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 73.5 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.83 83.61 1.58 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 70.099999999999994 110.134 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -74.84 -45.93 39.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.098 0.559 . . . . 73.129999999999995 111.169 175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 56.75 76.58 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.383 1.473 . . . . 73.219999999999999 110.356 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 68.5 94.07 0.07 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.741 1.616 . . . . 74.510000000000005 109.802 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.94 111.52 1.06 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.298 1.039 . . . . 62.219999999999999 110.446 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.1 p 35.43 48.08 0.39 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.052 1.741 . . . . 63.229999999999997 112.131 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.97 62.17 5.46 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.259 0.933 . . . . 64.120000000000005 112.505 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.9 p -154.43 -167.79 2.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.345 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.86 62.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.885 1.274 . . . . 75.209999999999994 109.195 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -161.57 66.63 2.14 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.616 0.766 . . . . 73.209999999999994 110.471 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.11 95.76 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.368 2.712 . . . . 72.209999999999994 110.331 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.96 141.34 5.35 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.488 -1.045 . . . . 74.099999999999994 110.488 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.88 125.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.536 1.534 . . . . 74.219999999999999 107.853 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.5 mt -82.63 143.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.743 1.217 . . . . 65.030000000000001 109.203 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.06 171.78 41.95 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.913 -0.875 . . . . 54.450000000000003 110.913 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.74 164.71 31.58 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.429 -1.069 . . . . 62.32 110.429 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.2 t -161.69 160.89 29.13 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.941 0.896 . . . . 74.230000000000004 109.877 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -154.49 71.79 6.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.026 0.93 . . . . 73.299999999999997 109.938 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.59 158.8 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.816 3.011 . . . . 71.340000000000003 111.971 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -86.44 82.6 7.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.895 1.278 . . . . 75.310000000000002 108.789 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.87 147.39 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.31 1.044 . . . . 64.420000000000002 110.327 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.53 169.91 23.62 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.954 1.702 . . . . 64.349999999999994 108.918 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -87.82 147.25 40.74 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.798 0.839 . . . . 72.239999999999995 110.557 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.83 -16.1 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.24 2.627 . . . . 72.099999999999994 111.865 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -57.95 -21.48 44.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.881 1.272 . . . . 75.109999999999999 113.242 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 70.109999999999999 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 73.0 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 74.329999999999998 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 74.540000000000006 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 73.319999999999993 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.549999999999997 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 64.420000000000002 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 73.349999999999994 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 73.420000000000002 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 74.420000000000002 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 74.030000000000001 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 72.400000000000006 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 55.140000000000001 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 75.510000000000005 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 74.140000000000001 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 70.150000000000006 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 71.430000000000007 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.349999999999994 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 72.230000000000004 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 74.129999999999995 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 72.239999999999995 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 75.329999999999998 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p -61.84 -24.79 67.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 74.519999999999996 112.05 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -87.85 -48.3 7.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.136 0.974 . . . . 74.140000000000001 110.359 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.75 92.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.557 1.143 . . . . 64.420000000000002 108.774 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.86 167.3 22.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.574 1.15 . . . . 74.430000000000007 109.993 167.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -116.54 140.72 27.02 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.66 1.184 . . . . 71.540000000000006 108.326 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.79 136.3 44.99 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.814 2.343 . . . . 74.329999999999998 110.353 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -84.33 67.86 9.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.897 0.879 . . . . 74.310000000000002 110.293 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 148.16 10.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.409 1.083 . . . . 72.209999999999994 109.794 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.1 tp -154.09 79.95 4.99 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 108.172 -1.047 . . . . 73.299999999999997 108.172 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.1 149.2 35.94 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.015 2.477 . . . . 75.430000000000007 110.628 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.7 ptm -163.83 162.71 23.83 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.709 1.203 . . . . 64.129999999999995 109.469 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.84 134.26 47.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.544 -0.539 . . . . 73.430000000000007 109.544 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.4 t -164.91 164.03 20.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.329 1.051 . . . . 74.340000000000003 109.197 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.84 61.92 4.9 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.383 -0.687 . . . . 71.349999999999994 111.383 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.81 73.11 69.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.664 1.186 . . . . 65.510000000000005 109.868 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.69 172.4 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.407 2.738 . . . . 74.299999999999997 110.996 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.61 179.29 48.29 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.67 -0.972 . . . . 72.519999999999996 110.67 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.9 165.45 36.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.342 -1.103 . . . . 73.329999999999998 110.342 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.31 83.71 0.05 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.837 -1.305 . . . . 55.409999999999997 109.837 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 m -152.86 89.18 1.37 Allowed 'General case' 0 C--N 1.338 0.074 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -139.7 134.72 32.33 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.668 1.187 . . . . 63.450000000000003 108.357 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -145.21 161.99 38.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.934 0.893 . . . . 74.420000000000002 110.283 -170.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -156.01 148.75 24.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.898 1.279 . . . . 70.019999999999996 108.484 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -142.73 155.19 44.83 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.479 1.112 . . . . 74.540000000000006 109.485 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -165.83 170.21 14.12 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.175 1.39 . . . . 75.329999999999998 108.893 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.127 -1.416 . . . . 72.219999999999999 109.461 173.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 118.651 -0.69 . . . . 70.129999999999995 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -61.78 109.72 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.129 2.553 . . . . 74.319999999999993 110.571 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -79.95 66.08 5.31 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.705 1.202 . . . . 74.230000000000004 109.675 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 72.329999999999998 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 75.209999999999994 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 63.32 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 61.439999999999998 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.319999999999993 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 61.25 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 75.120000000000005 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 75.040000000000006 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.28 70.25 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 74.209999999999994 109.477 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.71 -168.91 54.82 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.13 -0.788 . . . . 50.210000000000001 111.13 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.05 59.42 0.18 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.492 -1.443 . . . . 75.049999999999997 109.492 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.73 131.74 36.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.699 0.8 . . . . 74.25 110.201 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -144.26 139.56 28.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.616 1.566 . . . . 55.109999999999999 107.506 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.0 p 43.13 47.42 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.157 1.383 . . . . 72.450000000000003 110.99 -166.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -164.69 96.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.588 -1.634 . . . . 74.310000000000002 106.588 -171.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -47.09 3.38 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.948 -0.861 . . . . 73.120000000000005 110.948 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.78 136.06 78.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.256 1.022 . . . . 74.319999999999993 110.537 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.16 170.45 20.34 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.058 2.505 . . . . 73.430000000000007 109.866 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.15 70.38 68.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.763 0.825 . . . . 73.310000000000002 110.62 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.14 -162.9 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.572 2.848 . . . . 72.340000000000003 109.498 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 74.430000000000007 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 72.420000000000002 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 63.520000000000003 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 73.230000000000004 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 72.150000000000006 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 73.140000000000001 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 71.010000000000005 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 73.099999999999994 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 73.430000000000007 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 61.240000000000002 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 75.299999999999997 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 75.120000000000005 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 74.430000000000007 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 71.329999999999998 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 74.329999999999998 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 74.5 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 65.239999999999995 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.51 127.49 2.86 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -45.74 -49.49 14.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.761 1.225 . . . . 75.219999999999999 111.834 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -159.66 -66.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.643 1.177 . . . . 74.549999999999997 108.586 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -160.47 95.68 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.518 1.927 . . . . 75.420000000000002 106.084 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.03 170.35 11.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.96 0.409 . . . . 74.319999999999993 111.789 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -80.81 55.32 2.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.01 1.324 . . . . 74.150000000000006 112.068 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.35 -70.08 0.31 Allowed Glycine 0 C--N 1.336 0.568 0 N-CA-C 107.926 -2.07 . . . . 72.299999999999997 107.926 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -71.73 159.65 33.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.325 1.05 . . . . 72.340000000000003 110.221 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt 61.15 44.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.33 1.052 . . . . 74.540000000000006 110.822 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -164.54 147.0 7.13 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.423 1.089 . . . . 75.409999999999997 108.533 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.49 146.77 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.054 2.502 . . . . 75.319999999999993 111.886 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.81 72.46 2.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.196 -1.562 . . . . 73.319999999999993 109.196 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.63 -40.4 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.127 0.971 . . . . 72.329999999999998 111.816 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.4 mm -70.45 115.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.489 -0.93 . . . . 74.129999999999995 108.489 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.87 -171.1 24.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.99 1.281 . . . . 71.239999999999995 110.231 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.61 53.66 0.1 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.519 -1.032 . . . . 75.299999999999997 110.519 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -72.78 145.33 47.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.661 0.784 . . . . 63.530000000000001 110.467 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -126.1 74.46 72.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.681 1.192 . . . . 73.219999999999999 108.863 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.3 -24.46 19.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.919 2.412 . . . . 72.420000000000002 111.364 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -143.44 144.25 31.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.132 1.773 . . . . 73.329999999999998 106.56 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.42 135.15 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.727 1.211 . . . . 73.349999999999994 109.906 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.11 167.35 10.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.739 1.216 . . . . 75.540000000000006 110.593 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -155.06 147.74 17.86 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.639 1.176 . . . . 55.229999999999997 108.416 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.03 -19.22 62.17 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.288 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -57.1 -26.63 60.77 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.412 0.685 . . . . 73.040000000000006 111.708 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 74.120000000000005 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 75.430000000000007 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 74.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 73.230000000000004 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 75.109999999999999 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 71.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 64.140000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 75.530000000000001 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 72.409999999999997 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 75.200000000000003 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 73.310000000000002 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 62.409999999999997 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 71.25 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 73.109999999999999 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 70.299999999999997 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 72.109999999999999 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 74.329999999999998 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 74.439999999999998 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 74.230000000000004 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 75.439999999999998 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 73.230000000000004 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p -61.78 -31.53 71.74 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 52.130000000000003 111.658 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -70.3 -72.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.427 0.558 . . . . 65.319999999999993 109.815 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.73 87.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.889 1.276 . . . . 74.400000000000006 108.804 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -77.79 156.65 30.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.969 0.908 . . . . 74.450000000000003 110.68 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -135.65 69.28 66.48 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.616 1.167 . . . . 74.420000000000002 109.095 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.2 154.89 61.67 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.224 2.616 . . . . 71.099999999999994 110.517 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -108.97 150.4 27.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.48 1.112 . . . . 74.439999999999998 110.156 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -69.49 155.15 40.93 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.476 0.71 . . . . 74.540000000000006 110.859 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.65 84.63 19.88 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.283 1.433 . . . . 71.540000000000006 107.621 173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.36 143.39 31.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.752 2.301 . . . . 65.430000000000007 110.612 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.3 ttt -90.59 118.79 30.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.035 0.934 . . . . 73.510000000000005 109.263 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.23 147.57 32.54 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.324 0.65 . . . . 73.030000000000001 109.547 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 m -148.43 156.71 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.608 1.163 . . . . 73.310000000000002 109.528 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.43 166.55 39.75 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.477 -1.049 . . . . 74.319999999999993 110.477 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.1 140.99 73.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.334 0.654 . . . . 74.200000000000003 110.162 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.84 161.69 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.274 2.65 . . . . 71.239999999999995 110.818 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.08 176.98 45.91 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.111 -0.795 . . . . 72.230000000000004 111.111 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.58 -174.9 47.04 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.256 -1.138 . . . . 63.420000000000002 110.256 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.75 163.96 35.29 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.462 -1.055 . . . . 64.120000000000005 110.462 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.4 m -159.56 98.97 1.41 Allowed 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 106.815 -1.55 . . . . 74.430000000000007 106.815 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -136.05 140.74 44.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.153 0.981 . . . . 74.25 109.129 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -147.97 164.49 33.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.492 1.117 . . . . 75.010000000000005 109.26 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -144.11 152.39 40.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.388 1.075 . . . . 74.010000000000005 108.987 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -71.13 163.35 27.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.177 0.591 . . . . 70.019999999999996 111.189 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -76.96 93.99 3.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.022 . . . . 73.409999999999997 108.239 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 117.673 -1.156 . . . . 74.310000000000002 110.684 175.44 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 119.315 -0.374 . . . . 74.400000000000006 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.4 162.59 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.775 2.317 . . . . 75.129999999999995 110.797 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -154.78 -58.51 0.11 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.96 0.904 . . . . 73.319999999999993 109.007 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 75.219999999999999 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 73.099999999999994 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 62.119999999999997 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 74.150000000000006 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.450000000000003 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -115.19 112.57 22.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 71.439999999999998 108.522 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.48 -70.25 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.388 -1.485 . . . . 53.530000000000001 109.388 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.01 86.37 0.12 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.12 -1.192 . . . . 73.010000000000005 110.12 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.19 -179.08 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.037 0.935 . . . . 74.209999999999994 109.493 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -73.83 -80.08 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.382 0.673 . . . . 74.0 109.227 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.51 62.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 105.589 -2.004 . . . . 73.030000000000001 105.589 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.59 49.74 15.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.177 0.991 . . . . 74.430000000000007 109.352 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.46 165.95 40.3 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.325 -1.11 . . . . 52.109999999999999 110.325 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -169.08 136.6 1.55 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.426 -0.953 . . . . 75.329999999999998 108.426 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.62 147.45 57.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.763 2.308 . . . . 73.319999999999993 109.351 171.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.86 81.48 5.95 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.621 0.768 . . . . 72.019999999999996 111.626 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.14 -171.88 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.021 2.481 . . . . 62.109999999999999 108.586 159.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 75.450000000000003 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 71.040000000000006 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 72.219999999999999 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 74.030000000000001 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 74.239999999999995 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 53.399999999999999 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 74.109999999999999 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 53.229999999999997 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 74.420000000000002 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 73.120000000000005 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 73.239999999999995 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 62.5 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 74.340000000000003 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 71.400000000000006 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 74.340000000000003 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 52.130000000000003 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 64.010000000000005 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 72.120000000000005 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 64.319999999999993 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 63.340000000000003 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 74.239999999999995 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 163.32 11.2 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -74.81 -25.94 59.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.996 1.318 . . . . 75.329999999999998 109.582 163.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 78.87 115.27 0.06 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.063 1.745 . . . . 72.109999999999999 111.113 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 51.0 75.4 0.19 Allowed 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.83 1.252 . . . . 71.430000000000007 108.983 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -93.33 -172.05 2.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.111 -0.949 . . . . 72.540000000000006 110.374 -161.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.6 p -51.08 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.328 1.851 . . . . 73.25 112.461 -169.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.39 47.05 28.85 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.953 1.263 . . . . 74.439999999999998 112.052 -172.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -158.37 173.17 17.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.672 0.736 . . . . 64.120000000000005 111.095 -170.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mt 57.34 51.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.369 1.468 . . . . 70.209999999999994 109.715 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.88 67.57 22.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.616 1.566 . . . . 74.030000000000001 108.454 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.8 79.42 3.24 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.318 2.679 . . . . 73.209999999999994 110.342 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.45 60.28 0.18 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.757 -0.937 . . . . 75.030000000000001 110.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -84.91 53.37 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.094 0.958 . . . . 72.319999999999993 110.426 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.3 mt -77.91 132.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.306 -0.998 . . . . 73.230000000000004 108.306 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.89 167.95 53.9 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.555 0.597 . . . . 74.129999999999995 112.231 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.88 -144.5 5.37 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.983 0.801 . . . . 71.150000000000006 111.221 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.4 p -137.82 129.98 29.01 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.601 1.16 . . . . 72.540000000000006 109.502 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -74.04 150.07 87.75 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.818 0.847 . . . . 74.230000000000004 109.403 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.59 164.02 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.41 2.74 . . . . 74.120000000000005 110.87 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -159.19 113.72 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.355 -0.98 . . . . 65.340000000000003 108.355 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.26 135.32 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.164 0.586 . . . . 73.239999999999995 109.92 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.51 158.31 16.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.149 0.979 . . . . 73.430000000000007 110.18 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.4 p 45.75 52.37 10.91 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.98 1.712 . . . . 73.010000000000005 113.939 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.17 -59.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.474 2.116 . . . . 73.530000000000001 111.267 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -66.02 -24.01 66.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.779 0.831 . . . . 74.120000000000005 111.755 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.420000000000002 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 74.109999999999999 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 72.25 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 73.400000000000006 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 75.219999999999999 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 73.439999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 74.239999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 74.140000000000001 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 52.119999999999997 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 73.230000000000004 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 65.129999999999995 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 74.420000000000002 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 75.439999999999998 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 74.329999999999998 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 73.430000000000007 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 74.209999999999994 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 75.450000000000003 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 71.230000000000004 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 61.310000000000002 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 73.5 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 72.310000000000002 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 73.109999999999999 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.420000000000002 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 64.109999999999999 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 72.5 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.430000000000007 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 73.409999999999997 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 71.219999999999999 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 74.129999999999995 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 74.519999999999996 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 74.25 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p -56.86 -27.62 60.64 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.31 -64.05 0.97 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.429 0.558 . . . . 75.099999999999994 109.856 166.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.03 96.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.005 1.322 . . . . 74.140000000000001 108.027 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.07 39.03 0.55 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.225 1.41 . . . . 73.299999999999997 113.166 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.27 115.3 65.52 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 118.73 -0.653 . . . . 74.430000000000007 109.3 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.66 121.63 6.83 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.708 1.605 . . . . 74.209999999999994 108.553 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.98 71.15 10.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 109.637 -169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.42 147.95 7.8 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.581 1.153 . . . . 74.140000000000001 109.722 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 tp -155.5 89.18 2.99 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.101 -1.074 . . . . 74.239999999999995 108.101 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.11 68.8 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.517 2.811 . . . . 72.230000000000004 109.52 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 57.3 ttm -155.59 148.98 24.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.031 0.933 . . . . 73.219999999999999 109.074 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.87 152.91 28.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.38 1.072 . . . . 54.210000000000001 109.272 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 90.6 p -146.67 36.62 0.97 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.777 0.831 . . . . 71.140000000000001 110.135 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.55 71.23 2.49 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.99 0.805 . . . . 62.229999999999997 111.146 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.04 67.78 10.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.599 0.76 . . . . 63.140000000000001 110.666 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.77 167.56 25.13 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.26 2.64 . . . . 72.239999999999995 110.512 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.14 157.35 15.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.49 -1.044 . . . . 64.430000000000007 110.49 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 167.09 173.36 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.063 -0.815 . . . . 60.420000000000002 111.063 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.53 152.65 9.89 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.876 -1.289 . . . . 72.299999999999997 109.876 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.9 p -164.7 130.44 2.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.641 0.776 . . . . 75.299999999999997 109.422 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -164.48 155.89 15.61 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.577 1.151 . . . . 75.230000000000004 109.199 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -165.77 170.07 14.37 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.518 1.127 . . . . 74.409999999999997 109.484 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -159.97 155.51 25.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.247 1.019 . . . . 71.319999999999993 109.416 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -150.7 153.86 36.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.457 1.103 . . . . 71.310000000000002 108.542 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -74.47 -168.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.48 1.112 . . . . 63.450000000000003 110.486 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.728 -1.129 . . . . 73.340000000000003 108.996 175.577 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.02 -0.514 . . . . 75.510000000000005 110.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.96 73.05 6.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.203 2.602 . . . . 63.32 110.081 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -64.46 -61.08 2.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.086 0.955 . . . . 75.150000000000006 110.569 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 54.530000000000001 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.450000000000003 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 75.540000000000006 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 71.420000000000002 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt -154.71 145.04 22.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 73.430000000000007 108.852 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.33 141.67 8.82 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.113 -1.595 . . . . 54.299999999999997 109.113 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.47 179.62 19.45 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.41 1.005 . . . . 74.099999999999994 110.86 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 -177.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.432 1.493 . . . . 52.229999999999997 112.667 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -77.7 117.99 19.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.489 0.716 . . . . 73.299999999999997 109.334 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.7 t -140.08 -81.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.171 -1.418 . . . . 73.120000000000005 107.171 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -147.8 140.57 24.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.975 1.31 . . . . 70.540000000000006 107.846 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -8.69 53.22 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.268 -0.74 . . . . 73.109999999999999 111.931 -167.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -127.45 62.98 57.16 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.139 1.376 . . . . 74.140000000000001 109.077 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.08 139.23 35.26 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.402 2.068 . . . . 74.319999999999993 109.853 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 tp -156.42 -67.93 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 117.805 -1.093 . . . . 74.540000000000006 110.116 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -79.98 -159.37 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.736 2.291 . . . . 72.329999999999998 110.389 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 74.25 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 75.439999999999998 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.540000000000006 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 73.209999999999994 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 73.019999999999996 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 72.420000000000002 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 74.329999999999998 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 71.209999999999994 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.230000000000004 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 73.040000000000006 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 75.209999999999994 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 75.400000000000006 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.549999999999997 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 73.519999999999996 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 75.450000000000003 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 75.5 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 54.399999999999999 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 75.549999999999997 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 75.150000000000006 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 75.420000000000002 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.519999999999996 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 75.0 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 65.150000000000006 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.19 74.23 0.11 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 72.400000000000006 111.431 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -41.04 61.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.947 0.499 . . . . 73.030000000000001 110.199 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -74.4 0.54 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.154 0.982 . . . . 74.129999999999995 109.1 169.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -164.14 36.34 0.08 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.593 1.557 . . . . 75.0 109.76 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 51.54 -141.97 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.12 1.368 . . . . 71.310000000000002 109.104 -165.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.1 p -106.95 28.77 7.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.568 0.747 . . . . 72.230000000000004 109.586 165.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.07 -126.75 5.92 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.392 -1.083 . . . . 75.400000000000006 110.392 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -151.24 47.07 0.83 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.325 1.05 . . . . 75.209999999999994 109.231 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.7 mt -86.94 56.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.098 . . . . 73.0 108.404 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -140.84 71.54 29.49 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.783 1.233 . . . . 75.0 109.153 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.72 159.81 44.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.238 2.625 . . . . 72.140000000000001 110.871 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.93 -157.62 13.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.947 -1.261 . . . . 42.409999999999997 109.947 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.65 123.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 125.065 1.346 . . . . 73.230000000000004 107.9 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.48 127.36 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.387 -0.968 . . . . 70.430000000000007 108.387 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.57 -165.44 50.03 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.768 0.699 . . . . 61.009999999999998 112.414 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.19 171.53 44.61 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.945 -1.262 . . . . 62.149999999999999 109.945 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.1 p -74.18 144.72 44.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.421 0.688 . . . . 73.450000000000003 110.761 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -152.58 77.87 6.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.259 1.024 . . . . 75.230000000000004 108.53 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.75 161.2 33.83 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.931 2.421 . . . . 71.329999999999998 110.986 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -158.79 92.34 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.447 -1.316 . . . . 73.510000000000005 107.447 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.74 137.65 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.766 1.226 . . . . 73.420000000000002 108.632 -174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 168.93 14.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 53.100000000000001 111.173 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.2 t -119.17 142.91 33.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.122 1.369 . . . . 74.299999999999997 108.607 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.23 -15.98 51.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.994 2.462 . . . . 73.299999999999997 112.834 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -58.93 -28.95 66.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.536 0.607 . . . . 64.510000000000005 111.753 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 74.219999999999999 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 71.140000000000001 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 75.120000000000005 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.299999999999997 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 73.150000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 63.520000000000003 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 75.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 75.209999999999994 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.109999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 71.040000000000006 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 75.120000000000005 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.530000000000001 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 74.109999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 72.510000000000005 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 73.439999999999998 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.349999999999994 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 75.109999999999999 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 63.439999999999998 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 65.239999999999995 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 74.019999999999996 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 73.349999999999994 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 75.450000000000003 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 75.299999999999997 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.510000000000005 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p -66.73 -18.89 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 73.150000000000006 112.661 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -94.27 -76.29 0.49 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.131 0.973 . . . . 72.439999999999998 108.94 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.6 p -167.08 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.048 0.939 . . . . 62.43 110.006 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -99.09 89.42 4.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.398 1.079 . . . . 74.420000000000002 108.193 167.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -128.13 77.43 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.052 1.341 . . . . 70.239999999999995 108.469 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.28 166.11 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.195 2.597 . . . . 73.219999999999999 110.98 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -68.98 159.76 32.17 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.646 0.779 . . . . 73.540000000000006 111.309 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -152.93 153.92 33.98 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 73.209999999999994 108.971 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.47 97.19 15.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.954 1.302 . . . . 64.140000000000001 107.988 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.26 176.67 9.81 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.859 2.373 . . . . 75.340000000000003 110.756 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.846 1.258 . . . . 71.340000000000003 108.061 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -145.83 163.51 34.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 74.109999999999999 109.408 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.5 m -151.33 161.36 42.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.547 1.139 . . . . 63.310000000000002 109.683 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.49 -162.87 25.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.412 -1.075 . . . . 61.200000000000003 110.412 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.89 150.86 23.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.548 1.139 . . . . 71.439999999999998 108.855 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.25 164.87 34.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.093 2.529 . . . . 54.329999999999998 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -87.97 -161.36 36.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.857 0.742 . . . . 65.0 111.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.49 -178.16 41.71 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.479 -1.049 . . . . 71.209999999999994 110.479 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.67 174.65 46.71 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.08 -1.208 . . . . 75.219999999999999 110.08 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.1 t -161.19 162.3 31.21 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 109.617 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.25 -61.72 0.16 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.4 1.08 . . . . 73.5 108.681 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 78.4 m80 56.52 74.15 0.41 Allowed 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.48 1.112 . . . . 75.329999999999998 109.375 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -63.81 150.79 43.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.564 0.746 . . . . 75.040000000000006 110.518 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -131.65 168.75 17.19 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.566 1.146 . . . . 75.439999999999998 110.03 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -138.18 170.42 16.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.921 1.288 . . . . 75.329999999999998 109.547 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.927 -1.511 . . . . 74.420000000000002 110.49 174.177 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.112 -0.471 . . . . 64.439999999999998 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.19 135.94 30.65 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.92 2.413 . . . . 74.230000000000004 109.935 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -137.58 162.69 33.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.781 1.232 . . . . 75.239999999999995 109.265 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 71.439999999999998 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 73.340000000000003 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.439999999999998 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 74.450000000000003 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 74.129999999999995 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp 57.94 71.0 0.61 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 71.329999999999998 110.35 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.47 62.52 4.31 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.982 0.801 . . . . 73.0 111.294 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.46 44.53 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.782 -0.927 . . . . 73.299999999999997 110.782 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.07 67.15 9.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.109 0.964 . . . . 74.540000000000006 109.547 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -153.72 116.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.849 1.26 . . . . 71.409999999999997 109.095 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.17 162.0 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.161 1.384 . . . . 75.510000000000005 108.111 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.72 101.19 0.13 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.505 0.722 . . . . 74.209999999999994 109.685 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.53 -40.72 1.08 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.633 -1.387 . . . . 62.43 109.633 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -68.07 150.04 97.92 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.085 0.954 . . . . 75.109999999999999 110.189 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.07 166.51 27.73 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.314 2.676 . . . . 72.510000000000005 110.367 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.35 70.4 4.3 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.385 1.074 . . . . 75.209999999999994 110.342 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.27 -172.41 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.689 2.26 . . . . 64.019999999999996 109.396 170.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 73.319999999999993 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 74.239999999999995 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 64.140000000000001 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.319999999999993 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 74.200000000000003 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 74.409999999999997 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 73.439999999999998 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 72.019999999999996 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 73.519999999999996 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 72.040000000000006 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.319999999999993 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.420000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 48.34 26.01 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 60.340000000000003 111.678 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.91 -18.26 8.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.057 1.343 . . . . 74.319999999999993 114.392 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.75 -24.32 67.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.05 0.94 . . . . 74.140000000000001 111.859 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -123.21 -46.35 2.06 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.794 1.238 . . . . 72.450000000000003 110.243 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 72.09 149.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.858 2.063 . . . . 74.450000000000003 111.583 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.2 p -55.57 -36.94 67.4 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.696 1.198 . . . . 62.229999999999997 111.611 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.19 65.94 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 119.148 -0.807 . . . . 74.230000000000004 113.697 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 p -148.8 71.86 1.16 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.471 1.135 . . . . 73.530000000000001 110.128 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 mm -77.27 72.71 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.313 1.045 . . . . 75.420000000000002 108.196 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 49.3 63.78 9.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.586 1.555 . . . . 75.129999999999995 112.033 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.2 72.75 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.474 2.783 . . . . 75.129999999999995 110.512 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.73 5.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.549 -1.02 . . . . 72.239999999999995 110.549 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.32 -54.59 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.852 1.261 . . . . 71.319999999999993 110.609 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.7 mt 60.61 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.723 2.409 . . . . 75.310000000000002 113.186 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.1 -156.52 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 72.340000000000003 110.371 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.62 67.07 1.82 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.401 -1.08 . . . . 72.219999999999999 110.401 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -145.88 105.97 4.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.222 1.009 . . . . 70.019999999999996 109.273 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -132.92 74.67 73.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.552 1.141 . . . . 74.109999999999999 109.141 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.08 178.41 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.267 2.645 . . . . 60.240000000000002 110.497 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.47 132.59 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.418 -0.956 . . . . 71.450000000000003 108.418 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 154.79 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.423 1.089 . . . . 71.420000000000002 109.947 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 153.45 42.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.638 0.775 . . . . 71.230000000000004 109.966 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -154.83 141.52 13.3 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.453 -0.573 . . . . 74.219999999999999 109.453 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.63 -18.42 53.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.646 2.23 . . . . 71.349999999999994 111.378 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -13.5 33.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.875 0.87 . . . . 74.329999999999998 112.618 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 70.439999999999998 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 73.329999999999998 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 73.109999999999999 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 73.409999999999997 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 74.120000000000005 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 61.25 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 74.230000000000004 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 74.239999999999995 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 73.299999999999997 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 74.310000000000002 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 74.209999999999994 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 74.209999999999994 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 61.530000000000001 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 75.140000000000001 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 60.340000000000003 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 73.340000000000003 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 45.329999999999998 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 73.200000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 65.409999999999997 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 75.040000000000006 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 75.010000000000005 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 74.219999999999999 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 73.219999999999999 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 74.120000000000005 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 74.129999999999995 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p -59.51 -35.73 74.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -69.5 -65.85 0.66 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.161 0.437 . . . . 74.439999999999998 110.529 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.33 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.866 1.266 . . . . 73.510000000000005 108.368 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.23 155.36 17.53 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.2 1.0 . . . . 74.409999999999997 109.878 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -137.05 71.05 56.01 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.475 1.11 . . . . 75.430000000000007 109.195 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -71.64 154.28 59.65 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.092 2.528 . . . . 75.430000000000007 110.625 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -64.89 -49.82 68.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.657 0.783 . . . . 65.219999999999999 110.588 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.59 164.26 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.693 1.597 . . . . 54.5 111.745 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.92 150.36 95.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.032 -0.729 . . . . 74.349999999999994 109.032 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 139.33 53.41 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.026 2.484 . . . . 64.25 110.327 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.03 69.79 9.9 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.011 0.925 . . . . 73.230000000000004 109.293 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -69.19 155.13 40.91 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.79 0.836 . . . . 53.43 110.318 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.0 t -158.93 178.1 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.918 0.887 . . . . 73.340000000000003 109.964 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.24 164.21 39.85 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.525 1.06 . . . . 74.099999999999994 111.46 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.04 149.38 12.91 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.295 1.038 . . . . 73.439999999999998 109.164 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.31 178.26 7.73 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.585 2.857 . . . . 73.329999999999998 110.725 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.96 175.76 44.56 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.829 -0.908 . . . . 54.43 110.829 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.68 -178.66 48.71 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.218 -1.153 . . . . 44.009999999999998 110.218 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.2 -164.6 37.93 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.594 -1.003 . . . . 72.439999999999998 110.594 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 t 58.26 58.76 3.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.994 1.318 . . . . 75.0 111.297 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -133.5 70.09 1.47 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.67 1.188 . . . . 74.400000000000006 108.18 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -162.41 152.64 16.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.305 1.042 . . . . 75.049999999999997 109.542 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -150.71 151.49 32.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.522 1.129 . . . . 74.540000000000006 108.885 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.12 99.59 2.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.386 1.074 . . . . 75.200000000000003 108.282 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.62 132.58 45.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.19 -1.041 . . . . 75.099999999999994 108.19 167.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.8 m80 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 107.589 -1.263 . . . . 73.519999999999996 107.589 175.059 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 119.088 -0.482 . . . . 73.129999999999995 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -70.51 154.44 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.034 2.489 . . . . 73.099999999999994 110.39 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -158.84 -171.85 3.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.221 1.009 . . . . 71.519999999999996 109.29 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 73.209999999999994 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 64.219999999999999 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 72.209999999999994 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 75.209999999999994 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.29 61.77 6.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.9 -107.54 1.35 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.492 1.044 . . . . 64.200000000000003 111.283 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.24 71.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.467 -1.453 . . . . 74.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 167.36 15.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.327 1.051 . . . . 74.319999999999993 112.572 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -73.72 125.46 28.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.769 0.828 . . . . 74.530000000000001 108.898 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.7 t -71.38 -35.55 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.23 0.612 . . . . 74.019999999999996 111.55 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 64.25 77.3 0.32 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.994 1.318 . . . . 63.350000000000001 108.486 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.16 -41.46 0.64 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.296 -1.922 . . . . 73.400000000000006 108.296 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -54.79 153.19 11.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.62 1.168 . . . . 72.430000000000007 110.851 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.24 160.25 42.59 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.902 2.401 . . . . 63.409999999999997 110.152 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -119.45 70.64 12.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 75.439999999999998 110.449 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.03 -165.34 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.066 2.51 . . . . 73.340000000000003 109.844 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 65.329999999999998 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 61.130000000000003 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 75.230000000000004 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 74.409999999999997 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 62.100000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 74.140000000000001 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 74.239999999999995 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 74.319999999999993 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 64.219999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 75.319999999999993 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 74.329999999999998 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 72.439999999999998 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 74.219999999999999 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 75.239999999999995 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 74.5 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.450000000000003 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.319999999999993 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.49 80.64 0.33 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.73 -31.95 73.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.23 0.612 . . . . 74.25 109.652 173.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 78.11 -66.84 0.2 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 127.094 2.158 . . . . 71.209999999999994 109.764 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -110.14 69.59 0.7 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.156 0.983 . . . . 74.310000000000002 108.496 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -67.03 179.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.08 -1.082 . . . . 75.239999999999995 108.08 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -52.75 -30.99 35.8 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.536 -0.727 . . . . 74.450000000000003 111.232 167.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.8 -122.94 1.32 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.456 -1.058 . . . . 53.140000000000001 110.456 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.0 t -164.93 90.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.698 0.799 . . . . 72.209999999999994 109.659 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.12 -1.437 . . . . 72.109999999999999 107.12 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -132.89 66.59 76.62 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.529 0.732 . . . . 70.519999999999996 110.857 -167.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.62 117.24 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.276 2.651 . . . . 73.010000000000005 110.527 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.01 0.22 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.761 -0.936 . . . . 71.239999999999995 110.761 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.88 56.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.272 1.029 . . . . 60.119999999999997 110.608 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.69 129.54 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.081 0.952 . . . . 72.400000000000006 109.005 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.01 -178.96 43.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.899 -0.88 . . . . 74.209999999999994 110.899 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.24 115.09 3.39 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.584 1.088 . . . . 74.200000000000003 111.084 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -160.67 167.49 26.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.542 1.137 . . . . 72.549999999999997 109.773 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.36 75.05 5.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.883 0.873 . . . . 73.439999999999998 109.243 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.52 178.23 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.571 2.847 . . . . 70.519999999999996 111.527 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -142.99 146.98 34.4 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.475 1.91 . . . . 74.219999999999999 106.483 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -86.43 141.66 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.86 1.264 . . . . 62.409999999999997 110.801 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.59 138.19 31.69 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.31 1.044 . . . . 74.340000000000003 108.806 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 t -156.45 143.86 13.85 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.337 -0.616 . . . . 75.349999999999994 109.337 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.35 -12.77 30.14 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.845 2.363 . . . . 73.299999999999997 111.891 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -53.78 -22.29 9.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.653 1.581 . . . . 75.219999999999999 112.93 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 72.519999999999996 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 74.340000000000003 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 74.010000000000005 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 73.439999999999998 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 74.530000000000001 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 73.230000000000004 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.439999999999998 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 74.420000000000002 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 73.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 60.329999999999998 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 75.439999999999998 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 70.420000000000002 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 75.200000000000003 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 75.040000000000006 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 64.0 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 73.219999999999999 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 74.219999999999999 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 72.120000000000005 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 74.129999999999995 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 75.319999999999993 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 72.430000000000007 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 74.439999999999998 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 74.5 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 74.230000000000004 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p -61.19 -27.89 68.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -67.53 -71.99 0.19 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.784 0.72 . . . . 75.430000000000007 109.558 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.2 t -144.52 89.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.594 1.157 . . . . 71.400000000000006 108.658 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 148.62 41.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.501 0.721 . . . . 70.049999999999997 111.118 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -115.62 93.39 36.81 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.389 1.476 . . . . 74.340000000000003 107.574 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.25 155.85 14.6 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.059 2.506 . . . . 74.329999999999998 110.979 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.08 123.03 29.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.483 -0.932 . . . . 73.239999999999995 108.483 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -151.82 147.72 26.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.729 0.812 . . . . 74.120000000000005 109.712 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.4 tp -151.99 127.83 5.05 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.474 -1.306 . . . . 73.409999999999997 107.474 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.11 163.88 35.64 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.991 2.461 . . . . 65.530000000000001 110.889 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.8 ttm -153.74 145.26 23.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.995 0.918 . . . . 71.5 108.987 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -148.01 160.7 42.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.567 1.547 . . . . 75.150000000000006 108.429 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t -158.54 144.35 16.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.651 0.78 . . . . 74.140000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.46 152.2 10.13 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.591 -1.404 . . . . 54.350000000000001 109.591 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.99 149.51 11.74 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.842 . . . . 74.439999999999998 109.366 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.2 172.59 16.06 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.387 2.725 . . . . 73.519999999999996 110.505 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.67 164.84 37.65 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.688 -0.965 . . . . 73.239999999999995 110.688 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.44 39.46 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.068 -1.213 . . . . 64.329999999999998 110.068 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.36 173.78 40.63 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.991 -0.843 . . . . 72.030000000000001 110.991 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 76.0 p -163.97 170.07 17.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.107 1.363 . . . . 74.209999999999994 108.874 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -151.13 155.03 38.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.699 0.8 . . . . 73.450000000000003 109.275 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.33 171.65 14.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.114 0.966 . . . . 61.409999999999997 111.252 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -154.95 121.57 5.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.13 0.972 . . . . 74.409999999999997 108.615 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.37 113.83 10.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.407 -0.96 . . . . 75.400000000000006 108.407 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -62.27 162.93 9.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.846 0.858 . . . . 73.040000000000006 111.946 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.037 -1.459 . . . . 74.430000000000007 110.184 171.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.393 -0.336 . . . . 72.530000000000001 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.7 142.5 35.96 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.588 2.192 . . . . 73.239999999999995 110.05 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -162.9 161.79 25.98 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.263 1.025 . . . . 63.219999999999999 109.569 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 75.109999999999999 109.657 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 74.349999999999994 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 73.0 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 74.349999999999994 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -162.95 161.1 25.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 72.319999999999993 109.998 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.5 -171.43 41.45 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.845 -0.902 . . . . 54.409999999999997 110.845 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.1 110.72 0.9 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.96 0.79 . . . . 55.350000000000001 111.533 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.25 62.14 7.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.837 0.855 . . . . 75.239999999999995 109.982 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -87.22 142.65 27.75 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.701 0.8 . . . . 73.549999999999997 109.877 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.0 t 70.39 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.144 2.177 . . . . 72.040000000000006 112.833 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.78 65.57 1.48 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.581 1.553 . . . . 71.239999999999995 110.921 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.33 71.15 0.49 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 108.865 -1.694 . . . . 63.119999999999997 108.865 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.16 58.61 9.29 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.785 0.661 . . . . 71.209999999999994 112.785 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.69 67.4 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.679 2.92 . . . . 73.219999999999999 109.732 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.65 164.94 18.36 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 126.153 1.781 . . . . 64.140000000000001 108.26 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.16 -153.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.106 2.537 . . . . 74.230000000000004 111.426 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 71.140000000000001 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 74.010000000000005 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.540000000000006 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.209999999999994 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 74.340000000000003 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 72.420000000000002 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 74.420000000000002 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 75.420000000000002 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 65.409999999999997 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 72.150000000000006 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 75.310000000000002 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 75.129999999999995 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 74.0 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.37 108.14 1.05 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -53.57 -47.12 70.38 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.212 0.605 . . . . 73.430000000000007 111.406 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -141.52 -55.9 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.295 1.038 . . . . 75.25 110.365 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -139.42 -61.27 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.339 1.056 . . . . 74.409999999999997 111.703 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 102.85 178.3 0.0 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.957 3.303 . . . . 73.430000000000007 109.553 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -66.64 -66.97 0.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.986 -0.746 . . . . 51.409999999999997 108.986 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -125.62 32.42 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.15 -1.18 . . . . 63.100000000000001 110.15 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t -130.15 56.19 1.76 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.238 -1.393 . . . . 71.5 107.238 155.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.06 27.62 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.744 1.618 . . . . 73.430000000000007 108.307 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -139.35 66.5 37.01 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.039 -166.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.01 83.16 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.857 3.038 . . . . 75.510000000000005 110.026 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.12 4.91 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.841 0.734 . . . . 63.0 111.753 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -85.76 55.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.128 0.971 . . . . 75.230000000000004 110.167 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.9 mt -85.3 135.38 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.396 1.078 . . . . 75.019999999999996 109.404 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 -69.62 2.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.087 0.851 . . . . 70.120000000000005 111.633 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.66 -71.81 2.49 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.339 -1.105 . . . . 74.140000000000001 110.339 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.6 p -160.63 165.36 30.78 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.762 1.225 . . . . 64.329999999999998 109.287 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -155.49 75.44 5.16 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.927 0.891 . . . . 74.450000000000003 108.771 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.07 158.42 45.7 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.119 2.546 . . . . 70.310000000000002 110.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -133.55 92.98 3.06 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.24 1.416 . . . . 75.209999999999994 108.681 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.37 135.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.59 0.756 . . . . 74.150000000000006 109.255 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.28 157.22 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.361 1.064 . . . . 61.0 110.841 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 t -128.09 99.53 24.98 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.997 1.319 . . . . 73.530000000000001 108.341 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -74.42 -28.59 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.086 2.524 . . . . 74.310000000000002 112.285 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.0 -22.24 48.58 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.439 0.696 . . . . 72.319999999999993 112.491 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 74.140000000000001 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 74.400000000000006 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.120000000000005 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 63.5 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 74.439999999999998 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 65.540000000000006 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 61.109999999999999 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 71.140000000000001 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 65.140000000000001 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 74.209999999999994 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 73.430000000000007 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 73.329999999999998 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 73.340000000000003 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 62.210000000000001 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 75.209999999999994 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 44.030000000000001 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.510000000000005 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.43 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 75.310000000000002 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 72.150000000000006 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 72.030000000000001 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 71.430000000000007 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 72.549999999999997 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 75.519999999999996 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 75.209999999999994 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 74.439999999999998 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p -60.77 -27.74 68.21 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 75.120000000000005 112.598 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.32 -50.9 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.737 0.699 . . . . 74.319999999999993 110.288 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 p -159.09 114.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.0 0.92 . . . . 74.310000000000002 109.299 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -139.36 153.65 47.72 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.7 1.6 . . . . 74.25 110.461 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -136.65 70.45 59.17 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.98 1.312 . . . . 73.209999999999994 108.268 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.47 166.91 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.549 2.833 . . . . 72.349999999999994 111.46 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 61.53 32.67 18.71 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.325 1.45 . . . . 74.430000000000007 112.151 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -76.77 137.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.535 0.734 . . . . 70.230000000000004 109.888 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 tp -163.34 127.32 1.87 Allowed Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.303 -1.369 . . . . 74.299999999999997 107.303 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.28 146.08 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.565 2.176 . . . . 63.119999999999997 109.834 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mtp -81.91 69.18 8.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.336 -0.616 . . . . 71.439999999999998 109.336 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -76.02 75.77 2.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.058 0.943 . . . . 75.239999999999995 109.027 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.6 p -151.4 76.83 1.23 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.332 1.053 . . . . 73.299999999999997 109.315 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.5 78.28 0.23 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.414 -1.474 . . . . 65.299999999999997 109.414 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.16 76.08 15.73 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.788 1.235 . . . . 74.439999999999998 109.536 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.8 170.17 20.27 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.029 2.486 . . . . 73.049999999999997 110.552 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.46 167.38 40.52 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.081 -1.207 . . . . 73.400000000000006 110.081 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 174.92 -177.21 47.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.349 -1.1 . . . . 72.239999999999995 110.349 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.88 167.9 40.28 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.289 -1.124 . . . . 71.129999999999995 110.289 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.3 p -162.65 168.29 21.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.371 1.068 . . . . 71.439999999999998 109.248 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -158.33 163.29 37.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.279 1.032 . . . . 73.25 109.22 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -164.95 174.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.605 1.162 . . . . 71.219999999999999 109.001 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -147.89 116.52 6.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.33 -1.359 . . . . 74.040000000000006 107.33 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -69.71 162.68 27.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.059 0.457 . . . . 74.329999999999998 111.368 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -64.9 -41.87 95.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.524 0.729 . . . . 64.340000000000003 110.167 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.804 -1.57 . . . . 73.239999999999995 110.745 176.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 117.905 -1.045 . . . . 73.019999999999996 112.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.54 -41.66 6.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.084 1.856 . . . . 72.519999999999996 111.684 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.5 64.22 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.959 1.304 . . . . 75.420000000000002 110.586 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 62.530000000000001 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 72.319999999999993 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 74.319999999999993 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.87 -7.16 0.38 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.8 -105.67 1.32 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.418 -1.073 . . . . 63.25 110.418 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.71 67.75 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.882 0.753 . . . . 54.310000000000002 111.295 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.49 173.32 16.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.723 0.809 . . . . 75.319999999999993 110.5 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -71.44 144.97 49.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.213 0.605 . . . . 74.030000000000001 109.82 173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -128.69 137.56 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.459 -1.311 . . . . 74.299999999999997 107.459 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -71.44 78.09 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.079 0.951 . . . . 73.219999999999999 109.323 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.31 -25.97 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.051 -0.86 . . . . 72.019999999999996 112.314 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.5 148.01 96.9 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 118.564 1.182 . . . . 75.150000000000006 111.035 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.17 171.25 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.225 2.617 . . . . 72.230000000000004 110.904 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.47 71.74 3.45 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.609 1.164 . . . . 75.230000000000004 110.648 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.23 -164.67 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.053 2.502 . . . . 63.0 109.754 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 74.329999999999998 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 64.140000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 75.319999999999993 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 73.400000000000006 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.5 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 71.310000000000002 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 75.340000000000003 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 73.030000000000001 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 74.430000000000007 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 73.310000000000002 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 72.329999999999998 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 74.430000000000007 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 74.439999999999998 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 75.349999999999994 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 74.439999999999998 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 73.430000000000007 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 74.230000000000004 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 75.120000000000005 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 74.5 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.55 99.35 1.15 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 72.209999999999994 109.573 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -43.43 64.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.124 0.57 . . . . 71.239999999999995 110.073 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 55.51 41.24 31.01 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.899 1.279 . . . . 74.099999999999994 110.097 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -157.23 -63.58 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.836 1.655 . . . . 72.439999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 55.06 34.59 22.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.518 1.127 . . . . 73.420000000000002 111.876 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -82.75 68.53 9.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.134 1.374 . . . . 74.319999999999993 108.998 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.32 -157.6 13.59 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.604 -1.399 . . . . 53.450000000000003 109.604 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 m -81.34 47.24 1.01 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.728 0.811 . . . . 65.549999999999997 111.739 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -143.77 40.12 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.781 1.232 . . . . 75.230000000000004 109.734 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -156.58 70.85 4.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.175 -0.676 . . . . 72.230000000000004 109.175 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.97 94.51 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.253 2.636 . . . . 73.420000000000002 110.448 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.65 73.18 0.07 OUTLIER Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.771 -1.332 . . . . 63.240000000000002 109.771 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -84.26 56.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.284 1.034 . . . . 73.219999999999999 109.61 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.7 mm -77.32 136.54 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.402 1.081 . . . . 74.439999999999998 109.588 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.93 -115.09 1.17 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.164 -1.174 . . . . 63.119999999999997 110.164 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.93 -166.07 36.57 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.293 -1.123 . . . . 64.319999999999993 110.293 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.1 p -157.21 171.06 21.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.268 1.027 . . . . 51.549999999999997 109.575 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -145.8 71.52 13.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.949 0.899 . . . . 74.200000000000003 109.362 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.26 169.78 17.0 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.503 2.802 . . . . 71.519999999999996 111.572 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -143.35 111.42 6.12 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.596 1.559 . . . . 74.219999999999999 107.483 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.89 138.75 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.965 1.306 . . . . 75.219999999999999 108.248 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.95 152.6 41.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.628 0.771 . . . . 73.519999999999996 111.057 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -75.03 152.06 86.36 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.666 0.786 . . . . 73.400000000000006 109.059 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.3 -29.73 38.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.123 2.549 . . . . 71.129999999999995 112.255 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -56.45 -27.28 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.248 1.019 . . . . 75.25 113.086 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 65.129999999999995 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 71.129999999999995 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 72.420000000000002 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 74.420000000000002 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 71.219999999999999 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 74.430000000000007 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 73.109999999999999 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 73.019999999999996 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 74.450000000000003 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 74.239999999999995 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 74.400000000000006 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 74.219999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.450000000000003 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 75.340000000000003 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.430000000000007 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 72.200000000000003 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 73.540000000000006 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 73.540000000000006 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 73.109999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 72.049999999999997 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 72.25 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 64.099999999999994 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p -67.11 -26.06 66.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 74.340000000000003 111.66 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -67.9 0.71 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.45 -0.574 . . . . 73.299999999999997 109.45 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -168.61 105.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.463 1.105 . . . . 74.030000000000001 109.609 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -108.59 58.12 0.61 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.47 1.108 . . . . 74.420000000000002 109.565 166.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -122.48 75.31 43.96 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.178 0.991 . . . . 73.230000000000004 110.101 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.621 2.214 . . . . 75.329999999999998 109.798 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.32 134.03 43.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.066 0.946 . . . . 74.519999999999996 110.145 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -155.74 152.71 28.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.533 1.133 . . . . 63.119999999999997 109.004 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 tt -151.16 108.82 3.01 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.743 -1.577 . . . . 75.319999999999993 106.743 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.59 84.9 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.105 2.537 . . . . 65.140000000000001 110.22 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.75 140.55 58.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.921 0.889 . . . . 75.510000000000005 110.301 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -149.43 158.87 44.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.662 1.185 . . . . 73.409999999999997 109.21 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -158.69 144.19 16.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.262 1.025 . . . . 74.219999999999999 109.005 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.97 68.39 0.07 OUTLIER Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.716 -1.354 . . . . 63.340000000000003 109.716 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.51 69.85 81.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.436 1.094 . . . . 64.510000000000005 109.837 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.04 173.33 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.269 2.646 . . . . 75.239999999999995 110.677 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.34 164.18 35.88 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.248 -1.141 . . . . 62.340000000000003 110.248 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.93 41.0 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.341 -1.104 . . . . 72.209999999999994 110.341 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.92 166.18 34.01 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.202 -1.159 . . . . 73.340000000000003 110.202 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.7 m -144.71 137.67 26.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.46 1.104 . . . . 71.219999999999999 108.831 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -148.7 129.08 13.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.949 -1.13 . . . . 73.450000000000003 107.949 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -166.1 115.4 0.96 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.489 -0.93 . . . . 74.349999999999994 108.489 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.48 148.25 32.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.529 1.131 . . . . 75.120000000000005 108.862 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.25 166.65 32.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.646 1.178 . . . . 53.350000000000001 108.792 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -152.55 165.68 34.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.395 1.078 . . . . 75.5 109.237 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.174 -1.393 . . . . 62.450000000000003 109.963 175.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.584 -0.246 . . . . 72.129999999999995 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.71 73.31 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.427 2.751 . . . . 70.219999999999999 110.179 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -64.96 143.96 57.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.592 0.757 . . . . 75.349999999999994 110.58 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 75.349999999999994 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 54.409999999999997 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 72.409999999999997 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.52 107.45 2.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 75.0 109.623 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.42 137.49 4.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.422 -0.671 . . . . 74.230000000000004 111.422 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.82 159.8 20.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.625 -0.99 . . . . 74.420000000000002 110.625 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.99 41.12 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.413 0.685 . . . . 74.430000000000007 110.918 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.6 t80 77.55 -29.99 0.17 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.907 1.683 . . . . 75.439999999999998 113.164 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 -177.61 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 127.424 2.289 . . . . 60.420000000000002 107.81 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 60.39 76.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.424 1.09 . . . . 73.420000000000002 110.638 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.66 -52.79 2.67 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.14 -1.184 . . . . 72.430000000000007 110.14 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.68 121.86 64.11 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.991 -1.114 . . . . 74.209999999999994 107.991 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.84 141.88 21.96 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.059 2.506 . . . . 73.219999999999999 111.427 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.88 -45.99 0.53 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 117.471 -1.252 . . . . 74.010000000000005 112.03 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -89.37 176.29 3.09 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.718 2.279 . . . . 73.150000000000006 111.422 -171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 72.120000000000005 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 71.340000000000003 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 65.319999999999993 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 73.230000000000004 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 74.219999999999999 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 75.25 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 75.120000000000005 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 74.230000000000004 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 73.310000000000002 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 71.340000000000003 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 75.109999999999999 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 73.010000000000005 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 73.409999999999997 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 72.230000000000004 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 73.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 73.129999999999995 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 72.040000000000006 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 75.209999999999994 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.93 58.78 5.03 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 72.400000000000006 111.221 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -80.65 -57.34 3.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.182 0.993 . . . . 65.340000000000003 111.359 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -165.09 132.93 3.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.631 -1.618 . . . . 75.219999999999999 106.631 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.3 t80 71.23 -49.18 0.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.859 2.064 . . . . 71.150000000000006 111.845 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 69.79 11.71 7.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.802 1.641 . . . . 74.519999999999996 113.44 159.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 p -145.61 -177.89 5.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.146 1.379 . . . . 73.319999999999993 109.433 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 -87.53 0.58 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.296 0.95 . . . . 73.010000000000005 111.747 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 m -141.4 50.77 1.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.195 0.998 . . . . 73.040000000000006 110.273 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.75 31.92 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.992 -1.114 . . . . 64.439999999999998 107.992 166.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -155.23 156.03 30.63 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.274 1.83 . . . . 75.209999999999994 107.479 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.49 79.27 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.169 2.58 . . . . 65.420000000000002 109.99 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.79 144.93 5.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.032 -1.227 . . . . 71.340000000000003 110.032 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.7 p -165.52 129.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.261 1.424 . . . . 75.420000000000002 107.459 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.68 135.43 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.523 -0.917 . . . . 75.120000000000005 108.523 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.31 84.16 0.11 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.181 -1.167 . . . . 73.219999999999999 110.181 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.4 153.98 23.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.458 -1.057 . . . . 73.209999999999994 110.458 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -162.88 166.66 23.74 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.838 1.255 . . . . 75.349999999999994 108.924 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -150.24 86.18 5.25 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.21 0.604 . . . . 75.200000000000003 109.619 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.64 166.3 25.77 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.202 2.602 . . . . 74.510000000000005 110.892 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -160.42 116.44 2.35 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.348 1.059 . . . . 74.25 108.548 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.73 147.93 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.236 1.415 . . . . 71.450000000000003 108.859 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.33 127.12 32.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.517 0.727 . . . . 74.349999999999994 109.631 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.3 p -82.64 143.44 47.2 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 122.875 0.47 . . . . 73.329999999999998 110.436 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.68 -27.09 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.499 2.799 . . . . 74.120000000000005 112.12 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -49.1 -41.91 37.26 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.258 1.023 . . . . 75.450000000000003 112.676 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 65.019999999999996 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 75.030000000000001 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 74.340000000000003 110.586 165.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.210000000000001 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 71.420000000000002 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 71.340000000000003 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 73.510000000000005 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 71.129999999999995 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 73.439999999999998 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 73.019999999999996 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 75.209999999999994 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 72.140000000000001 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 70.409999999999997 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 74.129999999999995 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 72.310000000000002 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 72.219999999999999 112.235 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 71.420000000000002 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 71.239999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p -62.29 -29.8 70.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -112.21 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.446 -1.316 . . . . 71.140000000000001 107.446 167.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.3 t -145.36 71.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 70.549999999999997 109.437 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -80.53 115.99 20.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.489 -0.93 . . . . 74.409999999999997 108.489 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -124.99 119.62 25.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.429 1.091 . . . . 73.049999999999997 108.086 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 129.28 11.63 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.282 1.988 . . . . 64.239999999999995 109.316 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -74.59 98.46 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.869 0.868 . . . . 74.230000000000004 110.497 -169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -141.29 139.12 33.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.202 1.401 . . . . 63.329999999999998 107.393 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.6 tp -153.02 76.53 6.46 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.193 -1.04 . . . . 73.219999999999999 108.193 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.36 66.35 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.641 2.894 . . . . 61.5 109.42 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.9 mtp -136.39 133.37 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.047 1.339 . . . . 73.409999999999997 108.863 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.17 159.4 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.827 1.251 . . . . 73.510000000000005 109.324 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -159.02 147.93 18.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.536 1.134 . . . . 73.25 108.949 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.5 70.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.113 -1.195 . . . . 71.140000000000001 110.113 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.68 71.41 80.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.41 1.084 . . . . 71.209999999999994 110.116 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.94 171.95 17.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.348 2.699 . . . . 64.219999999999999 110.705 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.94 161.43 31.77 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.682 -0.967 . . . . 73.340000000000003 110.682 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.57 179.38 40.8 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.425 -1.07 . . . . 75.409999999999997 110.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 178.05 176.56 46.12 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.469 -1.052 . . . . 74.209999999999994 110.469 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.3 m -147.4 157.52 43.61 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.658 1.183 . . . . 64.200000000000003 109.947 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -163.21 173.43 13.4 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.74 1.216 . . . . 73.329999999999998 109.519 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -158.28 177.95 10.71 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 109.273 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -158.73 153.85 25.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.868 0.867 . . . . 75.25 109.61 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -155.55 155.94 34.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.757 1.223 . . . . 71.25 108.916 173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.11 -127.18 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.81 0.844 . . . . 72.510000000000005 108.959 172.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.988 -1.482 . . . . 74.219999999999999 110.906 168.313 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 119.342 -0.361 . . . . 71.219999999999999 110.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 134.82 21.63 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.679 2.253 . . . . 73.219999999999999 110.173 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.78 166.66 23.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.614 1.165 . . . . 73.340000000000003 109.095 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 75.239999999999995 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 73.109999999999999 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 74.209999999999994 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.98 148.27 22.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 74.25 108.923 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.71 176.38 47.91 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.236 -1.145 . . . . 74.219999999999999 110.236 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.38 64.84 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.48 -1.048 . . . . 70.040000000000006 110.48 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 140.73 18.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.139 0.975 . . . . 64.099999999999994 108.631 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.3 t80 55.5 64.13 1.86 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.09 0.956 . . . . 65.109999999999999 109.425 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.02 -54.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.934 1.294 . . . . 75.340000000000003 109.199 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -121.42 143.8 49.03 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.902 1.281 . . . . 73.439999999999998 109.388 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.89 -58.65 4.53 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.907 0.765 . . . . 74.310000000000002 111.976 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -52.06 151.66 6.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.976 1.711 . . . . 73.010000000000005 111.97 -174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.27 83.53 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.734 2.956 . . . . 74.150000000000006 110.543 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.18 167.82 25.26 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.615 1.166 . . . . 75.120000000000005 109.965 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 -152.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.707 2.938 . . . . 71.209999999999994 110.26 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 74.0 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 73.120000000000005 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 73.340000000000003 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 71.349999999999994 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 75.519999999999996 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 75.319999999999993 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 71.239999999999995 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 74.209999999999994 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 74.420000000000002 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 73.219999999999999 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 75.329999999999998 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.420000000000002 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 74.310000000000002 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 74.209999999999994 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 70.430000000000007 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 75.329999999999998 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 75.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 71.319999999999993 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.02 89.95 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 51.210000000000001 111.049 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -49.79 66.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.737 -0.838 . . . . 72.400000000000006 108.737 164.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 71.05 -3.93 1.91 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.582 1.953 . . . . 74.510000000000005 112.738 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -156.95 55.37 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.705 1.202 . . . . 73.5 108.877 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 153.87 42.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.536 0.734 . . . . 72.329999999999998 109.212 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 p -73.74 72.8 1.52 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.342 1.057 . . . . 74.340000000000003 110.463 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.95 -137.96 5.22 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.452 -1.059 . . . . 40.450000000000003 110.452 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.41 41.57 0.63 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.064 0.946 . . . . 65.329999999999998 113.405 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.69 50.91 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.735 -1.579 . . . . 71.409999999999997 106.735 160.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -142.43 72.14 21.23 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 65.230000000000004 108.068 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 143.08 44.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.939 2.426 . . . . 73.450000000000003 110.907 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.05 -154.27 10.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.91 1.243 . . . . 71.519999999999996 110.845 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 -156.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.673 1.589 . . . . 75.219999999999999 107.664 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.43 -54.06 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 109.595 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.33 73.4 1.27 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.316 -1.113 . . . . 70.239999999999995 110.316 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.29 -175.62 53.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.774 0.702 . . . . 72.549999999999997 112.441 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.3 p -161.93 164.28 28.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.911 1.284 . . . . 54.409999999999997 109.397 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -131.82 76.34 74.36 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.381 1.072 . . . . 75.400000000000006 109.13 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.29 -42.48 3.85 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.994 2.462 . . . . 65.150000000000006 111.108 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? 58.09 53.11 6.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.737 1.215 . . . . 73.319999999999993 109.965 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.47 146.98 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.587 0.755 . . . . 73.120000000000005 110.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.76 172.98 13.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.128 0.971 . . . . 73.329999999999998 110.887 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -157.74 143.54 12.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.418 1.087 . . . . 72.329999999999998 108.663 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.66 -14.49 44.97 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.324 2.683 . . . . 74.310000000000002 112.624 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -56.48 -36.57 69.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.479 0.581 . . . . 75.140000000000001 111.14 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 75.540000000000006 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 72.140000000000001 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 73.219999999999999 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 75.439999999999998 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 75.439999999999998 109.48 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 73.219999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 74.040000000000006 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 74.430000000000007 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 74.540000000000006 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.209999999999994 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 74.340000000000003 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 75.040000000000006 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 63.0 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 74.310000000000002 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 65.329999999999998 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 75.040000000000006 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 74.140000000000001 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 63.109999999999999 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p -63.05 -27.8 69.65 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 72.409999999999997 111.984 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -85.11 -40.87 16.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.721 0.808 . . . . 73.430000000000007 110.511 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.32 96.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.751 0.82 . . . . 75.430000000000007 109.833 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -141.21 167.16 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.717 1.207 . . . . 72.420000000000002 109.799 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 39.89 65.16 3.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.452 1.901 . . . . 74.150000000000006 112.568 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.57 128.11 17.56 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.576 2.184 . . . . 72.430000000000007 110.828 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.38 67.96 6.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.379 1.072 . . . . 75.239999999999995 110.024 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -69.71 138.39 52.84 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.529 0.732 . . . . 54.229999999999997 109.863 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.4 tp -158.82 100.13 1.64 Allowed Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.851 0.86 . . . . 73.129999999999995 108.688 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 76.39 4.39 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.138 2.559 . . . . 73.219999999999999 109.44 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.5 tpt -79.02 75.61 5.53 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.213 1.005 . . . . 72.25 110.056 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.37 117.09 5.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.712 0.805 . . . . 72.310000000000002 109.513 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.6 p -166.06 146.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.982 0.913 . . . . 64.010000000000005 109.222 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.2 66.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.608 -1.397 . . . . 43.030000000000001 109.608 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.28 75.45 78.99 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.547 1.139 . . . . 71.019999999999996 109.898 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.12 159.7 37.05 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.104 2.536 . . . . 74.25 110.871 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.58 176.71 40.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.563 -1.015 . . . . 73.409999999999997 110.563 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.14 117.65 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.917 -0.873 . . . . 65.0 110.917 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.53 160.86 29.54 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.519 -1.032 . . . . 70.219999999999999 110.519 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.6 t -161.2 158.56 27.56 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.527 1.131 . . . . 71.409999999999997 108.986 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -164.2 153.27 13.6 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.457 1.103 . . . . 72.409999999999997 109.27 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -169.44 158.43 7.94 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.744 1.218 . . . . 74.25 109.312 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -164.54 154.14 13.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.677 1.191 . . . . 75.219999999999999 108.762 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.88 153.87 37.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.171 0.988 . . . . 72.310000000000002 109.1 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -155.76 164.93 37.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.057 1.343 . . . . 70.450000000000003 108.92 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.384 -1.293 . . . . 73.019999999999996 108.878 169.612 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 118.992 -0.528 . . . . 74.129999999999995 110.365 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.2 124.46 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.054 2.503 . . . . 73.409999999999997 110.064 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -157.15 150.86 24.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.124 0.97 . . . . 72.230000000000004 109.047 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 70.5 106.464 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.450000000000003 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 73.430000000000007 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 70.129999999999995 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 74.420000000000002 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 64.16 -172.8 0.17 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.420000000000002 110.252 -165.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.22 -179.94 48.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.006 -1.238 . . . . 70.420000000000002 110.006 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.71 65.19 0.14 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.838 -1.305 . . . . 61.310000000000002 109.838 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.38 -177.87 6.86 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.602 1.161 . . . . 75.420000000000002 109.154 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.7 t80 60.38 59.83 2.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.521 1.128 . . . . 73.319999999999993 110.885 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.53 142.82 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.792 1.237 . . . . 54.200000000000003 108.018 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.16 71.14 2.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.634 0.774 . . . . 54.530000000000001 110.26 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.67 43.12 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.885 1.231 . . . . 74.040000000000006 110.422 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -147.77 154.85 44.51 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.717 1.607 . . . . 71.319999999999993 108.067 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.86 103.58 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.104 2.536 . . . . 72.239999999999995 109.753 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -126.69 149.76 69.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.437 1.495 . . . . 72.099999999999994 108.603 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.04 -168.45 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.455 2.77 . . . . 74.140000000000001 111.318 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 72.510000000000005 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 75.129999999999995 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 65.230000000000004 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 73.549999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 73.310000000000002 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 75.150000000000006 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 74.030000000000001 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 75.409999999999997 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 75.450000000000003 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 72.319999999999993 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 75.409999999999997 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 75.019999999999996 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 73.349999999999994 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 71.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 63.020000000000003 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 74.299999999999997 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.25 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 75.349999999999994 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.430000000000007 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.43 -40.05 49.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 71.129999999999995 111.664 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -18.12 64.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.495 0.647 . . . . 73.209999999999994 112.716 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -53.58 -53.03 57.6 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 118.962 0.801 . . . . 62.229999999999997 110.057 166.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.02 -35.51 23.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.446 1.099 . . . . 71.340000000000003 110.842 -166.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 59.39 33.81 22.51 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.098 1.759 . . . . 74.510000000000005 111.954 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.2 p -84.53 -179.14 7.08 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 75.129999999999995 110.219 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.92 -93.44 0.27 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.058 -1.217 . . . . 74.019999999999996 110.058 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -150.8 32.77 0.61 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.546 0.738 . . . . 74.200000000000003 111.048 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.96 61.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 108.324 -0.991 . . . . 73.510000000000005 108.324 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -148.86 78.21 9.03 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 108.174 -1.047 . . . . 75.530000000000001 108.174 -174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.87 75.74 4.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.384 2.723 . . . . 73.319999999999993 109.636 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.91 71.25 0.04 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.964 -1.255 . . . . 71.530000000000001 109.964 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.05 49.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.698 1.199 . . . . 75.129999999999995 109.385 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.64 133.82 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.361 -0.978 . . . . 75.129999999999995 108.361 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.28 -171.1 38.98 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.603 -0.999 . . . . 73.120000000000005 110.603 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.93 -163.34 29.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.108 -1.197 . . . . 62.310000000000002 110.108 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.9 m -155.95 145.76 21.21 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.47 1.108 . . . . 72.099999999999994 109.059 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.13 153.58 95.87 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.847 0.859 . . . . 74.549999999999997 109.763 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.98 -26.87 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.795 2.997 . . . . 74.120000000000005 112.785 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 63.61 69.16 0.56 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.517 1.527 . . . . 74.019999999999996 108.885 -171.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.66 145.26 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.391 0.676 . . . . 71.019999999999996 110.535 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.06 150.51 48.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.627 0.771 . . . . 73.400000000000006 110.827 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 t -160.14 144.55 10.78 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.954 0.902 . . . . 65.319999999999993 109.054 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.81 -15.3 46.83 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.818 2.346 . . . . 74.239999999999995 112.15 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -58.96 -20.92 56.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.669 0.788 . . . . 73.310000000000002 112.876 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 73.439999999999998 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 74.409999999999997 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 75.219999999999999 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 74.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 74.129999999999995 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 71.239999999999995 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 62.109999999999999 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 72.540000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 61.030000000000001 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.329999999999998 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 74.200000000000003 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 75.129999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 73.329999999999998 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 75.200000000000003 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 74.430000000000007 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 75.120000000000005 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 64.129999999999995 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 74.140000000000001 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 75.510000000000005 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 64.150000000000006 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 72.030000000000001 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p -115.16 96.34 5.63 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -51.48 -46.54 63.19 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.796 0.838 . . . . 62.420000000000002 111.994 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -84.74 55.68 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.937 0.895 . . . . 63.149999999999999 110.479 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.68 120.57 21.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.358 -0.979 . . . . 63.509999999999998 108.358 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -133.21 149.07 71.59 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.218 1.407 . . . . 75.5 108.321 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.79 147.63 85.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.022 2.482 . . . . 75.430000000000007 110.91 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -64.95 128.48 35.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.598 0.759 . . . . 73.129999999999995 109.966 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -155.23 158.99 39.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.832 0.853 . . . . 73.230000000000004 109.804 -172.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 tp 59.98 70.18 1.09 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.813 1.645 . . . . 74.239999999999995 111.184 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.43 171.03 18.33 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.234 2.623 . . . . 74.530000000000001 110.177 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -149.48 87.81 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.585 -0.894 . . . . 73.299999999999997 108.585 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.05 110.35 1.78 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 62.25 109.247 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.6 p -163.36 144.92 9.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.974 0.909 . . . . 73.200000000000003 109.209 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.25 111.41 0.3 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.849 -1.3 . . . . 73.219999999999999 109.849 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.8 68.27 18.89 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.807 0.843 . . . . 63.539999999999999 110.146 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.98 177.21 9.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.5 2.8 . . . . 70.319999999999993 110.856 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.19 65.11 2.25 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.969 -0.852 . . . . 74.329999999999998 110.969 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.67 74.1 0.45 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.614 -1.394 . . . . 62.149999999999999 109.614 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.37 144.79 9.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.423 -1.071 . . . . 74.430000000000007 110.423 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.9 t -157.88 120.31 3.79 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.511 -1.292 . . . . 72.209999999999994 107.511 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -146.03 97.42 2.95 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.006 0.922 . . . . 74.340000000000003 108.577 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -141.53 156.44 45.72 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.406 1.083 . . . . 73.420000000000002 109.432 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -155.76 -57.5 0.09 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.288 0.635 . . . . 74.150000000000006 110.425 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 71.0 151.33 0.1 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.099 1.76 . . . . 75.030000000000001 110.925 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -66.8 104.06 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.54 -0.541 . . . . 75.129999999999995 109.54 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.35 -1.31 . . . . 75.530000000000001 109.192 176.494 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 119.413 -0.327 . . . . 75.010000000000005 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.7 147.71 40.48 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.011 2.474 . . . . 73.230000000000004 110.798 -175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -167.02 167.18 14.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.153 1.381 . . . . 75.299999999999997 108.668 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 72.450000000000003 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 64.310000000000002 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 72.329999999999998 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp -70.5 127.69 33.57 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 117.29 4.46 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.939 -1.664 . . . . 62.25 108.939 168.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.31 64.69 3.46 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.974 0.797 . . . . 75.230000000000004 111.841 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.67 -168.02 2.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.96 1.304 . . . . 72.219999999999999 110.664 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.9 t80 67.03 98.53 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.943 1.697 . . . . 72.450000000000003 111.265 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.5 t 56.93 54.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.054 1.342 . . . . 75.400000000000006 109.262 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -153.31 90.62 1.44 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.61 -1.626 . . . . 72.319999999999993 106.61 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.41 -48.6 3.99 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.527 0.584 . . . . 61.409999999999997 111.748 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -45.9 -50.74 33.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.078 1.351 . . . . 73.329999999999998 114.372 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.48 77.91 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.816 1.677 . . . . 73.219999999999999 110.502 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -146.88 -63.5 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.855 -1.069 . . . . 74.030000000000001 110.048 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.137 1.891 . . . . 70.329999999999998 110.63 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 74.340000000000003 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 72.409999999999997 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 74.129999999999995 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 64.310000000000002 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 64.439999999999998 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 75.519999999999996 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 72.120000000000005 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 74.0 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 73.340000000000003 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 61.210000000000001 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 74.519999999999996 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 75.010000000000005 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 71.219999999999999 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 75.310000000000002 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.510000000000005 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.62 52.05 4.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -8.4 53.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.547 1.139 . . . . 73.140000000000001 112.831 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -69.47 -31.95 70.56 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.667 1.587 . . . . 74.150000000000006 110.142 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.1 -15.08 62.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.819 0.848 . . . . 65.109999999999999 111.559 171.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 59.95 57.43 3.07 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.508 1.523 . . . . 75.329999999999998 109.753 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.9 p -57.63 -42.23 82.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.939 1.295 . . . . 72.420000000000002 111.825 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.53 -92.12 0.39 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 72.140000000000001 110.402 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 p -164.17 52.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.536 1.134 . . . . 74.310000000000002 108.265 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 mt -90.95 53.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.439 0.696 . . . . 64.150000000000006 109.766 -163.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -144.32 68.22 15.22 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 125.079 1.351 . . . . 73.230000000000004 108.866 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.65 77.7 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.44 2.76 . . . . 73.099999999999994 110.372 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.36 152.52 6.29 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.161 -0.776 . . . . 62.539999999999999 111.161 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.5 118.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.097 1.359 . . . . 74.409999999999997 108.453 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.75 135.95 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.603 1.161 . . . . 75.019999999999996 108.803 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.68 -166.3 38.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.982 -0.847 . . . . 71.140000000000001 110.982 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.34 1.47 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.007 0.813 . . . . 54.049999999999997 111.735 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.7 p -79.28 164.38 24.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.423 0.689 . . . . 74.219999999999999 110.601 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -152.65 76.21 6.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.691 0.796 . . . . 71.25 109.173 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.35 164.97 31.73 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.337 2.691 . . . . 72.530000000000001 111.348 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -159.26 99.91 1.5 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.079 0.952 . . . . 73.140000000000001 108.837 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -92.69 139.24 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.899 0.88 . . . . 75.540000000000006 109.363 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.97 163.02 32.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.43 1.492 . . . . 75.420000000000002 108.4 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -161.7 141.48 7.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.066 0.546 . . . . 73.409999999999997 109.932 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.72 -11.82 26.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.272 2.648 . . . . 75.439999999999998 112.298 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -57.52 -24.08 53.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 112.209 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 71.129999999999995 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 71.420000000000002 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 73.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 74.329999999999998 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 71.430000000000007 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 75.099999999999994 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 75.409999999999997 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 73.340000000000003 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 61.219999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 75.519999999999996 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 73.150000000000006 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 72.129999999999995 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 71.120000000000005 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 63.439999999999998 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 71.120000000000005 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 72.099999999999994 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 74.010000000000005 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 71.299999999999997 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 74.510000000000005 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.540000000000006 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 75.0 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 74.319999999999993 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p -60.87 -28.5 68.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 75.219999999999999 112.093 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -73.74 -62.05 1.63 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.7 -0.482 . . . . 73.140000000000001 109.7 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.4 p -165.08 103.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.489 1.115 . . . . 64.329999999999998 109.814 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.89 69.68 0.69 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.098 0.959 . . . . 74.310000000000002 109.154 161.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -121.15 68.2 17.71 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.435 1.094 . . . . 71.430000000000007 110.186 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.53 153.5 49.64 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.951 2.434 . . . . 71.519999999999996 110.165 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.25 150.52 22.46 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.086 0.954 . . . . 74.230000000000004 110.268 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -157.07 155.19 30.73 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.531 1.133 . . . . 70.040000000000006 108.528 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.5 tp -148.39 89.41 5.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.843 -1.169 . . . . 73.439999999999998 107.843 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.63 147.72 32.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.856 2.371 . . . . 72.099999999999994 110.065 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.8 ptp -163.28 168.57 20.38 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.854 0.861 . . . . 72.150000000000006 110.294 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -147.2 162.85 38.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.062 1.345 . . . . 72.310000000000002 109.069 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -80.97 67.54 6.92 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.316 1.046 . . . . 62.450000000000003 109.903 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.86 68.83 3.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.057 -1.217 . . . . 50.200000000000003 110.057 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.9 79.43 64.52 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.051 1.341 . . . . 61.340000000000003 110.026 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.9 171.34 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.301 2.668 . . . . 73.150000000000006 110.966 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.96 168.05 40.47 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.001 -0.84 . . . . 71.230000000000004 111.001 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.92 -178.75 47.35 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.426 -1.069 . . . . 61.420000000000002 110.426 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.38 166.32 36.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.369 -0.693 . . . . 64.030000000000001 111.369 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 p -161.89 139.73 8.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 63.43 109.21 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -78.65 116.41 19.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.75 0.82 . . . . 75.319999999999993 109.808 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -103.12 132.44 49.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.464 1.106 . . . . 54.299999999999997 109.231 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -172.37 175.19 3.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 71.430000000000007 109.567 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -150.8 156.57 41.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.214 1.006 . . . . 75.540000000000006 109.515 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -71.93 156.27 39.44 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.182 0.593 . . . . 73.239999999999995 110.816 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 116.885 -1.531 . . . . 74.510000000000005 109.711 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 119.041 -0.504 . . . . 75.209999999999994 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.76 159.76 49.89 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.048 2.499 . . . . 71.439999999999998 110.822 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -72.94 -45.6 57.17 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.676 0.79 . . . . 73.310000000000002 110.474 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 73.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 73.549999999999997 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 44.240000000000002 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 75.030000000000001 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.99 89.36 2.56 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.87 160.09 53.95 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.596 0.617 . . . . 75.299999999999997 111.59 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.06 -58.84 4.99 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.894 -0.882 . . . . 71.439999999999998 110.894 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.5 178.4 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.651 1.58 . . . . 73.340000000000003 112.121 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.16 71.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.951 1.301 . . . . 74.129999999999995 108.585 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -106.63 147.83 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.725 1.21 . . . . 75.150000000000006 110.586 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -65.33 102.3 0.66 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.291 1.036 . . . . 75.25 109.408 172.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.25 -46.02 0.96 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.753 -1.339 . . . . 73.319999999999993 109.753 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -62.0 142.21 95.35 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.924 1.29 . . . . 72.109999999999999 109.821 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.42 91.02 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.145 2.563 . . . . 74.310000000000002 110.03 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.0 139.89 85.6 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 122.999 0.52 . . . . 75.329999999999998 110.892 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.24 -153.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.298 3.332 . . . . 64.510000000000005 109.691 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 75.349999999999994 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 72.439999999999998 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 74.319999999999993 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 75.219999999999999 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 75.400000000000006 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 70.099999999999994 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 73.409999999999997 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 65.450000000000003 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 74.239999999999995 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 64.129999999999995 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 74.409999999999997 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 75.120000000000005 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 73.109999999999999 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 71.099999999999994 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 63.009999999999998 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 65.400000000000006 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 75.549999999999997 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 176.13 145.12 5.43 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 72.209999999999994 110.452 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -65.57 -33.41 75.85 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.143 -0.622 . . . . 73.340000000000003 110.154 172.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 72.2 -67.96 0.24 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.717 2.407 . . . . 74.420000000000002 109.668 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -95.75 84.04 3.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.354 -0.98 . . . . 75.239999999999995 108.354 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 55.92 -92.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.929 1.292 . . . . 73.310000000000002 113.294 156.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p 36.88 70.79 0.16 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 127.117 2.167 . . . . 73.219999999999999 112.266 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.82 -57.77 4.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.851 -0.9 . . . . 63.009999999999998 110.851 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -82.65 -168.58 2.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.066 0.947 . . . . 65.150000000000006 110.091 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mt 40.31 55.06 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.792 2.437 . . . . 74.25 111.264 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -142.45 70.96 21.42 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.274 1.03 . . . . 74.030000000000001 109.787 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.05 69.69 7.39 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.187 2.591 . . . . 73.299999999999997 108.579 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.08 94.05 0.18 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.646 -1.382 . . . . 52.43 109.646 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -151.77 -47.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.124 0.97 . . . . 75.530000000000001 110.814 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.57 128.85 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.712 -0.848 . . . . 74.510000000000005 108.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.71 62.86 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.13 -1.588 . . . . 63.149999999999999 109.13 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.81 156.78 53.4 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.413 -0.675 . . . . 72.400000000000006 111.413 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -63.32 144.22 57.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.651 0.78 . . . . 73.510000000000005 110.551 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.33 79.05 19.7 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.7 1.2 . . . . 74.120000000000005 108.534 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.52 176.59 9.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.305 2.67 . . . . 73.439999999999998 111.364 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.73 -150.23 0.41 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 107.886 175.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.71 151.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.626 1.57 . . . . 75.120000000000005 109.354 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.82 43.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.414 0.686 . . . . 75.5 110.637 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 t -135.81 108.98 9.98 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.748 1.219 . . . . 75.409999999999997 108.295 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.93 -27.17 7.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.04 2.494 . . . . 74.030000000000001 112.403 -172.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -59.2 -21.2 59.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.881 0.873 . . . . 72.109999999999999 112.579 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 63.109999999999999 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 75.030000000000001 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 75.420000000000002 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 75.230000000000004 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 72.129999999999995 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 74.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 75.239999999999995 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 74.310000000000002 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 74.129999999999995 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 71.150000000000006 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 75.019999999999996 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 72.329999999999998 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 71.239999999999995 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 74.420000000000002 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 75.120000000000005 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 65.409999999999997 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 75.129999999999995 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 75.019999999999996 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p -72.01 -19.71 61.82 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 73.409999999999997 112.061 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.98 -100.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.96 0.904 . . . . 73.329999999999998 108.933 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.1 t -149.47 95.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.328 1.451 . . . . 71.439999999999998 107.668 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -70.26 151.49 45.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.514 0.726 . . . . 73.340000000000003 110.677 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -131.33 77.25 74.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.566 1.546 . . . . 64.329999999999998 107.628 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.19 154.62 46.78 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.956 2.437 . . . . 75.319999999999993 110.915 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -83.25 60.0 5.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.575 1.15 . . . . 73.439999999999998 109.509 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.73 165.19 11.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.216 1.407 . . . . 72.310000000000002 110.629 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.14 150.0 36.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.119 1.368 . . . . 71.239999999999995 109.279 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.61 160.51 38.06 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.224 2.616 . . . . 73.140000000000001 110.626 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.1 mtt -141.72 160.77 39.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.03 1.332 . . . . 64.439999999999998 108.873 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.4 160.36 43.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.901 0.88 . . . . 72.409999999999997 110.75 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.9 m -148.08 46.17 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.413 1.085 . . . . 74.420000000000002 110.05 171.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.05 86.71 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.499 -1.04 . . . . 54.210000000000001 110.499 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.19 70.52 61.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.326 1.05 . . . . 64.209999999999994 111.529 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.1 169.04 22.87 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.472 2.781 . . . . 75.129999999999995 111.167 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.56 170.15 42.01 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.416 -1.073 . . . . 64.340000000000003 110.416 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.82 45.06 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.054 -0.818 . . . . 70.549999999999997 111.054 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.45 166.08 36.82 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.339 -1.105 . . . . 73.329999999999998 110.339 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.9 t -161.38 159.77 28.7 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.126 0.97 . . . . 71.120000000000005 109.681 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -152.33 153.42 33.62 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.189 . . . . 63.039999999999999 109.45 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -152.98 155.39 36.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.63 1.172 . . . . 72.200000000000003 109.134 173.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -159.45 169.24 24.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.212 1.405 . . . . 74.209999999999994 108.697 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -147.43 146.37 29.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.042 -1.095 . . . . 72.510000000000005 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -144.24 149.61 36.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.838 1.255 . . . . 72.040000000000006 108.557 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.319 -1.324 . . . . 72.439999999999998 109.018 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.758 -0.639 . . . . 74.310000000000002 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.9 130.62 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.549 2.166 . . . . 75.209999999999994 110.074 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -136.08 136.1 39.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.701 1.2 . . . . 70.430000000000007 108.61 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 71.549999999999997 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 60.100000000000001 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 73.129999999999995 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 75.549999999999997 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp 70.32 -68.89 0.19 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 72.540000000000006 112.49 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 -72.12 2.29 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 109.608 -1.397 . . . . 73.450000000000003 109.608 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 70.63 0.98 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.202 0.906 . . . . 72.310000000000002 111.381 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.17 43.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.811 0.844 . . . . 71.120000000000005 110.205 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -74.76 148.94 39.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.519 0.728 . . . . 74.299999999999997 109.234 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -142.8 -72.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.917 0.887 . . . . 74.450000000000003 108.774 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -167.6 121.88 0.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.109 0.963 . . . . 63.009999999999998 108.732 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.84 35.32 91.77 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.416 0.531 . . . . 64.420000000000002 112.652 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 158.64 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 108.858 -0.793 . . . . 73.420000000000002 108.858 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.93 169.62 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.282 2.655 . . . . 71.150000000000006 110.947 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -122.77 71.05 39.52 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.322 1.049 . . . . 74.409999999999997 111.051 -171.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.89 163.04 36.32 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.717 2.278 . . . . 75.439999999999998 109.752 165.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 74.120000000000005 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 74.209999999999994 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 75.040000000000006 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.099999999999994 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 73.120000000000005 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.230000000000004 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 74.409999999999997 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 75.450000000000003 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 72.450000000000003 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 75.209999999999994 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 72.099999999999994 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 74.510000000000005 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 73.109999999999999 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 71.409999999999997 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 71.340000000000003 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 75.209999999999994 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 75.420000000000002 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 74.439999999999998 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.099999999999994 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.37 113.25 1.8 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 72.109999999999999 108.912 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -53.15 -49.89 65.67 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.495 0.718 . . . . 74.010000000000005 111.256 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.31 -59.45 0.09 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.617 1.167 . . . . 75.430000000000007 109.633 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.47 81.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.939 -2.245 . . . . 73.010000000000005 104.939 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.84 -60.48 1.9 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.748 -0.464 . . . . 72.349999999999994 109.748 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.4 p -104.97 -81.36 0.53 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.612 -1.255 . . . . 70.340000000000003 107.612 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.13 179.28 53.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.582 -1.007 . . . . 61.109999999999999 110.582 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -61.68 -64.75 0.84 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.118 0.967 . . . . 75.239999999999995 111.309 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 mt 58.17 30.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.101 1.76 . . . . 75.409999999999997 110.362 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.4 mmt-85 -152.44 100.05 2.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 75.439999999999998 106.831 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.67 147.51 40.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.467 2.112 . . . . 75.200000000000003 110.635 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.7 170.05 42.28 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.248 -1.541 . . . . 41.310000000000002 109.248 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.63 124.11 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 124.788 1.235 . . . . 73.409999999999997 108.575 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.39 140.43 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.419 1.088 . . . . 71.340000000000003 109.241 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.13 76.53 0.19 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.936 -1.266 . . . . 71.430000000000007 109.936 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.89 64.54 0.23 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.497 -1.041 . . . . 73.209999999999994 110.497 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -148.86 50.04 0.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.11 0.964 . . . . 75.540000000000006 109.431 177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -77.07 125.14 87.14 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 109.856 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.65 170.86 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.34 2.693 . . . . 74.430000000000007 110.785 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -149.57 104.27 3.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.632 0.773 . . . . 73.450000000000003 109.307 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.49 152.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.865 0.866 . . . . 75.430000000000007 110.384 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.7 164.15 36.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.911 1.284 . . . . 74.239999999999995 109.159 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.12 109.24 1.26 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.436 0.694 . . . . 64.140000000000001 109.785 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.59 -19.03 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.094 2.529 . . . . 74.239999999999995 112.252 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -55.09 -24.84 27.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.92 1.288 . . . . 61.439999999999998 112.696 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 72.510000000000005 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 75.150000000000006 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 53.109999999999999 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 73.319999999999993 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 73.540000000000006 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 74.019999999999996 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 75.230000000000004 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 72.150000000000006 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 72.319999999999993 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 73.530000000000001 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 72.329999999999998 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 73.409999999999997 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 73.150000000000006 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 73.319999999999993 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 74.129999999999995 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 75.150000000000006 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.420000000000002 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p -74.28 -7.04 51.38 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -7.5 53.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.622 1.101 . . . . 64.340000000000003 111.274 164.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t 69.15 69.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.107 2.163 . . . . 74.030000000000001 108.405 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.96 78.52 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.898 1.279 . . . . 74.409999999999997 110.687 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -63.6 145.64 97.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 75.439999999999998 110.564 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.0 164.33 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.239 2.626 . . . . 75.439999999999998 110.331 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -82.16 55.13 2.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.728 0.811 . . . . 72.540000000000006 110.232 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -166.24 145.1 5.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.713 1.205 . . . . 73.019999999999996 109.122 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.33 103.76 48.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.019 -1.474 . . . . 64.140000000000001 107.019 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.42 78.18 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.032 2.488 . . . . 72.319999999999993 110.216 -175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.5 mtp -69.01 136.61 52.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.52 0.728 . . . . 71.120000000000005 110.222 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.28 170.72 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.596 1.158 . . . . 73.129999999999995 110.998 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 m -146.78 149.66 33.78 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.559 1.144 . . . . 74.150000000000006 109.503 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.84 134.35 2.11 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.811 -1.316 . . . . 64.420000000000002 109.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.62 10.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.177 0.991 . . . . 75.120000000000005 109.455 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.63 177.79 8.39 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.573 2.848 . . . . 75.150000000000006 110.904 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -167.4 176.35 42.24 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.798 -0.921 . . . . 75.439999999999998 110.798 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.54 -169.57 41.21 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.568 -1.013 . . . . 60.240000000000002 110.568 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.75 66.84 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.303 -1.119 . . . . 74.340000000000003 110.303 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -74.1 146.32 43.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.74 0.816 . . . . 60.119999999999997 111.054 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -162.72 170.97 17.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.649 1.18 . . . . 72.409999999999997 109.559 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.41 173.32 7.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.323 1.049 . . . . 72.409999999999997 111.869 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -121.26 143.23 49.27 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.073 1.349 . . . . 73.129999999999995 108.3 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.3 t60 47.84 -108.98 0.26 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.482 1.513 . . . . 65.450000000000003 111.463 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -173.97 -61.23 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.17 1.388 . . . . 75.200000000000003 108.056 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.378 -1.296 . . . . 75.340000000000003 109.651 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 118.063 -0.97 . . . . 74.310000000000002 112.338 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.3 147.59 53.5 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.877 1.718 . . . . 73.030000000000001 110.765 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -70.04 134.58 48.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.517 0.727 . . . . 73.409999999999997 110.032 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 63.43 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 72.549999999999997 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 74.430000000000007 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 75.209999999999994 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 74.549999999999997 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 55.409999999999997 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 75.010000000000005 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.46 167.0 21.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.5 109.189 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 162.0 32.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.867 -0.893 . . . . 52.219999999999999 110.867 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.98 130.11 1.67 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.258 -1.137 . . . . 74.200000000000003 110.258 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.78 4.44 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.873 0.869 . . . . 75.340000000000003 110.315 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.42 68.65 1.39 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.992 1.317 . . . . 74.340000000000003 108.456 -174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.71 172.24 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.551 1.54 . . . . 64.239999999999995 109.473 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -59.69 127.56 32.58 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.968 -0.458 . . . . 74.129999999999995 110.099 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 37.14 92.7 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 123.295 0.474 . . . . 72.120000000000005 112.107 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -59.56 147.56 76.94 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.413 0.685 . . . . 74.310000000000002 110.087 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.16 147.98 93.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.359 2.706 . . . . 75.430000000000007 110.92 -175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.49 62.05 52.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.968 0.907 . . . . 75.219999999999999 112.16 -172.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -76.66 -165.97 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.935 2.423 . . . . 73.140000000000001 108.915 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 75.409999999999997 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 75.409999999999997 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 73.299999999999997 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 74.099999999999994 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 72.219999999999999 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 73.430000000000007 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 74.310000000000002 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 74.349999999999994 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 74.510000000000005 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 64.310000000000002 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 73.319999999999993 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 73.299999999999997 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.230000000000004 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 75.109999999999999 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 60.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 71.519999999999996 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 70.450000000000003 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 71.420000000000002 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 74.420000000000002 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 75.430000000000007 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.98 83.05 0.06 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.39 -32.35 68.35 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.089 0.444 . . . . 74.120000000000005 110.111 166.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 66.37 25.51 10.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.353 1.861 . . . . 73.549999999999997 111.555 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -169.5 48.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.833 1.253 . . . . 73.109999999999999 110.203 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.09 -170.78 2.63 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.821 -0.55 . . . . 73.540000000000006 110.572 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 p -53.27 -40.52 64.72 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.896 1.278 . . . . 72.209999999999994 111.489 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.05 -86.44 0.4 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.822 -1.311 . . . . 73.420000000000002 109.822 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -168.35 -71.34 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.13 0.972 . . . . 75.030000000000001 109.488 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mt 60.62 41.13 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.527 1.931 . . . . 72.019999999999996 109.302 -171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.53 83.82 22.48 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.179 1.392 . . . . 73.219999999999999 108.482 175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.1 93.95 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.2 2.6 . . . . 73.209999999999994 110.852 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.27 -112.09 0.5 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.923 -1.271 . . . . 63.130000000000003 109.923 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m 44.85 43.6 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.572 1.949 . . . . 65.120000000000005 113.466 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.41 -48.86 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.908 0.883 . . . . 73.340000000000003 109.758 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.68 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.819 -1.312 . . . . 74.439999999999998 109.819 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.49 39.22 14.8 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.394 1.473 . . . . 73.420000000000002 113.361 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.4 m -95.6 89.26 5.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.898 0.879 . . . . 71.129999999999995 110.266 -168.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -118.69 69.62 8.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.431 1.492 . . . . 73.540000000000006 109.785 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.64 173.45 14.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.339 2.693 . . . . 74.439999999999998 111.35 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? 61.46 76.76 0.36 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.098 1.359 . . . . 74.019999999999996 110.421 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 t -84.32 127.16 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 107.939 -1.134 . . . . 75.439999999999998 107.939 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 124.29 31.22 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.694 0.798 . . . . 75.329999999999998 109.031 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.276 0.2 OUTLIER -144.69 -67.29 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.792 -1.099 . . . . 64.099999999999994 112.152 -178.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.76 -46.25 1.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 73.010000000000005 111.915 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.55 -31.45 72.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.648 0.379 . . . . 75.239999999999995 111.829 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 74.299999999999997 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 74.129999999999995 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 75.439999999999998 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 74.319999999999993 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 75.239999999999995 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 71.349999999999994 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 75.219999999999999 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 74.439999999999998 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 74.129999999999995 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 64.209999999999994 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 70.510000000000005 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 61.140000000000001 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.349999999999994 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 74.150000000000006 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 70.420000000000002 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 74.540000000000006 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 74.019999999999996 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 73.430000000000007 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 73.129999999999995 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 74.109999999999999 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 73.420000000000002 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 73.519999999999996 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p -57.41 -15.05 5.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -104.78 -54.08 2.57 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.678 1.191 . . . . 75.540000000000006 111.551 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.09 106.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.154 0.582 . . . . 74.310000000000002 109.55 -165.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -156.58 166.62 32.88 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.842 1.257 . . . . 65.329999999999998 111.85 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.75 138.97 33.1 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.378 1.071 . . . . 71.200000000000003 109.192 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.19 161.84 44.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.653 2.902 . . . . 73.099999999999994 112.34 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.08 130.56 38.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.191 1.397 . . . . 75.510000000000005 108.64 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -145.77 160.54 41.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.764 0.826 . . . . 72.319999999999993 110.387 -175.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -149.76 80.05 7.62 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 107.901 -1.148 . . . . 73.349999999999994 107.901 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.72 74.96 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.526 2.817 . . . . 73.420000000000002 110.878 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -87.04 152.54 22.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.501 0.72 . . . . 74.219999999999999 111.438 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.91 153.89 19.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.162 1.385 . . . . 70.540000000000006 109.325 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.5 m -136.37 33.51 2.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.252 1.021 . . . . 75.349999999999994 110.62 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -89.79 134.63 12.48 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.156 -1.178 . . . . 50.399999999999999 110.156 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.44 70.55 3.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.703 0.801 . . . . 73.040000000000006 109.907 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.59 170.95 18.34 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.434 2.756 . . . . 70.430000000000007 111.238 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.45 169.8 39.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.415 -1.074 . . . . 74.329999999999998 110.415 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 172.31 -179.58 43.8 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.303 -0.719 . . . . 53.130000000000003 111.303 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.92 161.83 29.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.247 -1.141 . . . . 60.140000000000001 110.247 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 78.4 p -163.74 167.31 21.15 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.57 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -147.8 154.6 40.69 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.24 1.416 . . . . 75.400000000000006 109.187 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -151.1 52.18 0.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 72.049999999999997 108.534 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -88.05 68.25 9.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.696 0.798 . . . . 71.019999999999996 109.036 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.01 116.03 20.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.553 0.741 . . . . 75.329999999999998 109.338 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -77.74 151.51 34.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.204 1.002 . . . . 75.109999999999999 110.528 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.295 -1.336 . . . . 73.409999999999997 108.565 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.798 -0.445 . . . . 73.109999999999999 109.798 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.17 175.06 11.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.152 2.568 . . . . 62.409999999999997 110.877 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -137.05 145.36 43.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.806 1.242 . . . . 74.530000000000001 108.969 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 63.340000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 74.129999999999995 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 72.409999999999997 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 63.91 178.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 73.040000000000006 111.659 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.59 173.17 45.36 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.397 -0.681 . . . . 54.439999999999998 111.397 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.53 -167.5 42.87 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.394 0.997 . . . . 72.140000000000001 112.103 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.95 154.82 33.18 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.727 0.811 . . . . 74.109999999999999 110.771 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -83.08 59.81 5.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.213 1.405 . . . . 74.329999999999998 110.432 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -166.84 -36.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.648 1.179 . . . . 71.430000000000007 111.159 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -49.45 -47.76 48.0 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.164 1.386 . . . . 70.319999999999993 112.046 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.84 56.77 0.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.877 -1.689 . . . . 62.229999999999997 108.877 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -123.21 79.08 52.54 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.65 1.18 . . . . 73.420000000000002 110.022 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.33 69.61 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.436 3.424 . . . . 74.0 110.289 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.99 166.84 14.11 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.409 1.484 . . . . 73.439999999999998 110.206 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.14 -158.95 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.864 3.043 . . . . 73.400000000000006 110.805 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 73.140000000000001 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 73.319999999999993 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 73.109999999999999 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 60.140000000000001 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 74.239999999999995 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 71.340000000000003 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 75.340000000000003 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 72.109999999999999 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 70.430000000000007 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 73.109999999999999 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 71.409999999999997 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 75.150000000000006 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 74.129999999999995 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 60.100000000000001 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 74.540000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 73.319999999999993 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 72.219999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 72.310000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 72.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.420000000000002 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 72.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.93 119.42 0.53 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -61.3 -46.88 88.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.562 0.681 . . . . 71.239999999999995 109.81 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -159.39 39.97 0.21 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.703 0.801 . . . . 74.319999999999993 110.647 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 60.48 71.46 0.57 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.291 -1.003 . . . . 72.319999999999993 108.291 -165.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.46 136.66 20.33 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.579 1.552 . . . . 75.400000000000006 113.604 -160.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -79.03 -34.95 43.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.776 0.831 . . . . 53.299999999999997 111.292 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -83.36 0.17 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.767 -0.933 . . . . 72.239999999999995 110.767 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -77.83 173.01 12.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.001 0.521 . . . . 74.530000000000001 109.671 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mt 60.8 35.77 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.134 1.373 . . . . 71.329999999999998 111.138 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -144.14 67.67 15.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.501 1.121 . . . . 72.230000000000004 110.579 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.21 124.81 9.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.798 2.332 . . . . 65.420000000000002 109.919 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.39 159.57 20.21 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.729 -0.949 . . . . 74.430000000000007 110.729 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.63 125.88 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.644 1.577 . . . . 75.150000000000006 108.344 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.81 136.03 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.269 1.427 . . . . 75.219999999999999 109.028 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.39 164.5 33.18 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.559 -1.016 . . . . 75.150000000000006 110.559 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.58 164.61 27.5 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.185 -0.766 . . . . 73.120000000000005 111.185 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.6 m -154.73 143.45 20.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.626 1.17 . . . . 75.010000000000005 109.274 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -159.5 79.12 2.77 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 74.420000000000002 109.387 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.23 160.62 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.253 2.635 . . . . 74.329999999999998 111.966 -173.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -147.93 109.4 4.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.802 1.641 . . . . 72.200000000000003 108.089 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -139.4 135.55 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 73.349999999999994 108.912 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.97 132.03 34.4 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.284 1.034 . . . . 74.340000000000003 109.735 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER -154.84 -67.64 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.122 -0.942 . . . . 73.239999999999995 112.417 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.07 -41.62 7.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.335 2.023 . . . . 74.239999999999995 112.01 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.35 -26.34 63.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.692 0.797 . . . . 74.129999999999995 112.154 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 75.400000000000006 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 74.549999999999997 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 74.299999999999997 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 63.310000000000002 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 75.540000000000006 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 75.239999999999995 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 74.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 75.150000000000006 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 73.109999999999999 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 74.230000000000004 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 74.299999999999997 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 75.230000000000004 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 74.310000000000002 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 75.439999999999998 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 74.540000000000006 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 72.450000000000003 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 73.109999999999999 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 72.010000000000005 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 71.239999999999995 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 73.549999999999997 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 73.519999999999996 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 73.319999999999993 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p -66.32 -29.61 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 74.420000000000002 111.879 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.63 -78.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.936 -0.764 . . . . 65.510000000000005 108.936 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -170.36 101.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.542 1.537 . . . . 64.219999999999999 108.967 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -83.25 171.2 13.85 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.17 0.588 . . . . 72.430000000000007 109.839 166.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -121.22 82.46 38.07 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 125.319 1.448 . . . . 75.540000000000006 108.299 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.15 128.67 17.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.539 2.16 . . . . 73.409999999999997 110.916 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.89 67.85 7.27 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.236 1.014 . . . . 74.140000000000001 109.642 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.35 145.81 22.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.231 1.013 . . . . 71.430000000000007 109.237 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.9 tp -118.35 93.07 44.6 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 125.132 1.373 . . . . 74.109999999999999 107.408 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.67 158.1 39.7 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.709 2.273 . . . . 75.310000000000002 110.169 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -155.89 120.36 4.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.599 0.76 . . . . 74.120000000000005 109.244 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.35 155.46 30.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.996 0.919 . . . . 72.129999999999995 109.729 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -158.29 163.06 37.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.806 0.842 . . . . 75.140000000000001 109.757 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.39 177.19 42.55 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.344 -1.102 . . . . 62.240000000000002 110.344 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 69.83 6.15 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.705 0.802 . . . . 74.310000000000002 110.132 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.85 167.44 27.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.246 2.63 . . . . 55.25 110.855 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.66 179.51 48.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.515 -1.034 . . . . 75.430000000000007 110.515 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.5 -175.25 47.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.75 -0.94 . . . . 64.409999999999997 110.75 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.89 169.9 42.44 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.359 -1.096 . . . . 64.209999999999994 110.359 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.3 m -153.18 164.43 38.08 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.328 1.051 . . . . 75.349999999999994 109.411 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -162.89 171.49 16.56 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.231 1.012 . . . . 71.0 109.649 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -155.3 -171.36 3.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.662 1.185 . . . . 75.310000000000002 108.928 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -130.13 -178.61 4.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.023 1.329 . . . . 74.329999999999998 109.811 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.71 153.34 41.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.826 1.25 . . . . 73.439999999999998 109.08 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -150.36 148.6 29.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.986 1.315 . . . . 70.109999999999999 107.754 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.247 -1.358 . . . . 73.120000000000005 109.269 178.043 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 119.271 -0.395 . . . . 74.430000000000007 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.79 -45.96 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.7 2.267 . . . . 73.299999999999997 111.009 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 58.44 72.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 74.319999999999993 111.491 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 75.239999999999995 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 72.040000000000006 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 73.129999999999995 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 53.109999999999999 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 75.219999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.439999999999998 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 65.340000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt 56.19 -146.34 0.57 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.98 63.83 4.1 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.083 -1.207 . . . . 73.319999999999993 110.083 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.79 65.38 0.27 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.898 -0.39 . . . . 62.140000000000001 112.195 -168.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.11 142.2 21.36 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.173 0.989 . . . . 71.340000000000003 109.448 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -86.72 135.53 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.482 0.713 . . . . 75.519999999999996 109.934 -173.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 147.52 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.713 -0.847 . . . . 75.439999999999998 108.713 174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -50.97 120.39 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 74.430000000000007 111.563 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.92 84.04 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.806 -0.997 . . . . 75.409999999999997 114.079 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -101.81 116.43 63.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.804 1.302 . . . . 72.120000000000005 108.545 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.86 115.04 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.984 2.456 . . . . 74.299999999999997 109.832 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 32.94 62.96 1.44 Allowed Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 73.409999999999997 114.571 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.94 170.84 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.538 2.158 . . . . 73.030000000000001 110.128 174.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 74.120000000000005 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 73.219999999999999 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 70.109999999999999 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 74.239999999999995 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 72.420000000000002 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 74.0 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 74.319999999999993 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 74.319999999999993 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 71.099999999999994 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 65.209999999999994 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 75.549999999999997 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 72.030000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 64.409999999999997 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 75.109999999999999 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 74.450000000000003 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 72.049999999999997 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 74.140000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.5 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.6 73.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -81.91 -55.46 4.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.827 -0.805 . . . . 73.349999999999994 108.827 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -132.7 34.66 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.597 1.159 . . . . 73.329999999999998 109.882 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 57.96 46.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.669 1.587 . . . . 75.5 111.138 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 53.14 -142.18 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.232 1.013 . . . . 73.109999999999999 109.585 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -79.66 54.7 1.85 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.869 0.868 . . . . 72.409999999999997 109.033 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 44.32 36.92 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.743 1.163 . . . . 53.439999999999998 112.581 -171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -104.37 -22.48 13.33 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.749 1.22 . . . . 73.129999999999995 113.31 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.68 62.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.521 1.128 . . . . 71.439999999999998 109.556 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -119.04 77.39 15.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.139 1.376 . . . . 74.340000000000003 108.759 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.5 78.96 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.306 2.671 . . . . 72.129999999999995 109.984 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.91 74.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.413 -1.475 . . . . 72.310000000000002 109.413 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 p -150.82 87.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.014 0.926 . . . . 74.049999999999997 108.756 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.64 135.63 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.365 -0.976 . . . . 73.519999999999996 108.365 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.07 175.78 42.18 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.967 -0.853 . . . . 73.019999999999996 110.967 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.38 115.26 0.33 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.128 -1.589 . . . . 71.319999999999993 109.128 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -70.99 146.31 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.238 0.615 . . . . 54.149999999999999 110.991 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -103.7 151.95 38.85 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.567 1.547 . . . . 71.209999999999994 108.395 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.44 154.41 69.04 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.061 2.507 . . . . 73.239999999999995 110.476 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -101.65 66.59 1.08 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.134 0.974 . . . . 74.209999999999994 109.162 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.53 137.18 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.76 0.824 . . . . 74.239999999999995 108.807 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.4 126.27 32.56 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.812 0.845 . . . . 75.530000000000001 109.5 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 p 44.21 62.76 9.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.62 1.568 . . . . 75.129999999999995 112.17 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.47 -81.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.262 2.641 . . . . 75.540000000000006 111.752 -171.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.539 0.736 . . . . 74.409999999999997 111.756 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 71.209999999999994 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.409999999999997 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 75.150000000000006 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 71.439999999999998 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 71.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 63.530000000000001 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 75.239999999999995 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 64.540000000000006 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 75.129999999999995 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 75.129999999999995 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 73.109999999999999 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 75.329999999999998 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 75.109999999999999 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 71.409999999999997 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 73.299999999999997 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 73.310000000000002 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 72.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 74.310000000000002 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p -57.9 -34.84 70.25 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -72.65 -69.11 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.759 -0.46 . . . . 70.439999999999998 109.759 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -146.21 92.45 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.129 1.372 . . . . 72.329999999999998 108.077 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 165.25 20.71 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.041 0.537 . . . . 72.530000000000001 111.471 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -112.42 135.97 21.45 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.791 1.236 . . . . 74.420000000000002 107.689 171.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 154.29 52.39 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.987 2.458 . . . . 75.150000000000006 110.301 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.66 138.97 32.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.102 0.961 . . . . 72.209999999999994 109.231 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.35 162.79 30.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.256 1.022 . . . . 71.540000000000006 109.445 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.84 75.79 9.05 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.238 -1.023 . . . . 72.140000000000001 108.238 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.69 128.03 18.24 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.519 2.146 . . . . 74.239999999999995 108.951 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -150.8 140.57 21.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.604 -0.887 . . . . 73.040000000000006 108.604 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -146.25 159.55 43.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.949 1.299 . . . . 75.239999999999995 108.644 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -165.46 130.31 2.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.044 0.937 . . . . 75.420000000000002 109.115 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.72 146.03 11.12 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.672 -1.371 . . . . 62.43 109.672 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.72 74.26 10.36 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 109.371 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.69 162.66 37.32 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.958 2.439 . . . . 71.329999999999998 110.646 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.51 177.95 48.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.102 -1.199 . . . . 72.519999999999996 110.102 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.71 -175.75 46.32 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.441 -1.064 . . . . 75.430000000000007 110.441 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.4 166.74 39.22 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.14 -1.184 . . . . 73.109999999999999 110.14 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.8 t -161.63 161.49 29.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.505 1.122 . . . . 71.239999999999995 108.803 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -158.85 160.95 36.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 75.530000000000001 109.262 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -157.04 143.81 18.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.154 0.981 . . . . 75.0 109.087 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -106.58 109.67 21.65 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.855 1.262 . . . . 74.319999999999993 109.031 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -70.4 93.85 0.9 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.066 -1.087 . . . . 74.040000000000006 108.066 167.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -72.46 140.8 48.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.286 0.634 . . . . 74.200000000000003 110.626 -174.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.935 -1.507 . . . . 74.530000000000001 109.95 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 117.614 -1.184 . . . . 74.230000000000004 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.33 76.95 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.648 2.232 . . . . 74.140000000000001 110.862 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -68.4 136.1 52.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.709 0.804 . . . . 72.349999999999994 110.22 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 74.420000000000002 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 73.519999999999996 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 73.0 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 64.409999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 63.29 179.58 0.15 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 70.439999999999998 111.153 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.89 171.93 44.41 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.444 -1.062 . . . . 60.520000000000003 110.444 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.19 49.41 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.714 0.673 . . . . 65.219999999999999 112.06 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 154.92 33.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.318 1.047 . . . . 72.209999999999994 109.91 -174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.7 t80 69.21 1.77 3.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.816 1.647 . . . . 72.030000000000001 114.267 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.9 -48.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.543 1.137 . . . . 60.130000000000003 109.118 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.41 145.87 25.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.252 1.421 . . . . 71.319999999999993 107.388 168.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.07 -65.18 3.31 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.8 -1.32 . . . . 62.509999999999998 109.8 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -79.02 119.12 76.09 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.609 -0.886 . . . . 75.430000000000007 108.609 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.64 174.96 11.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.17 2.58 . . . . 74.230000000000004 111.501 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mp -124.28 71.56 55.56 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.826 1.25 . . . . 72.219999999999999 109.078 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.31 -156.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.417 2.745 . . . . 71.120000000000005 109.778 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 74.219999999999999 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.400000000000006 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 75.439999999999998 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 75.310000000000002 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 64.200000000000003 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 62.43 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 75.120000000000005 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 64.319999999999993 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 74.219999999999999 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 73.129999999999995 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 74.230000000000004 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 72.120000000000005 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 73.25 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 74.430000000000007 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 73.540000000000006 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.01 140.55 6.73 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -15.2 60.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.043 0.422 . . . . 74.120000000000005 111.206 168.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 79.47 128.29 0.05 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 127.067 2.147 . . . . 74.430000000000007 111.32 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 62.92 55.15 2.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.787 1.635 . . . . 74.439999999999998 110.561 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -50.95 152.46 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.597 1.159 . . . . 75.310000000000002 110.71 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -31.28 -62.34 0.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.433 1.893 . . . . 74.5 112.799 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.49 49.05 0.94 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.052 0.835 . . . . 63.32 111.319 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -159.29 168.32 26.71 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.101 0.95 . . . . 73.230000000000004 109.983 173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mt 59.83 50.83 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.838 1.255 . . . . 52.329999999999998 109.018 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.33 55.42 1.06 Allowed Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.244 1.018 . . . . 72.519999999999996 110.965 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.93 151.51 68.12 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.057 2.504 . . . . 72.219999999999999 110.79 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.92 104.5 0.64 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.268 -1.133 . . . . 63.020000000000003 110.268 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -152.95 110.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.962 0.905 . . . . 72.239999999999995 109.303 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.5 mt -77.18 139.94 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 74.120000000000005 108.72 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.69 157.06 29.35 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.459 -1.057 . . . . 74.519999999999996 110.459 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.39 55.0 33.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.041 0.829 . . . . 73.430000000000007 111.483 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.1 p -155.27 81.27 1.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.367 0.667 . . . . 72.219999999999999 110.027 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.97 67.66 9.29 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.973 0.909 . . . . 71.349999999999994 109.341 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.78 161.05 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.472 2.781 . . . . 72.140000000000001 111.562 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -158.35 113.91 2.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.458 -1.312 . . . . 74.129999999999995 107.458 172.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.22 121.02 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.473 0.709 . . . . 71.319999999999993 109.922 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 166.61 149.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.066 2.546 . . . . 72.329999999999998 108.846 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -158.19 142.34 11.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.327 -1.36 . . . . 63.439999999999998 107.327 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.11 -21.34 36.65 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 71.540000000000006 111.895 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -60.48 -19.16 55.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.577 1.151 . . . . 73.430000000000007 113.219 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 75.319999999999993 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 73.099999999999994 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 71.319999999999993 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 72.310000000000002 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 73.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 74.310000000000002 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 74.549999999999997 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 74.519999999999996 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 71.239999999999995 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 75.129999999999995 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 71.25 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.519999999999996 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 73.239999999999995 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 63.329999999999998 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 75.010000000000005 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 74.519999999999996 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 73.209999999999994 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 71.409999999999997 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 73.319999999999993 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 75.25 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 75.040000000000006 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 74.420000000000002 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 63.200000000000003 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 72.340000000000003 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 74.019999999999996 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 74.010000000000005 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 64.25 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p -63.91 -29.58 70.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -83.16 -46.93 12.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.704 0.802 . . . . 74.319999999999993 110.298 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.37 99.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.252 1.021 . . . . 74.319999999999993 109.238 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 165.55 12.04 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.598 1.159 . . . . 74.409999999999997 109.481 166.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -109.65 139.95 21.7 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 124.001 0.92 . . . . 65.329999999999998 109.358 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.32 165.28 33.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.079 2.519 . . . . 72.450000000000003 110.73 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -81.3 63.7 5.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.964 0.906 . . . . 71.340000000000003 110.294 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.62 154.75 23.04 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.311 1.444 . . . . 74.340000000000003 107.892 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.2 tp -147.83 77.32 10.29 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.221 1.008 . . . . 74.5 108.281 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -85.28 52.05 3.18 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.485 2.79 . . . . 73.439999999999998 110.553 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 38.5 mmt -86.64 67.88 9.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.942 0.897 . . . . 73.430000000000007 110.179 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.7 132.91 42.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.129 -0.693 . . . . 70.030000000000001 109.129 172.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.1 m -146.36 63.52 1.21 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.196 0.998 . . . . 74.319999999999993 109.26 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.26 127.06 2.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.642 -1.383 . . . . 63.109999999999999 109.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 147.26 14.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 70.420000000000002 109.312 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.38 170.96 18.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.531 2.821 . . . . 65.450000000000003 110.963 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.37 146.73 7.57 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.54 -1.424 . . . . 75.519999999999996 109.54 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.25 176.83 44.77 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.883 -0.887 . . . . 75.329999999999998 110.883 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.74 165.25 31.96 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.363 -1.095 . . . . 73.349999999999994 110.363 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -162.97 153.22 16.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.107 0.963 . . . . 73.209999999999994 109.372 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -163.23 153.71 16.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.576 1.15 . . . . 73.25 109.268 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -153.76 147.59 25.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.542 1.137 . . . . 63.420000000000002 108.384 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -153.92 164.04 39.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.577 1.151 . . . . 71.209999999999994 108.326 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -161.45 160.46 29.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.873 0.869 . . . . 73.530000000000001 109.262 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -69.57 146.78 51.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.359 0.663 . . . . 74.510000000000005 109.676 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.836 -1.078 . . . . 75.409999999999997 111.146 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.988 -1.006 . . . . 74.540000000000006 111.654 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.44 152.99 60.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.837 1.691 . . . . 71.230000000000004 109.712 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -138.79 74.8 1.49 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 74.109999999999999 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 74.230000000000004 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 64.430000000000007 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 72.129999999999995 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 72.549999999999997 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.439999999999998 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt -151.75 102.02 2.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 73.120000000000005 108.063 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.15 177.2 53.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.683 0.659 . . . . 54.340000000000003 112.244 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.07 176.57 45.81 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.63 -0.988 . . . . 54.5 110.63 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.21 140.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.378 1.871 . . . . 71.209999999999994 111.924 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.8 t80 54.44 51.96 13.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.638 1.175 . . . . 62.549999999999997 111.216 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.2 t -101.24 142.27 16.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.596 1.158 . . . . 75.099999999999994 108.479 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -71.01 84.84 0.7 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.667 0.787 . . . . 75.530000000000001 108.882 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 -44.98 0.57 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.228 -1.549 . . . . 75.109999999999999 109.228 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -65.57 135.27 95.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 65.310000000000002 108.591 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.48 133.85 16.37 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.75 2.3 . . . . 73.319999999999993 109.603 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.32 89.6 12.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.135 . . . . 62.439999999999998 108.214 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.09 -160.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.365 2.71 . . . . 74.25 110.431 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 70.540000000000006 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 75.040000000000006 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 72.439999999999998 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.219999999999999 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 71.310000000000002 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 71.299999999999997 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 71.230000000000004 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 61.119999999999997 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 65.540000000000006 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 74.430000000000007 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 73.510000000000005 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 74.319999999999993 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 71.439999999999998 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 71.310000000000002 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 75.299999999999997 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 72.549999999999997 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 74.230000000000004 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 72.129999999999995 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.79 138.81 2.64 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -69.47 -42.15 75.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.548 -0.908 . . . . 75.519999999999996 108.548 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.95 -63.04 1.45 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.277 1.431 . . . . 74.239999999999995 109.128 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.49 -52.11 0.39 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.757 1.623 . . . . 65.430000000000007 107.36 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -101.73 -177.57 3.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.983 -1.117 . . . . 74.510000000000005 107.983 152.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -63.08 -52.7 61.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.546 0.738 . . . . 64.109999999999999 110.374 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.03 69.73 0.27 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.176 -1.169 . . . . 74.540000000000006 110.176 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 t -160.34 -175.54 5.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.475 1.11 . . . . 74.420000000000002 108.933 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 mt 63.79 65.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.787 1.635 . . . . 74.129999999999995 108.183 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -139.22 70.64 40.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.239 1.016 . . . . 75.329999999999998 109.851 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.24 89.4 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.386 2.724 . . . . 63.539999999999999 109.453 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.96 -170.78 46.48 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.013 0.816 . . . . 71.129999999999995 111.917 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.96 92.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.662 1.585 . . . . 74.349999999999994 109.177 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.37 134.46 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.691 -0.855 . . . . 75.140000000000001 108.691 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.1 44.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.655 -0.978 . . . . 74.239999999999995 110.655 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.05 -169.68 42.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.561 -1.016 . . . . 62.149999999999999 110.561 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.3 m -65.71 144.99 56.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.566 0.746 . . . . 70.319999999999993 110.757 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -123.27 80.31 52.67 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.59 1.156 . . . . 72.340000000000003 109.348 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.51 164.78 33.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.187 2.591 . . . . 74.549999999999997 110.556 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -102.08 -157.25 0.6 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.249 1.019 . . . . 74.510000000000005 109.004 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.0 137.1 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.613 1.565 . . . . 75.549999999999997 108.126 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 157.24 28.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.709 0.804 . . . . 70.120000000000005 110.775 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.7 t -158.67 144.93 12.53 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.927 0.891 . . . . 72.430000000000007 108.966 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.65 -16.05 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.654 2.236 . . . . 75.230000000000004 111.842 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -60.24 -21.45 61.86 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 75.200000000000003 112.171 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 73.040000000000006 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 71.420000000000002 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.510000000000005 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 74.420000000000002 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 70.439999999999998 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 74.120000000000005 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 74.420000000000002 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 72.209999999999994 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 72.409999999999997 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 75.439999999999998 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.540000000000006 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 75.430000000000007 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 75.450000000000003 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 62.340000000000003 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 72.409999999999997 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 74.239999999999995 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 71.450000000000003 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 73.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 72.140000000000001 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 72.120000000000005 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 75.439999999999998 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 73.340000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p -60.57 -24.5 65.47 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.99 -43.51 11.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.082 0.953 . . . . 75.340000000000003 110.757 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.84 92.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.075 0.95 . . . . 75.430000000000007 110.348 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -145.95 167.64 22.81 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.789 1.235 . . . . 74.430000000000007 110.137 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.71 143.84 49.03 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.847 1.259 . . . . 75.120000000000005 108.483 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.03 172.78 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.366 2.711 . . . . 75.239999999999995 110.729 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -80.09 64.52 4.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.083 0.953 . . . . 65.409999999999997 109.94 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.39 148.94 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.546 1.139 . . . . 74.420000000000002 109.221 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.5 tp -112.56 91.66 17.67 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.942 1.297 . . . . 74.5 108.487 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.32 126.13 12.0 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.307 2.005 . . . . 72.450000000000003 109.236 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.5 tpt -154.44 106.48 2.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.737 0.815 . . . . 75.230000000000004 108.989 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.62 134.63 35.74 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.779 1.232 . . . . 71.049999999999997 108.535 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.7 m -164.17 165.11 22.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.373 1.469 . . . . 74.430000000000007 109.26 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.15 173.04 49.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.018 0.818 . . . . 73.439999999999998 112.231 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.8 73.58 6.49 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.384 1.073 . . . . 75.019999999999996 109.274 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.38 175.06 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.407 2.738 . . . . 74.310000000000002 111.213 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.47 98.33 1.98 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.067 -1.213 . . . . 52.439999999999998 110.067 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.95 173.88 42.25 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.214 -1.154 . . . . 71.319999999999993 110.214 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.39 -179.66 46.95 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.429 -1.068 . . . . 64.140000000000001 110.429 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 65.0 p -161.18 159.76 29.28 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.188 0.995 . . . . 71.510000000000005 109.647 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -160.38 106.58 1.53 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.506 -0.924 . . . . 73.430000000000007 108.506 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -132.99 62.36 1.66 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.931 0.892 . . . . 73.409999999999997 108.913 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -125.04 141.32 52.2 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.294 1.038 . . . . 74.209999999999994 109.725 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -166.2 167.5 16.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.631 1.172 . . . . 74.120000000000005 109.312 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -99.02 173.93 6.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.46 1.104 . . . . 72.299999999999997 109.435 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.549 -1.215 . . . . 64.239999999999995 109.76 174.15 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 117.914 -1.041 . . . . 74.120000000000005 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.82 159.82 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.929 1.753 . . . . 71.120000000000005 110.498 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -159.73 162.92 35.05 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.305 1.042 . . . . 72.109999999999999 109.516 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 74.540000000000006 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.319999999999993 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.5 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 64.099999999999994 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 71.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 72.310000000000002 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 73.209999999999994 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 72.430000000000007 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.96 154.82 46.98 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.310000000000002 110.293 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 163.2 33.83 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.752 -1.339 . . . . 65.519999999999996 109.752 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.88 39.26 77.47 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.737 0.684 . . . . 73.409999999999997 111.949 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.04 175.8 9.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.304 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.45 149.38 42.84 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 110.059 -0.348 . . . . 65.150000000000006 110.059 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.1 t 69.54 -56.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.17 2.188 . . . . 72.129999999999995 111.667 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -60.93 -64.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.136 0.974 . . . . 73.400000000000006 110.579 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.78 -60.38 2.08 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.841 -1.704 . . . . 71.420000000000002 108.841 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 66.41 150.49 0.12 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.672 2.389 . . . . 74.349999999999994 113.381 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.91 86.01 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.33 2.686 . . . . 74.140000000000001 111.098 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.0 mt -124.83 -70.06 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.938 1.295 . . . . 63.119999999999997 109.782 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.03 -178.39 3.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.723 1.615 . . . . 70.140000000000001 108.842 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 74.319999999999993 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 74.329999999999998 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 72.409999999999997 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 74.510000000000005 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 75.099999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 74.25 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 73.400000000000006 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 41.340000000000003 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 75.430000000000007 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 64.209999999999994 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.409999999999997 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 75.530000000000001 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 71.420000000000002 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.420000000000002 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 74.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 72.439999999999998 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 72.530000000000001 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 72.019999999999996 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.88 148.27 15.49 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 75.299999999999997 109.37 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -46.77 -56.55 6.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.388 1.475 . . . . 75.310000000000002 110.391 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -104.62 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.746 2.018 . . . . 73.010000000000005 107.41 167.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -148.13 74.53 1.3 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.898 -0.778 . . . . 74.150000000000006 108.898 164.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 56.61 34.07 23.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.264 1.426 . . . . 75.019999999999996 113.219 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.5 p -84.43 -79.99 0.21 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.011 0.823 . . . . 61.420000000000002 109.477 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.23 17.41 18.35 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.019 -0.879 . . . . 64.319999999999993 113.517 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -163.8 174.42 11.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.645 1.222 . . . . 72.239999999999995 109.629 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mt 58.76 25.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.056 1.742 . . . . 73.329999999999998 112.185 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -152.77 148.7 20.85 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.393 1.477 . . . . 72.129999999999995 108.598 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.4 158.63 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.251 2.634 . . . . 75.409999999999997 110.483 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 56.68 0.43 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.271 -1.132 . . . . 74.530000000000001 110.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -84.06 60.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.335 1.054 . . . . 74.400000000000006 110.561 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.3 mt -71.59 -54.26 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.853 0.861 . . . . 73.519999999999996 110.1 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.05 -139.6 32.86 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.77 -0.932 . . . . 70.430000000000007 110.77 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.43 146.02 6.89 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.788 -0.925 . . . . 73.010000000000005 110.788 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -81.76 149.77 28.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.218 1.007 . . . . 74.25 110.225 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 131.3 23.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.499 1.12 . . . . 74.150000000000006 108.792 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.64 157.72 39.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.439 2.759 . . . . 72.230000000000004 111.654 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -86.66 67.46 9.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.81 1.244 . . . . 75.150000000000006 109.691 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.1 t -73.06 135.68 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.231 -0.655 . . . . 75.510000000000005 109.231 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.49 140.28 34.68 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 109.641 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.41 144.26 11.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.759 0.824 . . . . 73.219999999999999 109.127 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.31 -5.3 16.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.591 2.86 . . . . 72.540000000000006 113.07 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -26.61 13.45 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.148 0.979 . . . . 75.319999999999993 112.617 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 73.409999999999997 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 74.349999999999994 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 75.040000000000006 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 74.109999999999999 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 71.129999999999995 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 73.219999999999999 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 73.329999999999998 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 73.109999999999999 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.400000000000006 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 74.319999999999993 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 75.019999999999996 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 71.319999999999993 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 73.209999999999994 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 74.519999999999996 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 74.040000000000006 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 72.099999999999994 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 64.109999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 75.430000000000007 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -67.89 -14.14 62.72 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 64.219999999999999 112.547 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -96.97 -111.92 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.45 -1.315 . . . . 73.430000000000007 107.45 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.41 84.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.293 -1.003 . . . . 73.409999999999997 108.293 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -79.48 91.48 5.14 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.285 1.034 . . . . 75.430000000000007 108.586 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -64.25 139.74 97.77 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.894 -0.78 . . . . 75.219999999999999 108.894 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.14 162.56 39.63 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.131 2.554 . . . . 74.349999999999994 111.488 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.38 60.68 4.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.496 1.118 . . . . 74.319999999999993 109.589 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -161.15 142.19 11.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.755 1.222 . . . . 74.230000000000004 109.583 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.8 149.76 46.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.819 1.248 . . . . 73.150000000000006 110.469 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.02 163.77 36.03 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.019 2.479 . . . . 74.040000000000006 110.734 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -121.04 156.88 31.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.824 1.25 . . . . 75.329999999999998 110.143 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.99 162.92 40.74 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.358 1.463 . . . . 75.430000000000007 109.097 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.0 m -158.62 143.0 15.8 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.061 1.344 . . . . 60.530000000000001 109.077 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.83 74.81 0.03 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.317 -1.113 . . . . 64.439999999999998 110.317 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.38 74.7 78.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 75.200000000000003 110.336 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.12 174.06 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.645 2.897 . . . . 71.329999999999998 111.165 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.04 179.13 48.1 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.045 -0.822 . . . . 70.319999999999993 111.045 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.93 47.66 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.767 -0.933 . . . . 73.340000000000003 110.767 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.32 47.91 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.196 -0.762 . . . . 65.040000000000006 111.196 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.8 t -162.72 169.79 19.43 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.76 1.224 . . . . 75.310000000000002 109.513 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -154.02 179.42 8.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.851 1.261 . . . . 72.140000000000001 109.822 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -150.43 108.23 3.69 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.515 1.126 . . . . 64.319999999999993 108.39 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -102.04 135.48 43.53 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.235 1.014 . . . . 73.540000000000006 109.09 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -168.25 167.44 12.18 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.037 1.335 . . . . 73.25 108.834 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -155.69 173.81 16.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.598 0.759 . . . . 71.329999999999998 110.544 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.436 -1.269 . . . . 73.540000000000006 109.225 173.499 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.032 -0.359 . . . . 62.420000000000002 110.032 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.310000000000002 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 61.329999999999998 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 65.409999999999997 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 62.109999999999999 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 62.030000000000001 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 64.129999999999995 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 62.409999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 70.239999999999995 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 65.510000000000005 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp . . . . . 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 109.122 -1.145 . . . . 41.310000000000002 109.122 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 64.430000000000007 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 54.119999999999997 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 71.439999999999998 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 65.329999999999998 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 71.519999999999996 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 54.530000000000001 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 52.109999999999999 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 52.32 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 53.200000000000003 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 73.010000000000005 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 73.140000000000001 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 62.439999999999998 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 35.149999999999999 110.134 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.242 0.83 . . . . 41.030000000000001 113.242 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 35.409999999999997 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 72.319999999999993 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 54.229999999999997 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 73.329999999999998 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 61.0 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.129999999999995 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 52.450000000000003 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 41.020000000000003 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 62.399999999999999 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 63.229999999999997 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 62.119999999999997 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 62.119999999999997 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 52.329999999999998 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 70.349999999999994 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 73.109999999999999 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 64.049999999999997 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 63.450000000000003 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.030000000000001 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 71.400000000000006 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 73.030000000000001 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 71.25 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 74.430000000000007 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 71.310000000000002 112.05 -178.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.675 -0.491 . . . . 74.230000000000004 109.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 63.100000000000001 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 73.299999999999997 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 62.140000000000001 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 24.420000000000002 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.209999999999994 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 55.149999999999999 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 73.209999999999994 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 73.409999999999997 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 70.439999999999998 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 60.119999999999997 109.477 -179.135 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 N-CA-C 109.498 -1.001 . . . . 72.340000000000003 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 53.350000000000001 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 65.349999999999994 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 62.039999999999999 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 70.219999999999999 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 62.399999999999999 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 63.130000000000003 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 53.439999999999998 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 55.149999999999999 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 72.439999999999998 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 54.119999999999997 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 71.530000000000001 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 54.240000000000002 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 43.219999999999999 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 62.43 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 53.149999999999999 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 71.540000000000006 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 119.44 -0.314 . . . . 73.040000000000006 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 73.299999999999997 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 74.349999999999994 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 64.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 70.120000000000005 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 54.420000000000002 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 64.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 62.350000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 52.119999999999997 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 65.319999999999993 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 72.510000000000005 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 65.030000000000001 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 61.240000000000002 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 64.340000000000003 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 72.340000000000003 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 52.310000000000002 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 62.049999999999997 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 71.129999999999995 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 73.409999999999997 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 71.540000000000006 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 70.030000000000001 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 71.010000000000005 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 51.119999999999997 111.658 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.007 -0.738 . . . . 73.310000000000002 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 55.43 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 53.119999999999997 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 55.32 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 72.450000000000003 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.049999999999997 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 64.549999999999997 108.522 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 108.586 -1.352 . . . . 62.109999999999999 108.586 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 55.539999999999999 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 62.039999999999999 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 71.430000000000007 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 71.420000000000002 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 70.219999999999999 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 51.229999999999997 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 60.310000000000002 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 50.130000000000003 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 73.349999999999994 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 65.420000000000002 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 61.32 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 53.520000000000003 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 73.239999999999995 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 54.350000000000001 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 63.210000000000001 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 30.5 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 63.43 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 70.439999999999998 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 62.43 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 51.399999999999999 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 72.349999999999994 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 111.755 0.279 . . . . 74.120000000000005 111.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.140000000000001 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 72.239999999999995 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 60.229999999999997 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 62.210000000000001 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 62.310000000000002 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 63.329999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 72.129999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 63.25 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 43.340000000000003 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 71.420000000000002 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 62.039999999999999 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 73.409999999999997 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 64.010000000000005 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 65.530000000000001 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 65.299999999999997 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 54.310000000000002 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 72.109999999999999 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 63.439999999999998 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 51.210000000000001 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 64.239999999999995 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 54.299999999999997 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 62.549999999999997 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.32 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 43.32 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 64.340000000000003 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.409999999999997 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 64.439999999999998 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 64.120000000000005 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 52.119999999999997 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 72.120000000000005 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 73.129999999999995 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 110.569 -0.159 . . . . 64.510000000000005 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 51.43 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.430000000000007 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 72.439999999999998 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 63.219999999999999 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 72.109999999999999 108.852 -178.757 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.539 0.773 0 N-CA-C 110.389 -0.658 . . . . 72.329999999999998 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 55.130000000000003 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 45.409999999999997 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.140000000000001 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 65.019999999999996 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 71.140000000000001 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 61.520000000000003 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 62.140000000000001 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 64.140000000000001 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.219999999999999 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 71.049999999999997 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 72.230000000000004 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 61.509999999999998 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.540000000000006 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 64.040000000000006 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 64.040000000000006 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 74.310000000000002 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 51.229999999999997 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 74.030000000000001 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 71.120000000000005 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 65.140000000000001 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.340000000000003 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 74.400000000000006 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 64.329999999999998 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 65.340000000000003 111.431 170.493 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.753 0.279 . . . . 54.020000000000003 111.753 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 45.020000000000003 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 62.109999999999999 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 63.539999999999999 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.239999999999995 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 72.540000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 44.399999999999999 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 74.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 74.439999999999998 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.039999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 52.409999999999997 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 70.409999999999997 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.209999999999994 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 64.219999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 63.450000000000003 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 71.019999999999996 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.120000000000005 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 70.510000000000005 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 61.450000000000003 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 34.200000000000003 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 72.129999999999995 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 71.430000000000007 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 71.049999999999997 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 71.230000000000004 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.349999999999994 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 72.230000000000004 112.661 -179.789 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.265 -0.643 . . . . 71.040000000000006 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 61.119999999999997 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 64.209999999999994 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.430000000000007 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 63.439999999999998 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 73.319999999999993 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 64.420000000000002 110.35 -175.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 N--CA 1.455 -0.742 0 N-CA-C 109.396 -1.04 . . . . 64.019999999999996 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 70.420000000000002 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 72.430000000000007 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 63.5 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.019999999999996 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 73.099999999999994 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 71.0 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 72.230000000000004 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 53.439999999999998 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 61.030000000000001 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.099999999999994 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.310000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 52.439999999999998 111.678 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.618 0.599 . . . . 74.329999999999998 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 64.409999999999997 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 70.129999999999995 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 72.439999999999998 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 71.340000000000003 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 71.430000000000007 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 63.109999999999999 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 44.210000000000001 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 71.329999999999998 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 72.140000000000001 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 71.019999999999996 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 65.450000000000003 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 73.430000000000007 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 63.399999999999999 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 60.310000000000002 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 72.319999999999993 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 55.219999999999999 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 71.209999999999994 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 25.539999999999999 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 72.450000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 24.210000000000001 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 62.119999999999997 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 72.319999999999993 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 73.540000000000006 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 65.329999999999998 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 71.219999999999999 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 61.140000000000001 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.29 -0.633 . . . . 71.519999999999996 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 61.509999999999998 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 52.030000000000001 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 71.439999999999998 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 73.519999999999996 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 109.844 -0.868 . . . . 62.020000000000003 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 54.240000000000002 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 44.030000000000001 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 74.430000000000007 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 70.209999999999994 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 61.030000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 71.230000000000004 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 71.230000000000004 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 65.109999999999999 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 60.399999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 73.340000000000003 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 73.219999999999999 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 71.420000000000002 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 64.230000000000004 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 60.240000000000002 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 71.209999999999994 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.109999999999999 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.93 0.715 . . . . 44.119999999999997 112.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 62.130000000000003 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 62.009999999999998 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 54.140000000000001 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 62.310000000000002 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 62.0 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.409999999999997 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 73.150000000000006 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 64.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 51.240000000000002 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 71.209999999999994 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 65.239999999999995 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 74.030000000000001 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 52.020000000000003 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 63.119999999999997 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 61.310000000000002 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 70.109999999999999 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 63.109999999999999 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 72.510000000000005 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 63.32 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 73.109999999999999 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 72.010000000000005 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 63.439999999999998 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 73.140000000000001 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 62.32 109.569 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 73.109999999999999 109.657 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 64.129999999999995 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 72.319999999999993 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 72.319999999999993 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 63.329999999999998 109.998 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 CA--C 1.539 0.769 0 N-CA-C 111.426 -0.259 . . . . 74.230000000000004 111.426 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 62.149999999999999 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 71.439999999999998 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.120000000000005 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.150000000000006 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 73.310000000000002 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 71.439999999999998 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 64.540000000000006 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 72.230000000000004 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 50.439999999999998 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 63.240000000000002 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 70.239999999999995 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 71.25 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 65.140000000000001 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.491 0.552 . . . . 72.319999999999993 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 71.340000000000003 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 41.109999999999999 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 54.020000000000003 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.030000000000001 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 61.009999999999998 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 65.25 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 64.310000000000002 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 51.450000000000003 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 65.0 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 53.020000000000003 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 65.120000000000005 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 64.030000000000001 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 72.019999999999996 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 71.409999999999997 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 51.229999999999997 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 74.430000000000007 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 43.119999999999997 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.140000000000001 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.020000000000003 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 74.25 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 64.430000000000007 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 64.150000000000006 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 61.240000000000002 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 63.109999999999999 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 52.310000000000002 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 71.030000000000001 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 73.299999999999997 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 74.230000000000004 112.598 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.272 0.558 . . . . 75.420000000000002 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 55.119999999999997 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 71.510000000000005 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 54.439999999999998 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 109.754 -0.902 . . . . 52.219999999999999 109.754 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 64.319999999999993 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 63.530000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 65.209999999999994 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 72.129999999999995 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.140000000000001 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 65.209999999999994 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 71.109999999999999 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 71.209999999999994 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 63.530000000000001 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 51.439999999999998 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 61.240000000000002 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 72.010000000000005 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 71.409999999999997 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 63.009999999999998 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 50.119999999999997 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 72.310000000000002 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 71.430000000000007 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 52.25 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 71.230000000000004 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 61.140000000000001 109.573 -174.067 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 113.086 0.773 . . . . 74.420000000000002 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 63.130000000000003 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 63.229999999999997 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 60.539999999999999 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 63.520000000000003 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 34.100000000000001 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 64.230000000000004 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 44.530000000000001 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 53.310000000000002 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 70.439999999999998 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 62.43 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 53.109999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.109999999999999 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 55.409999999999997 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.010000000000005 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 71.239999999999995 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 72.019999999999996 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 61.350000000000001 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 63.149999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 63.329999999999998 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 54.5 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 71.209999999999994 111.66 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 110.58 -0.156 . . . . 75.349999999999994 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 73.120000000000005 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 53.240000000000002 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 61.43 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 51.140000000000001 109.623 -174.459 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 N-CA-C 111.422 -0.261 . . . . 73.150000000000006 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 71.230000000000004 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 64.239999999999995 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 62.520000000000003 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 45.32 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 64.310000000000002 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 62.520000000000003 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 74.329999999999998 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 31.210000000000001 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 65.340000000000003 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 61.240000000000002 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 72.430000000000007 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 52.520000000000003 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 63.210000000000001 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 61.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 64.439999999999998 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 65.310000000000002 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 71.510000000000005 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 71.319999999999993 111.221 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.676 0.621 . . . . 71.430000000000007 112.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 61.020000000000003 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 62.119999999999997 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 128' ' ' ILE . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 72.549999999999997 110.586 165.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.119999999999997 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 63.030000000000001 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 63.140000000000001 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 51.539999999999999 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 71.299999999999997 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 55.229999999999997 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 63.420000000000002 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 71.549999999999997 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 74.439999999999998 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 63.409999999999997 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 44.329999999999998 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 73.430000000000007 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 63.009999999999998 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 92' ' ' ILE . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 54.109999999999999 112.235 -173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 45.219999999999999 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 70.129999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.095 -0.706 . . . . 73.340000000000003 109.095 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 74.120000000000005 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 52.299999999999997 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 70.230000000000004 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 65.5 108.923 176.972 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 110.26 -0.708 . . . . 64.340000000000003 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 64.25 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 61.130000000000003 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 71.219999999999999 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 71.340000000000003 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 65.230000000000004 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 73.25 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 62.509999999999998 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 70.120000000000005 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 73.109999999999999 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 70.430000000000007 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 72.209999999999994 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 72.530000000000001 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.239999999999995 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 71.140000000000001 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 63.109999999999999 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 51.509999999999998 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 72.5 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 64.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 64.230000000000004 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 42.350000000000001 111.049 -170.542 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 75.109999999999999 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 71.439999999999998 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 70.540000000000006 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 64.400000000000006 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 74.319999999999993 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 92' ' ' ILE . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 52.32 109.48 172.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 63.149999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 72.549999999999997 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 65.219999999999999 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 71.340000000000003 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.129999999999995 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 72.120000000000005 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 71.030000000000001 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 53.030000000000001 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 53.539999999999999 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 61.530000000000001 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 71.230000000000004 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 52.329999999999998 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 51.140000000000001 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 61.109999999999999 111.984 -176.923 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.047 -0.723 . . . . 55.43 109.047 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 51.100000000000001 106.464 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.019999999999996 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 62.299999999999997 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 54.130000000000003 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 71.340000000000003 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.319999999999993 110.252 -165.041 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 N-CA-C 111.318 -0.301 . . . . 74.140000000000001 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 52.240000000000002 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 73.540000000000006 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 64.150000000000006 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 54.049999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 72.209999999999994 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 73.299999999999997 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 70.340000000000003 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 74.239999999999995 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 61.409999999999997 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 64.219999999999999 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 72.439999999999998 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 74.439999999999998 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 63.340000000000003 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 50.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 60.25 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 30.52 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.239999999999995 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 72.340000000000003 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.219999999999999 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 62.450000000000003 111.664 -173.714 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.876 0.695 . . . . 71.209999999999994 112.876 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 70.140000000000001 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 63.149999999999999 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 65.409999999999997 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 73.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 64.420000000000002 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 65.450000000000003 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 52.229999999999997 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 64.040000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 50.539999999999999 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.109999999999999 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 73.409999999999997 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 73.239999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 52.409999999999997 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 71.510000000000005 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 72.319999999999993 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 63.109999999999999 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 62.030000000000001 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 64.129999999999995 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 71.430000000000007 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 63.020000000000003 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 65.319999999999993 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 108.668 -0.864 . . . . 75.299999999999997 108.668 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 70.409999999999997 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 43.219999999999999 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 N-CA-C 110.63 -0.565 . . . . 55.340000000000003 110.63 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 72.010000000000005 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 65.0 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 71.329999999999998 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 62.030000000000001 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 63.210000000000001 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 74.400000000000006 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 63.109999999999999 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 54.5 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 65.040000000000006 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 44.020000000000003 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 64.200000000000003 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 64.239999999999995 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 44.549999999999997 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 72.519999999999996 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.340000000000003 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.209 0.448 . . . . 73.109999999999999 112.209 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 64.019999999999996 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 54.0 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 55.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 62.130000000000003 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 44.140000000000001 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 72.519999999999996 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 60.240000000000002 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 62.530000000000001 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 60.109999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 43.32 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 63.520000000000003 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 62.32 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 70.340000000000003 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 55.240000000000002 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 64.099999999999994 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 62.200000000000003 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 72.549999999999997 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 63.420000000000002 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 72.109999999999999 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.129999999999995 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 70.120000000000005 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 73.329999999999998 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 71.400000000000006 112.093 -178.133 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.474 -0.195 . . . . 62.329999999999998 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 72.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 54.009999999999998 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 42.439999999999998 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 71.510000000000005 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 N-CA-C 109.691 -0.927 . . . . 43.310000000000002 109.691 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 70.239999999999995 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 64.120000000000005 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 73.150000000000006 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 74.439999999999998 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 52.049999999999997 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 65.510000000000005 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 53.149999999999999 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 53.310000000000002 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 63.350000000000001 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 54.229999999999997 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 71.230000000000004 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 62.240000000000002 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 55.219999999999999 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 61.130000000000003 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 74.310000000000002 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 64.209999999999994 110.452 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.579 0.585 . . . . 72.109999999999999 112.579 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 51.439999999999998 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 72.150000000000006 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 62.229999999999997 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 63.539999999999999 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 63.119999999999997 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 64.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 63.32 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 44.299999999999997 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 63.030000000000001 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 65.219999999999999 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 72.010000000000005 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 62.100000000000001 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 52.229999999999997 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 63.229999999999997 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 72.230000000000004 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 61.140000000000001 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 71.120000000000005 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 65.010000000000005 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 52.229999999999997 112.061 -179.196 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.61 -0.885 . . . . 64.140000000000001 108.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 65.109999999999999 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 40.509999999999998 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 70.140000000000001 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 73.150000000000006 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 64.219999999999999 112.49 179.249 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 109.752 -0.903 . . . . 63.140000000000001 109.752 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 65.409999999999997 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 64.219999999999999 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 64.209999999999994 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.040000000000006 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 62.43 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.129999999999995 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 54.439999999999998 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 64.049999999999997 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 70.010000000000005 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 44.219999999999999 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 64.129999999999995 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 64.420000000000002 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 60.310000000000002 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 70.099999999999994 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 61.299999999999997 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 74.5 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 74.219999999999999 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 72.540000000000006 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.040000000000006 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 61.299999999999997 108.912 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.696 0.628 . . . . 61.439999999999998 112.696 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 70.140000000000001 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 71.450000000000003 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 40.5 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 72.519999999999996 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 64.519999999999996 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 60.020000000000003 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 71.420000000000002 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 62.149999999999999 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 61.140000000000001 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 70.420000000000002 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 54.100000000000001 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 55.25 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 63.450000000000003 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 72.329999999999998 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 73.540000000000006 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 73.340000000000003 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.239999999999995 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.032 -0.359 . . . . 62.310000000000002 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 61.310000000000002 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 64.420000000000002 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 71.349999999999994 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 64.430000000000007 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 52.439999999999998 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 53.009999999999998 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 53.229999999999997 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.030000000000001 109.189 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 108.915 -1.225 . . . . 73.140000000000001 108.915 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 65.030000000000001 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 71.420000000000002 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 72.230000000000004 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 71.329999999999998 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 70.510000000000005 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 71.420000000000002 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 70.230000000000004 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 63.100000000000001 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 55.32 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 51.119999999999997 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 65.129999999999995 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 64.430000000000007 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.219999999999999 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 64.349999999999994 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 43.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 50.439999999999998 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 55.219999999999999 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 51.409999999999997 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 62.450000000000003 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 65.349999999999994 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.829 0.307 . . . . 75.239999999999995 111.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 73.209999999999994 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 73.319999999999993 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 53.450000000000003 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 72.400000000000006 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 63.32 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 64.200000000000003 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 72.010000000000005 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 73.400000000000006 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 62.200000000000003 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 72.450000000000003 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 61.130000000000003 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 43.43 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.140000000000001 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 72.340000000000003 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 62.450000000000003 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 63.020000000000003 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 62.439999999999998 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 62.329999999999998 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 72.439999999999998 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 71.530000000000001 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 73.239999999999995 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 64.510000000000005 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 64.239999999999995 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.969 -0.752 . . . . 73.109999999999999 108.969 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 43.200000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 72.030000000000001 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 71.099999999999994 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 55.009999999999998 111.659 -172.121 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 110.805 -0.498 . . . . 52.229999999999997 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 40.049999999999997 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 72.25 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 72.150000000000006 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 55.229999999999997 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 73.209999999999994 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 22.329999999999998 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 74.230000000000004 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 71.430000000000007 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 45.210000000000001 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 71.439999999999998 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 52.420000000000002 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 54.140000000000001 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 71.310000000000002 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 43.149999999999999 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 72.040000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 63.130000000000003 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 33.109999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 62.240000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 63.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.150000000000006 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 71.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.154 0.428 . . . . 64.299999999999997 112.154 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 73.299999999999997 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 72.329999999999998 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 71.019999999999996 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 60.5 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 54.539999999999999 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 72.329999999999998 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 51.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 65.310000000000002 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 64.230000000000004 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 45.229999999999997 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 72.040000000000006 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 53.340000000000003 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 64.209999999999994 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 72.129999999999995 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 73.209999999999994 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 60.25 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 64.040000000000006 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 70.109999999999999 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 61.409999999999997 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 71.200000000000003 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 64.129999999999995 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 64.219999999999999 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 72.329999999999998 111.879 -176.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.932 0.396 . . . . 74.319999999999993 111.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 71.0 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 72.230000000000004 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 43.130000000000003 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 51.539999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.0 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 60.520000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 110.128 -0.759 . . . . 73.030000000000001 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 73.340000000000003 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 63.340000000000003 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 44.340000000000003 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 65.0 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 73.109999999999999 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 60.039999999999999 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 62.409999999999997 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 54.109999999999999 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 54.350000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 61.210000000000001 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 73.430000000000007 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 72.409999999999997 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 71.510000000000005 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 64.030000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.756 0.28 . . . . 74.409999999999997 111.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 70.400000000000006 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.310000000000002 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 72.310000000000002 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 64.219999999999999 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 41.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 55.43 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 63.43 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 61.439999999999998 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 63.240000000000002 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 42.310000000000002 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 62.130000000000003 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 72.019999999999996 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 62.130000000000003 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 61.350000000000001 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 64.439999999999998 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 55.149999999999999 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 70.340000000000003 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 44.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 70.129999999999995 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.22 -0.289 . . . . 72.349999999999994 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 72.319999999999993 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 71.430000000000007 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 52.299999999999997 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 54.229999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 61.329999999999998 111.153 -172.631 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 109.778 -0.893 . . . . 71.120000000000005 109.778 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 72.420000000000002 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.340000000000003 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 74.319999999999993 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 61.130000000000003 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 63.030000000000001 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 54.509999999999998 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 62.25 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 62.310000000000002 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 64.299999999999997 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 64.439999999999998 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 70.349999999999994 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 44.329999999999998 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 70.120000000000005 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.219 0.822 . . . . 72.439999999999998 113.219 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 71.329999999999998 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 65.5 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 63.240000000000002 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 63.399999999999999 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 52.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 40.32 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 51.420000000000002 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 53.5 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 62.409999999999997 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 62.119999999999997 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 71.5 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 64.129999999999995 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.209999999999994 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 71.530000000000001 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 60.539999999999999 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 54.219999999999999 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 73.040000000000006 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 70.439999999999998 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 64.420000000000002 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 72.129999999999995 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 63.229999999999997 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 74.25 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 73.349999999999994 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 54.140000000000001 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 71.129999999999995 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 63.439999999999998 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 72.030000000000001 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 62.149999999999999 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 73.030000000000001 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 54.009999999999998 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 63.0 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 63.240000000000002 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.030000000000001 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 65.430000000000007 108.063 -175.245 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 CA--C 1.539 0.748 0 N-CA-C 110.431 -0.642 . . . . 74.25 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 63.119999999999997 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 64.420000000000002 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 62.039999999999999 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.140000000000001 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 62.539999999999999 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 63.030000000000001 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 44.439999999999998 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 63.229999999999997 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 63.509999999999998 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 71.25 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 73.450000000000003 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 54.420000000000002 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 62.009999999999998 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 74.200000000000003 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 65.329999999999998 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 63.5 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 62.229999999999997 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.171 0.434 . . . . 44.520000000000003 112.171 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 65.519999999999996 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 63.210000000000001 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.099999999999994 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 72.129999999999995 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 65.349999999999994 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 71.519999999999996 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 73.349999999999994 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 60.130000000000003 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 53.100000000000001 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 73.319999999999993 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.209999999999994 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 71.310000000000002 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 71.230000000000004 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 33.109999999999999 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 62.439999999999998 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 65.430000000000007 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 70.420000000000002 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 72.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 55.219999999999999 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 62.32 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 73.209999999999994 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 63.130000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.516 -0.549 . . . . 63.329999999999998 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 63.43 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.299999999999997 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 35.409999999999997 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 45.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 71.129999999999995 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 54.329999999999998 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 62.409999999999997 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.299999999999997 110.293 -174.556 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 N-CA-C 108.842 -1.253 . . . . 41.210000000000001 108.842 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' VAL . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 28' ' ' GLU . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 62.409999999999997 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 70.109999999999999 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 65.409999999999997 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 74.349999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 54.009999999999998 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 62.210000000000001 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 33.310000000000002 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 71.230000000000004 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 62.130000000000003 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.030000000000001 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 72.540000000000006 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 62.439999999999998 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.329999999999998 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 71.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 44.340000000000003 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 60.109999999999999 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 25.43 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 54.210000000000001 109.37 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.617 0.599 . . . . 73.129999999999995 112.617 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 71.519999999999996 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 73.340000000000003 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 62.43 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 73.349999999999994 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 65.030000000000001 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 71.150000000000006 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 64.140000000000001 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 71.140000000000001 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.120000000000005 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 72.510000000000005 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 73.010000000000005 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 70.040000000000006 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 63.420000000000002 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 72.209999999999994 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 55.030000000000001 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 54.219999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 73.510000000000005 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 63.130000000000003 112.547 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 118.684 -0.674 . . . . 70.299999999999997 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.77 104.29 1.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.664 2.242 . . . . 70.200000000000003 109.676 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -78.28 78.65 4.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.798 0.839 . . . . 62.420000000000002 110.032 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.310000000000002 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 61.329999999999998 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 65.409999999999997 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 62.109999999999999 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 62.030000000000001 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 64.129999999999995 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 62.409999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 70.239999999999995 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 65.510000000000005 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp 70.9 141.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.69 33.2 75.51 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.39 0.519 . . . . 73.010000000000005 112.671 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.47 83.82 1.49 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.615 -1.794 . . . . 72.299999999999997 108.615 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.26 89.61 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.996 1.318 . . . . 75.299999999999997 111.466 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 53.75 45.43 27.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.881 1.272 . . . . 73.239999999999995 111.034 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.2 t -112.05 -83.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 108.2 -1.037 . . . . 74.230000000000004 108.2 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -169.8 153.02 4.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.677 1.191 . . . . 70.439999999999998 108.344 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.53 55.3 29.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.334 -1.106 . . . . 75.540000000000006 110.334 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -117.76 96.35 49.34 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.932 1.293 . . . . 65.239999999999995 109.42 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.0 136.01 14.42 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.117 2.544 . . . . 73.329999999999998 110.486 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.1 mt 46.23 63.07 10.28 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.339 1.456 . . . . 74.340000000000003 111.681 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.9 93.44 1.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.341 2.694 . . . . 41.310000000000002 109.122 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 64.430000000000007 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 54.119999999999997 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 71.439999999999998 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 65.329999999999998 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 71.519999999999996 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 54.530000000000001 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 52.109999999999999 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 52.32 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 53.200000000000003 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 73.010000000000005 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 73.140000000000001 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 62.439999999999998 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.83 83.61 1.58 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 35.149999999999999 110.134 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -74.84 -45.93 39.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.098 0.559 . . . . 64.239999999999995 111.169 175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 56.75 76.58 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.383 1.473 . . . . 73.219999999999999 110.356 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 68.5 94.07 0.07 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.741 1.616 . . . . 73.230000000000004 109.802 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.94 111.52 1.06 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.298 1.039 . . . . 55.240000000000002 110.446 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.1 p 35.43 48.08 0.39 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.052 1.741 . . . . 61.43 112.131 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.97 62.17 5.46 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.259 0.933 . . . . 32.409999999999997 112.505 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.9 p -154.43 -167.79 2.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.974 0.909 . . . . 73.140000000000001 109.345 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.86 62.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.885 1.274 . . . . 75.209999999999994 109.195 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -161.57 66.63 2.14 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.616 0.766 . . . . 73.209999999999994 110.471 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.11 95.76 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.368 2.712 . . . . 62.340000000000003 110.331 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.96 141.34 5.35 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.488 -1.045 . . . . 63.200000000000003 110.488 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.88 125.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.536 1.534 . . . . 74.219999999999999 107.853 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.5 mt -82.63 143.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.743 1.217 . . . . 65.030000000000001 109.203 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.06 171.78 41.95 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.913 -0.875 . . . . 54.450000000000003 110.913 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.74 164.71 31.58 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.429 -1.069 . . . . 62.32 110.429 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.2 t -161.69 160.89 29.13 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.941 0.896 . . . . 74.230000000000004 109.877 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -154.49 71.79 6.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.026 0.93 . . . . 73.299999999999997 109.938 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.59 158.8 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.816 3.011 . . . . 71.340000000000003 111.971 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -86.44 82.6 7.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.895 1.278 . . . . 71.400000000000006 108.789 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.87 147.39 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.31 1.044 . . . . 45.43 110.327 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.53 169.91 23.62 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.954 1.702 . . . . 63.509999999999998 108.918 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -87.82 147.25 40.74 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.798 0.839 . . . . 61.229999999999997 110.557 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.83 -16.1 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.24 2.627 . . . . 72.099999999999994 111.865 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -57.95 -21.48 44.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.881 1.272 . . . . 41.030000000000001 113.242 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 35.409999999999997 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 72.319999999999993 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 54.229999999999997 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 73.329999999999998 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 61.0 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.129999999999995 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 52.450000000000003 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 41.020000000000003 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 62.399999999999999 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 63.229999999999997 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 62.119999999999997 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 62.119999999999997 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 52.329999999999998 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 70.349999999999994 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 73.109999999999999 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 64.049999999999997 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 63.450000000000003 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.030000000000001 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 71.400000000000006 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 73.030000000000001 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 71.25 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 74.430000000000007 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p -61.84 -24.79 67.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 71.310000000000002 112.05 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -87.85 -48.3 7.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.136 0.974 . . . . 72.349999999999994 110.359 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.75 92.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.557 1.143 . . . . 62.020000000000003 108.774 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.86 167.3 22.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 109.993 167.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -116.54 140.72 27.02 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.66 1.184 . . . . 71.209999999999994 108.326 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.79 136.3 44.99 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.814 2.343 . . . . 74.329999999999998 110.353 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -84.33 67.86 9.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.897 0.879 . . . . 73.519999999999996 110.293 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 148.16 10.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.409 1.083 . . . . 70.439999999999998 109.794 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.1 tp -154.09 79.95 4.99 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 108.172 -1.047 . . . . 73.299999999999997 108.172 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.1 149.2 35.94 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.015 2.477 . . . . 65.409999999999997 110.628 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.7 ptm -163.83 162.71 23.83 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.709 1.203 . . . . 62.25 109.469 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.84 134.26 47.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.544 -0.539 . . . . 73.430000000000007 109.544 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.4 t -164.91 164.03 20.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.329 1.051 . . . . 73.239999999999995 109.197 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.84 61.92 4.9 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.383 -0.687 . . . . 71.349999999999994 111.383 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.81 73.11 69.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.664 1.186 . . . . 65.510000000000005 109.868 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.69 172.4 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.407 2.738 . . . . 54.229999999999997 110.996 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.61 179.29 48.29 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.67 -0.972 . . . . 72.519999999999996 110.67 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.9 165.45 36.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.342 -1.103 . . . . 73.329999999999998 110.342 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.31 83.71 0.05 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.837 -1.305 . . . . 52.149999999999999 109.837 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 m -152.86 89.18 1.37 Allowed 'General case' 0 C--N 1.338 0.074 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -139.7 134.72 32.33 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.668 1.187 . . . . 63.450000000000003 108.357 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -145.21 161.99 38.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.934 0.893 . . . . 74.420000000000002 110.283 -170.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -156.01 148.75 24.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.898 1.279 . . . . 70.019999999999996 108.484 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -142.73 155.19 44.83 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.479 1.112 . . . . 74.540000000000006 109.485 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -165.83 170.21 14.12 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.175 1.39 . . . . 65.409999999999997 108.893 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.127 -1.416 . . . . 72.219999999999999 109.461 173.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 118.651 -0.69 . . . . 70.129999999999995 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -61.78 109.72 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.129 2.553 . . . . 74.319999999999993 110.571 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -79.95 66.08 5.31 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.705 1.202 . . . . 74.230000000000004 109.675 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 63.100000000000001 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 73.299999999999997 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 62.140000000000001 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 24.420000000000002 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.209999999999994 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 55.149999999999999 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 73.209999999999994 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 73.409999999999997 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 70.439999999999998 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.28 70.25 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 60.119999999999997 109.477 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.71 -168.91 54.82 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.13 -0.788 . . . . 50.210000000000001 111.13 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.05 59.42 0.18 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.492 -1.443 . . . . 75.049999999999997 109.492 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.73 131.74 36.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.699 0.8 . . . . 24.300000000000001 110.201 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -144.26 139.56 28.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.616 1.566 . . . . 55.109999999999999 107.506 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.0 p 43.13 47.42 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 110.99 -166.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -164.69 96.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.588 -1.634 . . . . 74.310000000000002 106.588 -171.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -47.09 3.38 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.948 -0.861 . . . . 61.420000000000002 110.948 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.78 136.06 78.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.256 1.022 . . . . 74.319999999999993 110.537 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.16 170.45 20.34 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.058 2.505 . . . . 73.430000000000007 109.866 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.15 70.38 68.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.763 0.825 . . . . 64.230000000000004 110.62 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.14 -162.9 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.572 2.848 . . . . 72.340000000000003 109.498 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 53.350000000000001 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 65.349999999999994 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 62.039999999999999 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 70.219999999999999 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 62.399999999999999 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 63.130000000000003 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 53.439999999999998 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 55.149999999999999 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 72.439999999999998 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 54.119999999999997 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 71.530000000000001 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 54.240000000000002 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 43.219999999999999 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 62.43 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 53.149999999999999 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 71.540000000000006 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.51 127.49 2.86 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -45.74 -49.49 14.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.761 1.225 . . . . 75.219999999999999 111.834 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -159.66 -66.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.643 1.177 . . . . 74.549999999999997 108.586 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -160.47 95.68 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.518 1.927 . . . . 75.25 106.084 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.03 170.35 11.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.96 0.409 . . . . 73.239999999999995 111.789 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -80.81 55.32 2.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.01 1.324 . . . . 71.299999999999997 112.068 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.35 -70.08 0.31 Allowed Glycine 0 C--N 1.336 0.568 0 N-CA-C 107.926 -2.07 . . . . 72.299999999999997 107.926 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -71.73 159.65 33.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.325 1.05 . . . . 72.310000000000002 110.221 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt 61.15 44.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.33 1.052 . . . . 72.310000000000002 110.822 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -164.54 147.0 7.13 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.423 1.089 . . . . 75.409999999999997 108.533 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.49 146.77 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.054 2.502 . . . . 75.319999999999993 111.886 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.81 72.46 2.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.196 -1.562 . . . . 73.319999999999993 109.196 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.63 -40.4 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.127 0.971 . . . . 61.420000000000002 111.816 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.4 mm -70.45 115.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.489 -0.93 . . . . 73.239999999999995 108.489 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.87 -171.1 24.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.99 1.281 . . . . 52.32 110.231 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.61 53.66 0.1 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.519 -1.032 . . . . 75.299999999999997 110.519 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -72.78 145.33 47.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.661 0.784 . . . . 53.32 110.467 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -126.1 74.46 72.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.681 1.192 . . . . 73.219999999999999 108.863 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.3 -24.46 19.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.919 2.412 . . . . 72.420000000000002 111.364 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -143.44 144.25 31.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.132 1.773 . . . . 73.329999999999998 106.56 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.42 135.15 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.727 1.211 . . . . 73.349999999999994 109.906 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.11 167.35 10.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.739 1.216 . . . . 74.519999999999996 110.593 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -155.06 147.74 17.86 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.639 1.176 . . . . 55.229999999999997 108.416 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.03 -19.22 62.17 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.288 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -57.1 -26.63 60.77 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.412 0.685 . . . . 73.040000000000006 111.708 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 73.299999999999997 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 74.349999999999994 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 64.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 70.120000000000005 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 54.420000000000002 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 64.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 62.350000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 52.119999999999997 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 65.319999999999993 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 72.510000000000005 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 65.030000000000001 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 61.240000000000002 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 64.340000000000003 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 72.340000000000003 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 52.310000000000002 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 62.049999999999997 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 71.129999999999995 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 73.409999999999997 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 71.540000000000006 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 70.030000000000001 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 71.010000000000005 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p -61.78 -31.53 71.74 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 51.119999999999997 111.658 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -70.3 -72.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.427 0.558 . . . . 64.109999999999999 109.815 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.73 87.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.889 1.276 . . . . 52.140000000000001 108.804 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -77.79 156.65 30.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.969 0.908 . . . . 74.450000000000003 110.68 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -135.65 69.28 66.48 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.616 1.167 . . . . 74.420000000000002 109.095 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.2 154.89 61.67 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.224 2.616 . . . . 71.099999999999994 110.517 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -108.97 150.4 27.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.48 1.112 . . . . 74.439999999999998 110.156 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -69.49 155.15 40.93 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.476 0.71 . . . . 74.540000000000006 110.859 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.65 84.63 19.88 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.283 1.433 . . . . 71.540000000000006 107.621 173.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.36 143.39 31.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.752 2.301 . . . . 65.430000000000007 110.612 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.3 ttt -90.59 118.79 30.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.035 0.934 . . . . 73.420000000000002 109.263 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.23 147.57 32.54 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.324 0.65 . . . . 73.030000000000001 109.547 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 m -148.43 156.71 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.608 1.163 . . . . 70.409999999999997 109.528 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.43 166.55 39.75 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.477 -1.049 . . . . 73.530000000000001 110.477 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.1 140.99 73.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.334 0.654 . . . . 73.219999999999999 110.162 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.84 161.69 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.274 2.65 . . . . 71.140000000000001 110.818 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.08 176.98 45.91 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.111 -0.795 . . . . 72.230000000000004 111.111 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.58 -174.9 47.04 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.256 -1.138 . . . . 40.0 110.256 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.75 163.96 35.29 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.462 -1.055 . . . . 53.420000000000002 110.462 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.4 m -159.56 98.97 1.41 Allowed 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 106.815 -1.55 . . . . 74.430000000000007 106.815 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -136.05 140.74 44.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.153 0.981 . . . . 74.25 109.129 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -147.97 164.49 33.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.492 1.117 . . . . 74.329999999999998 109.26 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -144.11 152.39 40.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.388 1.075 . . . . 72.420000000000002 108.987 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -71.13 163.35 27.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.177 0.591 . . . . 51.009999999999998 111.189 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -76.96 93.99 3.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.022 . . . . 73.409999999999997 108.239 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 117.673 -1.156 . . . . 73.049999999999997 110.684 175.44 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 119.315 -0.374 . . . . 52.329999999999998 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.4 162.59 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.775 2.317 . . . . 75.129999999999995 110.797 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -154.78 -58.51 0.11 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.96 0.904 . . . . 73.310000000000002 109.007 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 55.43 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 53.119999999999997 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 55.32 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 72.450000000000003 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.049999999999997 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -115.19 112.57 22.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 64.549999999999997 108.522 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.48 -70.25 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.388 -1.485 . . . . 53.530000000000001 109.388 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.01 86.37 0.12 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.12 -1.192 . . . . 73.010000000000005 110.12 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.19 -179.08 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.037 0.935 . . . . 51.329999999999998 109.493 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -73.83 -80.08 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.382 0.673 . . . . 74.0 109.227 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.51 62.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 105.589 -2.004 . . . . 53.240000000000002 105.589 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.59 49.74 15.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.177 0.991 . . . . 74.430000000000007 109.352 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.46 165.95 40.3 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.325 -1.11 . . . . 52.109999999999999 110.325 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -169.08 136.6 1.55 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.426 -0.953 . . . . 75.329999999999998 108.426 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.62 147.45 57.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.763 2.308 . . . . 73.319999999999993 109.351 171.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.86 81.48 5.95 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.621 0.768 . . . . 72.019999999999996 111.626 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.14 -171.88 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.021 2.481 . . . . 62.109999999999999 108.586 159.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 55.539999999999999 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 62.039999999999999 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 71.430000000000007 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 71.420000000000002 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 70.219999999999999 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 51.229999999999997 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 60.310000000000002 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 50.130000000000003 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 73.349999999999994 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 65.420000000000002 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 61.32 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 53.520000000000003 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 73.239999999999995 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 54.350000000000001 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 63.210000000000001 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 30.5 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 63.43 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 70.439999999999998 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 62.43 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 51.399999999999999 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 72.349999999999994 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 163.32 11.2 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -74.81 -25.94 59.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.996 1.318 . . . . 75.329999999999998 109.582 163.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 78.87 115.27 0.06 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.063 1.745 . . . . 72.109999999999999 111.113 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 51.0 75.4 0.19 Allowed 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.83 1.252 . . . . 71.430000000000007 108.983 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -93.33 -172.05 2.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.111 -0.949 . . . . 71.409999999999997 110.374 -161.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.6 p -51.08 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.328 1.851 . . . . 73.25 112.461 -169.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.39 47.05 28.85 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.953 1.263 . . . . 62.32 112.052 -172.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -158.37 173.17 17.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.672 0.736 . . . . 61.310000000000002 111.095 -170.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mt 57.34 51.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.369 1.468 . . . . 63.299999999999997 109.715 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.88 67.57 22.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.616 1.566 . . . . 53.310000000000002 108.454 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.8 79.42 3.24 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.318 2.679 . . . . 65.200000000000003 110.342 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.45 60.28 0.18 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.757 -0.937 . . . . 64.439999999999998 110.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -84.91 53.37 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.094 0.958 . . . . 72.319999999999993 110.426 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.3 mt -77.91 132.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.306 -0.998 . . . . 71.040000000000006 108.306 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.89 167.95 53.9 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.555 0.597 . . . . 74.129999999999995 112.231 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.88 -144.5 5.37 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.983 0.801 . . . . 71.150000000000006 111.221 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.4 p -137.82 129.98 29.01 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.601 1.16 . . . . 72.540000000000006 109.502 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -74.04 150.07 87.75 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.818 0.847 . . . . 74.230000000000004 109.403 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.59 164.02 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.41 2.74 . . . . 71.319999999999993 110.87 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -159.19 113.72 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.355 -0.98 . . . . 65.340000000000003 108.355 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.26 135.32 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.164 0.586 . . . . 73.239999999999995 109.92 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.51 158.31 16.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.149 0.979 . . . . 73.409999999999997 110.18 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.4 p 45.75 52.37 10.91 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.98 1.712 . . . . 72.450000000000003 113.939 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.17 -59.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.474 2.116 . . . . 73.530000000000001 111.267 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -66.02 -24.01 66.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.779 0.831 . . . . 74.120000000000005 111.755 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.140000000000001 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 72.239999999999995 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 60.229999999999997 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 62.210000000000001 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 62.310000000000002 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 63.329999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 72.129999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 63.25 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 43.340000000000003 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 71.420000000000002 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 62.039999999999999 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 73.409999999999997 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 64.010000000000005 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 65.530000000000001 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 65.299999999999997 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 54.310000000000002 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 72.109999999999999 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 63.439999999999998 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 51.210000000000001 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 64.239999999999995 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 54.299999999999997 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 62.549999999999997 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.32 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 43.32 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 64.340000000000003 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.409999999999997 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 64.439999999999998 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 64.120000000000005 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 52.119999999999997 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 72.120000000000005 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 73.129999999999995 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p -56.86 -27.62 60.64 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.31 -64.05 0.97 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.429 0.558 . . . . 70.230000000000004 109.856 166.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.03 96.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.005 1.322 . . . . 73.219999999999999 108.027 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.07 39.03 0.55 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.225 1.41 . . . . 65.319999999999993 113.166 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.27 115.3 65.52 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 118.73 -0.653 . . . . 74.430000000000007 109.3 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.66 121.63 6.83 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.708 1.605 . . . . 74.209999999999994 108.553 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.98 71.15 10.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 109.637 -169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.42 147.95 7.8 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.581 1.153 . . . . 74.140000000000001 109.722 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 tp -155.5 89.18 2.99 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.101 -1.074 . . . . 74.239999999999995 108.101 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.11 68.8 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.517 2.811 . . . . 63.210000000000001 109.52 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 57.3 ttm -155.59 148.98 24.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.031 0.933 . . . . 71.25 109.074 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.87 152.91 28.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.38 1.072 . . . . 51.350000000000001 109.272 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 90.6 p -146.67 36.62 0.97 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.777 0.831 . . . . 65.450000000000003 110.135 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.55 71.23 2.49 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.99 0.805 . . . . 62.229999999999997 111.146 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.04 67.78 10.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.599 0.76 . . . . 54.009999999999998 110.666 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.77 167.56 25.13 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.26 2.64 . . . . 72.239999999999995 110.512 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.14 157.35 15.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.49 -1.044 . . . . 32.43 110.49 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 167.09 173.36 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.063 -0.815 . . . . 60.420000000000002 111.063 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.53 152.65 9.89 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.876 -1.289 . . . . 62.520000000000003 109.876 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.9 p -164.7 130.44 2.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.641 0.776 . . . . 50.25 109.422 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -164.48 155.89 15.61 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.577 1.151 . . . . 75.230000000000004 109.199 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -165.77 170.07 14.37 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.518 1.127 . . . . 73.329999999999998 109.484 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -159.97 155.51 25.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.247 1.019 . . . . 63.119999999999997 109.416 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -150.7 153.86 36.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.457 1.103 . . . . 71.219999999999999 108.542 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -74.47 -168.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.48 1.112 . . . . 63.450000000000003 110.486 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.728 -1.129 . . . . 72.519999999999996 108.996 175.577 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.02 -0.514 . . . . 75.510000000000005 110.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.96 73.05 6.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.203 2.602 . . . . 53.549999999999997 110.081 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -64.46 -61.08 2.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.086 0.955 . . . . 64.510000000000005 110.569 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 51.43 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.430000000000007 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 72.439999999999998 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 63.219999999999999 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt -154.71 145.04 22.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 72.109999999999999 108.852 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.33 141.67 8.82 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.113 -1.595 . . . . 53.32 109.113 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.47 179.62 19.45 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.41 1.005 . . . . 74.099999999999994 110.86 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 -177.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.432 1.493 . . . . 22.109999999999999 112.667 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -77.7 117.99 19.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.489 0.716 . . . . 73.299999999999997 109.334 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.7 t -140.08 -81.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.171 -1.418 . . . . 63.399999999999999 107.171 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -147.8 140.57 24.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.975 1.31 . . . . 70.540000000000006 107.846 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -8.69 53.22 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.268 -0.74 . . . . 73.109999999999999 111.931 -167.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -127.45 62.98 57.16 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.139 1.376 . . . . 74.140000000000001 109.077 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.08 139.23 35.26 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.402 2.068 . . . . 65.420000000000002 109.853 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 tp -156.42 -67.93 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 117.805 -1.093 . . . . 74.540000000000006 110.116 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -79.98 -159.37 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.736 2.291 . . . . 72.329999999999998 110.389 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 55.130000000000003 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 45.409999999999997 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.140000000000001 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 65.019999999999996 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 71.140000000000001 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 61.520000000000003 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 62.140000000000001 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 64.140000000000001 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.219999999999999 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 71.049999999999997 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 72.230000000000004 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 61.509999999999998 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.540000000000006 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 64.040000000000006 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 64.040000000000006 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 74.310000000000002 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 51.229999999999997 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 74.030000000000001 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 71.120000000000005 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 65.140000000000001 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.340000000000003 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 74.400000000000006 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 64.329999999999998 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.19 74.23 0.11 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 65.340000000000003 111.431 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -41.04 61.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.947 0.499 . . . . 73.030000000000001 110.199 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -74.4 0.54 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.154 0.982 . . . . 73.310000000000002 109.1 169.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -164.14 36.34 0.08 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.593 1.557 . . . . 74.230000000000004 109.76 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 51.54 -141.97 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.12 1.368 . . . . 55.439999999999998 109.104 -165.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.1 p -106.95 28.77 7.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.568 0.747 . . . . 72.230000000000004 109.586 165.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.07 -126.75 5.92 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.392 -1.083 . . . . 75.400000000000006 110.392 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -151.24 47.07 0.83 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.325 1.05 . . . . 75.209999999999994 109.231 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.7 mt -86.94 56.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.098 . . . . 70.430000000000007 108.404 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -140.84 71.54 29.49 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.783 1.233 . . . . 75.0 109.153 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.72 159.81 44.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.238 2.625 . . . . 72.140000000000001 110.871 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.93 -157.62 13.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.947 -1.261 . . . . 24.140000000000001 109.947 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.65 123.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 125.065 1.346 . . . . 73.230000000000004 107.9 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.48 127.36 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.387 -0.968 . . . . 35.25 108.387 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.57 -165.44 50.03 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.768 0.699 . . . . 61.009999999999998 112.414 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.19 171.53 44.61 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.945 -1.262 . . . . 43.420000000000002 109.945 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.1 p -74.18 144.72 44.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.421 0.688 . . . . 73.450000000000003 110.761 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -152.58 77.87 6.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.259 1.024 . . . . 70.329999999999998 108.53 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.75 161.2 33.83 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.931 2.421 . . . . 55.25 110.986 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -158.79 92.34 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.447 -1.316 . . . . 73.510000000000005 107.447 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.74 137.65 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.766 1.226 . . . . 65.010000000000005 108.632 -174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 168.93 14.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 51.140000000000001 111.173 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.2 t -119.17 142.91 33.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.122 1.369 . . . . 64.430000000000007 108.607 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.23 -15.98 51.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.994 2.462 . . . . 73.299999999999997 112.834 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -58.93 -28.95 66.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.536 0.607 . . . . 54.020000000000003 111.753 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 45.020000000000003 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 62.109999999999999 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 63.539999999999999 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.239999999999995 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 72.540000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 44.399999999999999 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 74.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 74.439999999999998 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.039999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 52.409999999999997 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 70.409999999999997 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.209999999999994 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 64.219999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 63.450000000000003 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 71.019999999999996 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.120000000000005 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 70.510000000000005 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 61.450000000000003 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 34.200000000000003 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 72.129999999999995 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 71.430000000000007 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 71.049999999999997 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 71.230000000000004 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.349999999999994 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p -66.73 -18.89 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 72.230000000000004 112.661 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -94.27 -76.29 0.49 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.131 0.973 . . . . 63.119999999999997 108.94 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.6 p -167.08 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.048 0.939 . . . . 53.219999999999999 110.006 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -99.09 89.42 4.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.398 1.079 . . . . 70.430000000000007 108.193 167.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -128.13 77.43 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.052 1.341 . . . . 64.239999999999995 108.469 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.28 166.11 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.195 2.597 . . . . 64.109999999999999 110.98 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -68.98 159.76 32.17 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.646 0.779 . . . . 71.120000000000005 111.309 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -152.93 153.92 33.98 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 71.219999999999999 108.971 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.47 97.19 15.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.954 1.302 . . . . 64.140000000000001 107.988 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.26 176.67 9.81 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.859 2.373 . . . . 74.209999999999994 110.756 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.846 1.258 . . . . 55.039999999999999 108.061 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -145.83 163.51 34.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 64.439999999999998 109.408 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.5 m -151.33 161.36 42.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.547 1.139 . . . . 63.310000000000002 109.683 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.49 -162.87 25.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.412 -1.075 . . . . 14.210000000000001 110.412 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.89 150.86 23.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.548 1.139 . . . . 71.010000000000005 108.855 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.25 164.87 34.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.093 2.529 . . . . 41.329999999999998 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -87.97 -161.36 36.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.857 0.742 . . . . 44.210000000000001 111.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.49 -178.16 41.71 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.479 -1.049 . . . . 71.209999999999994 110.479 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.67 174.65 46.71 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.08 -1.208 . . . . 75.219999999999999 110.08 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.1 t -161.19 162.3 31.21 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 109.617 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.25 -61.72 0.16 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.4 1.08 . . . . 73.5 108.681 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 78.4 m80 56.52 74.15 0.41 Allowed 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.48 1.112 . . . . 62.43 109.375 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -63.81 150.79 43.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.564 0.746 . . . . 75.040000000000006 110.518 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -131.65 168.75 17.19 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.566 1.146 . . . . 75.439999999999998 110.03 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -138.18 170.42 16.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.921 1.288 . . . . 75.329999999999998 109.547 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.927 -1.511 . . . . 74.420000000000002 110.49 174.177 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.112 -0.471 . . . . 64.439999999999998 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.19 135.94 30.65 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.92 2.413 . . . . 74.230000000000004 109.935 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -137.58 162.69 33.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.781 1.232 . . . . 71.040000000000006 109.265 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 61.119999999999997 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 64.209999999999994 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.430000000000007 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 63.439999999999998 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 73.319999999999993 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp 57.94 71.0 0.61 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 64.420000000000002 110.35 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.47 62.52 4.31 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.982 0.801 . . . . 73.0 111.294 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.46 44.53 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.782 -0.927 . . . . 64.310000000000002 110.782 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.07 67.15 9.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.109 0.964 . . . . 71.140000000000001 109.547 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -153.72 116.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.849 1.26 . . . . 64.319999999999993 109.095 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.17 162.0 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.161 1.384 . . . . 75.219999999999999 108.111 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.72 101.19 0.13 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.505 0.722 . . . . 74.209999999999994 109.685 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.53 -40.72 1.08 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.633 -1.387 . . . . 33.219999999999999 109.633 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -68.07 150.04 97.92 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.085 0.954 . . . . 62.130000000000003 110.189 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.07 166.51 27.73 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.314 2.676 . . . . 71.219999999999999 110.367 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.35 70.4 4.3 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.385 1.074 . . . . 75.209999999999994 110.342 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.27 -172.41 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.689 2.26 . . . . 64.019999999999996 109.396 170.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 70.420000000000002 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 72.430000000000007 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 63.5 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.019999999999996 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 73.099999999999994 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 71.0 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 72.230000000000004 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 53.439999999999998 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 61.030000000000001 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.099999999999994 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.310000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 48.34 26.01 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 52.439999999999998 111.678 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.91 -18.26 8.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.057 1.343 . . . . 74.319999999999993 114.392 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.75 -24.32 67.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.05 0.94 . . . . 73.450000000000003 111.859 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -123.21 -46.35 2.06 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.794 1.238 . . . . 72.450000000000003 110.243 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 72.09 149.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.858 2.063 . . . . 72.329999999999998 111.583 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.2 p -55.57 -36.94 67.4 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.696 1.198 . . . . 54.219999999999999 111.611 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.19 65.94 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 119.148 -0.807 . . . . 22.350000000000001 113.697 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 p -148.8 71.86 1.16 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.471 1.135 . . . . 73.530000000000001 110.128 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 mm -77.27 72.71 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.313 1.045 . . . . 75.420000000000002 108.196 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 49.3 63.78 9.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.586 1.555 . . . . 73.420000000000002 112.033 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.2 72.75 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.474 2.783 . . . . 65.109999999999999 110.512 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.73 5.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.549 -1.02 . . . . 72.239999999999995 110.549 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.32 -54.59 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.852 1.261 . . . . 64.420000000000002 110.609 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.7 mt 60.61 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.723 2.409 . . . . 65.329999999999998 113.186 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.1 -156.52 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 71.0 110.371 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.62 67.07 1.82 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.401 -1.08 . . . . 72.219999999999999 110.401 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -145.88 105.97 4.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.222 1.009 . . . . 70.019999999999996 109.273 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -132.92 74.67 73.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.552 1.141 . . . . 70.349999999999994 109.141 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.08 178.41 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.267 2.645 . . . . 52.329999999999998 110.497 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.47 132.59 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.418 -0.956 . . . . 71.450000000000003 108.418 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 154.79 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.423 1.089 . . . . 71.420000000000002 109.947 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 153.45 42.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.638 0.775 . . . . 71.230000000000004 109.966 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -154.83 141.52 13.3 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.453 -0.573 . . . . 72.140000000000001 109.453 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.63 -18.42 53.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.646 2.23 . . . . 71.349999999999994 111.378 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -13.5 33.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.875 0.87 . . . . 74.329999999999998 112.618 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 64.409999999999997 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 70.129999999999995 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 72.439999999999998 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 71.340000000000003 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 71.430000000000007 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 63.109999999999999 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 44.210000000000001 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 71.329999999999998 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 72.140000000000001 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 71.019999999999996 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 65.450000000000003 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 73.430000000000007 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 63.399999999999999 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 60.310000000000002 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 72.319999999999993 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 55.219999999999999 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 71.209999999999994 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 25.539999999999999 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 72.450000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 24.210000000000001 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 62.119999999999997 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 72.319999999999993 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 73.540000000000006 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 65.329999999999998 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 71.219999999999999 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 61.140000000000001 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p -59.51 -35.73 74.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -69.5 -65.85 0.66 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.161 0.437 . . . . 74.340000000000003 110.529 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.33 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.866 1.266 . . . . 52.109999999999999 108.368 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.23 155.36 17.53 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.2 1.0 . . . . 55.340000000000003 109.878 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -137.05 71.05 56.01 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.475 1.11 . . . . 72.430000000000007 109.195 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -71.64 154.28 59.65 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.092 2.528 . . . . 75.430000000000007 110.625 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -64.89 -49.82 68.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.657 0.783 . . . . 65.219999999999999 110.588 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.59 164.26 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.693 1.597 . . . . 54.5 111.745 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.92 150.36 95.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.032 -0.729 . . . . 71.310000000000002 109.032 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 139.33 53.41 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.026 2.484 . . . . 64.25 110.327 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.03 69.79 9.9 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.011 0.925 . . . . 71.329999999999998 109.293 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -69.19 155.13 40.91 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.79 0.836 . . . . 53.43 110.318 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.0 t -158.93 178.1 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.918 0.887 . . . . 64.329999999999998 109.964 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.24 164.21 39.85 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.525 1.06 . . . . 74.099999999999994 111.46 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.04 149.38 12.91 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.295 1.038 . . . . 73.439999999999998 109.164 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.31 178.26 7.73 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.585 2.857 . . . . 71.140000000000001 110.725 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.96 175.76 44.56 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.829 -0.908 . . . . 51.210000000000001 110.829 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.68 -178.66 48.71 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.218 -1.153 . . . . 44.009999999999998 110.218 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.2 -164.6 37.93 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.594 -1.003 . . . . 72.439999999999998 110.594 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 t 58.26 58.76 3.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.994 1.318 . . . . 75.0 111.297 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -133.5 70.09 1.47 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.67 1.188 . . . . 63.450000000000003 108.18 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -162.41 152.64 16.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.305 1.042 . . . . 75.049999999999997 109.542 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -150.71 151.49 32.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.522 1.129 . . . . 72.409999999999997 108.885 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.12 99.59 2.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.386 1.074 . . . . 75.200000000000003 108.282 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.62 132.58 45.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.19 -1.041 . . . . 71.120000000000005 108.19 167.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.8 m80 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 107.589 -1.263 . . . . 51.420000000000002 107.589 175.059 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 119.088 -0.482 . . . . 64.239999999999995 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -70.51 154.44 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.034 2.489 . . . . 62.020000000000003 110.39 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -158.84 -171.85 3.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.221 1.009 . . . . 71.519999999999996 109.29 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 61.509999999999998 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 52.030000000000001 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 71.439999999999998 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 73.519999999999996 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.29 61.77 6.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.9 -107.54 1.35 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.492 1.044 . . . . 64.200000000000003 111.283 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.24 71.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.467 -1.453 . . . . 74.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 167.36 15.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.327 1.051 . . . . 71.319999999999993 112.572 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -73.72 125.46 28.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.769 0.828 . . . . 74.530000000000001 108.898 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.7 t -71.38 -35.55 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.23 0.612 . . . . 64.209999999999994 111.55 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 64.25 77.3 0.32 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.994 1.318 . . . . 54.329999999999998 108.486 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.16 -41.46 0.64 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.296 -1.922 . . . . 73.400000000000006 108.296 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -54.79 153.19 11.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.62 1.168 . . . . 72.430000000000007 110.851 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.24 160.25 42.59 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.902 2.401 . . . . 62.399999999999999 110.152 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -119.45 70.64 12.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 74.310000000000002 110.449 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.03 -165.34 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.066 2.51 . . . . 62.020000000000003 109.844 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 54.240000000000002 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 44.030000000000001 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 74.430000000000007 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 70.209999999999994 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 61.030000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 71.230000000000004 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 71.230000000000004 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 65.109999999999999 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 60.399999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 73.340000000000003 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 73.219999999999999 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 71.420000000000002 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 64.230000000000004 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 60.240000000000002 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 71.209999999999994 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.109999999999999 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.49 80.64 0.33 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.73 -31.95 73.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.23 0.612 . . . . 74.25 109.652 173.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 78.11 -66.84 0.2 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 127.094 2.158 . . . . 71.209999999999994 109.764 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -110.14 69.59 0.7 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.156 0.983 . . . . 74.310000000000002 108.496 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -67.03 179.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.08 -1.082 . . . . 71.0 108.08 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -52.75 -30.99 35.8 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.536 -0.727 . . . . 72.5 111.232 167.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.8 -122.94 1.32 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.456 -1.058 . . . . 52.299999999999997 110.456 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.0 t -164.93 90.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.698 0.799 . . . . 72.209999999999994 109.659 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.12 -1.437 . . . . 72.109999999999999 107.12 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -132.89 66.59 76.62 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.529 0.732 . . . . 70.519999999999996 110.857 -167.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.62 117.24 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.276 2.651 . . . . 73.010000000000005 110.527 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.01 0.22 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.761 -0.936 . . . . 71.239999999999995 110.761 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.88 56.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.272 1.029 . . . . 60.119999999999997 110.608 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.69 129.54 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.081 0.952 . . . . 71.25 109.005 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.01 -178.96 43.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.899 -0.88 . . . . 74.209999999999994 110.899 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.24 115.09 3.39 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.584 1.088 . . . . 74.200000000000003 111.084 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -160.67 167.49 26.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.542 1.137 . . . . 72.549999999999997 109.773 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.36 75.05 5.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.883 0.873 . . . . 63.340000000000003 109.243 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.52 178.23 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.571 2.847 . . . . 70.519999999999996 111.527 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -142.99 146.98 34.4 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.475 1.91 . . . . 65.319999999999993 106.483 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -86.43 141.66 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.86 1.264 . . . . 54.240000000000002 110.801 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.59 138.19 31.69 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 108.806 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 t -156.45 143.86 13.85 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.337 -0.616 . . . . 75.349999999999994 109.337 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.35 -12.77 30.14 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.845 2.363 . . . . 73.299999999999997 111.891 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -53.78 -22.29 9.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.653 1.581 . . . . 44.119999999999997 112.93 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 62.130000000000003 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 62.009999999999998 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 54.140000000000001 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 62.310000000000002 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 62.0 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.409999999999997 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 73.150000000000006 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 64.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 51.240000000000002 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 71.209999999999994 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 65.239999999999995 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 74.030000000000001 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 52.020000000000003 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 63.119999999999997 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 61.310000000000002 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 70.109999999999999 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 63.109999999999999 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 72.510000000000005 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 63.32 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 73.109999999999999 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 72.010000000000005 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 63.439999999999998 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 73.140000000000001 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p -61.19 -27.89 68.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -67.53 -71.99 0.19 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.784 0.72 . . . . 54.409999999999997 109.558 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.2 t -144.52 89.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.594 1.157 . . . . 71.400000000000006 108.658 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 148.62 41.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.501 0.721 . . . . 70.049999999999997 111.118 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -115.62 93.39 36.81 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.389 1.476 . . . . 74.340000000000003 107.574 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.25 155.85 14.6 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.059 2.506 . . . . 72.450000000000003 110.979 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.08 123.03 29.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.483 -0.932 . . . . 71.219999999999999 108.483 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -151.82 147.72 26.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.729 0.812 . . . . 71.450000000000003 109.712 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.4 tp -151.99 127.83 5.05 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.474 -1.306 . . . . 73.409999999999997 107.474 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.11 163.88 35.64 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.991 2.461 . . . . 65.530000000000001 110.889 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.8 ttm -153.74 145.26 23.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.995 0.918 . . . . 71.5 108.987 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -148.01 160.7 42.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.567 1.547 . . . . 75.150000000000006 108.429 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t -158.54 144.35 16.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.651 0.78 . . . . 64.140000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.46 152.2 10.13 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.591 -1.404 . . . . 54.350000000000001 109.591 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.99 149.51 11.74 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.842 . . . . 74.439999999999998 109.366 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.2 172.59 16.06 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.387 2.725 . . . . 73.120000000000005 110.505 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.67 164.84 37.65 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.688 -0.965 . . . . 73.239999999999995 110.688 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.44 39.46 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.068 -1.213 . . . . 64.329999999999998 110.068 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.36 173.78 40.63 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.991 -0.843 . . . . 44.310000000000002 110.991 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 76.0 p -163.97 170.07 17.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.107 1.363 . . . . 74.209999999999994 108.874 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -151.13 155.03 38.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.699 0.8 . . . . 70.420000000000002 109.275 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.33 171.65 14.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.114 0.966 . . . . 51.210000000000001 111.252 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -154.95 121.57 5.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.13 0.972 . . . . 74.409999999999997 108.615 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.37 113.83 10.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.407 -0.96 . . . . 61.240000000000002 108.407 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -62.27 162.93 9.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.846 0.858 . . . . 72.319999999999993 111.946 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.037 -1.459 . . . . 74.430000000000007 110.184 171.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.393 -0.336 . . . . 72.530000000000001 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.7 142.5 35.96 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.588 2.192 . . . . 42.039999999999999 110.05 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -162.9 161.79 25.98 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.263 1.025 . . . . 62.32 109.569 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 73.109999999999999 109.657 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 64.129999999999995 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 72.319999999999993 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 72.319999999999993 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -162.95 161.1 25.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 63.329999999999998 109.998 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.5 -171.43 41.45 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.845 -0.902 . . . . 54.409999999999997 110.845 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.1 110.72 0.9 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.96 0.79 . . . . 51.32 111.533 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.25 62.14 7.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.837 0.855 . . . . 65.030000000000001 109.982 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -87.22 142.65 27.75 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.701 0.8 . . . . 73.549999999999997 109.877 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.0 t 70.39 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.144 2.177 . . . . 64.239999999999995 112.833 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.78 65.57 1.48 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.581 1.553 . . . . 71.239999999999995 110.921 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.33 71.15 0.49 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 108.865 -1.694 . . . . 44.240000000000002 108.865 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.16 58.61 9.29 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.785 0.661 . . . . 71.209999999999994 112.785 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.69 67.4 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.679 2.92 . . . . 72.219999999999999 109.732 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.65 164.94 18.36 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 126.153 1.781 . . . . 64.140000000000001 108.26 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.16 -153.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.106 2.537 . . . . 74.230000000000004 111.426 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 62.149999999999999 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 71.439999999999998 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.120000000000005 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.150000000000006 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 73.310000000000002 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 71.439999999999998 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 64.540000000000006 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 72.230000000000004 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 50.439999999999998 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 63.240000000000002 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 70.239999999999995 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 71.25 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 65.140000000000001 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.37 108.14 1.05 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -53.57 -47.12 70.38 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.212 0.605 . . . . 70.219999999999999 111.406 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -141.52 -55.9 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.295 1.038 . . . . 75.25 110.365 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -139.42 -61.27 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.339 1.056 . . . . 74.409999999999997 111.703 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 102.85 178.3 0.0 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.957 3.303 . . . . 61.149999999999999 109.553 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -66.64 -66.97 0.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.986 -0.746 . . . . 51.409999999999997 108.986 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -125.62 32.42 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.15 -1.18 . . . . 53.539999999999999 110.15 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t -130.15 56.19 1.76 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.238 -1.393 . . . . 52.299999999999997 107.238 155.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.06 27.62 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.744 1.618 . . . . 72.420000000000002 108.307 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -139.35 66.5 37.01 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.039 -166.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.01 83.16 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.857 3.038 . . . . 70.019999999999996 110.026 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.12 4.91 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.841 0.734 . . . . 63.0 111.753 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -85.76 55.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.128 0.971 . . . . 52.439999999999998 110.167 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.9 mt -85.3 135.38 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.396 1.078 . . . . 75.019999999999996 109.404 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 -69.62 2.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.087 0.851 . . . . 63.229999999999997 111.633 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.66 -71.81 2.49 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.339 -1.105 . . . . 74.0 110.339 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.6 p -160.63 165.36 30.78 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.762 1.225 . . . . 62.240000000000002 109.287 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -155.49 75.44 5.16 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.927 0.891 . . . . 73.420000000000002 108.771 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.07 158.42 45.7 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.119 2.546 . . . . 63.32 110.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -133.55 92.98 3.06 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.24 1.416 . . . . 75.030000000000001 108.681 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.37 135.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.59 0.756 . . . . 74.150000000000006 109.255 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.28 157.22 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.361 1.064 . . . . 53.100000000000001 110.841 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 t -128.09 99.53 24.98 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.997 1.319 . . . . 73.530000000000001 108.341 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -74.42 -28.59 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.086 2.524 . . . . 74.209999999999994 112.285 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.0 -22.24 48.58 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.439 0.696 . . . . 72.319999999999993 112.491 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 71.340000000000003 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 41.109999999999999 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 54.020000000000003 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.030000000000001 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 61.009999999999998 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 65.25 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 64.310000000000002 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 51.450000000000003 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 65.0 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 53.020000000000003 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 65.120000000000005 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 64.030000000000001 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 72.019999999999996 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 71.409999999999997 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 51.229999999999997 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 74.430000000000007 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 43.119999999999997 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.140000000000001 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.020000000000003 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 74.25 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 64.430000000000007 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 64.150000000000006 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 61.240000000000002 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 63.109999999999999 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 52.310000000000002 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 71.030000000000001 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 73.299999999999997 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p -60.77 -27.74 68.21 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 74.230000000000004 112.598 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.32 -50.9 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.737 0.699 . . . . 74.319999999999993 110.288 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 p -159.09 114.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.0 0.92 . . . . 65.239999999999995 109.299 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -139.36 153.65 47.72 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.7 1.6 . . . . 74.25 110.461 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -136.65 70.45 59.17 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.98 1.312 . . . . 73.209999999999994 108.268 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.47 166.91 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.549 2.833 . . . . 72.349999999999994 111.46 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 61.53 32.67 18.71 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.325 1.45 . . . . 73.420000000000002 112.151 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -76.77 137.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.535 0.734 . . . . 62.32 109.888 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 tp -163.34 127.32 1.87 Allowed Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.303 -1.369 . . . . 74.299999999999997 107.303 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.28 146.08 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.565 2.176 . . . . 63.119999999999997 109.834 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mtp -81.91 69.18 8.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.336 -0.616 . . . . 71.439999999999998 109.336 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -76.02 75.77 2.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.058 0.943 . . . . 62.340000000000003 109.027 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.6 p -151.4 76.83 1.23 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.332 1.053 . . . . 73.299999999999997 109.315 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.5 78.28 0.23 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.414 -1.474 . . . . 41.140000000000001 109.414 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.16 76.08 15.73 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.788 1.235 . . . . 72.200000000000003 109.536 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.8 170.17 20.27 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.029 2.486 . . . . 54.530000000000001 110.552 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.46 167.38 40.52 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.081 -1.207 . . . . 73.400000000000006 110.081 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 174.92 -177.21 47.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.349 -1.1 . . . . 61.539999999999999 110.349 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.88 167.9 40.28 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.289 -1.124 . . . . 71.129999999999995 110.289 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.3 p -162.65 168.29 21.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.371 1.068 . . . . 71.439999999999998 109.248 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -158.33 163.29 37.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.279 1.032 . . . . 73.25 109.22 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -164.95 174.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.605 1.162 . . . . 71.219999999999999 109.001 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -147.89 116.52 6.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.33 -1.359 . . . . 65.409999999999997 107.33 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -69.71 162.68 27.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.059 0.457 . . . . 74.329999999999998 111.368 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -64.9 -41.87 95.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.524 0.729 . . . . 52.450000000000003 110.167 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.804 -1.57 . . . . 70.129999999999995 110.745 176.603 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 117.905 -1.045 . . . . 71.310000000000002 112.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.54 -41.66 6.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.084 1.856 . . . . 65.129999999999995 111.684 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.5 64.22 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.959 1.304 . . . . 75.420000000000002 110.586 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 55.119999999999997 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 71.510000000000005 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 54.439999999999998 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.87 -7.16 0.38 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.8 -105.67 1.32 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.418 -1.073 . . . . 44.439999999999998 110.418 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.71 67.75 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.882 0.753 . . . . 54.310000000000002 111.295 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.49 173.32 16.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.723 0.809 . . . . 60.530000000000001 110.5 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -71.44 144.97 49.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.213 0.605 . . . . 74.030000000000001 109.82 173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -128.69 137.56 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.459 -1.311 . . . . 74.030000000000001 107.459 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -71.44 78.09 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.079 0.951 . . . . 73.219999999999999 109.323 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.31 -25.97 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.051 -0.86 . . . . 72.019999999999996 112.314 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.5 148.01 96.9 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 118.564 1.182 . . . . 70.219999999999999 111.035 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.17 171.25 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.225 2.617 . . . . 54.439999999999998 110.904 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.47 71.74 3.45 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.609 1.164 . . . . 75.230000000000004 110.648 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.23 -164.67 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.053 2.502 . . . . 52.219999999999999 109.754 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 64.319999999999993 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 63.530000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 65.209999999999994 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 72.129999999999995 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.140000000000001 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 65.209999999999994 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 71.109999999999999 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 71.209999999999994 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 63.530000000000001 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 51.439999999999998 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 61.240000000000002 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 72.010000000000005 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 71.409999999999997 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 63.009999999999998 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 50.119999999999997 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 72.310000000000002 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 71.430000000000007 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 52.25 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 71.230000000000004 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.55 99.35 1.15 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 61.140000000000001 109.573 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -43.43 64.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.124 0.57 . . . . 64.409999999999997 110.073 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 55.51 41.24 31.01 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.899 1.279 . . . . 73.530000000000001 110.097 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -157.23 -63.58 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.836 1.655 . . . . 72.310000000000002 108.265 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 55.06 34.59 22.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.518 1.127 . . . . 73.420000000000002 111.876 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -82.75 68.53 9.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.134 1.374 . . . . 74.319999999999993 108.998 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.32 -157.6 13.59 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.604 -1.399 . . . . 53.450000000000003 109.604 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 m -81.34 47.24 1.01 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.728 0.811 . . . . 65.549999999999997 111.739 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -143.77 40.12 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.781 1.232 . . . . 74.150000000000006 109.734 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -156.58 70.85 4.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.175 -0.676 . . . . 72.230000000000004 109.175 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.97 94.51 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.253 2.636 . . . . 71.409999999999997 110.448 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.65 73.18 0.07 OUTLIER Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.771 -1.332 . . . . 63.240000000000002 109.771 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -84.26 56.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.284 1.034 . . . . 73.219999999999999 109.61 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.7 mm -77.32 136.54 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.402 1.081 . . . . 63.130000000000003 109.588 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.93 -115.09 1.17 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.164 -1.174 . . . . 63.119999999999997 110.164 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.93 -166.07 36.57 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.293 -1.123 . . . . 64.319999999999993 110.293 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.1 p -157.21 171.06 21.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.268 1.027 . . . . 51.549999999999997 109.575 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -145.8 71.52 13.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.949 0.899 . . . . 74.200000000000003 109.362 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.26 169.78 17.0 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.503 2.802 . . . . 71.519999999999996 111.572 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -143.35 111.42 6.12 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.596 1.559 . . . . 71.010000000000005 107.483 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.89 138.75 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.965 1.306 . . . . 45.229999999999997 108.248 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.95 152.6 41.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.628 0.771 . . . . 73.519999999999996 111.057 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -75.03 152.06 86.36 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.666 0.786 . . . . 64.010000000000005 109.059 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.3 -29.73 38.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.123 2.549 . . . . 71.129999999999995 112.255 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -56.45 -27.28 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.248 1.019 . . . . 74.420000000000002 113.086 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 63.130000000000003 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 63.229999999999997 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 60.539999999999999 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 63.520000000000003 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 34.100000000000001 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 64.230000000000004 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 44.530000000000001 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 53.310000000000002 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 70.439999999999998 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 62.43 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 53.109999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.109999999999999 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 55.409999999999997 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.010000000000005 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 71.239999999999995 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 72.019999999999996 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 61.350000000000001 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 63.149999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 63.329999999999998 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 54.5 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p -67.11 -26.06 66.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 71.209999999999994 111.66 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -67.9 0.71 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.45 -0.574 . . . . 71.299999999999997 109.45 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -168.61 105.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.463 1.105 . . . . 74.030000000000001 109.609 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -108.59 58.12 0.61 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.47 1.108 . . . . 43.219999999999999 109.565 166.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -122.48 75.31 43.96 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.178 0.991 . . . . 55.119999999999997 110.101 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.621 2.214 . . . . 75.329999999999998 109.798 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.32 134.03 43.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.066 0.946 . . . . 74.519999999999996 110.145 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -155.74 152.71 28.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.533 1.133 . . . . 63.119999999999997 109.004 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 tt -151.16 108.82 3.01 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.743 -1.577 . . . . 62.439999999999998 106.743 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.59 84.9 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.105 2.537 . . . . 65.140000000000001 110.22 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.75 140.55 58.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.921 0.889 . . . . 75.510000000000005 110.301 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -149.43 158.87 44.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.662 1.185 . . . . 73.409999999999997 109.21 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -158.69 144.19 16.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.262 1.025 . . . . 70.430000000000007 109.005 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.97 68.39 0.07 OUTLIER Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.716 -1.354 . . . . 63.340000000000003 109.716 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.51 69.85 81.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.436 1.094 . . . . 64.200000000000003 109.837 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.04 173.33 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.269 2.646 . . . . 75.239999999999995 110.677 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.34 164.18 35.88 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.248 -1.141 . . . . 62.340000000000003 110.248 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.93 41.0 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.341 -1.104 . . . . 72.209999999999994 110.341 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.92 166.18 34.01 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.202 -1.159 . . . . 73.340000000000003 110.202 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.7 m -144.71 137.67 26.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.46 1.104 . . . . 71.219999999999999 108.831 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -148.7 129.08 13.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.949 -1.13 . . . . 73.450000000000003 107.949 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -166.1 115.4 0.96 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.489 -0.93 . . . . 74.349999999999994 108.489 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.48 148.25 32.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.529 1.131 . . . . 74.310000000000002 108.862 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.25 166.65 32.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.646 1.178 . . . . 53.350000000000001 108.792 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -152.55 165.68 34.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.395 1.078 . . . . 74.519999999999996 109.237 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.174 -1.393 . . . . 62.130000000000003 109.963 175.858 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.584 -0.246 . . . . 72.129999999999995 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.71 73.31 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.427 2.751 . . . . 63.43 110.179 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -64.96 143.96 57.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.592 0.757 . . . . 75.349999999999994 110.58 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 73.120000000000005 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 53.240000000000002 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 61.43 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.52 107.45 2.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 51.140000000000001 109.623 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.42 137.49 4.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.422 -0.671 . . . . 74.230000000000004 111.422 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.82 159.8 20.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.625 -0.99 . . . . 74.420000000000002 110.625 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.99 41.12 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.413 0.685 . . . . 74.420000000000002 110.918 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.6 t80 77.55 -29.99 0.17 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.907 1.683 . . . . 75.439999999999998 113.164 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 22' ' ' ASN . 13.0 p -109.81 -177.61 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 127.424 2.289 . . . . 33.420000000000002 107.81 172.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 21' ' ' VAL . 19.2 t-20 60.39 76.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.424 1.09 . . . . 71.129999999999995 110.638 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.66 -52.79 2.67 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.14 -1.184 . . . . 54.43 110.14 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.68 121.86 64.11 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.991 -1.114 . . . . 74.209999999999994 107.991 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.84 141.88 21.96 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.059 2.506 . . . . 64.25 111.427 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 26' ' ' LEU . 1.8 mm? -86.88 -45.99 0.53 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 117.471 -1.252 . . . . 74.010000000000005 112.03 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -89.37 176.29 3.09 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.718 2.279 . . . . 73.150000000000006 111.422 -171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 71.230000000000004 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 64.239999999999995 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 62.520000000000003 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 45.32 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 64.310000000000002 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 62.520000000000003 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 74.329999999999998 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 31.210000000000001 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 65.340000000000003 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 61.240000000000002 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 72.430000000000007 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 52.520000000000003 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 63.210000000000001 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 61.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 64.439999999999998 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 65.310000000000002 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 71.510000000000005 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.93 58.78 5.03 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 71.319999999999993 111.221 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -80.65 -57.34 3.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.182 0.993 . . . . 63.140000000000001 111.359 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -165.09 132.93 3.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.631 -1.618 . . . . 75.219999999999999 106.631 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.3 t80 71.23 -49.18 0.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.859 2.064 . . . . 71.150000000000006 111.845 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 69.79 11.71 7.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.802 1.641 . . . . 74.519999999999996 113.44 159.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 p -145.61 -177.89 5.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.146 1.379 . . . . 73.129999999999995 109.433 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 -87.53 0.58 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.296 0.95 . . . . 72.120000000000005 111.747 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 m -141.4 50.77 1.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.195 0.998 . . . . 73.040000000000006 110.273 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.75 31.92 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.992 -1.114 . . . . 62.140000000000001 107.992 166.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -155.23 156.03 30.63 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.274 1.83 . . . . 75.209999999999994 107.479 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.49 79.27 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.169 2.58 . . . . 65.420000000000002 109.99 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.79 144.93 5.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.032 -1.227 . . . . 51.009999999999998 110.032 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.7 p -165.52 129.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.261 1.424 . . . . 75.420000000000002 107.459 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.68 135.43 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.523 -0.917 . . . . 75.099999999999994 108.523 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.31 84.16 0.11 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.181 -1.167 . . . . 73.219999999999999 110.181 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.4 153.98 23.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.458 -1.057 . . . . 73.209999999999994 110.458 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -162.88 166.66 23.74 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.838 1.255 . . . . 75.349999999999994 108.924 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -150.24 86.18 5.25 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.21 0.604 . . . . 75.200000000000003 109.619 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.64 166.3 25.77 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.202 2.602 . . . . 74.510000000000005 110.892 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -160.42 116.44 2.35 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.348 1.059 . . . . 74.25 108.548 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.73 147.93 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.236 1.415 . . . . 71.450000000000003 108.859 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.33 127.12 32.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.517 0.727 . . . . 74.349999999999994 109.631 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.3 p -82.64 143.44 47.2 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 122.875 0.47 . . . . 62.030000000000001 110.436 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.68 -27.09 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.499 2.799 . . . . 74.120000000000005 112.12 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -49.1 -41.91 37.26 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.258 1.023 . . . . 71.430000000000007 112.676 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 61.020000000000003 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 62.119999999999997 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 128' ' ' ILE . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 72.549999999999997 110.586 165.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.119999999999997 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 63.030000000000001 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 63.140000000000001 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 51.539999999999999 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 71.299999999999997 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 55.229999999999997 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 63.420000000000002 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 71.549999999999997 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 74.439999999999998 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 63.409999999999997 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 44.329999999999998 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 73.430000000000007 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 63.009999999999998 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 92' ' ' ILE . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 54.109999999999999 112.235 -173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 45.219999999999999 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 70.129999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p -62.29 -29.8 70.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -112.21 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.446 -1.316 . . . . 51.100000000000001 107.446 167.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.3 t -145.36 71.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 64.540000000000006 109.437 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -80.53 115.99 20.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.489 -0.93 . . . . 74.409999999999997 108.489 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -124.99 119.62 25.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.429 1.091 . . . . 73.049999999999997 108.086 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 129.28 11.63 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.282 1.988 . . . . 64.239999999999995 109.316 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -74.59 98.46 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.869 0.868 . . . . 74.230000000000004 110.497 -169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -141.29 139.12 33.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.202 1.401 . . . . 63.329999999999998 107.393 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.6 tp -153.02 76.53 6.46 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.193 -1.04 . . . . 73.219999999999999 108.193 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.36 66.35 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.641 2.894 . . . . 54.119999999999997 109.42 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.9 mtp -136.39 133.37 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.047 1.339 . . . . 61.509999999999998 108.863 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.17 159.4 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.827 1.251 . . . . 73.510000000000005 109.324 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -159.02 147.93 18.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.536 1.134 . . . . 73.25 108.949 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.5 70.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.113 -1.195 . . . . 55.520000000000003 110.113 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.68 71.41 80.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.41 1.084 . . . . 71.209999999999994 110.116 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.94 171.95 17.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.348 2.699 . . . . 64.219999999999999 110.705 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.94 161.43 31.77 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.682 -0.967 . . . . 73.340000000000003 110.682 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.57 179.38 40.8 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.425 -1.07 . . . . 62.420000000000002 110.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 178.05 176.56 46.12 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.469 -1.052 . . . . 54.030000000000001 110.469 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.3 m -147.4 157.52 43.61 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.658 1.183 . . . . 64.200000000000003 109.947 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -163.21 173.43 13.4 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.74 1.216 . . . . 62.0 109.519 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -158.28 177.95 10.71 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 109.273 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -158.73 153.85 25.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.868 0.867 . . . . 75.25 109.61 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -155.55 155.94 34.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.757 1.223 . . . . 55.539999999999999 108.916 173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.11 -127.18 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.81 0.844 . . . . 72.510000000000005 108.959 172.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.988 -1.482 . . . . 71.530000000000001 110.906 168.313 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 119.342 -0.361 . . . . 64.109999999999999 110.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 134.82 21.63 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.679 2.253 . . . . 73.219999999999999 110.173 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.78 166.66 23.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.614 1.165 . . . . 73.340000000000003 109.095 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 74.120000000000005 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 52.299999999999997 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 70.230000000000004 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.98 148.27 22.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 65.5 108.923 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.71 176.38 47.91 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.236 -1.145 . . . . 71.230000000000004 110.236 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.38 64.84 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.48 -1.048 . . . . 70.040000000000006 110.48 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 140.73 18.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.139 0.975 . . . . 64.099999999999994 108.631 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.3 t80 55.5 64.13 1.86 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.09 0.956 . . . . 64.219999999999999 109.425 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.02 -54.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.934 1.294 . . . . 70.549999999999997 109.199 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -121.42 143.8 49.03 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.902 1.281 . . . . 53.229999999999997 109.388 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.89 -58.65 4.53 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.907 0.765 . . . . 74.310000000000002 111.976 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -52.06 151.66 6.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.976 1.711 . . . . 73.010000000000005 111.97 -174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.27 83.53 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.734 2.956 . . . . 74.150000000000006 110.543 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.18 167.82 25.26 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.615 1.166 . . . . 74.340000000000003 109.965 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 -152.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.707 2.938 . . . . 64.340000000000003 110.26 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 64.25 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 61.130000000000003 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 71.219999999999999 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 71.340000000000003 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 65.230000000000004 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 73.25 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 62.509999999999998 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 70.120000000000005 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 73.109999999999999 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 70.430000000000007 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 72.209999999999994 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 72.530000000000001 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.239999999999995 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 71.140000000000001 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 63.109999999999999 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 51.509999999999998 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 72.5 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 64.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 64.230000000000004 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.02 89.95 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 42.350000000000001 111.049 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -49.79 66.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.737 -0.838 . . . . 72.400000000000006 108.737 164.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 71.05 -3.93 1.91 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.582 1.953 . . . . 71.510000000000005 112.738 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -156.95 55.37 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.705 1.202 . . . . 73.5 108.877 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 153.87 42.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.536 0.734 . . . . 72.329999999999998 109.212 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 p -73.74 72.8 1.52 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.342 1.057 . . . . 54.539999999999999 110.463 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.95 -137.96 5.22 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.452 -1.059 . . . . 40.450000000000003 110.452 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.41 41.57 0.63 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.064 0.946 . . . . 65.329999999999998 113.405 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.69 50.91 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.735 -1.579 . . . . 71.409999999999997 106.735 160.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -142.43 72.14 21.23 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 64.420000000000002 108.068 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 143.08 44.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.939 2.426 . . . . 73.239999999999995 110.907 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.05 -154.27 10.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.91 1.243 . . . . 50.329999999999998 110.845 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 -156.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.673 1.589 . . . . 71.010000000000005 107.664 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.43 -54.06 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 109.595 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.33 73.4 1.27 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.316 -1.113 . . . . 54.109999999999999 110.316 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.29 -175.62 53.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.774 0.702 . . . . 64.340000000000003 112.441 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.3 p -161.93 164.28 28.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.911 1.284 . . . . 54.140000000000001 109.397 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -131.82 76.34 74.36 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.381 1.072 . . . . 72.439999999999998 109.13 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.29 -42.48 3.85 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.994 2.462 . . . . 65.150000000000006 111.108 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? 58.09 53.11 6.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.737 1.215 . . . . 73.319999999999993 109.965 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.47 146.98 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.587 0.755 . . . . 65.430000000000007 110.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.76 172.98 13.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.128 0.971 . . . . 71.019999999999996 110.887 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -157.74 143.54 12.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.418 1.087 . . . . 72.040000000000006 108.663 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.66 -14.49 44.97 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.324 2.683 . . . . 74.310000000000002 112.624 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -56.48 -36.57 69.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.479 0.581 . . . . 75.109999999999999 111.14 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 71.439999999999998 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 70.540000000000006 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 64.400000000000006 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 74.319999999999993 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 92' ' ' ILE . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 52.32 109.48 172.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 63.149999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 72.549999999999997 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 65.219999999999999 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 71.340000000000003 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.129999999999995 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 72.120000000000005 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 71.030000000000001 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 53.030000000000001 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 53.539999999999999 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 61.530000000000001 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 71.230000000000004 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 52.329999999999998 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 51.140000000000001 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p -63.05 -27.8 69.65 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 61.109999999999999 111.984 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -85.11 -40.87 16.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.721 0.808 . . . . 44.32 110.511 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.32 96.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.751 0.82 . . . . 73.030000000000001 109.833 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -141.21 167.16 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.717 1.207 . . . . 72.420000000000002 109.799 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 39.89 65.16 3.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.452 1.901 . . . . 74.150000000000006 112.568 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.57 128.11 17.56 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.576 2.184 . . . . 72.040000000000006 110.828 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.38 67.96 6.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.379 1.072 . . . . 75.239999999999995 110.024 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -69.71 138.39 52.84 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.529 0.732 . . . . 54.229999999999997 109.863 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.4 tp -158.82 100.13 1.64 Allowed Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.851 0.86 . . . . 65.540000000000006 108.688 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 76.39 4.39 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.138 2.559 . . . . 73.219999999999999 109.44 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.5 tpt -79.02 75.61 5.53 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.213 1.005 . . . . 72.120000000000005 110.056 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.37 117.09 5.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.712 0.805 . . . . 72.310000000000002 109.513 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.6 p -166.06 146.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.982 0.913 . . . . 64.010000000000005 109.222 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.2 66.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.608 -1.397 . . . . 43.030000000000001 109.608 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.28 75.45 78.99 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.547 1.139 . . . . 71.019999999999996 109.898 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.12 159.7 37.05 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.104 2.536 . . . . 74.200000000000003 110.871 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.58 176.71 40.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.563 -1.015 . . . . 73.409999999999997 110.563 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.14 117.65 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.917 -0.873 . . . . 65.0 110.917 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.53 160.86 29.54 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.519 -1.032 . . . . 21.52 110.519 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.6 t -161.2 158.56 27.56 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.527 1.131 . . . . 71.409999999999997 108.986 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -164.2 153.27 13.6 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.457 1.103 . . . . 54.43 109.27 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -169.44 158.43 7.94 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.744 1.218 . . . . 74.25 109.312 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -164.54 154.14 13.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.677 1.191 . . . . 64.230000000000004 108.762 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.88 153.87 37.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.171 0.988 . . . . 70.319999999999993 109.1 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -155.76 164.93 37.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.057 1.343 . . . . 70.450000000000003 108.92 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.384 -1.293 . . . . 73.019999999999996 108.878 169.612 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 118.992 -0.528 . . . . 53.520000000000003 110.365 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.2 124.46 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.054 2.503 . . . . 73.409999999999997 110.064 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -157.15 150.86 24.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.124 0.97 . . . . 55.43 109.047 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 51.100000000000001 106.464 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.019999999999996 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 62.299999999999997 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 54.130000000000003 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 71.340000000000003 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 64.16 -172.8 0.17 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.319999999999993 110.252 -165.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.22 -179.94 48.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.006 -1.238 . . . . 34.210000000000001 110.006 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.71 65.19 0.14 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.838 -1.305 . . . . 61.310000000000002 109.838 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.38 -177.87 6.86 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.602 1.161 . . . . 75.420000000000002 109.154 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.7 t80 60.38 59.83 2.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.521 1.128 . . . . 73.319999999999993 110.885 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.53 142.82 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.792 1.237 . . . . 53.399999999999999 108.018 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.16 71.14 2.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.634 0.774 . . . . 54.530000000000001 110.26 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.67 43.12 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.885 1.231 . . . . 71.129999999999995 110.422 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -147.77 154.85 44.51 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.717 1.607 . . . . 65.140000000000001 108.067 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.86 103.58 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.104 2.536 . . . . 71.310000000000002 109.753 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -126.69 149.76 69.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.437 1.495 . . . . 71.319999999999993 108.603 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.04 -168.45 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.455 2.77 . . . . 74.140000000000001 111.318 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 52.240000000000002 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 73.540000000000006 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 64.150000000000006 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 54.049999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 72.209999999999994 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 73.299999999999997 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 70.340000000000003 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 74.239999999999995 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 61.409999999999997 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 64.219999999999999 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 72.439999999999998 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 74.439999999999998 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 63.340000000000003 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 50.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 60.25 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 30.52 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.239999999999995 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 72.340000000000003 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.219999999999999 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.43 -40.05 49.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 62.450000000000003 111.664 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -18.12 64.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.495 0.647 . . . . 71.109999999999999 112.716 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -53.58 -53.03 57.6 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 118.962 0.801 . . . . 62.229999999999997 110.057 166.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.02 -35.51 23.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.446 1.099 . . . . 71.340000000000003 110.842 -166.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 59.39 33.81 22.51 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.098 1.759 . . . . 74.510000000000005 111.954 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.2 p -84.53 -179.14 7.08 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 75.129999999999995 110.219 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.92 -93.44 0.27 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.058 -1.217 . . . . 74.019999999999996 110.058 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -150.8 32.77 0.61 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.546 0.738 . . . . 73.409999999999997 111.048 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.96 61.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 108.324 -0.991 . . . . 73.319999999999993 108.324 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -148.86 78.21 9.03 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 108.174 -1.047 . . . . 75.530000000000001 108.174 -174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.87 75.74 4.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.384 2.723 . . . . 73.319999999999993 109.636 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.91 71.25 0.04 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.964 -1.255 . . . . 65.349999999999994 109.964 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.05 49.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.698 1.199 . . . . 61.039999999999999 109.385 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.64 133.82 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.361 -0.978 . . . . 75.129999999999995 108.361 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.28 -171.1 38.98 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.603 -0.999 . . . . 64.530000000000001 110.603 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.93 -163.34 29.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.108 -1.197 . . . . 62.310000000000002 110.108 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.9 m -155.95 145.76 21.21 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.47 1.108 . . . . 55.420000000000002 109.059 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.13 153.58 95.87 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.847 0.859 . . . . 73.340000000000003 109.763 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.98 -26.87 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.795 2.997 . . . . 74.120000000000005 112.785 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 63.61 69.16 0.56 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.517 1.527 . . . . 74.019999999999996 108.885 -171.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.66 145.26 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.391 0.676 . . . . 64.010000000000005 110.535 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.06 150.51 48.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.627 0.771 . . . . 72.439999999999998 110.827 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 t -160.14 144.55 10.78 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.954 0.902 . . . . 65.319999999999993 109.054 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.81 -15.3 46.83 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.818 2.346 . . . . 74.239999999999995 112.15 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -58.96 -20.92 56.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.669 0.788 . . . . 71.209999999999994 112.876 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 70.140000000000001 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 63.149999999999999 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 65.409999999999997 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 73.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 64.420000000000002 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 65.450000000000003 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 52.229999999999997 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 64.040000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 50.539999999999999 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.109999999999999 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 73.409999999999997 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 73.239999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 52.409999999999997 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 71.510000000000005 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 72.319999999999993 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 63.109999999999999 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 62.030000000000001 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 64.129999999999995 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 71.430000000000007 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 63.020000000000003 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 65.319999999999993 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p -115.16 96.34 5.63 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -51.48 -46.54 63.19 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.796 0.838 . . . . 55.219999999999999 111.994 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -84.74 55.68 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.937 0.895 . . . . 63.149999999999999 110.479 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.68 120.57 21.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.358 -0.979 . . . . 52.299999999999997 108.358 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -133.21 149.07 71.59 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.218 1.407 . . . . 64.329999999999998 108.321 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.79 147.63 85.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.022 2.482 . . . . 75.430000000000007 110.91 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -64.95 128.48 35.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.598 0.759 . . . . 73.129999999999995 109.966 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -155.23 158.99 39.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.832 0.853 . . . . 72.519999999999996 109.804 -172.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 tp 59.98 70.18 1.09 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.813 1.645 . . . . 74.239999999999995 111.184 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.43 171.03 18.33 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.234 2.623 . . . . 71.129999999999995 110.177 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -149.48 87.81 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.585 -0.894 . . . . 70.25 108.585 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.05 110.35 1.78 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 62.210000000000001 109.247 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.6 p -163.36 144.92 9.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.974 0.909 . . . . 52.439999999999998 109.209 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.25 111.41 0.3 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.849 -1.3 . . . . 72.049999999999997 109.849 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.8 68.27 18.89 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.807 0.843 . . . . 34.109999999999999 110.146 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.98 177.21 9.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.5 2.8 . . . . 60.5 110.856 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.19 65.11 2.25 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.969 -0.852 . . . . 74.329999999999998 110.969 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.67 74.1 0.45 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.614 -1.394 . . . . 51.450000000000003 109.614 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.37 144.79 9.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.423 -1.071 . . . . 74.430000000000007 110.423 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.9 t -157.88 120.31 3.79 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.511 -1.292 . . . . 72.209999999999994 107.511 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -146.03 97.42 2.95 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.006 0.922 . . . . 73.219999999999999 108.577 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -141.53 156.44 45.72 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.406 1.083 . . . . 72.439999999999998 109.432 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -155.76 -57.5 0.09 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.288 0.635 . . . . 64.430000000000007 110.425 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 71.0 151.33 0.1 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.099 1.76 . . . . 75.030000000000001 110.925 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -66.8 104.06 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.54 -0.541 . . . . 65.439999999999998 109.54 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.35 -1.31 . . . . 75.530000000000001 109.192 176.494 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 119.413 -0.327 . . . . 72.409999999999997 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.7 147.71 40.48 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.011 2.474 . . . . 72.049999999999997 110.798 -175.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -167.02 167.18 14.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.153 1.381 . . . . 75.299999999999997 108.668 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 70.409999999999997 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 43.219999999999999 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp -70.5 127.69 33.57 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 117.29 4.46 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.939 -1.664 . . . . 54.509999999999998 108.939 168.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.31 64.69 3.46 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.974 0.797 . . . . 75.230000000000004 111.841 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.67 -168.02 2.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.96 1.304 . . . . 71.430000000000007 110.664 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.9 t80 67.03 98.53 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.943 1.697 . . . . 72.450000000000003 111.265 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.5 t 56.93 54.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.054 1.342 . . . . 72.420000000000002 109.262 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -153.31 90.62 1.44 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.61 -1.626 . . . . 72.319999999999993 106.61 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.41 -48.6 3.99 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.527 0.584 . . . . 51.32 111.748 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -45.9 -50.74 33.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.078 1.351 . . . . 52.520000000000003 114.372 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.48 77.91 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.816 1.677 . . . . 71.239999999999995 110.502 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -146.88 -63.5 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.855 -1.069 . . . . 73.310000000000002 110.048 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.137 1.891 . . . . 55.340000000000003 110.63 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 72.010000000000005 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 65.0 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 71.329999999999998 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 62.030000000000001 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 63.210000000000001 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 74.400000000000006 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 63.109999999999999 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 54.5 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 65.040000000000006 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 44.020000000000003 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 64.200000000000003 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 64.239999999999995 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 44.549999999999997 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 72.519999999999996 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.340000000000003 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.62 52.05 4.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -8.4 53.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.547 1.139 . . . . 73.140000000000001 112.831 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -69.47 -31.95 70.56 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.667 1.587 . . . . 74.150000000000006 110.142 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.1 -15.08 62.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.819 0.848 . . . . 65.109999999999999 111.559 171.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 59.95 57.43 3.07 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.508 1.523 . . . . 75.329999999999998 109.753 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.9 p -57.63 -42.23 82.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.939 1.295 . . . . 62.310000000000002 111.825 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.53 -92.12 0.39 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 72.140000000000001 110.402 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 p -164.17 52.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.536 1.134 . . . . 35.32 108.265 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 mt -90.95 53.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.439 0.696 . . . . 64.150000000000006 109.766 -163.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -144.32 68.22 15.22 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 125.079 1.351 . . . . 71.439999999999998 108.866 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.65 77.7 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.44 2.76 . . . . 72.219999999999999 110.372 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.36 152.52 6.29 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.161 -0.776 . . . . 54.219999999999999 111.161 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.5 118.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.097 1.359 . . . . 74.409999999999997 108.453 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.75 135.95 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.603 1.161 . . . . 73.340000000000003 108.803 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.68 -166.3 38.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.982 -0.847 . . . . 71.140000000000001 110.982 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.34 1.47 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.007 0.813 . . . . 54.049999999999997 111.735 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.7 p -79.28 164.38 24.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.601 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -152.65 76.21 6.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.691 0.796 . . . . 65.439999999999998 109.173 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.35 164.97 31.73 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.337 2.691 . . . . 72.530000000000001 111.348 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -159.26 99.91 1.5 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.079 0.952 . . . . 72.150000000000006 108.837 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -92.69 139.24 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.899 0.88 . . . . 75.030000000000001 109.363 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.97 163.02 32.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.43 1.492 . . . . 62.109999999999999 108.4 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -161.7 141.48 7.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.066 0.546 . . . . 73.409999999999997 109.932 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.72 -11.82 26.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.272 2.648 . . . . 75.439999999999998 112.298 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -57.52 -24.08 53.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 112.209 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 64.019999999999996 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 54.0 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 55.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 62.130000000000003 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 44.140000000000001 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 72.519999999999996 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 60.240000000000002 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 62.530000000000001 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 60.109999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 43.32 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 63.520000000000003 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 62.32 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 70.340000000000003 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 55.240000000000002 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 64.099999999999994 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 62.200000000000003 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 72.549999999999997 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 63.420000000000002 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 72.109999999999999 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.129999999999995 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 70.120000000000005 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 73.329999999999998 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p -60.87 -28.5 68.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 71.400000000000006 112.093 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -73.74 -62.05 1.63 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.7 -0.482 . . . . 72.400000000000006 109.7 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.4 p -165.08 103.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.489 1.115 . . . . 64.209999999999994 109.814 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.89 69.68 0.69 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.098 0.959 . . . . 62.039999999999999 109.154 161.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -121.15 68.2 17.71 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.435 1.094 . . . . 53.409999999999997 110.186 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.53 153.5 49.64 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.951 2.434 . . . . 71.519999999999996 110.165 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.25 150.52 22.46 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.086 0.954 . . . . 74.230000000000004 110.268 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -157.07 155.19 30.73 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.531 1.133 . . . . 70.040000000000006 108.528 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.5 tp -148.39 89.41 5.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.843 -1.169 . . . . 73.439999999999998 107.843 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.63 147.72 32.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.856 2.371 . . . . 72.099999999999994 110.065 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.8 ptp -163.28 168.57 20.38 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.854 0.861 . . . . 71.340000000000003 110.294 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -147.2 162.85 38.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.062 1.345 . . . . 64.129999999999995 109.069 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -80.97 67.54 6.92 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.316 1.046 . . . . 50.240000000000002 109.903 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.86 68.83 3.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.057 -1.217 . . . . 50.200000000000003 110.057 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.9 79.43 64.52 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.051 1.341 . . . . 43.439999999999998 110.026 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.9 171.34 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.301 2.668 . . . . 73.150000000000006 110.966 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.96 168.05 40.47 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.001 -0.84 . . . . 32.310000000000002 111.001 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.92 -178.75 47.35 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.426 -1.069 . . . . 61.420000000000002 110.426 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.38 166.32 36.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.369 -0.693 . . . . 64.030000000000001 111.369 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 p -161.89 139.73 8.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 41.039999999999999 109.21 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -78.65 116.41 19.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.75 0.82 . . . . 75.319999999999993 109.808 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -103.12 132.44 49.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.464 1.106 . . . . 54.299999999999997 109.231 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -172.37 175.19 3.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 71.209999999999994 109.567 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -150.8 156.57 41.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.214 1.006 . . . . 64.310000000000002 109.515 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -71.93 156.27 39.44 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.182 0.593 . . . . 73.239999999999995 110.816 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 116.885 -1.531 . . . . 74.510000000000005 109.711 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 119.041 -0.504 . . . . 75.209999999999994 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.76 159.76 49.89 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.048 2.499 . . . . 71.439999999999998 110.822 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -72.94 -45.6 57.17 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.676 0.79 . . . . 62.329999999999998 110.474 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 72.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 54.009999999999998 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 42.439999999999998 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 71.510000000000005 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.99 89.36 2.56 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.87 160.09 53.95 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.596 0.617 . . . . 55.240000000000002 111.59 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.06 -58.84 4.99 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.894 -0.882 . . . . 71.439999999999998 110.894 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.5 178.4 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.651 1.58 . . . . 73.340000000000003 112.121 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.16 71.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.951 1.301 . . . . 72.109999999999999 108.585 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -106.63 147.83 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.725 1.21 . . . . 65.430000000000007 110.586 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -65.33 102.3 0.66 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.291 1.036 . . . . 75.25 109.408 172.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.25 -46.02 0.96 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.753 -1.339 . . . . 73.319999999999993 109.753 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -62.0 142.21 95.35 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.924 1.29 . . . . 72.109999999999999 109.821 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.42 91.02 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.145 2.563 . . . . 64.140000000000001 110.03 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.0 139.89 85.6 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 122.999 0.52 . . . . 62.299999999999997 110.892 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.24 -153.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.298 3.332 . . . . 43.310000000000002 109.691 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 70.239999999999995 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 64.120000000000005 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 73.150000000000006 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 74.439999999999998 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 52.049999999999997 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 65.510000000000005 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 53.149999999999999 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 53.310000000000002 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 63.350000000000001 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 54.229999999999997 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 71.230000000000004 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 62.240000000000002 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 55.219999999999999 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 61.130000000000003 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 74.310000000000002 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 176.13 145.12 5.43 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 64.209999999999994 110.452 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -65.57 -33.41 75.85 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.143 -0.622 . . . . 73.340000000000003 110.154 172.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 72.2 -67.96 0.24 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.717 2.407 . . . . 74.420000000000002 109.668 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -95.75 84.04 3.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.354 -0.98 . . . . 75.239999999999995 108.354 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 55.92 -92.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.929 1.292 . . . . 73.310000000000002 113.294 156.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p 36.88 70.79 0.16 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 127.117 2.167 . . . . 53.539999999999999 112.266 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.82 -57.77 4.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.851 -0.9 . . . . 63.009999999999998 110.851 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -82.65 -168.58 2.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.066 0.947 . . . . 54.520000000000003 110.091 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mt 40.31 55.06 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.792 2.437 . . . . 74.25 111.264 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -142.45 70.96 21.42 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.274 1.03 . . . . 74.030000000000001 109.787 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.05 69.69 7.39 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.187 2.591 . . . . 73.299999999999997 108.579 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.08 94.05 0.18 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.646 -1.382 . . . . 52.43 109.646 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -151.77 -47.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.124 0.97 . . . . 75.530000000000001 110.814 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.57 128.85 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.712 -0.848 . . . . 74.510000000000005 108.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.71 62.86 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.13 -1.588 . . . . 43.329999999999998 109.13 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.81 156.78 53.4 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.413 -0.675 . . . . 72.400000000000006 111.413 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -63.32 144.22 57.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.651 0.78 . . . . 71.5 110.551 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.33 79.05 19.7 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.7 1.2 . . . . 74.120000000000005 108.534 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.52 176.59 9.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.305 2.67 . . . . 73.439999999999998 111.364 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.73 -150.23 0.41 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 107.886 175.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.71 151.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.626 1.57 . . . . 52.140000000000001 109.354 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.82 43.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.414 0.686 . . . . 75.5 110.637 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 t -135.81 108.98 9.98 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.748 1.219 . . . . 75.409999999999997 108.295 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.93 -27.17 7.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.04 2.494 . . . . 73.439999999999998 112.403 -172.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -59.2 -21.2 59.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.881 0.873 . . . . 72.109999999999999 112.579 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 51.439999999999998 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 72.150000000000006 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 62.229999999999997 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 63.539999999999999 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 63.119999999999997 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 64.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 63.32 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 44.299999999999997 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 63.030000000000001 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 65.219999999999999 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 72.010000000000005 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 62.100000000000001 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 52.229999999999997 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 63.229999999999997 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 72.230000000000004 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 61.140000000000001 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 71.120000000000005 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 65.010000000000005 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p -72.01 -19.71 61.82 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 52.229999999999997 112.061 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.98 -100.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.96 0.904 . . . . 64.319999999999993 108.933 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.1 t -149.47 95.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.328 1.451 . . . . 71.439999999999998 107.668 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -70.26 151.49 45.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.514 0.726 . . . . 71.409999999999997 110.677 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -131.33 77.25 74.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.566 1.546 . . . . 64.329999999999998 107.628 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.19 154.62 46.78 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.956 2.437 . . . . 62.32 110.915 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -83.25 60.0 5.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.575 1.15 . . . . 73.439999999999998 109.509 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.73 165.19 11.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.216 1.407 . . . . 61.140000000000001 110.629 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.14 150.0 36.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.119 1.368 . . . . 71.239999999999995 109.279 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.61 160.51 38.06 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.224 2.616 . . . . 71.420000000000002 110.626 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.1 mtt -141.72 160.77 39.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.03 1.332 . . . . 64.439999999999998 108.873 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.4 160.36 43.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.901 0.88 . . . . 72.409999999999997 110.75 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.9 m -148.08 46.17 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.413 1.085 . . . . 60.210000000000001 110.05 171.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.05 86.71 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.499 -1.04 . . . . 42.020000000000003 110.499 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.19 70.52 61.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.326 1.05 . . . . 63.130000000000003 111.529 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.1 169.04 22.87 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.472 2.781 . . . . 70.010000000000005 111.167 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.56 170.15 42.01 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.416 -1.073 . . . . 64.340000000000003 110.416 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.82 45.06 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.054 -0.818 . . . . 70.549999999999997 111.054 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.45 166.08 36.82 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.339 -1.105 . . . . 73.329999999999998 110.339 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.9 t -161.38 159.77 28.7 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.126 0.97 . . . . 71.120000000000005 109.681 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -152.33 153.42 33.62 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.189 . . . . 54.520000000000003 109.45 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -152.98 155.39 36.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.63 1.172 . . . . 72.200000000000003 109.134 173.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -159.45 169.24 24.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.212 1.405 . . . . 74.209999999999994 108.697 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -147.43 146.37 29.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.042 -1.095 . . . . 61.119999999999997 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -144.24 149.61 36.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.838 1.255 . . . . 71.040000000000006 108.557 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.319 -1.324 . . . . 72.439999999999998 109.018 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.758 -0.639 . . . . 74.230000000000004 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.9 130.62 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.549 2.166 . . . . 75.209999999999994 110.074 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -136.08 136.1 39.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.701 1.2 . . . . 64.140000000000001 108.61 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 65.109999999999999 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 40.509999999999998 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 70.140000000000001 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 73.150000000000006 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp 70.32 -68.89 0.19 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 64.219999999999999 112.49 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 -72.12 2.29 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 109.608 -1.397 . . . . 73.450000000000003 109.608 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 70.63 0.98 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.202 0.906 . . . . 72.310000000000002 111.381 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.17 43.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.811 0.844 . . . . 61.140000000000001 110.205 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -74.76 148.94 39.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.519 0.728 . . . . 74.299999999999997 109.234 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -142.8 -72.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.917 0.887 . . . . 74.450000000000003 108.774 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -167.6 121.88 0.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.109 0.963 . . . . 63.009999999999998 108.732 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.84 35.32 91.77 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.416 0.531 . . . . 64.420000000000002 112.652 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 158.64 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.93 169.62 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.282 2.655 . . . . 70.530000000000001 110.947 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -122.77 71.05 39.52 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.322 1.049 . . . . 72.200000000000003 111.051 -171.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.89 163.04 36.32 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.717 2.278 . . . . 63.140000000000001 109.752 165.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 65.409999999999997 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 64.219999999999999 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 64.209999999999994 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.040000000000006 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 62.43 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.129999999999995 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 54.439999999999998 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 64.049999999999997 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 70.010000000000005 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 44.219999999999999 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 64.129999999999995 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 64.420000000000002 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 60.310000000000002 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 70.099999999999994 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 61.299999999999997 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 74.5 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 74.219999999999999 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 72.540000000000006 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.040000000000006 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.37 113.25 1.8 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 61.299999999999997 108.912 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -53.15 -49.89 65.67 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.495 0.718 . . . . 74.010000000000005 111.256 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.31 -59.45 0.09 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.617 1.167 . . . . 75.430000000000007 109.633 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.47 81.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.939 -2.245 . . . . 72.319999999999993 104.939 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.84 -60.48 1.9 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.748 -0.464 . . . . 72.349999999999994 109.748 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.4 p -104.97 -81.36 0.53 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.612 -1.255 . . . . 70.340000000000003 107.612 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.13 179.28 53.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.582 -1.007 . . . . 44.43 110.582 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -61.68 -64.75 0.84 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.118 0.967 . . . . 71.219999999999999 111.309 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 mt 58.17 30.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.101 1.76 . . . . 75.409999999999997 110.362 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.4 mmt-85 -152.44 100.05 2.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 75.439999999999998 106.831 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.67 147.51 40.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.467 2.112 . . . . 70.129999999999995 110.635 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.7 170.05 42.28 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.248 -1.541 . . . . 41.310000000000002 109.248 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.63 124.11 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 124.788 1.235 . . . . 73.409999999999997 108.575 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.39 140.43 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.419 1.088 . . . . 61.009999999999998 109.241 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.13 76.53 0.19 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.936 -1.266 . . . . 71.430000000000007 109.936 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.89 64.54 0.23 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.497 -1.041 . . . . 71.319999999999993 110.497 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -148.86 50.04 0.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.11 0.964 . . . . 75.540000000000006 109.431 177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -77.07 125.14 87.14 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 109.856 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.65 170.86 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.34 2.693 . . . . 74.430000000000007 110.785 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -149.57 104.27 3.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.632 0.773 . . . . 63.109999999999999 109.307 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.49 152.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.865 0.866 . . . . 75.430000000000007 110.384 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.7 164.15 36.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.911 1.284 . . . . 74.030000000000001 109.159 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.12 109.24 1.26 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.436 0.694 . . . . 44.130000000000003 109.785 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.59 -19.03 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.094 2.529 . . . . 23.210000000000001 112.252 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -55.09 -24.84 27.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.92 1.288 . . . . 61.439999999999998 112.696 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 70.140000000000001 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 71.450000000000003 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 40.5 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 72.519999999999996 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 64.519999999999996 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 60.020000000000003 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 71.420000000000002 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 62.149999999999999 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 61.140000000000001 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 70.420000000000002 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 54.100000000000001 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 55.25 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 63.450000000000003 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 72.329999999999998 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 73.540000000000006 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 73.340000000000003 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.239999999999995 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p -74.28 -7.04 51.38 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -7.5 53.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.622 1.101 . . . . 64.340000000000003 111.274 164.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t 69.15 69.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.107 2.163 . . . . 73.25 108.405 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.96 78.52 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.898 1.279 . . . . 74.409999999999997 110.687 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -63.6 145.64 97.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 75.439999999999998 110.564 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.0 164.33 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.239 2.626 . . . . 73.329999999999998 110.331 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -82.16 55.13 2.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.728 0.811 . . . . 71.010000000000005 110.232 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -166.24 145.1 5.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.713 1.205 . . . . 73.019999999999996 109.122 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.33 103.76 48.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.019 -1.474 . . . . 55.219999999999999 107.019 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.42 78.18 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.032 2.488 . . . . 72.319999999999993 110.216 -175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.5 mtp -69.01 136.61 52.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.52 0.728 . . . . 65.099999999999994 110.222 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.28 170.72 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.596 1.158 . . . . 72.329999999999998 110.998 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 m -146.78 149.66 33.78 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.559 1.144 . . . . 74.150000000000006 109.503 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.84 134.35 2.11 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.811 -1.316 . . . . 64.420000000000002 109.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.62 10.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.177 0.991 . . . . 62.420000000000002 109.455 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.63 177.79 8.39 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.573 2.848 . . . . 74.0 110.904 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -167.4 176.35 42.24 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.798 -0.921 . . . . 75.439999999999998 110.798 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.54 -169.57 41.21 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.568 -1.013 . . . . 41.439999999999998 110.568 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.75 66.84 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.303 -1.119 . . . . 52.140000000000001 110.303 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -74.1 146.32 43.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.74 0.816 . . . . 55.210000000000001 111.054 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -162.72 170.97 17.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.649 1.18 . . . . 72.409999999999997 109.559 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.41 173.32 7.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.323 1.049 . . . . 62.219999999999999 111.869 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -121.26 143.23 49.27 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.073 1.349 . . . . 71.129999999999995 108.3 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.3 t60 47.84 -108.98 0.26 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.482 1.513 . . . . 65.450000000000003 111.463 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -173.97 -61.23 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.17 1.388 . . . . 75.200000000000003 108.056 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.378 -1.296 . . . . 65.200000000000003 109.651 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 118.063 -0.97 . . . . 74.120000000000005 112.338 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.3 147.59 53.5 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.877 1.718 . . . . 65.030000000000001 110.765 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -70.04 134.58 48.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.517 0.727 . . . . 62.310000000000002 110.032 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 61.310000000000002 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 64.420000000000002 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 71.349999999999994 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 64.430000000000007 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 52.439999999999998 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 53.009999999999998 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 53.229999999999997 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.46 167.0 21.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.030000000000001 109.189 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 162.0 32.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.867 -0.893 . . . . 52.219999999999999 110.867 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.98 130.11 1.67 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.258 -1.137 . . . . 54.409999999999997 110.258 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.78 4.44 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.873 0.869 . . . . 75.340000000000003 110.315 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.42 68.65 1.39 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.992 1.317 . . . . 74.310000000000002 108.456 -174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.71 172.24 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.551 1.54 . . . . 54.119999999999997 109.473 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -59.69 127.56 32.58 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.968 -0.458 . . . . 73.209999999999994 110.099 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 37.14 92.7 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 123.295 0.474 . . . . 72.120000000000005 112.107 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -59.56 147.56 76.94 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.413 0.685 . . . . 71.329999999999998 110.087 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.16 147.98 93.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.359 2.706 . . . . 71.409999999999997 110.92 -175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.49 62.05 52.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.968 0.907 . . . . 75.219999999999999 112.16 -172.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -76.66 -165.97 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.935 2.423 . . . . 73.140000000000001 108.915 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 65.030000000000001 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 71.420000000000002 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 72.230000000000004 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 71.329999999999998 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 70.510000000000005 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 71.420000000000002 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 70.230000000000004 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 63.100000000000001 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 55.32 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 51.119999999999997 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 65.129999999999995 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 64.430000000000007 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.219999999999999 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 64.349999999999994 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 43.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 50.439999999999998 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 55.219999999999999 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 51.409999999999997 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 62.450000000000003 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 65.349999999999994 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.98 83.05 0.06 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.39 -32.35 68.35 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.089 0.444 . . . . 65.209999999999994 110.111 166.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 66.37 25.51 10.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.353 1.861 . . . . 73.549999999999997 111.555 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -169.5 48.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.833 1.253 . . . . 73.109999999999999 110.203 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.09 -170.78 2.63 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.821 -0.55 . . . . 73.540000000000006 110.572 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 p -53.27 -40.52 64.72 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.896 1.278 . . . . 62.520000000000003 111.489 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.05 -86.44 0.4 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.822 -1.311 . . . . 70.450000000000003 109.822 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -168.35 -71.34 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.13 0.972 . . . . 71.0 109.488 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mt 60.62 41.13 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.527 1.931 . . . . 71.140000000000001 109.302 -171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.53 83.82 22.48 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.179 1.392 . . . . 73.219999999999999 108.482 175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.1 93.95 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.2 2.6 . . . . 63.100000000000001 110.852 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.27 -112.09 0.5 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.923 -1.271 . . . . 63.130000000000003 109.923 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m 44.85 43.6 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.572 1.949 . . . . 63.530000000000001 113.466 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.41 -48.86 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.908 0.883 . . . . 73.340000000000003 109.758 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.68 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.819 -1.312 . . . . 51.210000000000001 109.819 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.49 39.22 14.8 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.394 1.473 . . . . 65.109999999999999 113.361 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.4 m -95.6 89.26 5.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.898 0.879 . . . . 71.129999999999995 110.266 -168.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -118.69 69.62 8.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.431 1.492 . . . . 72.230000000000004 109.785 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.64 173.45 14.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.339 2.693 . . . . 73.430000000000007 111.35 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? 61.46 76.76 0.36 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.098 1.359 . . . . 74.019999999999996 110.421 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 t -84.32 127.16 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 124.29 31.22 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.694 0.798 . . . . 75.329999999999998 109.031 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.276 0.2 OUTLIER -144.69 -67.29 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.792 -1.099 . . . . 64.099999999999994 112.152 -178.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.76 -46.25 1.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 71.439999999999998 111.915 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.55 -31.45 72.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.648 0.379 . . . . 75.239999999999995 111.829 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 73.209999999999994 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 73.319999999999993 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 53.450000000000003 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 72.400000000000006 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 63.32 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 64.200000000000003 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 72.010000000000005 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 73.400000000000006 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 62.200000000000003 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 72.450000000000003 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 61.130000000000003 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 43.43 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.140000000000001 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 72.340000000000003 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 62.450000000000003 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 63.020000000000003 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 62.439999999999998 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 62.329999999999998 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 72.439999999999998 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 71.530000000000001 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 73.239999999999995 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 64.510000000000005 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 64.239999999999995 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p -57.41 -15.05 5.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -104.78 -54.08 2.57 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.678 1.191 . . . . 53.420000000000002 111.551 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.09 106.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.154 0.582 . . . . 74.310000000000002 109.55 -165.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -156.58 166.62 32.88 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.842 1.257 . . . . 65.329999999999998 111.85 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.75 138.97 33.1 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.378 1.071 . . . . 71.200000000000003 109.192 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.19 161.84 44.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.653 2.902 . . . . 71.109999999999999 112.34 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.08 130.56 38.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.191 1.397 . . . . 75.510000000000005 108.64 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -145.77 160.54 41.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.764 0.826 . . . . 72.319999999999993 110.387 -175.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -149.76 80.05 7.62 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 107.901 -1.148 . . . . 61.030000000000001 107.901 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.72 74.96 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.526 2.817 . . . . 73.409999999999997 110.878 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -87.04 152.54 22.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.501 0.72 . . . . 73.200000000000003 111.438 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.91 153.89 19.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.162 1.385 . . . . 70.540000000000006 109.325 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.5 m -136.37 33.51 2.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.252 1.021 . . . . 75.349999999999994 110.62 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -89.79 134.63 12.48 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.156 -1.178 . . . . 50.399999999999999 110.156 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.44 70.55 3.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.703 0.801 . . . . 70.129999999999995 109.907 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.59 170.95 18.34 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.434 2.756 . . . . 70.430000000000007 111.238 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.45 169.8 39.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.415 -1.074 . . . . 74.329999999999998 110.415 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 172.31 -179.58 43.8 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.303 -0.719 . . . . 52.229999999999997 111.303 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.92 161.83 29.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.247 -1.141 . . . . 31.199999999999999 110.247 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 78.4 p -163.74 167.31 21.15 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.57 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -147.8 154.6 40.69 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.24 1.416 . . . . 64.230000000000004 109.187 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -151.1 52.18 0.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 71.120000000000005 108.534 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -88.05 68.25 9.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.696 0.798 . . . . 71.019999999999996 109.036 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.01 116.03 20.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.553 0.741 . . . . 75.329999999999998 109.338 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -77.74 151.51 34.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.204 1.002 . . . . 61.450000000000003 110.528 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.295 -1.336 . . . . 73.409999999999997 108.565 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.798 -0.445 . . . . 70.219999999999999 109.798 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.17 175.06 11.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.152 2.568 . . . . 62.409999999999997 110.877 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -137.05 145.36 43.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.806 1.242 . . . . 73.109999999999999 108.969 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 43.200000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 72.030000000000001 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 71.099999999999994 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 63.91 178.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 55.009999999999998 111.659 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.59 173.17 45.36 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.397 -0.681 . . . . 31.329999999999998 111.397 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.53 -167.5 42.87 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.394 0.997 . . . . 72.140000000000001 112.103 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.95 154.82 33.18 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.727 0.811 . . . . 74.109999999999999 110.771 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -83.08 59.81 5.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.213 1.405 . . . . 72.430000000000007 110.432 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -166.84 -36.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.648 1.179 . . . . 71.430000000000007 111.159 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -49.45 -47.76 48.0 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.164 1.386 . . . . 64.0 112.046 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.84 56.77 0.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.877 -1.689 . . . . 50.109999999999999 108.877 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -123.21 79.08 52.54 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.65 1.18 . . . . 73.420000000000002 110.022 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.33 69.61 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.436 3.424 . . . . 62.119999999999997 110.289 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.99 166.84 14.11 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.409 1.484 . . . . 71.530000000000001 110.206 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.14 -158.95 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.864 3.043 . . . . 52.229999999999997 110.805 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 40.049999999999997 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 72.25 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 72.150000000000006 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 55.229999999999997 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 73.209999999999994 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 22.329999999999998 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 74.230000000000004 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 71.430000000000007 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 45.210000000000001 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 71.439999999999998 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 52.420000000000002 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 54.140000000000001 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 71.310000000000002 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 43.149999999999999 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 72.040000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 63.130000000000003 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 33.109999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 62.240000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 63.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.150000000000006 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 71.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.93 119.42 0.53 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -61.3 -46.88 88.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.562 0.681 . . . . 71.239999999999995 109.81 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -159.39 39.97 0.21 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.703 0.801 . . . . 74.319999999999993 110.647 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 60.48 71.46 0.57 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.291 -1.003 . . . . 71.140000000000001 108.291 -165.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.46 136.66 20.33 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.579 1.552 . . . . 74.549999999999997 113.604 -160.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -79.03 -34.95 43.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.776 0.831 . . . . 45.420000000000002 111.292 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -83.36 0.17 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.767 -0.933 . . . . 72.239999999999995 110.767 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -77.83 173.01 12.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.001 0.521 . . . . 74.519999999999996 109.671 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mt 60.8 35.77 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.134 1.373 . . . . 55.32 111.138 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -144.14 67.67 15.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.501 1.121 . . . . 71.040000000000006 110.579 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.21 124.81 9.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.798 2.332 . . . . 45.100000000000001 109.919 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.39 159.57 20.21 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.729 -0.949 . . . . 74.430000000000007 110.729 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.63 125.88 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.644 1.577 . . . . 75.150000000000006 108.344 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.81 136.03 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.269 1.427 . . . . 75.219999999999999 109.028 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.39 164.5 33.18 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.559 -1.016 . . . . 75.150000000000006 110.559 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.58 164.61 27.5 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.185 -0.766 . . . . 53.119999999999997 111.185 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.6 m -154.73 143.45 20.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.626 1.17 . . . . 75.010000000000005 109.274 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -159.5 79.12 2.77 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 64.540000000000006 109.387 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.23 160.62 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.253 2.635 . . . . 74.329999999999998 111.966 -173.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -147.93 109.4 4.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.802 1.641 . . . . 72.200000000000003 108.089 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -139.4 135.55 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 73.349999999999994 108.912 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.97 132.03 34.4 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.284 1.034 . . . . 74.340000000000003 109.735 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER -154.84 -67.64 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.122 -0.942 . . . . 73.239999999999995 112.417 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.07 -41.62 7.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.335 2.023 . . . . 74.239999999999995 112.01 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.35 -26.34 63.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.692 0.797 . . . . 64.299999999999997 112.154 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 73.299999999999997 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 72.329999999999998 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 71.019999999999996 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 60.5 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 54.539999999999999 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 72.329999999999998 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 51.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 65.310000000000002 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 64.230000000000004 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 45.229999999999997 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 72.040000000000006 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 53.340000000000003 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 64.209999999999994 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 72.129999999999995 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 73.209999999999994 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 60.25 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 64.040000000000006 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 70.109999999999999 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 61.409999999999997 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 71.200000000000003 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 64.129999999999995 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 64.219999999999999 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p -66.32 -29.61 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 72.329999999999998 111.879 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.63 -78.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.936 -0.764 . . . . 60.009999999999998 108.936 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -170.36 101.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.542 1.537 . . . . 64.219999999999999 108.967 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -83.25 171.2 13.85 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.17 0.588 . . . . 55.32 109.839 166.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -121.22 82.46 38.07 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 125.319 1.448 . . . . 75.540000000000006 108.299 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.15 128.67 17.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.539 2.16 . . . . 73.409999999999997 110.916 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.89 67.85 7.27 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.236 1.014 . . . . 71.540000000000006 109.642 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.35 145.81 22.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.231 1.013 . . . . 71.430000000000007 109.237 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.9 tp -118.35 93.07 44.6 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 125.132 1.373 . . . . 73.120000000000005 107.408 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.67 158.1 39.7 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.709 2.273 . . . . 65.040000000000006 110.169 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -155.89 120.36 4.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.599 0.76 . . . . 52.350000000000001 109.244 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.35 155.46 30.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.996 0.919 . . . . 53.43 109.729 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -158.29 163.06 37.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.806 0.842 . . . . 75.140000000000001 109.757 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.39 177.19 42.55 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.344 -1.102 . . . . 32.329999999999998 110.344 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 69.83 6.15 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.705 0.802 . . . . 74.310000000000002 110.132 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.85 167.44 27.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.246 2.63 . . . . 55.25 110.855 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.66 179.51 48.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.515 -1.034 . . . . 75.430000000000007 110.515 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.5 -175.25 47.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.75 -0.94 . . . . 64.239999999999995 110.75 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.89 169.9 42.44 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.359 -1.096 . . . . 60.420000000000002 110.359 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.3 m -153.18 164.43 38.08 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.328 1.051 . . . . 75.349999999999994 109.411 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -162.89 171.49 16.56 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.231 1.012 . . . . 43.210000000000001 109.649 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -155.3 -171.36 3.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.662 1.185 . . . . 75.310000000000002 108.928 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -130.13 -178.61 4.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.023 1.329 . . . . 74.329999999999998 109.811 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.71 153.34 41.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.826 1.25 . . . . 62.109999999999999 109.08 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -150.36 148.6 29.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.986 1.315 . . . . 70.109999999999999 107.754 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.247 -1.358 . . . . 73.120000000000005 109.269 178.043 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 119.271 -0.395 . . . . 74.430000000000007 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.79 -45.96 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.7 2.267 . . . . 73.299999999999997 111.009 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 58.44 72.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 74.319999999999993 111.491 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 71.0 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 72.230000000000004 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 43.130000000000003 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 51.539999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.0 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 60.520000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt 56.19 -146.34 0.57 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.98 63.83 4.1 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.083 -1.207 . . . . 53.109999999999999 110.083 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.79 65.38 0.27 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.898 -0.39 . . . . 62.140000000000001 112.195 -168.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.11 142.2 21.36 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.173 0.989 . . . . 71.340000000000003 109.448 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -86.72 135.53 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.482 0.713 . . . . 75.519999999999996 109.934 -173.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 147.52 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.713 -0.847 . . . . 62.310000000000002 108.713 174.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -50.97 120.39 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 74.430000000000007 111.563 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.92 84.04 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.806 -0.997 . . . . 75.409999999999997 114.079 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -101.81 116.43 63.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.804 1.302 . . . . 72.120000000000005 108.545 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.86 115.04 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.984 2.456 . . . . 61.420000000000002 109.832 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 32.94 62.96 1.44 Allowed Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 71.409999999999997 114.571 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.94 170.84 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.538 2.158 . . . . 73.030000000000001 110.128 174.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 73.340000000000003 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 63.340000000000003 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 44.340000000000003 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 65.0 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 73.109999999999999 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 60.039999999999999 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 62.409999999999997 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 54.109999999999999 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 54.350000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 61.210000000000001 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 73.430000000000007 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 72.409999999999997 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 71.510000000000005 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 64.030000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.6 73.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -81.91 -55.46 4.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.827 -0.805 . . . . 54.399999999999999 108.827 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -132.7 34.66 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.597 1.159 . . . . 64.120000000000005 109.882 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 57.96 46.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.669 1.587 . . . . 63.030000000000001 111.138 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 53.14 -142.18 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.232 1.013 . . . . 71.349999999999994 109.585 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -79.66 54.7 1.85 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 109.033 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 44.32 36.92 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.743 1.163 . . . . 25.32 112.581 -171.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -104.37 -22.48 13.33 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.749 1.22 . . . . 73.129999999999995 113.31 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.68 62.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.521 1.128 . . . . 71.439999999999998 109.556 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -119.04 77.39 15.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.139 1.376 . . . . 65.209999999999994 108.759 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.5 78.96 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.306 2.671 . . . . 72.129999999999995 109.984 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.91 74.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.413 -1.475 . . . . 72.310000000000002 109.413 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 p -150.82 87.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.014 0.926 . . . . 72.340000000000003 108.756 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.64 135.63 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.365 -0.976 . . . . 72.150000000000006 108.365 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.07 175.78 42.18 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.967 -0.853 . . . . 73.019999999999996 110.967 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.38 115.26 0.33 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.128 -1.589 . . . . 71.319999999999993 109.128 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -70.99 146.31 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.238 0.615 . . . . 54.149999999999999 110.991 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -103.7 151.95 38.85 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.567 1.547 . . . . 64.409999999999997 108.395 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.44 154.41 69.04 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.061 2.507 . . . . 72.230000000000004 110.476 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -101.65 66.59 1.08 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.134 0.974 . . . . 52.020000000000003 109.162 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.53 137.18 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.76 0.824 . . . . 74.239999999999995 108.807 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.4 126.27 32.56 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.812 0.845 . . . . 74.340000000000003 109.5 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 p 44.21 62.76 9.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.62 1.568 . . . . 75.129999999999995 112.17 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.47 -81.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.262 2.641 . . . . 55.140000000000001 111.752 -171.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.539 0.736 . . . . 74.409999999999997 111.756 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 70.400000000000006 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.310000000000002 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 72.310000000000002 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 64.219999999999999 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 41.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 55.43 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 63.43 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 61.439999999999998 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 63.240000000000002 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 42.310000000000002 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 62.130000000000003 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 72.019999999999996 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 62.130000000000003 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 61.350000000000001 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 64.439999999999998 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 55.149999999999999 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 70.340000000000003 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 44.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 70.129999999999995 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p -57.9 -34.84 70.25 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -72.65 -69.11 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.759 -0.46 . . . . 70.439999999999998 109.759 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -146.21 92.45 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.129 1.372 . . . . 72.329999999999998 108.077 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 165.25 20.71 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.041 0.537 . . . . 72.430000000000007 111.471 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -112.42 135.97 21.45 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.791 1.236 . . . . 74.420000000000002 107.689 171.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 154.29 52.39 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.987 2.458 . . . . 71.049999999999997 110.301 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.66 138.97 32.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.102 0.961 . . . . 72.209999999999994 109.231 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.35 162.79 30.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.256 1.022 . . . . 71.540000000000006 109.445 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.84 75.79 9.05 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.238 -1.023 . . . . 71.439999999999998 108.238 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.69 128.03 18.24 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.519 2.146 . . . . 74.239999999999995 108.951 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -150.8 140.57 21.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.604 -0.887 . . . . 44.229999999999997 108.604 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -146.25 159.55 43.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.949 1.299 . . . . 75.239999999999995 108.644 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -165.46 130.31 2.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.044 0.937 . . . . 75.420000000000002 109.115 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.72 146.03 11.12 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.672 -1.371 . . . . 54.149999999999999 109.672 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.72 74.26 10.36 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 109.371 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.69 162.66 37.32 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.958 2.439 . . . . 71.329999999999998 110.646 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.51 177.95 48.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.102 -1.199 . . . . 55.43 110.102 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.71 -175.75 46.32 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.441 -1.064 . . . . 74.120000000000005 110.441 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.4 166.74 39.22 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.14 -1.184 . . . . 73.109999999999999 110.14 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.8 t -161.63 161.49 29.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.505 1.122 . . . . 44.25 108.803 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -158.85 160.95 36.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 73.409999999999997 109.262 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -157.04 143.81 18.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.154 0.981 . . . . 73.540000000000006 109.087 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -106.58 109.67 21.65 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.855 1.262 . . . . 65.310000000000002 109.031 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -70.4 93.85 0.9 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.066 -1.087 . . . . 73.120000000000005 108.066 167.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -72.46 140.8 48.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.286 0.634 . . . . 74.200000000000003 110.626 -174.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.935 -1.507 . . . . 74.0 109.95 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 117.614 -1.184 . . . . 52.329999999999998 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.33 76.95 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.648 2.232 . . . . 74.140000000000001 110.862 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -68.4 136.1 52.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.709 0.804 . . . . 72.349999999999994 110.22 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 72.319999999999993 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 71.430000000000007 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 52.299999999999997 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 54.229999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 63.29 179.58 0.15 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 61.329999999999998 111.153 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.89 171.93 44.41 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.444 -1.062 . . . . 60.520000000000003 110.444 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.19 49.41 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.714 0.673 . . . . 65.219999999999999 112.06 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 154.92 33.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.318 1.047 . . . . 72.209999999999994 109.91 -174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.7 t80 69.21 1.77 3.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.816 1.647 . . . . 63.329999999999998 114.267 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.9 -48.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.543 1.137 . . . . 60.130000000000003 109.118 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.41 145.87 25.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.252 1.421 . . . . 71.230000000000004 107.388 168.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.07 -65.18 3.31 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.8 -1.32 . . . . 52.409999999999997 109.8 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -79.02 119.12 76.09 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.609 -0.886 . . . . 75.430000000000007 108.609 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.64 174.96 11.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.17 2.58 . . . . 71.129999999999995 111.501 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mp -124.28 71.56 55.56 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.826 1.25 . . . . 62.409999999999997 109.078 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.31 -156.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.417 2.745 . . . . 71.120000000000005 109.778 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 72.420000000000002 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.340000000000003 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 74.319999999999993 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 61.130000000000003 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 63.030000000000001 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 54.509999999999998 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 62.25 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 62.310000000000002 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 64.299999999999997 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 64.439999999999998 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 70.349999999999994 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 44.329999999999998 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 70.120000000000005 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.01 140.55 6.73 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -15.2 60.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.043 0.422 . . . . 73.439999999999998 111.206 168.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 79.47 128.29 0.05 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 127.067 2.147 . . . . 74.430000000000007 111.32 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 62.92 55.15 2.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.787 1.635 . . . . 64.239999999999995 110.561 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -50.95 152.46 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.597 1.159 . . . . 75.310000000000002 110.71 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -31.28 -62.34 0.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.433 1.893 . . . . 73.400000000000006 112.799 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.49 49.05 0.94 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.052 0.835 . . . . 63.32 111.319 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -159.29 168.32 26.71 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.101 0.95 . . . . 73.230000000000004 109.983 173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mt 59.83 50.83 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.838 1.255 . . . . 44.450000000000003 109.018 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.33 55.42 1.06 Allowed Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.244 1.018 . . . . 72.519999999999996 110.965 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.93 151.51 68.12 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.057 2.504 . . . . 72.219999999999999 110.79 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.92 104.5 0.64 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.268 -1.133 . . . . 63.020000000000003 110.268 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -152.95 110.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.962 0.905 . . . . 72.239999999999995 109.303 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.5 mt -77.18 139.94 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 73.430000000000007 108.72 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.69 157.06 29.35 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.459 -1.057 . . . . 74.519999999999996 110.459 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.39 55.0 33.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.041 0.829 . . . . 73.430000000000007 111.483 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.1 p -155.27 81.27 1.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.367 0.667 . . . . 72.219999999999999 110.027 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.97 67.66 9.29 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.973 0.909 . . . . 70.549999999999997 109.341 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.78 161.05 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.472 2.781 . . . . 64.239999999999995 111.562 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -158.35 113.91 2.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.458 -1.312 . . . . 71.129999999999995 107.458 172.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.22 121.02 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.473 0.709 . . . . 62.049999999999997 109.922 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 166.61 149.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.066 2.546 . . . . 64.140000000000001 108.846 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -158.19 142.34 11.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.327 -1.36 . . . . 63.439999999999998 107.327 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.11 -21.34 36.65 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 71.340000000000003 111.895 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -60.48 -19.16 55.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.577 1.151 . . . . 72.439999999999998 113.219 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 71.329999999999998 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 65.5 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 63.240000000000002 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 63.399999999999999 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 52.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 40.32 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 51.420000000000002 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 53.5 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 62.409999999999997 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 62.119999999999997 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 71.5 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 64.129999999999995 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.209999999999994 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 71.530000000000001 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 60.539999999999999 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 54.219999999999999 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 73.040000000000006 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 70.439999999999998 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 64.420000000000002 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 72.129999999999995 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 63.229999999999997 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 74.25 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 73.349999999999994 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 54.140000000000001 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 71.129999999999995 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 63.439999999999998 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 72.030000000000001 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 62.149999999999999 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p -63.91 -29.58 70.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -83.16 -46.93 12.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.704 0.802 . . . . 54.520000000000003 110.298 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.37 99.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.252 1.021 . . . . 74.319999999999993 109.238 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 165.55 12.04 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.598 1.159 . . . . 63.100000000000001 109.481 166.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -109.65 139.95 21.7 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 124.001 0.92 . . . . 65.329999999999998 109.358 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.32 165.28 33.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.079 2.519 . . . . 72.450000000000003 110.73 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -81.3 63.7 5.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.964 0.906 . . . . 63.229999999999997 110.294 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.62 154.75 23.04 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.311 1.444 . . . . 70.120000000000005 107.892 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.2 tp -147.83 77.32 10.29 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.221 1.008 . . . . 74.5 108.281 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -85.28 52.05 3.18 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.485 2.79 . . . . 73.439999999999998 110.553 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 38.5 mmt -86.64 67.88 9.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.942 0.897 . . . . 64.349999999999994 110.179 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.7 132.91 42.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.129 -0.693 . . . . 70.030000000000001 109.129 172.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.1 m -146.36 63.52 1.21 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.196 0.998 . . . . 74.319999999999993 109.26 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.26 127.06 2.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.642 -1.383 . . . . 61.420000000000002 109.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 147.26 14.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 70.420000000000002 109.312 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.38 170.96 18.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.531 2.821 . . . . 65.450000000000003 110.963 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.37 146.73 7.57 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.54 -1.424 . . . . 75.519999999999996 109.54 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.25 176.83 44.77 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.883 -0.887 . . . . 73.299999999999997 110.883 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.74 165.25 31.96 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.363 -1.095 . . . . 73.349999999999994 110.363 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -162.97 153.22 16.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.107 0.963 . . . . 73.209999999999994 109.372 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -163.23 153.71 16.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.576 1.15 . . . . 73.239999999999995 109.268 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -153.76 147.59 25.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.542 1.137 . . . . 63.420000000000002 108.384 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -153.92 164.04 39.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.577 1.151 . . . . 71.209999999999994 108.326 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -161.45 160.46 29.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.873 0.869 . . . . 73.439999999999998 109.262 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -69.57 146.78 51.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.359 0.663 . . . . 74.510000000000005 109.676 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.836 -1.078 . . . . 74.409999999999997 111.146 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.988 -1.006 . . . . 74.540000000000006 111.654 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.44 152.99 60.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.837 1.691 . . . . 71.230000000000004 109.712 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -138.79 74.8 1.49 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 73.030000000000001 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 54.009999999999998 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 63.0 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 63.240000000000002 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.030000000000001 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt -151.75 102.02 2.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 65.430000000000007 108.063 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.15 177.2 53.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.683 0.659 . . . . 25.43 112.244 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.07 176.57 45.81 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.63 -0.988 . . . . 53.43 110.63 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.21 140.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.378 1.871 . . . . 71.209999999999994 111.924 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.8 t80 54.44 51.96 13.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.638 1.175 . . . . 62.549999999999997 111.216 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.2 t -101.24 142.27 16.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.596 1.158 . . . . 74.040000000000006 108.479 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -71.01 84.84 0.7 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.667 0.787 . . . . 75.530000000000001 108.882 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 -44.98 0.57 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.228 -1.549 . . . . 64.049999999999997 109.228 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -65.57 135.27 95.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 65.310000000000002 108.591 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.48 133.85 16.37 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.75 2.3 . . . . 72.239999999999995 109.603 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.32 89.6 12.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.135 . . . . 50.420000000000002 108.214 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.09 -160.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.365 2.71 . . . . 74.25 110.431 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 63.119999999999997 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 64.420000000000002 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 62.039999999999999 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.140000000000001 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 62.539999999999999 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 63.030000000000001 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 44.439999999999998 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 63.229999999999997 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 63.509999999999998 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 71.25 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 73.450000000000003 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 54.420000000000002 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 62.009999999999998 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 74.200000000000003 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 65.329999999999998 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 63.5 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 62.229999999999997 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.79 138.81 2.64 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -69.47 -42.15 75.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.548 -0.908 . . . . 63.350000000000001 108.548 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.95 -63.04 1.45 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.277 1.431 . . . . 74.239999999999995 109.128 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.49 -52.11 0.39 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.757 1.623 . . . . 64.349999999999994 107.36 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -101.73 -177.57 3.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.983 -1.117 . . . . 74.510000000000005 107.983 152.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -63.08 -52.7 61.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.546 0.738 . . . . 64.109999999999999 110.374 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.03 69.73 0.27 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.176 -1.169 . . . . 74.540000000000006 110.176 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 t -160.34 -175.54 5.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.475 1.11 . . . . 53.329999999999998 108.933 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 mt 63.79 65.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.787 1.635 . . . . 71.530000000000001 108.183 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -139.22 70.64 40.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.239 1.016 . . . . 75.329999999999998 109.851 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.24 89.4 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.386 2.724 . . . . 63.539999999999999 109.453 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.96 -170.78 46.48 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.013 0.816 . . . . 71.129999999999995 111.917 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.96 92.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.662 1.585 . . . . 60.140000000000001 109.177 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.37 134.46 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.691 -0.855 . . . . 72.430000000000007 108.691 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.1 44.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.655 -0.978 . . . . 74.239999999999995 110.655 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.05 -169.68 42.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.561 -1.016 . . . . 45.32 110.561 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.3 m -65.71 144.99 56.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.566 0.746 . . . . 70.319999999999993 110.757 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -123.27 80.31 52.67 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.59 1.156 . . . . 72.340000000000003 109.348 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.51 164.78 33.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 110.556 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -102.08 -157.25 0.6 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.249 1.019 . . . . 71.409999999999997 109.004 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.0 137.1 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.613 1.565 . . . . 74.129999999999995 108.126 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 157.24 28.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.709 0.804 . . . . 53.100000000000001 110.775 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.7 t -158.67 144.93 12.53 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.927 0.891 . . . . 72.430000000000007 108.966 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.65 -16.05 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.654 2.236 . . . . 75.230000000000004 111.842 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -60.24 -21.45 61.86 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 44.520000000000003 112.171 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 65.519999999999996 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 63.210000000000001 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.099999999999994 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 72.129999999999995 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 65.349999999999994 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 71.519999999999996 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 73.349999999999994 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 60.130000000000003 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 53.100000000000001 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 73.319999999999993 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.209999999999994 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 71.310000000000002 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 71.230000000000004 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 33.109999999999999 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 62.439999999999998 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 65.430000000000007 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 70.420000000000002 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 72.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 55.219999999999999 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 62.32 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 73.209999999999994 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 63.130000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p -60.57 -24.5 65.47 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.99 -43.51 11.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.082 0.953 . . . . 65.340000000000003 110.757 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.84 92.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.075 0.95 . . . . 60.310000000000002 110.348 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -145.95 167.64 22.81 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.789 1.235 . . . . 61.109999999999999 110.137 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.71 143.84 49.03 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.847 1.259 . . . . 74.230000000000004 108.483 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.03 172.78 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.366 2.711 . . . . 64.129999999999995 110.729 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -80.09 64.52 4.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.083 0.953 . . . . 63.43 109.94 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.39 148.94 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.546 1.139 . . . . 74.420000000000002 109.221 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.5 tp -112.56 91.66 17.67 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.942 1.297 . . . . 61.32 108.487 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.32 126.13 12.0 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.307 2.005 . . . . 72.450000000000003 109.236 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.5 tpt -154.44 106.48 2.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.737 0.815 . . . . 75.230000000000004 108.989 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.62 134.63 35.74 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.779 1.232 . . . . 63.210000000000001 108.535 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.7 m -164.17 165.11 22.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.373 1.469 . . . . 74.430000000000007 109.26 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.15 173.04 49.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.018 0.818 . . . . 73.439999999999998 112.231 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.8 73.58 6.49 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.384 1.073 . . . . 75.019999999999996 109.274 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.38 175.06 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.407 2.738 . . . . 74.310000000000002 111.213 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.47 98.33 1.98 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.067 -1.213 . . . . 51.130000000000003 110.067 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.95 173.88 42.25 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.214 -1.154 . . . . 71.319999999999993 110.214 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.39 -179.66 46.95 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.429 -1.068 . . . . 64.140000000000001 110.429 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 65.0 p -161.18 159.76 29.28 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.188 0.995 . . . . 71.510000000000005 109.647 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -160.38 106.58 1.53 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.506 -0.924 . . . . 72.329999999999998 108.506 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -132.99 62.36 1.66 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.931 0.892 . . . . 73.409999999999997 108.913 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -125.04 141.32 52.2 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.294 1.038 . . . . 73.450000000000003 109.725 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -166.2 167.5 16.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.631 1.172 . . . . 62.32 109.312 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -99.02 173.93 6.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.46 1.104 . . . . 72.299999999999997 109.435 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.549 -1.215 . . . . 52.240000000000002 109.76 174.15 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 117.914 -1.041 . . . . 62.450000000000003 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.82 159.82 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.929 1.753 . . . . 61.140000000000001 110.498 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -159.73 162.92 35.05 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.305 1.042 . . . . 63.329999999999998 109.516 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 63.43 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.299999999999997 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 35.409999999999997 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 45.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 71.129999999999995 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 54.329999999999998 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 62.409999999999997 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.96 154.82 46.98 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.299999999999997 110.293 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 163.2 33.83 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.752 -1.339 . . . . 65.519999999999996 109.752 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.88 39.26 77.47 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.737 0.684 . . . . 65.430000000000007 111.949 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.04 175.8 9.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.304 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.45 149.38 42.84 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 110.059 -0.348 . . . . 65.150000000000006 110.059 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.1 t 69.54 -56.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.17 2.188 . . . . 72.129999999999995 111.667 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -60.93 -64.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.136 0.974 . . . . 71.219999999999999 110.579 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.78 -60.38 2.08 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.841 -1.704 . . . . 61.100000000000001 108.841 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 66.41 150.49 0.12 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.672 2.389 . . . . 74.349999999999994 113.381 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.91 86.01 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.33 2.686 . . . . 70.200000000000003 111.098 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.0 mt -124.83 -70.06 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.938 1.295 . . . . 55.409999999999997 109.782 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.03 -178.39 3.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.723 1.615 . . . . 41.210000000000001 108.842 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' VAL . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 28' ' ' GLU . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 62.409999999999997 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 70.109999999999999 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 65.409999999999997 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 74.349999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 54.009999999999998 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 62.210000000000001 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 33.310000000000002 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 71.230000000000004 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 62.130000000000003 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.030000000000001 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 72.540000000000006 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 62.439999999999998 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.329999999999998 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 71.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 44.340000000000003 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 60.109999999999999 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 25.43 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.88 148.27 15.49 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 54.210000000000001 109.37 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -46.77 -56.55 6.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.388 1.475 . . . . 75.310000000000002 110.391 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -104.62 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.746 2.018 . . . . 73.010000000000005 107.41 167.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -148.13 74.53 1.3 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.898 -0.778 . . . . 74.150000000000006 108.898 164.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 56.61 34.07 23.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.264 1.426 . . . . 52.039999999999999 113.219 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.5 p -84.43 -79.99 0.21 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.011 0.823 . . . . 61.420000000000002 109.477 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.23 17.41 18.35 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.019 -0.879 . . . . 64.319999999999993 113.517 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -163.8 174.42 11.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.645 1.222 . . . . 71.219999999999999 109.629 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mt 58.76 25.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.056 1.742 . . . . 73.329999999999998 112.185 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -152.77 148.7 20.85 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.393 1.477 . . . . 63.219999999999999 108.598 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.4 158.63 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.251 2.634 . . . . 75.409999999999997 110.483 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 56.68 0.43 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.271 -1.132 . . . . 74.530000000000001 110.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -84.06 60.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.335 1.054 . . . . 71.299999999999997 110.561 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.3 mt -71.59 -54.26 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.853 0.861 . . . . 62.409999999999997 110.1 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.05 -139.6 32.86 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.77 -0.932 . . . . 70.430000000000007 110.77 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.43 146.02 6.89 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.788 -0.925 . . . . 73.010000000000005 110.788 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -81.76 149.77 28.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.218 1.007 . . . . 74.25 110.225 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 131.3 23.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.499 1.12 . . . . 73.0 108.792 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.64 157.72 39.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.439 2.759 . . . . 72.230000000000004 111.654 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -86.66 67.46 9.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.81 1.244 . . . . 55.0 109.691 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.1 t -73.06 135.68 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.231 -0.655 . . . . 71.299999999999997 109.231 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.49 140.28 34.68 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 109.641 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.41 144.26 11.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.759 0.824 . . . . 64.010000000000005 109.127 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.31 -5.3 16.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.591 2.86 . . . . 72.540000000000006 113.07 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -26.61 13.45 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.148 0.979 . . . . 73.129999999999995 112.617 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 71.519999999999996 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 73.340000000000003 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 62.43 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 73.349999999999994 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 65.030000000000001 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 71.150000000000006 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 64.140000000000001 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 71.140000000000001 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.120000000000005 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 72.510000000000005 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 73.010000000000005 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 70.040000000000006 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 63.420000000000002 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 72.209999999999994 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 55.030000000000001 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 54.219999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 73.510000000000005 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -67.89 -14.14 62.72 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 63.130000000000003 112.547 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -96.97 -111.92 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.45 -1.315 . . . . 72.239999999999995 107.45 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.41 84.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.293 -1.003 . . . . 72.239999999999995 108.293 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -79.48 91.48 5.14 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.285 1.034 . . . . 72.450000000000003 108.586 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -64.25 139.74 97.77 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.894 -0.78 . . . . 75.219999999999999 108.894 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.14 162.56 39.63 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.131 2.554 . . . . 74.349999999999994 111.488 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.38 60.68 4.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.496 1.118 . . . . 74.319999999999993 109.589 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -161.15 142.19 11.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.755 1.222 . . . . 54.229999999999997 109.583 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.0 pt? -87.8 149.76 46.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.819 1.248 . . . . 71.430000000000007 110.469 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.02 163.77 36.03 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.019 2.479 . . . . 74.040000000000006 110.734 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -121.04 156.88 31.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.824 1.25 . . . . 73.140000000000001 110.143 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.99 162.92 40.74 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.358 1.463 . . . . 72.0 109.097 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.0 m -158.62 143.0 15.8 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.061 1.344 . . . . 60.530000000000001 109.077 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.83 74.81 0.03 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.317 -1.113 . . . . 62.439999999999998 110.317 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.38 74.7 78.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 51.109999999999999 110.336 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.12 174.06 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.645 2.897 . . . . 71.329999999999998 111.165 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.04 179.13 48.1 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.045 -0.822 . . . . 70.319999999999993 111.045 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.93 47.66 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.767 -0.933 . . . . 63.43 110.767 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.32 47.91 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.196 -0.762 . . . . 65.040000000000006 111.196 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.8 t -162.72 169.79 19.43 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.76 1.224 . . . . 75.310000000000002 109.513 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -154.02 179.42 8.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.851 1.261 . . . . 72.140000000000001 109.822 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -150.43 108.23 3.69 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.515 1.126 . . . . 44.25 108.39 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -102.04 135.48 43.53 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.235 1.014 . . . . 73.540000000000006 109.09 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -168.25 167.44 12.18 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.037 1.335 . . . . 73.25 108.834 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -155.69 173.81 16.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.598 0.759 . . . . 71.329999999999998 110.544 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.436 -1.269 . . . . 73.540000000000006 109.225 173.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.032 -0.359 . . . . 62.420000000000002 110.032 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.310000000000002 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 61.329999999999998 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 65.409999999999997 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 62.109999999999999 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 62.030000000000001 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 64.129999999999995 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 62.409999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 70.239999999999995 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 65.510000000000005 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp . . . . . 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 109.122 -1.145 . . . . 41.310000000000002 109.122 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 64.430000000000007 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 54.119999999999997 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 71.439999999999998 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 65.329999999999998 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 71.519999999999996 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 54.530000000000001 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 52.109999999999999 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 52.32 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 53.200000000000003 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 73.010000000000005 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 73.140000000000001 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 62.439999999999998 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 35.149999999999999 110.134 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.242 0.83 . . . . 41.030000000000001 113.242 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 35.409999999999997 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 72.319999999999993 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 54.229999999999997 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 73.329999999999998 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 61.0 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.129999999999995 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 52.450000000000003 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 41.020000000000003 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 62.399999999999999 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 63.229999999999997 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 62.119999999999997 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 62.119999999999997 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 52.329999999999998 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 70.349999999999994 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 73.109999999999999 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 64.049999999999997 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 63.450000000000003 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.030000000000001 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 71.400000000000006 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 73.030000000000001 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 71.25 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 74.430000000000007 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 71.310000000000002 112.05 -178.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.675 -0.491 . . . . 74.230000000000004 109.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 63.100000000000001 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 73.299999999999997 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 62.140000000000001 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 24.420000000000002 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.209999999999994 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 55.149999999999999 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 73.209999999999994 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 73.409999999999997 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 70.439999999999998 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 60.119999999999997 109.477 -179.135 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 N-CA-C 109.498 -1.001 . . . . 72.340000000000003 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 53.350000000000001 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 65.349999999999994 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 62.039999999999999 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 70.219999999999999 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 62.399999999999999 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 63.130000000000003 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 53.439999999999998 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 55.149999999999999 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 72.439999999999998 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 54.119999999999997 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 71.530000000000001 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 54.240000000000002 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 43.219999999999999 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 62.43 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 53.149999999999999 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 71.540000000000006 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 119.44 -0.314 . . . . 73.040000000000006 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 73.299999999999997 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 74.349999999999994 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 64.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 70.120000000000005 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 54.420000000000002 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 64.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 62.350000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 52.119999999999997 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 65.319999999999993 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 72.510000000000005 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 65.030000000000001 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 61.240000000000002 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 64.340000000000003 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 72.340000000000003 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 52.310000000000002 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 62.049999999999997 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 71.129999999999995 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 73.409999999999997 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 71.540000000000006 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 70.030000000000001 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 71.010000000000005 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 51.119999999999997 111.658 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.007 -0.738 . . . . 73.310000000000002 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 55.43 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 53.119999999999997 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 55.32 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 72.450000000000003 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.049999999999997 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 64.549999999999997 108.522 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 108.586 -1.352 . . . . 62.109999999999999 108.586 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 55.539999999999999 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 62.039999999999999 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 71.430000000000007 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 71.420000000000002 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 70.219999999999999 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 51.229999999999997 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 60.310000000000002 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 50.130000000000003 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 73.349999999999994 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 65.420000000000002 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 61.32 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 53.520000000000003 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 73.239999999999995 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 54.350000000000001 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 63.210000000000001 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 30.5 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 63.43 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 70.439999999999998 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 62.43 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 51.399999999999999 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 72.349999999999994 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 111.755 0.279 . . . . 74.120000000000005 111.755 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.140000000000001 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 72.239999999999995 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 60.229999999999997 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 62.210000000000001 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 62.310000000000002 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 63.329999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 72.129999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 63.25 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 43.340000000000003 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 71.420000000000002 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 62.039999999999999 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 73.409999999999997 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 64.010000000000005 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 65.530000000000001 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 65.299999999999997 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 54.310000000000002 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 72.109999999999999 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 63.439999999999998 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 51.210000000000001 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 64.239999999999995 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 54.299999999999997 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 62.549999999999997 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.32 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 43.32 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 64.340000000000003 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.409999999999997 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 64.439999999999998 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 64.120000000000005 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 52.119999999999997 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 72.120000000000005 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 73.129999999999995 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 110.569 -0.159 . . . . 64.510000000000005 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 51.43 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.430000000000007 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 72.439999999999998 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 63.219999999999999 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 72.109999999999999 108.852 -178.757 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.539 0.773 0 N-CA-C 110.389 -0.658 . . . . 72.329999999999998 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 55.130000000000003 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 45.409999999999997 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.140000000000001 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 65.019999999999996 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 71.140000000000001 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 61.520000000000003 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 62.140000000000001 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 64.140000000000001 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.219999999999999 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 71.049999999999997 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 72.230000000000004 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 61.509999999999998 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.540000000000006 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 64.040000000000006 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 64.040000000000006 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 74.310000000000002 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 51.229999999999997 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 74.030000000000001 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 71.120000000000005 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 65.140000000000001 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.340000000000003 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 74.400000000000006 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 64.329999999999998 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 65.340000000000003 111.431 170.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.753 0.279 . . . . 54.020000000000003 111.753 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 45.020000000000003 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 62.109999999999999 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 63.539999999999999 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.239999999999995 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 72.540000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 44.399999999999999 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 74.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 74.439999999999998 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.039999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 52.409999999999997 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 70.409999999999997 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.209999999999994 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 64.219999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 63.450000000000003 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 71.019999999999996 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.120000000000005 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 70.510000000000005 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 61.450000000000003 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 34.200000000000003 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 72.129999999999995 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 71.430000000000007 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 71.049999999999997 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 71.230000000000004 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.349999999999994 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 72.230000000000004 112.661 -179.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.265 -0.643 . . . . 71.040000000000006 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 61.119999999999997 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 64.209999999999994 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.430000000000007 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 63.439999999999998 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 73.319999999999993 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 64.420000000000002 110.35 -175.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 N--CA 1.455 -0.742 0 N-CA-C 109.396 -1.04 . . . . 64.019999999999996 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 70.420000000000002 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 72.430000000000007 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 63.5 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.019999999999996 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 73.099999999999994 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 71.0 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 72.230000000000004 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 53.439999999999998 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 61.030000000000001 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.099999999999994 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.310000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 52.439999999999998 111.678 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.618 0.599 . . . . 74.329999999999998 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 64.409999999999997 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 70.129999999999995 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 72.439999999999998 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 71.340000000000003 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 71.430000000000007 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 63.109999999999999 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 44.210000000000001 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 71.329999999999998 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 72.140000000000001 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 71.019999999999996 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 65.450000000000003 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 73.430000000000007 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 63.399999999999999 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 60.310000000000002 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 72.319999999999993 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 55.219999999999999 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 71.209999999999994 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 25.539999999999999 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 72.450000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 24.210000000000001 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 62.119999999999997 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 72.319999999999993 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 73.540000000000006 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 65.329999999999998 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 71.219999999999999 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 61.140000000000001 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.29 -0.633 . . . . 71.519999999999996 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 61.509999999999998 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 52.030000000000001 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 71.439999999999998 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 73.519999999999996 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 109.844 -0.868 . . . . 62.020000000000003 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 54.240000000000002 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 44.030000000000001 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 74.430000000000007 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 70.209999999999994 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 61.030000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 71.230000000000004 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 71.230000000000004 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 65.109999999999999 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 60.399999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 73.340000000000003 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 73.219999999999999 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 71.420000000000002 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 64.230000000000004 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 60.240000000000002 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 71.209999999999994 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.109999999999999 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.93 0.715 . . . . 44.119999999999997 112.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 62.130000000000003 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 62.009999999999998 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 54.140000000000001 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 62.310000000000002 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 62.0 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.409999999999997 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 73.150000000000006 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 64.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 51.240000000000002 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 71.209999999999994 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 65.239999999999995 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 74.030000000000001 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 52.020000000000003 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 63.119999999999997 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 61.310000000000002 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 70.109999999999999 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 63.109999999999999 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 72.510000000000005 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 63.32 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 73.109999999999999 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 72.010000000000005 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 63.439999999999998 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 73.140000000000001 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 62.32 109.569 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 73.109999999999999 109.657 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 64.129999999999995 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 72.319999999999993 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 72.319999999999993 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 63.329999999999998 109.998 178.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 CA--C 1.539 0.769 0 N-CA-C 111.426 -0.259 . . . . 74.230000000000004 111.426 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 62.149999999999999 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 71.439999999999998 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.120000000000005 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.150000000000006 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 73.310000000000002 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 71.439999999999998 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 64.540000000000006 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 72.230000000000004 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 50.439999999999998 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 63.240000000000002 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 70.239999999999995 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 71.25 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 65.140000000000001 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.491 0.552 . . . . 72.319999999999993 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 71.340000000000003 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 41.109999999999999 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 54.020000000000003 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.030000000000001 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 61.009999999999998 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 65.25 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 64.310000000000002 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 51.450000000000003 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 65.0 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 53.020000000000003 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 65.120000000000005 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 64.030000000000001 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 72.019999999999996 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 71.409999999999997 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 51.229999999999997 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 74.430000000000007 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 43.119999999999997 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.140000000000001 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.020000000000003 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 74.25 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 64.430000000000007 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 64.150000000000006 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 61.240000000000002 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 63.109999999999999 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 52.310000000000002 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 71.030000000000001 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 73.299999999999997 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 74.230000000000004 112.598 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.272 0.558 . . . . 75.420000000000002 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 55.119999999999997 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 71.510000000000005 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 54.439999999999998 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 109.754 -0.902 . . . . 52.219999999999999 109.754 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 64.319999999999993 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 63.530000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 65.209999999999994 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 72.129999999999995 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.140000000000001 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 65.209999999999994 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 71.109999999999999 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 71.209999999999994 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 63.530000000000001 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 51.439999999999998 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 61.240000000000002 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 72.010000000000005 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 71.409999999999997 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 63.009999999999998 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 50.119999999999997 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 72.310000000000002 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 71.430000000000007 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 52.25 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 71.230000000000004 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 61.140000000000001 109.573 -174.067 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 113.086 0.773 . . . . 74.420000000000002 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 63.130000000000003 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 63.229999999999997 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 60.539999999999999 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 63.520000000000003 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 34.100000000000001 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 64.230000000000004 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 44.530000000000001 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 53.310000000000002 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 70.439999999999998 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 62.43 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 53.109999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.109999999999999 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 55.409999999999997 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.010000000000005 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 71.239999999999995 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 72.019999999999996 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 61.350000000000001 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 63.149999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 63.329999999999998 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 54.5 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 71.209999999999994 111.66 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 110.58 -0.156 . . . . 75.349999999999994 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 73.120000000000005 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 53.240000000000002 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 61.43 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 51.140000000000001 109.623 -174.459 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 N-CA-C 111.422 -0.261 . . . . 73.150000000000006 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 71.230000000000004 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 64.239999999999995 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 62.520000000000003 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 45.32 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 64.310000000000002 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 62.520000000000003 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 74.329999999999998 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 31.210000000000001 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 65.340000000000003 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 61.240000000000002 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 72.430000000000007 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 52.520000000000003 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 63.210000000000001 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 61.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 64.439999999999998 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 65.310000000000002 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 71.510000000000005 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 71.319999999999993 111.221 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.676 0.621 . . . . 71.430000000000007 112.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 61.020000000000003 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 62.119999999999997 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 128' ' ' ILE . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 72.549999999999997 110.586 165.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.119999999999997 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 63.030000000000001 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 63.140000000000001 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 51.539999999999999 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 71.299999999999997 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 55.229999999999997 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 63.420000000000002 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 71.549999999999997 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 74.439999999999998 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 63.409999999999997 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 44.329999999999998 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 73.430000000000007 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 63.009999999999998 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 92' ' ' ILE . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 54.109999999999999 112.235 -173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 45.219999999999999 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 70.129999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.095 -0.706 . . . . 73.340000000000003 109.095 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 74.120000000000005 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 52.299999999999997 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 70.230000000000004 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 65.5 108.923 176.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 110.26 -0.708 . . . . 64.340000000000003 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 64.25 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 61.130000000000003 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 71.219999999999999 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 71.340000000000003 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 65.230000000000004 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 73.25 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 62.509999999999998 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 70.120000000000005 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 73.109999999999999 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 70.430000000000007 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 72.209999999999994 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 72.530000000000001 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.239999999999995 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 71.140000000000001 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 63.109999999999999 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 51.509999999999998 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 72.5 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 64.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 64.230000000000004 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 42.350000000000001 111.049 -170.542 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 75.109999999999999 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 71.439999999999998 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 70.540000000000006 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 64.400000000000006 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 74.319999999999993 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 92' ' ' ILE . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 52.32 109.48 172.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 63.149999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 72.549999999999997 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 65.219999999999999 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 71.340000000000003 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.129999999999995 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 72.120000000000005 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 71.030000000000001 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 53.030000000000001 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 53.539999999999999 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 61.530000000000001 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 71.230000000000004 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 52.329999999999998 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 51.140000000000001 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 61.109999999999999 111.984 -176.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.047 -0.723 . . . . 55.43 109.047 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 51.100000000000001 106.464 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.019999999999996 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 62.299999999999997 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 54.130000000000003 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 71.340000000000003 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.319999999999993 110.252 -165.041 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 N-CA-C 111.318 -0.301 . . . . 74.140000000000001 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 52.240000000000002 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 73.540000000000006 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 64.150000000000006 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 54.049999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 72.209999999999994 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 73.299999999999997 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 70.340000000000003 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 74.239999999999995 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 61.409999999999997 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 64.219999999999999 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 72.439999999999998 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 74.439999999999998 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 63.340000000000003 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 50.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 60.25 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 30.52 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.239999999999995 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 72.340000000000003 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.219999999999999 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 62.450000000000003 111.664 -173.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.876 0.695 . . . . 71.209999999999994 112.876 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 70.140000000000001 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 63.149999999999999 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 65.409999999999997 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 73.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 64.420000000000002 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 65.450000000000003 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 52.229999999999997 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 64.040000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 50.539999999999999 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.109999999999999 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 73.409999999999997 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 73.239999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 52.409999999999997 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 71.510000000000005 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 72.319999999999993 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 63.109999999999999 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 62.030000000000001 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 64.129999999999995 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 71.430000000000007 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 63.020000000000003 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 65.319999999999993 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 108.668 -0.864 . . . . 75.299999999999997 108.668 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 70.409999999999997 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 43.219999999999999 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 N-CA-C 110.63 -0.565 . . . . 55.340000000000003 110.63 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 72.010000000000005 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 65.0 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 71.329999999999998 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 62.030000000000001 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 63.210000000000001 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 74.400000000000006 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 63.109999999999999 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 54.5 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 65.040000000000006 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 44.020000000000003 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 64.200000000000003 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 64.239999999999995 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 44.549999999999997 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 72.519999999999996 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.340000000000003 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.209 0.448 . . . . 73.109999999999999 112.209 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 64.019999999999996 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 54.0 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 55.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 62.130000000000003 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 44.140000000000001 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 72.519999999999996 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 60.240000000000002 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 62.530000000000001 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 60.109999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 43.32 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 63.520000000000003 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 62.32 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 70.340000000000003 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 55.240000000000002 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 64.099999999999994 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 62.200000000000003 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 72.549999999999997 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 63.420000000000002 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 72.109999999999999 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.129999999999995 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 70.120000000000005 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 73.329999999999998 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 71.400000000000006 112.093 -178.133 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.474 -0.195 . . . . 62.329999999999998 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 72.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 54.009999999999998 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 42.439999999999998 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 71.510000000000005 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 N-CA-C 109.691 -0.927 . . . . 43.310000000000002 109.691 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 70.239999999999995 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 64.120000000000005 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 73.150000000000006 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 74.439999999999998 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 52.049999999999997 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 65.510000000000005 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 53.149999999999999 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 53.310000000000002 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 63.350000000000001 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 54.229999999999997 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 71.230000000000004 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 62.240000000000002 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 55.219999999999999 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 61.130000000000003 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 74.310000000000002 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 64.209999999999994 110.452 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.579 0.585 . . . . 72.109999999999999 112.579 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 51.439999999999998 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 72.150000000000006 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 62.229999999999997 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 63.539999999999999 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 63.119999999999997 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 64.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 63.32 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 44.299999999999997 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 63.030000000000001 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 65.219999999999999 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 72.010000000000005 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 62.100000000000001 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 52.229999999999997 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 63.229999999999997 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 72.230000000000004 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 61.140000000000001 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 71.120000000000005 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 65.010000000000005 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 52.229999999999997 112.061 -179.196 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.61 -0.885 . . . . 64.140000000000001 108.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 65.109999999999999 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 40.509999999999998 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 70.140000000000001 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 73.150000000000006 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 64.219999999999999 112.49 179.249 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 109.752 -0.903 . . . . 63.140000000000001 109.752 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 65.409999999999997 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 64.219999999999999 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 64.209999999999994 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.040000000000006 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 62.43 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.129999999999995 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 54.439999999999998 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 64.049999999999997 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 70.010000000000005 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 44.219999999999999 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 64.129999999999995 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 64.420000000000002 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 60.310000000000002 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 70.099999999999994 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 61.299999999999997 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 74.5 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 74.219999999999999 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 72.540000000000006 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.040000000000006 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 61.299999999999997 108.912 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.696 0.628 . . . . 61.439999999999998 112.696 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 70.140000000000001 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 71.450000000000003 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 40.5 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 72.519999999999996 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 64.519999999999996 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 60.020000000000003 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 71.420000000000002 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 62.149999999999999 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 61.140000000000001 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 70.420000000000002 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 54.100000000000001 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 55.25 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 63.450000000000003 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 72.329999999999998 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 73.540000000000006 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 73.340000000000003 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.239999999999995 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.032 -0.359 . . . . 62.310000000000002 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 61.310000000000002 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 64.420000000000002 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 71.349999999999994 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 64.430000000000007 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 52.439999999999998 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 53.009999999999998 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 53.229999999999997 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.030000000000001 109.189 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 108.915 -1.225 . . . . 73.140000000000001 108.915 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 65.030000000000001 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 71.420000000000002 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 72.230000000000004 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 71.329999999999998 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 70.510000000000005 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 71.420000000000002 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 70.230000000000004 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 63.100000000000001 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 55.32 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 51.119999999999997 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 65.129999999999995 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 64.430000000000007 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.219999999999999 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 64.349999999999994 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 43.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 50.439999999999998 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 55.219999999999999 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 51.409999999999997 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 62.450000000000003 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 65.349999999999994 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.829 0.307 . . . . 75.239999999999995 111.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 73.209999999999994 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 73.319999999999993 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 53.450000000000003 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 72.400000000000006 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 63.32 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 64.200000000000003 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 72.010000000000005 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 73.400000000000006 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 62.200000000000003 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 72.450000000000003 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 61.130000000000003 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 43.43 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.140000000000001 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 72.340000000000003 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 62.450000000000003 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 63.020000000000003 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 62.439999999999998 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 62.329999999999998 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 72.439999999999998 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 71.530000000000001 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 73.239999999999995 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 64.510000000000005 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 64.239999999999995 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.969 -0.752 . . . . 73.109999999999999 108.969 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 43.200000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 72.030000000000001 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 71.099999999999994 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 55.009999999999998 111.659 -172.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 110.805 -0.498 . . . . 52.229999999999997 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 40.049999999999997 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 72.25 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 72.150000000000006 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 55.229999999999997 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 73.209999999999994 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 22.329999999999998 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 74.230000000000004 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 71.430000000000007 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 45.210000000000001 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 71.439999999999998 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 52.420000000000002 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 54.140000000000001 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 71.310000000000002 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 43.149999999999999 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 72.040000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 63.130000000000003 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 33.109999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 62.240000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 63.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.150000000000006 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 71.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.154 0.428 . . . . 64.299999999999997 112.154 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 73.299999999999997 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 72.329999999999998 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 71.019999999999996 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 60.5 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 54.539999999999999 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 72.329999999999998 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 51.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 65.310000000000002 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 64.230000000000004 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 45.229999999999997 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 72.040000000000006 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 53.340000000000003 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 64.209999999999994 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 72.129999999999995 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 73.209999999999994 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 60.25 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 64.040000000000006 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 70.109999999999999 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 61.409999999999997 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 71.200000000000003 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 64.129999999999995 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 64.219999999999999 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 72.329999999999998 111.879 -176.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.932 0.396 . . . . 74.319999999999993 111.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 71.0 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 72.230000000000004 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 43.130000000000003 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 51.539999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.0 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 60.520000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 110.128 -0.759 . . . . 73.030000000000001 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 73.340000000000003 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 63.340000000000003 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 44.340000000000003 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 65.0 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 73.109999999999999 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 60.039999999999999 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 62.409999999999997 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 54.109999999999999 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 54.350000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 61.210000000000001 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 73.430000000000007 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 72.409999999999997 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 71.510000000000005 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 64.030000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.756 0.28 . . . . 74.409999999999997 111.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 70.400000000000006 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.310000000000002 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 72.310000000000002 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 64.219999999999999 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 41.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 55.43 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 63.43 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 61.439999999999998 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 63.240000000000002 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 42.310000000000002 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 62.130000000000003 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 72.019999999999996 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 62.130000000000003 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 61.350000000000001 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 64.439999999999998 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 55.149999999999999 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 70.340000000000003 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 44.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 70.129999999999995 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.22 -0.289 . . . . 72.349999999999994 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 72.319999999999993 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 71.430000000000007 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 52.299999999999997 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 54.229999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 61.329999999999998 111.153 -172.631 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 109.778 -0.893 . . . . 71.120000000000005 109.778 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 72.420000000000002 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.340000000000003 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 74.319999999999993 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 61.130000000000003 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 63.030000000000001 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 54.509999999999998 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 62.25 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 62.310000000000002 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 64.299999999999997 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 64.439999999999998 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 70.349999999999994 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 44.329999999999998 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 70.120000000000005 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.219 0.822 . . . . 72.439999999999998 113.219 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 71.329999999999998 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 65.5 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 63.240000000000002 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 63.399999999999999 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 52.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 40.32 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 51.420000000000002 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 53.5 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 62.409999999999997 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 62.119999999999997 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 71.5 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 64.129999999999995 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.209999999999994 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 71.530000000000001 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 60.539999999999999 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 54.219999999999999 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 73.040000000000006 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 70.439999999999998 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 64.420000000000002 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 72.129999999999995 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 63.229999999999997 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 74.25 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 73.349999999999994 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 54.140000000000001 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 71.129999999999995 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 63.439999999999998 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 72.030000000000001 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 62.149999999999999 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 73.030000000000001 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 54.009999999999998 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 63.0 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 63.240000000000002 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.030000000000001 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 65.430000000000007 108.063 -175.245 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 CA--C 1.539 0.748 0 N-CA-C 110.431 -0.642 . . . . 74.25 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 63.119999999999997 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 64.420000000000002 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 62.039999999999999 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.140000000000001 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 62.539999999999999 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 63.030000000000001 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 44.439999999999998 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 63.229999999999997 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 63.509999999999998 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 71.25 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 73.450000000000003 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 54.420000000000002 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 62.009999999999998 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 74.200000000000003 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 65.329999999999998 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 63.5 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 62.229999999999997 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.171 0.434 . . . . 44.520000000000003 112.171 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 65.519999999999996 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 63.210000000000001 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.099999999999994 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 72.129999999999995 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 65.349999999999994 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 71.519999999999996 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 73.349999999999994 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 60.130000000000003 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 53.100000000000001 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 73.319999999999993 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.209999999999994 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 71.310000000000002 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 71.230000000000004 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 33.109999999999999 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 62.439999999999998 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 65.430000000000007 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 70.420000000000002 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 72.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 55.219999999999999 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 62.32 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 73.209999999999994 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 63.130000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.516 -0.549 . . . . 63.329999999999998 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 63.43 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.299999999999997 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 35.409999999999997 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 45.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 71.129999999999995 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 54.329999999999998 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 62.409999999999997 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.299999999999997 110.293 -174.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 N-CA-C 108.842 -1.253 . . . . 41.210000000000001 108.842 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' VAL . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 28' ' ' GLU . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 62.409999999999997 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 70.109999999999999 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 65.409999999999997 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 74.349999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 54.009999999999998 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 62.210000000000001 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 33.310000000000002 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 71.230000000000004 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 62.130000000000003 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.030000000000001 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 72.540000000000006 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 62.439999999999998 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.329999999999998 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 71.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 44.340000000000003 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 60.109999999999999 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 25.43 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 54.210000000000001 109.37 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.617 0.599 . . . . 73.129999999999995 112.617 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 71.519999999999996 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 73.340000000000003 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 62.43 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 73.349999999999994 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 65.030000000000001 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 71.150000000000006 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 64.140000000000001 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 71.140000000000001 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.120000000000005 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 72.510000000000005 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 73.010000000000005 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 70.040000000000006 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 63.420000000000002 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 72.209999999999994 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 55.030000000000001 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 54.219999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 73.510000000000005 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 63.130000000000003 112.547 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 118.684 -0.674 . . . . 70.299999999999997 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.77 104.29 1.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.664 2.242 . . . . 70.200000000000003 109.676 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -78.28 78.65 4.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.798 0.839 . . . . 62.420000000000002 110.032 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 75.41 154.42 0.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.895 2.078 . . . . 74.239999999999995 111.706 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.7 m -68.3 154.46 41.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.739 0.816 . . . . 75.25 110.834 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 pt -134.85 160.52 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.709 1.203 . . . . 74.310000000000002 110.008 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 68.6 8.94 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.6 1.16 . . . . 61.329999999999998 109.32 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 m -66.76 143.81 56.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.46 0.704 . . . . 65.409999999999997 109.886 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.05 152.7 18.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.625 0.631 . . . . 63.329999999999998 111.775 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -74.85 160.02 31.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.342 1.057 . . . . 62.109999999999999 111.096 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.99 66.91 3.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.48 -1.448 . . . . 62.030000000000001 109.48 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.71 -123.7 25.14 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.024 -1.23 . . . . 64.129999999999995 110.024 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.08 100.69 3.42 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.529 -1.286 . . . . 62.409999999999997 107.529 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -73.1 131.7 42.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.256 0.622 . . . . 70.239999999999995 109.519 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -56.92 -47.62 80.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.354 0.662 . . . . 65.510000000000005 110.848 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.7 tp 70.9 141.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.386 1.874 . . . . 74.510000000000005 111.547 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.69 33.2 75.51 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.39 0.519 . . . . 73.010000000000005 112.671 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.47 83.82 1.49 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.615 -1.794 . . . . 72.299999999999997 108.615 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.26 89.61 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.996 1.318 . . . . 75.299999999999997 111.466 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 53.75 45.43 27.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.881 1.272 . . . . 73.239999999999995 111.034 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.2 t -112.05 -83.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 108.2 -1.037 . . . . 74.230000000000004 108.2 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -169.8 153.02 4.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.677 1.191 . . . . 70.439999999999998 108.344 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.53 55.3 29.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.334 -1.106 . . . . 75.540000000000006 110.334 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -117.76 96.35 49.34 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.932 1.293 . . . . 65.239999999999995 109.42 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.0 136.01 14.42 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.117 2.544 . . . . 73.329999999999998 110.486 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.1 mt 46.23 63.07 10.28 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.339 1.456 . . . . 74.340000000000003 111.681 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.9 93.44 1.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.341 2.694 . . . . 41.310000000000002 109.122 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.34 -35.34 37.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.45 1.1 . . . . 73.109999999999999 112.992 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 p -46.82 -39.97 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.643 1.577 . . . . 64.430000000000007 112.869 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.41 -56.17 17.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.574 0.624 . . . . 52.520000000000003 109.796 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -48.4 17.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.795 . . . . 74.510000000000005 110.714 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 53.32 112.276 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp-105 -56.14 -55.65 30.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.152 0.581 . . . . 54.119999999999997 110.846 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mm -60.71 -45.09 98.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.633 0.373 . . . . 71.439999999999998 110.624 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.52 -48.09 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.808 0.843 . . . . 65.329999999999998 110.81 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.63 -59.32 5.59 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.139 0.576 . . . . 75.150000000000006 110.607 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.68 -36.92 74.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 111.67 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.02 74.89 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 119.026 -0.511 . . . . 71.519999999999996 112.22 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -61.97 -59.58 4.9 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.584 0.629 . . . . 73.209999999999994 111.043 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -72.02 -18.45 61.96 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.1 0.409 . . . . 73.230000000000004 111.922 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 65.24 1.61 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.797 -0.921 . . . . 73.109999999999999 110.797 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.8 112.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.501 -0.926 . . . . 54.530000000000001 108.501 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -60.71 150.67 75.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.854 1.662 . . . . 74.349999999999994 110.263 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.98 -40.39 78.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.388 2.725 . . . . 52.109999999999999 112.614 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.61 -5.9 4.59 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.287 1.035 . . . . 52.32 113.471 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -116.4 -26.09 7.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.255 1.422 . . . . 74.450000000000003 111.739 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.4 mt -56.06 -45.81 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.411 -0.959 . . . . 75.420000000000002 108.411 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -49.0 -41.88 35.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.561 1.144 . . . . 53.200000000000003 112.115 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -67.81 -63.5 1.05 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.792 0.837 . . . . 73.109999999999999 110.083 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -54.64 -42.2 70.98 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.906 1.076 . . . . 73.010000000000005 113.906 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.78 -11.8 32.87 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.939 -0.553 . . . . 63.210000000000001 111.504 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.14 65.49 1.19 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 109.82 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.29 172.56 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.415 1.086 . . . . 73.140000000000001 110.661 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.2 m -82.28 -105.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.45 1.1 . . . . 74.409999999999997 111.456 -170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -154.65 -45.26 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.308 1.043 . . . . 73.209999999999994 110.232 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.39 96.51 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.559 -1.417 . . . . 71.5 109.559 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.3 m -58.97 -48.46 81.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.098 0.959 . . . . 62.439999999999998 109.855 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.93 -43.94 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.474 0.71 . . . . 71.109999999999999 110.47 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -57.54 -48.03 80.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.239 0.616 . . . . 72.319999999999993 111.038 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.64 -42.36 95.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.214 0.606 . . . . 65.409999999999997 111.502 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -66.01 -60.04 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.57 1.148 . . . . 71.530000000000001 109.976 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.0 -54.76 25.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 74.200000000000003 109.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.83 83.61 1.58 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.134 -1.186 . . . . 35.149999999999999 110.134 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -74.84 -45.93 39.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.098 0.559 . . . . 64.239999999999995 111.169 175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 56.75 76.58 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.383 1.473 . . . . 73.219999999999999 110.356 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 68.5 94.07 0.07 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.741 1.616 . . . . 73.230000000000004 109.802 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.94 111.52 1.06 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.298 1.039 . . . . 55.240000000000002 110.446 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.1 p 35.43 48.08 0.39 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.052 1.741 . . . . 61.43 112.131 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.97 62.17 5.46 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.259 0.933 . . . . 32.409999999999997 112.505 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.9 p -154.43 -167.79 2.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.974 0.909 . . . . 73.140000000000001 109.345 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt 62.86 62.63 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.885 1.274 . . . . 75.209999999999994 109.195 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -161.57 66.63 2.14 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.616 0.766 . . . . 73.209999999999994 110.471 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.11 95.76 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.368 2.712 . . . . 62.340000000000003 110.331 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.96 141.34 5.35 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.488 -1.045 . . . . 63.200000000000003 110.488 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.88 125.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.536 1.534 . . . . 74.219999999999999 107.853 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.5 mt -82.63 143.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.743 1.217 . . . . 65.030000000000001 109.203 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.06 171.78 41.95 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.913 -0.875 . . . . 54.450000000000003 110.913 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.74 164.71 31.58 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.429 -1.069 . . . . 62.32 110.429 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.2 t -161.69 160.89 29.13 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.941 0.896 . . . . 74.230000000000004 109.877 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -154.49 71.79 6.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.026 0.93 . . . . 73.299999999999997 109.938 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.59 158.8 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.816 3.011 . . . . 71.340000000000003 111.971 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -86.44 82.6 7.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.895 1.278 . . . . 71.400000000000006 108.789 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.87 147.39 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.31 1.044 . . . . 45.43 110.327 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.53 169.91 23.62 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.954 1.702 . . . . 63.509999999999998 108.918 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -87.82 147.25 40.74 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.798 0.839 . . . . 61.229999999999997 110.557 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.83 -16.1 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.24 2.627 . . . . 72.099999999999994 111.865 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -57.95 -21.48 44.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.881 1.272 . . . . 41.030000000000001 113.242 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -54.69 -32.1 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.225 0.61 . . . . 73.299999999999997 111.192 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.73 -43.57 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.719 0.808 . . . . 35.409999999999997 110.63 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.6 -40.04 93.38 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.739 -0.467 . . . . 72.319999999999993 109.739 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -62.89 -36.39 83.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.879 -0.581 . . . . 54.229999999999997 112.281 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.27 -45.99 95.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.094 0.861 . . . . 71.319999999999993 109.199 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.18 -50.14 56.9 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.738 0.685 . . . . 63.530000000000001 111.48 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.94 -40.49 89.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.033 0.933 . . . . 73.200000000000003 111.611 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -74.51 -25.72 59.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.465 -0.302 . . . . 73.329999999999998 110.932 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -48.44 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.721 0.691 . . . . 61.0 110.731 160.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -60.78 -41.51 95.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.247 -0.406 . . . . 75.239999999999995 111.094 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.2 -39.61 71.66 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.306 0.503 . . . . 73.129999999999995 110.694 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -140.99 89.27 9.89 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.362 1.465 . . . . 52.450000000000003 109.03 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.66 -29.0 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.238 2.625 . . . . 74.329999999999998 112.352 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -62.63 -39.21 93.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.283 0.633 . . . . 41.020000000000003 111.081 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 43.0 mtp -63.1 129.27 39.6 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.416 0.626 . . . . 62.399999999999999 110.441 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.02 171.11 15.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.516 1.527 . . . . 73.329999999999998 111.428 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.8 -49.66 37.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.982 1.313 . . . . 53.299999999999997 112.395 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -75.24 -19.46 59.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.779 1.231 . . . . 75.140000000000001 112.071 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -49.85 12.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.923 1.289 . . . . 74.549999999999997 107.946 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.0 mm -64.21 -28.48 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.466 1.106 . . . . 71.329999999999998 112.014 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -51.56 -46.89 63.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.102 0.41 . . . . 72.5 109.936 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.51 -28.59 61.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.82 0.848 . . . . 72.420000000000002 112.9 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -52.48 -36.41 54.87 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.232 0.924 . . . . 71.420000000000002 111.858 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.14 -49.04 63.58 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.412 0.685 . . . . 63.229999999999997 111.383 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.47 -42.48 87.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.769 0.828 . . . . 62.119999999999997 110.964 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -45.45 86.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.36 1.064 . . . . 73.109999999999999 110.978 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -72.66 -29.54 63.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.644 0.777 . . . . 62.119999999999997 111.08 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.31 52.96 2.74 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.208 -1.157 . . . . 61.310000000000002 110.208 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -95.24 -45.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 C-N-CA 124.217 1.007 . . . . 75.310000000000002 110.49 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.0 170.88 14.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.913 0.885 . . . . 71.349999999999994 110.637 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.94 153.3 22.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.251 1.021 . . . . 74.25 110.414 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -57.34 -26.5 61.06 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.924 1.69 . . . . 74.209999999999994 113.513 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.21 -49.14 11.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.979 0.912 . . . . 52.329999999999998 109.264 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.8 p -72.09 -25.17 61.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.958 1.303 . . . . 70.349999999999994 112.885 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.96 129.93 48.58 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.237 1.015 . . . . 73.109999999999999 109.769 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.98 155.71 47.86 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.689 2.259 . . . . 64.049999999999997 112.489 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 m -57.95 136.66 57.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.017 1.727 . . . . 73.120000000000005 112.488 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.64 -39.92 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.945 1.298 . . . . 74.430000000000007 111.596 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 -29.73 69.56 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.209 1.004 . . . . 72.129999999999995 112.084 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.1 m -78.49 -52.36 8.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.052 0.387 . . . . 63.450000000000003 109.976 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.6 pt -55.49 -33.12 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.213 0.605 . . . . 73.030000000000001 112.366 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.99 -43.29 50.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.748 1.219 . . . . 73.450000000000003 112.771 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.07 -24.68 67.24 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.7 0.63 . . . . 71.400000000000006 112.7 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.41 -49.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.989 0.916 . . . . 73.030000000000001 109.733 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.21 -53.19 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.236 1.414 . . . . 71.25 111.292 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -52.45 -37.5 57.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.409 0.892 . . . . 74.430000000000007 113.409 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.6 p -61.84 -24.79 67.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.167 0.894 . . . . 71.310000000000002 112.05 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -87.85 -48.3 7.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.136 0.974 . . . . 72.349999999999994 110.359 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.75 92.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.557 1.143 . . . . 62.020000000000003 108.774 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.86 167.3 22.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 109.993 167.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -116.54 140.72 27.02 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.66 1.184 . . . . 71.209999999999994 108.326 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.79 136.3 44.99 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.814 2.343 . . . . 74.329999999999998 110.353 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -84.33 67.86 9.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.897 0.879 . . . . 73.519999999999996 110.293 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 148.16 10.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.409 1.083 . . . . 70.439999999999998 109.794 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.1 tp -154.09 79.95 4.99 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 108.172 -1.047 . . . . 73.299999999999997 108.172 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.1 149.2 35.94 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.015 2.477 . . . . 65.409999999999997 110.628 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.7 ptm -163.83 162.71 23.83 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.709 1.203 . . . . 62.25 109.469 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.84 134.26 47.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.544 -0.539 . . . . 73.430000000000007 109.544 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.4 t -164.91 164.03 20.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.329 1.051 . . . . 73.239999999999995 109.197 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.84 61.92 4.9 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.383 -0.687 . . . . 71.349999999999994 111.383 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.81 73.11 69.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.664 1.186 . . . . 65.510000000000005 109.868 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.69 172.4 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.407 2.738 . . . . 54.229999999999997 110.996 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.61 179.29 48.29 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.67 -0.972 . . . . 72.519999999999996 110.67 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.9 165.45 36.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.342 -1.103 . . . . 73.329999999999998 110.342 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.31 83.71 0.05 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.837 -1.305 . . . . 52.149999999999999 109.837 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.4 m -152.86 89.18 1.37 Allowed 'General case' 0 C--N 1.338 0.074 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -139.7 134.72 32.33 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.668 1.187 . . . . 63.450000000000003 108.357 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -145.21 161.99 38.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.934 0.893 . . . . 74.420000000000002 110.283 -170.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -156.01 148.75 24.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.898 1.279 . . . . 70.019999999999996 108.484 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -142.73 155.19 44.83 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.479 1.112 . . . . 74.540000000000006 109.485 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -165.83 170.21 14.12 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.175 1.39 . . . . 65.409999999999997 108.893 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.127 -1.416 . . . . 72.219999999999999 109.461 173.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 118.651 -0.69 . . . . 70.129999999999995 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -61.78 109.72 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.129 2.553 . . . . 74.319999999999993 110.571 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -79.95 66.08 5.31 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.705 1.202 . . . . 74.230000000000004 109.675 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -138.44 146.64 42.36 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.747 1.219 . . . . 63.100000000000001 109.232 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 p -155.14 -66.17 0.13 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.306 1.043 . . . . 74.150000000000006 108.891 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 mp 50.33 68.85 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.369 1.868 . . . . 73.299999999999997 110.067 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -94.63 177.74 5.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.343 1.057 . . . . 73.299999999999997 109.771 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 p -149.67 166.24 29.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.643 1.177 . . . . 62.140000000000001 109.475 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 150.74 8.01 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.254 -0.738 . . . . 24.420000000000002 111.254 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -165.92 169.92 14.29 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.523 1.129 . . . . 72.209999999999994 109.325 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.42 -178.23 47.1 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.251 -1.139 . . . . 55.149999999999999 110.251 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.22 161.89 27.52 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.28 -1.128 . . . . 54.409999999999997 110.28 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.96 122.74 6.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.276 -1.009 . . . . 73.209999999999994 108.276 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -150.15 148.69 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.69 1.196 . . . . 73.409999999999997 108.378 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -131.32 -62.7 0.87 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.86 0.864 . . . . 70.439999999999998 110.418 -173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.28 70.25 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.44 0.696 . . . . 60.119999999999997 109.477 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.71 -168.91 54.82 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.13 -0.788 . . . . 50.210000000000001 111.13 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.05 59.42 0.18 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.492 -1.443 . . . . 75.049999999999997 109.492 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.73 131.74 36.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.699 0.8 . . . . 24.300000000000001 110.201 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -144.26 139.56 28.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.616 1.566 . . . . 55.109999999999999 107.506 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.0 p 43.13 47.42 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 110.99 -166.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -164.69 96.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.588 -1.634 . . . . 74.310000000000002 106.588 -171.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -47.09 3.38 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.948 -0.861 . . . . 61.420000000000002 110.948 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.78 136.06 78.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.256 1.022 . . . . 74.319999999999993 110.537 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.16 170.45 20.34 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.058 2.505 . . . . 73.430000000000007 109.866 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.15 70.38 68.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.763 0.825 . . . . 64.230000000000004 110.62 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.14 -162.9 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.572 2.848 . . . . 72.340000000000003 109.498 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -55.86 -14.49 2.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.782 1.401 . . . . 61.140000000000001 114.782 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.9 -34.22 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.089 0.859 . . . . 53.350000000000001 111.052 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.95 -25.22 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.135 1.374 . . . . 73.310000000000002 112.233 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -53.13 -46.24 68.69 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.267 0.627 . . . . 71.450000000000003 110.891 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.03 73.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.47 -0.3 . . . . 72.239999999999995 111.078 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -68.15 -42.16 80.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.285 0.493 . . . . 75.409999999999997 110.38 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.18 -49.85 73.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.287 -0.634 . . . . 65.349999999999994 109.287 173.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.55 -50.36 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.119 0.968 . . . . 62.039999999999999 110.357 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.61 -52.3 66.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.194 0.998 . . . . 74.340000000000003 111.242 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.48 -45.59 79.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.191 0.596 . . . . 70.219999999999999 110.649 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.07 77.19 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.931 -0.481 . . . . 62.399999999999999 111.027 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -51.04 65.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.209 1.004 . . . . 63.130000000000003 111.643 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.79 -20.11 65.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.314 0.506 . . . . 53.439999999999998 112.343 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.9 62.17 0.49 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.511 1.053 . . . . 62.509999999999998 110.867 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.82 110.14 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.295 1.038 . . . . 55.149999999999999 108.437 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -64.65 161.25 46.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 125.767 1.627 . . . . 75.120000000000005 109.463 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -54.04 -38.17 86.84 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.652 2.235 . . . . 72.439999999999998 111.941 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.4 m -61.31 -44.06 97.83 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.34 0.656 . . . . 74.239999999999995 111.012 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.17 -29.65 69.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.344 0.658 . . . . 63.25 111.465 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.94 -55.83 21.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 N-CA-C 107.855 -1.165 . . . . 75.150000000000006 107.855 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -51.84 -47.04 64.57 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.468 0.707 . . . . 54.119999999999997 112.402 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -43.24 72.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.592 -0.718 . . . . 71.530000000000001 112.216 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.34 -38.27 90.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.716 1.144 . . . . 70.010000000000005 112.765 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.52 -13.46 59.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.035 0.534 . . . . 54.240000000000002 110.89 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 62.53 58.07 1.74 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.479 1.912 . . . . 43.219999999999999 110.874 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.0 173.07 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.362 1.465 . . . . 62.43 109.308 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -104.23 -49.9 3.48 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.652 1.181 . . . . 72.209999999999994 109.835 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -143.03 -34.84 0.42 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.343 1.057 . . . . 75.299999999999997 112.145 -173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.05 -66.98 1.9 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.916 1.246 . . . . 75.439999999999998 113.394 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.76 -28.19 44.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.179 0.489 . . . . 64.230000000000004 110.787 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.22 -51.74 16.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 123.999 0.919 . . . . 73.409999999999997 109.883 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 t -48.98 -48.78 43.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.314 1.046 . . . . 53.149999999999999 111.109 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.18 -44.56 88.07 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.251 0.62 . . . . 73.430000000000007 111.213 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.04 -58.09 8.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.572 0.749 . . . . 71.540000000000006 110.606 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.47 -33.27 71.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 111.565 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.51 127.49 2.86 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.758 -1.737 . . . . 74.409999999999997 108.758 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -45.74 -49.49 14.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.761 1.225 . . . . 75.219999999999999 111.834 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -159.66 -66.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.643 1.177 . . . . 74.549999999999997 108.586 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -160.47 95.68 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.518 1.927 . . . . 75.25 106.084 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.03 170.35 11.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.96 0.409 . . . . 73.239999999999995 111.789 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -80.81 55.32 2.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.01 1.324 . . . . 71.299999999999997 112.068 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.35 -70.08 0.31 Allowed Glycine 0 C--N 1.336 0.568 0 N-CA-C 107.926 -2.07 . . . . 72.299999999999997 107.926 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -71.73 159.65 33.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.325 1.05 . . . . 72.310000000000002 110.221 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt 61.15 44.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.33 1.052 . . . . 72.310000000000002 110.822 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -164.54 147.0 7.13 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.423 1.089 . . . . 75.409999999999997 108.533 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.49 146.77 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.054 2.502 . . . . 75.319999999999993 111.886 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.81 72.46 2.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.196 -1.562 . . . . 73.319999999999993 109.196 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.63 -40.4 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.127 0.971 . . . . 61.420000000000002 111.816 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.4 mm -70.45 115.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.489 -0.93 . . . . 73.239999999999995 108.489 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.87 -171.1 24.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.99 1.281 . . . . 52.32 110.231 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.61 53.66 0.1 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.519 -1.032 . . . . 75.299999999999997 110.519 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -72.78 145.33 47.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.661 0.784 . . . . 53.32 110.467 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -126.1 74.46 72.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.681 1.192 . . . . 73.219999999999999 108.863 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.3 -24.46 19.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.919 2.412 . . . . 72.420000000000002 111.364 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -143.44 144.25 31.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.132 1.773 . . . . 73.329999999999998 106.56 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.42 135.15 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.727 1.211 . . . . 73.349999999999994 109.906 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.11 167.35 10.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.739 1.216 . . . . 74.519999999999996 110.593 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -155.06 147.74 17.86 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.639 1.176 . . . . 55.229999999999997 108.416 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.03 -19.22 62.17 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.288 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -57.1 -26.63 60.77 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.412 0.685 . . . . 73.040000000000006 111.708 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.79 -45.59 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.829 0.852 . . . . 75.200000000000003 110.802 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.98 -44.11 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.219 0.607 . . . . 73.299999999999997 110.085 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.07 -36.15 82.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.734 -0.65 . . . . 74.349999999999994 111.4 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -60.87 -45.99 92.36 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.788 0.722 . . . . 64.409999999999997 110.983 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.0 mm -54.47 -41.3 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.796 0.725 . . . . 75.329999999999998 110.861 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.02 -54.27 36.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.559 0.599 . . . . 75.329999999999998 111.994 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -57.03 -49.52 75.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.543 1.137 . . . . 71.209999999999994 110.987 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -80.66 21.76 0.63 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.146 0.795 . . . . 74.400000000000006 113.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -18.14 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.171 0.989 . . . . 70.120000000000005 110.216 157.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -85.35 -52.76 5.66 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.312 1.045 . . . . 75.120000000000005 108.813 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -72.79 -70.68 0.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.108 1.363 . . . . 54.420000000000002 109.29 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -74.68 160.29 81.29 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 108.971 -0.751 . . . . 71.400000000000006 108.971 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.3 -169.01 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.81 3.007 . . . . 64.409999999999997 110.854 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.3 p -78.44 64.9 3.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.603 1.161 . . . . 62.350000000000001 110.85 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.18 177.0 7.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.921 1.288 . . . . 52.119999999999997 111.034 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.18 161.31 13.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.875 1.67 . . . . 72.129999999999995 109.191 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.49 12.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.605 1.162 . . . . 61.119999999999997 113.859 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -53.92 -49.19 69.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.102 0.961 . . . . 75.239999999999995 109.568 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.49 -54.49 13.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.847 0.859 . . . . 62.310000000000002 110.292 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.09 -39.4 66.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.38 0.511 . . . . 65.319999999999993 112.38 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -49.27 -63.51 1.08 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.637 0.775 . . . . 72.510000000000005 110.022 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.59 -11.46 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 112.63 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.04 50.7 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.842 . . . . 75.219999999999999 108.749 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt -52.11 -47.22 65.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.269 1.027 . . . . 73.140000000000001 111.447 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.5 -52.2 54.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.768 0.827 . . . . 65.030000000000001 110.431 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.6 87.29 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.767 1.227 . . . . 61.240000000000002 111.714 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.85 -14.58 62.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.974 0.91 . . . . 71.450000000000003 111.634 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 34.44 50.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.885 0.755 . . . . 73.430000000000007 111.325 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 -36.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.726 1.21 . . . . 64.340000000000003 109.467 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.8 m -127.29 158.82 36.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.132 1.373 . . . . 72.340000000000003 111.238 -171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.18 158.15 32.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.41 1.084 . . . . 74.219999999999999 109.012 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -46.17 -31.26 2.32 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.199 1.799 . . . . 61.119999999999997 113.709 -173.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.58 141.56 46.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 72.010000000000005 108.4 159.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.9 p -154.34 -59.86 0.12 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.701 2.0 . . . . 73.230000000000004 107.705 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.83 145.9 82.79 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.311 -0.859 . . . . 74.129999999999995 110.449 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.79 -175.93 1.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.579 2.853 . . . . 75.099999999999994 110.591 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 m -20.39 115.33 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 127.852 2.461 . . . . 52.310000000000002 113.803 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.46 -32.06 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.868 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.8 t -66.29 -24.39 66.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 112.026 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 t -81.44 -48.3 12.07 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.235 0.47 . . . . 65.239999999999995 109.903 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -62.37 -28.94 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.916 0.78 . . . . 62.049999999999997 111.491 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -60.22 -33.08 71.76 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 122.056 -0.402 . . . . 71.129999999999995 111.817 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -58.39 -24.71 60.78 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.978 0.732 . . . . 73.409999999999997 112.978 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -55.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.61 -0.885 . . . . 71.540000000000006 108.61 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.3 -42.73 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.981 0.912 . . . . 70.030000000000001 110.44 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -61.98 -50.58 71.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.555 0.616 . . . . 71.010000000000005 111.67 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 34.5 p -61.78 -31.53 71.74 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.961 -0.462 . . . . 51.119999999999997 111.658 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -70.3 -72.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.427 0.558 . . . . 64.109999999999999 109.815 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.73 87.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.889 1.276 . . . . 52.140000000000001 108.804 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -77.79 156.65 30.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.969 0.908 . . . . 74.450000000000003 110.68 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -135.65 69.28 66.48 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.616 1.167 . . . . 74.420000000000002 109.095 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.2 154.89 61.67 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.224 2.616 . . . . 71.099999999999994 110.517 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -108.97 150.4 27.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.48 1.112 . . . . 74.439999999999998 110.156 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -69.49 155.15 40.93 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.476 0.71 . . . . 74.540000000000006 110.859 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.65 84.63 19.88 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.283 1.433 . . . . 71.540000000000006 107.621 173.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.36 143.39 31.31 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.752 2.301 . . . . 65.430000000000007 110.612 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.3 ttt -90.59 118.79 30.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.035 0.934 . . . . 73.420000000000002 109.263 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.23 147.57 32.54 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.324 0.65 . . . . 73.030000000000001 109.547 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 m -148.43 156.71 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.608 1.163 . . . . 70.409999999999997 109.528 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.43 166.55 39.75 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.477 -1.049 . . . . 73.530000000000001 110.477 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.1 140.99 73.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.334 0.654 . . . . 73.219999999999999 110.162 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.84 161.69 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.274 2.65 . . . . 71.140000000000001 110.818 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.08 176.98 45.91 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.111 -0.795 . . . . 72.230000000000004 111.111 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.58 -174.9 47.04 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.256 -1.138 . . . . 40.0 110.256 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.75 163.96 35.29 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.462 -1.055 . . . . 53.420000000000002 110.462 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.4 m -159.56 98.97 1.41 Allowed 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 106.815 -1.55 . . . . 74.430000000000007 106.815 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -136.05 140.74 44.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.153 0.981 . . . . 74.25 109.129 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -147.97 164.49 33.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.492 1.117 . . . . 74.329999999999998 109.26 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -144.11 152.39 40.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.388 1.075 . . . . 72.420000000000002 108.987 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -71.13 163.35 27.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.177 0.591 . . . . 51.009999999999998 111.189 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -76.96 93.99 3.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.022 . . . . 73.409999999999997 108.239 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.3 t60 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 117.673 -1.156 . . . . 73.049999999999997 110.684 175.44 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 119.315 -0.374 . . . . 52.329999999999998 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.4 162.59 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.775 2.317 . . . . 75.129999999999995 110.797 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -154.78 -58.51 0.11 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.96 0.904 . . . . 73.310000000000002 109.007 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.9 157.93 0.17 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.424 1.89 . . . . 55.43 111.926 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 m -147.03 91.45 2.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.37 -0.974 . . . . 74.230000000000004 108.37 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.85 138.02 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.776 -0.824 . . . . 53.119999999999997 108.776 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -136.44 154.04 50.89 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.334 1.054 . . . . 75.430000000000007 109.107 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.9 t -156.24 90.52 1.2 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.297 -1.001 . . . . 55.32 108.297 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.83 145.0 36.04 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.146 -0.782 . . . . 63.219999999999999 111.146 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.79 160.13 40.82 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.524 1.13 . . . . 72.450000000000003 109.481 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.1 -168.92 41.37 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.331 -1.108 . . . . 44.020000000000003 110.331 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.16 166.2 37.54 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.616 -1.393 . . . . 65.450000000000003 109.616 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.78 149.05 28.67 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.225 1.01 . . . . 73.319999999999993 109.671 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -71.81 135.46 46.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.021 0.528 . . . . 74.109999999999999 109.922 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -97.3 -56.15 2.62 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.134 0.974 . . . . 65.049999999999997 109.629 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -115.19 112.57 22.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.111 1.364 . . . . 64.549999999999997 108.522 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.48 -70.25 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.388 -1.485 . . . . 53.530000000000001 109.388 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.01 86.37 0.12 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.12 -1.192 . . . . 73.010000000000005 110.12 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.19 -179.08 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.037 0.935 . . . . 51.329999999999998 109.493 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -73.83 -80.08 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.382 0.673 . . . . 74.0 109.227 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.51 62.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 105.589 -2.004 . . . . 53.240000000000002 105.589 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.59 49.74 15.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.177 0.991 . . . . 74.430000000000007 109.352 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.46 165.95 40.3 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.325 -1.11 . . . . 52.109999999999999 110.325 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -169.08 136.6 1.55 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.426 -0.953 . . . . 75.329999999999998 108.426 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.62 147.45 57.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.763 2.308 . . . . 73.319999999999993 109.351 171.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.86 81.48 5.95 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.621 0.768 . . . . 72.019999999999996 111.626 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.14 -171.88 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.021 2.481 . . . . 62.109999999999999 108.586 159.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.88 -7.15 2.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.295 1.22 . . . . 74.109999999999999 114.295 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.46 -36.48 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.834 -1.166 . . . . 75.129999999999995 110.894 168.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 -35.79 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 73.239999999999995 111.216 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.14 -48.36 70.92 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.4 0.68 . . . . 55.539999999999999 109.742 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -62.97 -45.87 90.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.651 0.78 . . . . 62.039999999999999 110.384 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.1 mtp-105 -56.48 -45.77 80.77 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.428 0.291 . . . . 71.430000000000007 111.265 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.56 -48.65 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.86 0.864 . . . . 71.420000000000002 109.628 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.9 -53.63 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.083 0.953 . . . . 70.219999999999999 110.727 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.96 -51.53 69.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.094 0.958 . . . . 74.209999999999994 110.959 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 tp -65.37 -42.4 92.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.165 0.986 . . . . 75.319999999999993 111.014 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.52 60.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.848 1.259 . . . . 73.099999999999994 112.708 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -55.6 -32.76 63.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.847 0.859 . . . . 75.310000000000002 111.452 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -57.76 -34.21 69.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.648 0.779 . . . . 73.340000000000003 112.481 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.42 0.76 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.93 -1.668 . . . . 51.229999999999997 108.93 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.34 120.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.943 0.897 . . . . 72.409999999999997 110.828 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -85.5 155.95 59.35 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.936 1.294 . . . . 63.219999999999999 108.273 167.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.48 67.68 6.28 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.66 2.907 . . . . 60.310000000000002 109.897 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.5 p 167.81 -29.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.541 2.736 . . . . 50.130000000000003 109.731 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -62.35 -26.6 68.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.388 0.675 . . . . 73.349999999999994 111.7 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -60.17 -55.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.96 -0.756 . . . . 65.420000000000002 108.96 167.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -50.01 -42.42 49.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.587 1.155 . . . . 61.32 111.509 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -55.69 -67.5 0.28 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 123.316 0.646 . . . . 53.520000000000003 110.996 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.73 -46.48 85.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.203 1.001 . . . . 73.319999999999993 112.708 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.1 -11.97 51.3 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.374 1.069 . . . . 73.239999999999995 111.054 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 69.63 38.93 1.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.219 1.408 . . . . 72.530000000000001 111.133 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.82 179.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.951 1.3 . . . . 54.350000000000001 111.021 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.8 p -99.06 -88.76 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.761 1.224 . . . . 63.210000000000001 109.838 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.97 -41.01 0.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.321 1.449 . . . . 72.340000000000003 111.34 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.6 -45.96 75.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.336 0.493 . . . . 30.5 112.188 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.57 -23.08 40.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.607 -0.711 . . . . 63.43 111.684 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -57.2 -45.48 84.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 CA-C-N 119.184 0.902 . . . . 70.439999999999998 109.507 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -56.95 -46.4 82.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.095 0.558 . . . . 62.43 111.347 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.58 -46.95 87.41 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.787 0.435 . . . . 51.399999999999999 110.847 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.7 mm -56.24 -45.15 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.992 0.917 . . . . 72.349999999999994 110.065 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -13.32 61.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.897 0.879 . . . . 64.200000000000003 113.123 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 163.32 11.2 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.253 0.93 . . . . 73.400000000000006 111.793 168.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -74.81 -25.94 59.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.996 1.318 . . . . 75.329999999999998 109.582 163.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 78.87 115.27 0.06 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.063 1.745 . . . . 72.109999999999999 111.113 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 51.0 75.4 0.19 Allowed 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.83 1.252 . . . . 71.430000000000007 108.983 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -93.33 -172.05 2.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.111 -0.949 . . . . 71.409999999999997 110.374 -161.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.6 p -51.08 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.328 1.851 . . . . 73.25 112.461 -169.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.39 47.05 28.85 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.953 1.263 . . . . 62.32 112.052 -172.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -158.37 173.17 17.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.672 0.736 . . . . 61.310000000000002 111.095 -170.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mt 57.34 51.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.369 1.468 . . . . 63.299999999999997 109.715 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.88 67.57 22.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.616 1.566 . . . . 53.310000000000002 108.454 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.8 79.42 3.24 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.318 2.679 . . . . 65.200000000000003 110.342 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.45 60.28 0.18 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.757 -0.937 . . . . 64.439999999999998 110.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -84.91 53.37 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.094 0.958 . . . . 72.319999999999993 110.426 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.3 mt -77.91 132.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.306 -0.998 . . . . 71.040000000000006 108.306 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.89 167.95 53.9 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.555 0.597 . . . . 74.129999999999995 112.231 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.88 -144.5 5.37 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.983 0.801 . . . . 71.150000000000006 111.221 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.4 p -137.82 129.98 29.01 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.601 1.16 . . . . 72.540000000000006 109.502 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -74.04 150.07 87.75 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.818 0.847 . . . . 74.230000000000004 109.403 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.59 164.02 35.97 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.41 2.74 . . . . 71.319999999999993 110.87 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -159.19 113.72 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.355 -0.98 . . . . 65.340000000000003 108.355 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.26 135.32 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.164 0.586 . . . . 73.239999999999995 109.92 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.51 158.31 16.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.149 0.979 . . . . 73.409999999999997 110.18 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.4 p 45.75 52.37 10.91 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.98 1.712 . . . . 72.450000000000003 113.939 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.17 -59.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.474 2.116 . . . . 73.530000000000001 111.267 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -66.02 -24.01 66.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.779 0.831 . . . . 74.120000000000005 111.755 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.05 -52.73 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.374 1.069 . . . . 73.519999999999996 109.571 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.7 t -59.4 -40.78 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.625 0.77 . . . . 74.140000000000001 110.608 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -62.66 -17.83 61.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.369 -0.824 . . . . 73.219999999999999 112.8 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -63.33 -65.04 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.837 1.198 . . . . 72.239999999999995 109.211 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -44.29 -50.97 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.039 0.936 . . . . 60.229999999999997 111.151 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -62.4 5.03 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.987 0.804 . . . . 62.210000000000001 111.928 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.22 -44.04 95.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.628 0.771 . . . . 62.310000000000002 111.523 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -59.7 -34.14 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.251 0.62 . . . . 75.540000000000006 111.413 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.57 -39.55 31.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.714 0.806 . . . . 63.329999999999998 111.784 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -55.04 -42.86 73.19 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.029 0.831 . . . . 72.129999999999995 110.594 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -66.56 -64.9 0.76 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.558 1.143 . . . . 74.129999999999995 109.51 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -120.1 82.58 29.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 125.051 1.34 . . . . 63.25 109.334 -171.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.69 -33.61 12.78 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.835 2.357 . . . . 43.340000000000003 111.638 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.0 p -62.79 -39.54 94.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.437 1.095 . . . . 71.420000000000002 111.373 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 82.5 mmm -68.27 158.64 32.93 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.69 0.757 . . . . 62.039999999999999 111.523 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.5 25.93 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.294 -1.321 . . . . 75.450000000000003 111.678 -166.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.41 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.191 1.396 . . . . 71.209999999999994 112.354 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -53.25 -45.12 68.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.625 1.17 . . . . 73.409999999999997 111.342 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.56 -48.0 36.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.794 1.238 . . . . 73.340000000000003 109.185 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.13 -12.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.664 1.586 . . . . 74.340000000000003 112.742 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -38.49 -51.78 1.59 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.068 0.947 . . . . 64.010000000000005 110.222 157.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -79.21 -13.03 59.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.808 0.843 . . . . 75.120000000000005 112.56 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -29.36 63.46 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.21 0.914 . . . . 72.099999999999994 111.132 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.5 mt -57.38 -44.25 84.29 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.814 -0.439 . . . . 72.109999999999999 109.814 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -66.65 -52.18 47.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.509 0.724 . . . . 65.530000000000001 110.45 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.7 92.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.433 1.093 . . . . 75.519999999999996 111.978 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -70.3 -25.82 63.5 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.11 0.564 . . . . 65.299999999999997 111.242 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.0 48.48 3.34 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.743 -0.943 . . . . 54.030000000000001 110.743 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.7 t -91.49 -40.61 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.584 1.154 . . . . 54.310000000000002 109.507 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.58 168.95 23.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.547 1.139 . . . . 72.109999999999999 109.775 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.59 168.06 12.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.591 1.156 . . . . 63.439999999999998 111.34 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.67 -31.2 64.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.819 1.648 . . . . 51.210000000000001 114.069 -170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -95.24 -42.65 8.44 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.221 1.009 . . . . 64.239999999999995 110.43 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 p -68.97 -21.47 64.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.121 0.968 . . . . 54.299999999999997 112.703 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.77 130.39 8.56 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.733 1.213 . . . . 62.549999999999997 111.128 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -69.07 170.97 14.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.999 2.466 . . . . 63.32 111.893 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.2 m -47.17 125.07 7.29 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.763 1.625 . . . . 43.32 112.203 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.0 -42.09 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.261 1.024 . . . . 64.340000000000003 109.426 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.4 m -55.54 -34.05 64.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.977 . . . . 65.549999999999997 112.254 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.4 t -72.98 -51.19 19.23 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.629 0.65 . . . . 71.409999999999997 110.058 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.9 pt -59.76 -33.37 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 122.792 0.437 . . . . 64.439999999999998 111.856 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.2 -57.17 10.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.918 0.487 . . . . 71.219999999999999 111.561 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -67.43 -7.07 22.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.318 1.229 . . . . 64.120000000000005 114.318 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.12 -54.19 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 120.16 1.345 . . . . 52.119999999999997 108.823 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mt -47.64 -46.22 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.32 1.848 . . . . 72.120000000000005 111.156 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.9 -50.52 34.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.309 0.644 . . . . 73.129999999999995 111.074 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.9 p -56.86 -27.62 60.64 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.858 -0.526 . . . . 74.519999999999996 112.118 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.31 -64.05 0.97 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.429 0.558 . . . . 70.230000000000004 109.856 166.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.03 96.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.005 1.322 . . . . 73.219999999999999 108.027 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.07 39.03 0.55 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.225 1.41 . . . . 65.319999999999993 113.166 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.27 115.3 65.52 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 118.73 -0.653 . . . . 74.430000000000007 109.3 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.66 121.63 6.83 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.708 1.605 . . . . 74.209999999999994 108.553 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.98 71.15 10.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 109.637 -169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.42 147.95 7.8 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.581 1.153 . . . . 74.140000000000001 109.722 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 tp -155.5 89.18 2.99 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.101 -1.074 . . . . 74.239999999999995 108.101 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.11 68.8 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.517 2.811 . . . . 63.210000000000001 109.52 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 57.3 ttm -155.59 148.98 24.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.031 0.933 . . . . 71.25 109.074 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.87 152.91 28.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.38 1.072 . . . . 51.350000000000001 109.272 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 90.6 p -146.67 36.62 0.97 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.777 0.831 . . . . 65.450000000000003 110.135 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.55 71.23 2.49 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.99 0.805 . . . . 62.229999999999997 111.146 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.04 67.78 10.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.599 0.76 . . . . 54.009999999999998 110.666 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.77 167.56 25.13 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.26 2.64 . . . . 72.239999999999995 110.512 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.14 157.35 15.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.49 -1.044 . . . . 32.43 110.49 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 167.09 173.36 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.063 -0.815 . . . . 60.420000000000002 111.063 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.53 152.65 9.89 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.876 -1.289 . . . . 62.520000000000003 109.876 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.9 p -164.7 130.44 2.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.641 0.776 . . . . 50.25 109.422 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -164.48 155.89 15.61 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.577 1.151 . . . . 75.230000000000004 109.199 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -165.77 170.07 14.37 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.518 1.127 . . . . 73.329999999999998 109.484 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -159.97 155.51 25.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.247 1.019 . . . . 63.119999999999997 109.416 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -150.7 153.86 36.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.457 1.103 . . . . 71.219999999999999 108.542 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -74.47 -168.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.48 1.112 . . . . 63.450000000000003 110.486 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.728 -1.129 . . . . 72.519999999999996 108.996 175.577 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.02 -0.514 . . . . 75.510000000000005 110.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.96 73.05 6.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.203 2.602 . . . . 53.549999999999997 110.081 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -64.46 -61.08 2.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.086 0.955 . . . . 64.510000000000005 110.569 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 68.69 163.2 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.677 1.591 . . . . 51.43 111.68 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -146.46 96.18 2.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.558 -1.275 . . . . 64.439999999999998 107.558 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.4 134.17 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.299 0.639 . . . . 75.430000000000007 109.361 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -146.98 165.95 28.28 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.741 1.216 . . . . 73.549999999999997 108.938 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -153.12 128.51 9.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.737 0.815 . . . . 71.219999999999999 109.0 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.3 172.56 49.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.212 -0.755 . . . . 71.450000000000003 111.212 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -162.31 161.38 27.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.269 1.028 . . . . 75.25 109.49 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.31 -166.56 36.07 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.082 -1.207 . . . . 72.420000000000002 110.082 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.1 146.77 13.14 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.035 -1.226 . . . . 72.25 110.035 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 75.67 9.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.929 0.891 . . . . 74.430000000000007 108.816 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.81 151.52 22.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.515 1.126 . . . . 72.439999999999998 110.242 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.21 160.48 35.45 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.016 1.326 . . . . 63.219999999999999 109.213 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tt -154.71 145.04 22.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 72.109999999999999 108.852 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.33 141.67 8.82 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.113 -1.595 . . . . 53.32 109.113 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.47 179.62 19.45 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.41 1.005 . . . . 74.099999999999994 110.86 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 -177.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.432 1.493 . . . . 22.109999999999999 112.667 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -77.7 117.99 19.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.489 0.716 . . . . 73.299999999999997 109.334 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.7 t -140.08 -81.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.171 -1.418 . . . . 63.399999999999999 107.171 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -147.8 140.57 24.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.975 1.31 . . . . 70.540000000000006 107.846 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.49 -8.69 53.22 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.268 -0.74 . . . . 73.109999999999999 111.931 -167.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -127.45 62.98 57.16 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.139 1.376 . . . . 74.140000000000001 109.077 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.08 139.23 35.26 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.402 2.068 . . . . 65.420000000000002 109.853 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 tp -156.42 -67.93 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 117.805 -1.093 . . . . 74.540000000000006 110.116 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -79.98 -159.37 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.736 2.291 . . . . 72.329999999999998 110.389 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -39.58 -36.98 0.44 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.438 2.295 . . . . 55.130000000000003 114.217 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -46.33 -29.95 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.168 1.387 . . . . 45.409999999999997 113.247 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.34 -48.05 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 111.203 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -56.68 -52.87 63.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.265 1.026 . . . . 74.140000000000001 110.01 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -54.84 -52.0 64.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.431 0.692 . . . . 65.019999999999996 110.647 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -57.69 -50.52 72.92 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.504 0.722 . . . . 74.409999999999997 111.998 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.0 mm -63.58 -40.27 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.767 0.427 . . . . 71.140000000000001 110.925 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.45 -54.19 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.409 0.684 . . . . 61.520000000000003 110.329 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -57.95 -41.74 83.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.511 1.125 . . . . 73.319999999999993 111.212 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.55 -57.36 9.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.884 0.473 . . . . 62.140000000000001 109.978 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.77 55.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.748 1.219 . . . . 64.140000000000001 112.209 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -55.99 -30.77 62.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.308 1.443 . . . . 74.219999999999999 113.152 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.34 -22.6 66.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.15 0.886 . . . . 72.219999999999999 112.207 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.15 63.7 0.7 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 109.721 -1.351 . . . . 73.540000000000006 109.721 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.7 130.47 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 71.129999999999995 109.896 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -69.28 151.04 97.1 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.868 0.867 . . . . 71.049999999999997 108.929 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -55.47 -44.81 44.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.643 2.229 . . . . 72.230000000000004 111.679 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.2 p -61.26 -37.93 84.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.254 0.622 . . . . 61.509999999999998 112.065 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -70.66 -34.19 71.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.033 0.533 . . . . 62.450000000000003 111.4 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.7 mt -56.88 -53.77 38.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 108.469 -0.937 . . . . 74.540000000000006 108.469 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 m -51.66 -50.39 60.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.63 0.772 . . . . 74.310000000000002 112.215 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -64.23 -46.97 81.51 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.94 -0.552 . . . . 73.430000000000007 112.402 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.6 -39.13 87.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.001 0.819 . . . . 73.200000000000003 112.185 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.86 1.31 50.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.678 0.791 . . . . 64.040000000000006 111.262 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 44.54 57.46 4.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.138 2.175 . . . . 64.040000000000006 113.578 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 -175.07 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.343 1.857 . . . . 74.310000000000002 108.738 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 m -104.42 -69.41 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.447 1.099 . . . . 51.229999999999997 110.969 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -166.1 -42.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.852 0.861 . . . . 74.030000000000001 111.439 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.32 -42.84 93.79 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.697 -0.561 . . . . 70.140000000000001 111.697 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.9 m -73.35 -36.65 66.17 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.578 0.751 . . . . 71.120000000000005 110.834 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.49 -42.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.882 0.873 . . . . 73.209999999999994 110.381 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 t -48.94 -59.48 3.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.776 0.83 . . . . 65.140000000000001 111.803 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -68.02 -34.45 76.52 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.31 0.485 . . . . 73.340000000000003 112.31 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.6 mt -63.26 -40.47 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.577 0.751 . . . . 74.400000000000006 110.711 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.77 -41.56 78.65 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.189 0.595 . . . . 64.329999999999998 110.516 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.19 74.23 0.11 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.431 -0.668 . . . . 65.340000000000003 111.431 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -41.04 61.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.947 0.499 . . . . 73.030000000000001 110.199 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -74.4 0.54 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.154 0.982 . . . . 73.310000000000002 109.1 169.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -164.14 36.34 0.08 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.593 1.557 . . . . 74.230000000000004 109.76 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 51.54 -141.97 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.12 1.368 . . . . 55.439999999999998 109.104 -165.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.1 p -106.95 28.77 7.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.568 0.747 . . . . 72.230000000000004 109.586 165.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.07 -126.75 5.92 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.392 -1.083 . . . . 75.400000000000006 110.392 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -151.24 47.07 0.83 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.325 1.05 . . . . 75.209999999999994 109.231 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.7 mt -86.94 56.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.098 . . . . 70.430000000000007 108.404 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -140.84 71.54 29.49 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.783 1.233 . . . . 75.0 109.153 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.72 159.81 44.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.238 2.625 . . . . 72.140000000000001 110.871 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.93 -157.62 13.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.947 -1.261 . . . . 24.140000000000001 109.947 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.65 123.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 125.065 1.346 . . . . 73.230000000000004 107.9 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.48 127.36 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.387 -0.968 . . . . 35.25 108.387 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.57 -165.44 50.03 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.768 0.699 . . . . 61.009999999999998 112.414 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.19 171.53 44.61 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.945 -1.262 . . . . 43.420000000000002 109.945 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.1 p -74.18 144.72 44.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.421 0.688 . . . . 73.450000000000003 110.761 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -152.58 77.87 6.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.259 1.024 . . . . 70.329999999999998 108.53 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.75 161.2 33.83 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.931 2.421 . . . . 55.25 110.986 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -158.79 92.34 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.447 -1.316 . . . . 73.510000000000005 107.447 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.74 137.65 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.766 1.226 . . . . 65.010000000000005 108.632 -174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 168.93 14.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 51.140000000000001 111.173 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.2 t -119.17 142.91 33.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.122 1.369 . . . . 64.430000000000007 108.607 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.23 -15.98 51.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.994 2.462 . . . . 73.299999999999997 112.834 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -58.93 -28.95 66.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.536 0.607 . . . . 54.020000000000003 111.753 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.8 t -54.93 -37.35 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.131 0.573 . . . . 45.020000000000003 110.623 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.39 -48.91 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.202 0.601 . . . . 62.109999999999999 109.932 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -54.61 -37.81 66.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.008 0.923 . . . . 63.539999999999999 112.021 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -53.2 -34.62 57.79 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.342 1.057 . . . . 75.109999999999999 113.809 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.58 -41.03 72.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 118.882 0.765 . . . . 64.239999999999995 109.753 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.38 -55.43 19.59 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.96 0.79 . . . . 44.439999999999998 111.232 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -59.98 -49.81 76.2 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 117.755 0.777 . . . . 72.540000000000006 111.614 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -63.88 -36.7 84.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.532 0.567 . . . . 72.120000000000005 112.532 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -63.25 -45.9 89.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.172 0.897 . . . . 44.399999999999999 111.725 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -59.8 -52.51 65.16 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 74.409999999999997 111.066 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -67.8 -39.75 83.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.474 0.31 . . . . 74.140000000000001 110.997 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.24 95.89 46.79 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.806 1.243 . . . . 71.409999999999997 109.017 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -32.31 11.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.27 2.647 . . . . 64.540000000000006 112.573 -174.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.7 p -67.65 -38.82 84.33 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.312 0.645 . . . . 73.129999999999995 111.941 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 71.2 mtp -60.07 133.31 55.98 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.883 0.473 . . . . 75.510000000000005 111.017 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -97.08 170.5 9.09 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.758 1.623 . . . . 74.230000000000004 110.367 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.2 -45.62 11.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.757 1.223 . . . . 74.140000000000001 113.51 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -74.98 -32.44 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.998 0.919 . . . . 74.439999999999998 111.546 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -64.14 -48.55 75.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.741 -0.837 . . . . 71.310000000000002 108.741 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.13 -41.08 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.623 1.169 . . . . 62.039999999999999 111.242 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -49.21 -53.62 20.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.413 0.685 . . . . 52.409999999999997 109.448 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -76.87 -20.56 56.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.044 0.537 . . . . 74.540000000000006 111.719 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -58.48 -46.21 87.12 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.283 0.633 . . . . 70.409999999999997 110.508 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -54.73 -44.0 73.14 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.3 0.64 . . . . 74.209999999999994 110.843 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.58 -48.06 76.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.337 0.655 . . . . 72.310000000000002 110.371 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.23 86.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.068 0.947 . . . . 64.219999999999999 111.636 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.11 -16.65 62.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.075 0.95 . . . . 63.450000000000003 112.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.87 42.06 39.39 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.868 0.747 . . . . 72.450000000000003 111.277 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.8 t -83.54 -41.62 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 109.506 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.0 p -152.31 169.23 23.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.453 1.101 . . . . 71.019999999999996 109.981 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.68 163.12 20.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.29 1.036 . . . . 72.25 111.028 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -52.36 -33.07 41.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.554 1.942 . . . . 73.120000000000005 113.205 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.15 -43.98 7.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.816 1.246 . . . . 75.540000000000006 110.271 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.0 p -66.22 -24.44 66.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.975 0.91 . . . . 70.510000000000005 112.585 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.75 131.45 20.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.425 1.09 . . . . 75.239999999999995 110.394 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.61 159.3 54.05 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.93 2.42 . . . . 61.450000000000003 112.035 -170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.9 m -64.22 144.98 56.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.917 1.287 . . . . 34.200000000000003 111.524 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 81.4 t -57.11 -37.79 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 109.52 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -61.26 -40.92 95.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.937 0.895 . . . . 72.129999999999995 112.007 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 92.4 p -69.85 -53.91 15.93 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.439 0.563 . . . . 71.120000000000005 110.545 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.3 -41.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.878 0.871 . . . . 71.430000000000007 111.531 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -65.91 -51.83 55.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.705 0.402 . . . . 71.049999999999997 110.615 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -52.26 -36.13 51.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.473 1.109 . . . . 75.409999999999997 112.347 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.9 mm -58.92 -53.63 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.894 -0.78 . . . . 71.230000000000004 108.894 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.1 mt -68.17 -32.95 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.123 1.369 . . . . 62.509999999999998 111.414 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -51.53 -45.22 62.88 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 123.873 0.869 . . . . 72.349999999999994 111.573 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 81.7 p -66.73 -18.89 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.661 0.615 . . . . 72.230000000000004 112.661 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -94.27 -76.29 0.49 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.131 0.973 . . . . 63.119999999999997 108.94 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.6 p -167.08 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.048 0.939 . . . . 53.219999999999999 110.006 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -99.09 89.42 4.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.398 1.079 . . . . 70.430000000000007 108.193 167.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -128.13 77.43 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.052 1.341 . . . . 64.239999999999995 108.469 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.28 166.11 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.195 2.597 . . . . 64.109999999999999 110.98 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -68.98 159.76 32.17 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.646 0.779 . . . . 71.120000000000005 111.309 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -152.93 153.92 33.98 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 71.219999999999999 108.971 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.47 97.19 15.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.954 1.302 . . . . 64.140000000000001 107.988 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.26 176.67 9.81 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.859 2.373 . . . . 74.209999999999994 110.756 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.846 1.258 . . . . 55.039999999999999 108.061 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -145.83 163.51 34.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 64.439999999999998 109.408 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.5 m -151.33 161.36 42.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.547 1.139 . . . . 63.310000000000002 109.683 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.49 -162.87 25.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.412 -1.075 . . . . 14.210000000000001 110.412 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.89 150.86 23.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.548 1.139 . . . . 71.010000000000005 108.855 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.25 164.87 34.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.093 2.529 . . . . 41.329999999999998 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -87.97 -161.36 36.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.857 0.742 . . . . 44.210000000000001 111.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.49 -178.16 41.71 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.479 -1.049 . . . . 71.209999999999994 110.479 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.67 174.65 46.71 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.08 -1.208 . . . . 75.219999999999999 110.08 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.1 t -161.19 162.3 31.21 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 109.617 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.25 -61.72 0.16 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.4 1.08 . . . . 73.5 108.681 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 78.4 m80 56.52 74.15 0.41 Allowed 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.48 1.112 . . . . 62.43 109.375 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -63.81 150.79 43.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.564 0.746 . . . . 75.040000000000006 110.518 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -131.65 168.75 17.19 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.566 1.146 . . . . 75.439999999999998 110.03 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -138.18 170.42 16.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.921 1.288 . . . . 75.329999999999998 109.547 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.927 -1.511 . . . . 74.420000000000002 110.49 174.177 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.112 -0.471 . . . . 64.439999999999998 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.19 135.94 30.65 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.92 2.413 . . . . 74.230000000000004 109.935 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -137.58 162.69 33.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.781 1.232 . . . . 71.040000000000006 109.265 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -63.5 -57.54 9.87 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.287 0.635 . . . . 73.150000000000006 110.304 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m 64.07 -178.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.881 1.272 . . . . 72.530000000000001 111.627 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.6 pt 43.73 50.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.284 1.833 . . . . 72.25 113.02 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.33 166.67 17.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.901 0.88 . . . . 74.329999999999998 110.232 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -157.05 166.16 34.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.936 0.894 . . . . 61.119999999999997 109.577 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 99.02 0.12 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.845 -1.702 . . . . 62.5 108.845 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -154.61 169.45 23.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.448 1.099 . . . . 71.519999999999996 109.421 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.91 26.47 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.241 -0.744 . . . . 64.230000000000004 111.241 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.55 93.89 1.83 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.836 -1.306 . . . . 64.209999999999994 109.836 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.15 152.03 45.65 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.335 0.654 . . . . 72.430000000000007 109.93 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -69.35 142.2 54.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.059 0.543 . . . . 63.439999999999998 110.945 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -80.51 -32.97 36.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.173 0.989 . . . . 73.319999999999993 112.039 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp 57.94 71.0 0.61 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.23 1.412 . . . . 64.420000000000002 110.35 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.47 62.52 4.31 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.982 0.801 . . . . 73.0 111.294 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.46 44.53 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.782 -0.927 . . . . 64.310000000000002 110.782 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.07 67.15 9.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.109 0.964 . . . . 71.140000000000001 109.547 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -153.72 116.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.849 1.26 . . . . 64.319999999999993 109.095 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.17 162.0 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.161 1.384 . . . . 75.219999999999999 108.111 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.72 101.19 0.13 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.505 0.722 . . . . 74.209999999999994 109.685 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.53 -40.72 1.08 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.633 -1.387 . . . . 33.219999999999999 109.633 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -68.07 150.04 97.92 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.085 0.954 . . . . 62.130000000000003 110.189 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.07 166.51 27.73 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.314 2.676 . . . . 71.219999999999999 110.367 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.35 70.4 4.3 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.385 1.074 . . . . 75.209999999999994 110.342 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.27 -172.41 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.689 2.26 . . . . 64.019999999999996 109.396 170.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -41.95 -43.75 3.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.458 1.503 . . . . 73.230000000000004 112.739 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.24 -26.02 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.944 1.298 . . . . 70.420000000000002 113.844 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.08 -33.42 16.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 CA-C-N 118.561 0.619 . . . . 71.150000000000006 111.203 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -51.38 -39.48 57.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.934 0.893 . . . . 72.430000000000007 112.911 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -62.13 -38.33 88.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 111.084 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -68.2 -40.44 82.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.051 0.54 . . . . 73.420000000000002 110.977 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.56 -49.32 84.86 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 109.244 -0.65 . . . . 75.540000000000006 109.244 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.9 -51.64 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.392 1.077 . . . . 75.409999999999997 110.313 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.16 -52.81 63.83 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.19 0.996 . . . . 64.310000000000002 111.357 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.97 -50.14 67.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.824 0.45 . . . . 74.040000000000006 110.345 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.28 -31.02 67.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.873 0.869 . . . . 63.5 112.376 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -53.2 -43.9 67.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.443 0.697 . . . . 74.019999999999996 112.285 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.09 -19.88 62.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.447 0.567 . . . . 73.099999999999994 112.281 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.93 52.81 2.85 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.637 1.113 . . . . 62.329999999999998 111.555 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 t -74.68 129.44 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 108.964 -0.754 . . . . 74.209999999999994 108.964 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.33 147.23 98.92 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.154 -0.684 . . . . 71.0 109.154 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.52 -41.98 70.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.958 2.439 . . . . 72.230000000000004 111.323 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.7 p -61.62 -29.13 69.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.628 0.771 . . . . 72.25 112.754 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.28 -31.91 21.37 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.82 0.848 . . . . 53.439999999999998 112.531 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.87 -47.03 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.781 -0.822 . . . . 73.349999999999994 108.781 169.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.4 m -51.92 -43.07 63.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.252 1.021 . . . . 72.120000000000005 112.025 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -67.0 -56.46 10.05 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.203 0.601 . . . . 64.349999999999994 110.558 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -59.58 -31.7 69.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.834 0.679 . . . . 61.030000000000001 112.834 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.83 -13.51 29.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.977 0.911 . . . . 72.099999999999994 111.61 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.84 63.3 1.31 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.246 1.818 . . . . 75.319999999999993 110.932 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.67 -179.43 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.725 1.61 . . . . 73.329999999999998 108.965 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.8 m -109.01 -72.83 0.71 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.004 0.922 . . . . 74.530000000000001 111.024 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -157.47 -40.88 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.837 0.855 . . . . 75.420000000000002 111.801 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.93 92.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.67 -0.572 . . . . 74.0 111.67 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.4 m -74.63 -35.52 62.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.412 0.685 . . . . 63.219999999999999 110.61 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.85 -43.04 44.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.694 0.798 . . . . 75.439999999999998 109.935 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -45.62 -61.19 1.81 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.994 0.917 . . . . 74.209999999999994 111.507 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.46 -30.71 67.61 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.891 0.7 . . . . 73.310000000000002 112.891 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -62.82 -38.19 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.187 0.595 . . . . 74.439999999999998 110.374 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.34 -0.73 20.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 71.140000000000001 112.423 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 48.34 26.01 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.817 0.735 . . . . 52.439999999999998 111.678 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.91 -18.26 8.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.057 1.343 . . . . 74.319999999999993 114.392 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.75 -24.32 67.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.05 0.94 . . . . 73.450000000000003 111.859 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -123.21 -46.35 2.06 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.794 1.238 . . . . 72.450000000000003 110.243 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 72.09 149.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.858 2.063 . . . . 72.329999999999998 111.583 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.2 p -55.57 -36.94 67.4 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.696 1.198 . . . . 54.219999999999999 111.611 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.19 65.94 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 119.148 -0.807 . . . . 22.350000000000001 113.697 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 p -148.8 71.86 1.16 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.471 1.135 . . . . 73.530000000000001 110.128 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 mm -77.27 72.71 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.313 1.045 . . . . 75.420000000000002 108.196 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 49.3 63.78 9.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.586 1.555 . . . . 73.420000000000002 112.033 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.2 72.75 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.474 2.783 . . . . 65.109999999999999 110.512 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.73 5.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.549 -1.02 . . . . 72.239999999999995 110.549 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.32 -54.59 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.852 1.261 . . . . 64.420000000000002 110.609 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.7 mt 60.61 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.723 2.409 . . . . 65.329999999999998 113.186 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.1 -156.52 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 71.0 110.371 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.62 67.07 1.82 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.401 -1.08 . . . . 72.219999999999999 110.401 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -145.88 105.97 4.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.222 1.009 . . . . 70.019999999999996 109.273 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -132.92 74.67 73.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.552 1.141 . . . . 70.349999999999994 109.141 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.08 178.41 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.267 2.645 . . . . 52.329999999999998 110.497 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.47 132.59 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.418 -0.956 . . . . 71.450000000000003 108.418 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 154.79 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.423 1.089 . . . . 71.420000000000002 109.947 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 153.45 42.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.638 0.775 . . . . 71.230000000000004 109.966 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -154.83 141.52 13.3 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.453 -0.573 . . . . 72.140000000000001 109.453 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.63 -18.42 53.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.646 2.23 . . . . 71.349999999999994 111.378 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -13.5 33.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.875 0.87 . . . . 74.329999999999998 112.618 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.07 -42.03 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.729 0.812 . . . . 64.409999999999997 110.908 165.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.12 -42.92 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.113 0.565 . . . . 70.129999999999995 110.903 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.814 0.445 . . . . 72.439999999999998 109.87 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -61.08 -36.81 80.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.651 -1.166 . . . . 72.349999999999994 112.181 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -56.53 -49.08 79.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 120.565 1.529 . . . . 72.5 109.791 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.92 -55.09 10.36 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.833 0.73 . . . . 64.420000000000002 111.853 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.36 -47.17 86.46 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.475 0.71 . . . . 75.530000000000001 111.311 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.93 -21.15 63.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.147 -0.93 . . . . 71.340000000000003 113.254 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -70.35 -41.95 72.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.193 1.36 . . . . 75.519999999999996 109.988 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -64.56 -43.9 92.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 111.343 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -77.68 -50.66 12.01 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.324 1.05 . . . . 71.430000000000007 110.716 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -119.11 75.22 14.6 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.801 1.64 . . . . 63.109999999999999 109.642 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.74 -6.38 19.02 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.34 2.694 . . . . 71.510000000000005 112.988 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.6 p -57.75 -59.16 5.64 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.66 1.184 . . . . 44.210000000000001 111.948 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 91.7 mtp -115.36 168.68 9.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.162 0.982 . . . . 71.329999999999998 112.215 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -92.59 177.84 5.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.428 1.891 . . . . 72.140000000000001 110.546 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.23 -39.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.912 2.085 . . . . 63.219999999999999 114.137 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -50.0 -40.78 45.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.873 1.269 . . . . 72.549999999999997 112.296 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -86.54 -41.3 14.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 71.019999999999996 111.036 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.4 mm -61.25 -31.51 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.104 0.411 . . . . 75.340000000000003 111.261 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -37.66 -49.79 1.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.494 1.518 . . . . 65.450000000000003 111.399 164.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.72 -25.36 32.99 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.61 1.164 . . . . 73.299999999999997 112.52 -174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.43 -37.46 78.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.271 0.942 . . . . 73.430000000000007 110.576 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -59.04 -47.3 85.73 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.01 0.524 . . . . 73.099999999999994 109.903 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.64 -41.34 96.22 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.121 0.968 . . . . 63.399999999999999 110.823 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.81 88.68 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.026 0.93 . . . . 60.310000000000002 111.296 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.88 -42.3 90.48 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.869 -0.419 . . . . 72.319999999999993 109.869 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.94 3.93 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.7 1.143 . . . . 55.219999999999999 110.533 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.69 -44.55 79.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.292 -1.003 . . . . 71.209999999999994 108.292 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 m -138.79 161.86 36.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.958 1.703 . . . . 64.239999999999995 109.095 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -95.37 172.52 8.04 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.913 1.285 . . . . 54.43 109.007 163.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -58.61 -21.77 54.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.042 1.337 . . . . 25.539999999999999 113.61 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.84 -52.51 6.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.655 0.782 . . . . 60.329999999999998 109.07 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.1 p -74.4 -27.84 60.82 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.762 0.825 . . . . 75.129999999999995 112.677 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.06 131.44 83.66 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.879 0.871 . . . . 73.209999999999994 109.895 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.5 167.53 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.527 2.152 . . . . 72.450000000000003 110.823 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.8 m -51.8 137.34 26.12 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.217 1.007 . . . . 24.210000000000001 111.305 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.21 -30.42 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.804 0.442 . . . . 62.119999999999997 110.446 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -59.88 -37.0 78.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.827 0.851 . . . . 72.540000000000006 111.626 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.9 m -79.84 -15.77 56.74 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-O 118.422 -0.799 . . . . 74.310000000000002 112.755 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.2 pt -94.66 -39.61 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.304 1.042 . . . . 72.319999999999993 110.526 166.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -53.02 -50.39 64.34 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.653 1.181 . . . . 73.540000000000006 111.966 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -47.8 -40.32 20.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.443 1.097 . . . . 65.329999999999998 113.168 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.6 -60.81 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 108.98 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.9 mm -49.52 -45.71 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.525 1.13 . . . . 71.219999999999999 111.37 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -60.87 -54.19 48.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.123 0.569 . . . . 61.140000000000001 111.467 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.7 p -59.51 -35.73 74.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.308 -0.377 . . . . 73.219999999999999 111.662 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -69.5 -65.85 0.66 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.161 0.437 . . . . 74.340000000000003 110.529 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.33 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.866 1.266 . . . . 52.109999999999999 108.368 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.23 155.36 17.53 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.2 1.0 . . . . 55.340000000000003 109.878 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -137.05 71.05 56.01 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.475 1.11 . . . . 72.430000000000007 109.195 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -71.64 154.28 59.65 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.092 2.528 . . . . 75.430000000000007 110.625 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -64.89 -49.82 68.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.657 0.783 . . . . 65.219999999999999 110.588 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.59 164.26 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.693 1.597 . . . . 54.5 111.745 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.92 150.36 95.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.032 -0.729 . . . . 71.310000000000002 109.032 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 139.33 53.41 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.026 2.484 . . . . 64.25 110.327 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.03 69.79 9.9 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.011 0.925 . . . . 71.329999999999998 109.293 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -69.19 155.13 40.91 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.79 0.836 . . . . 53.43 110.318 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.0 t -158.93 178.1 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.918 0.887 . . . . 64.329999999999998 109.964 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.24 164.21 39.85 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.525 1.06 . . . . 74.099999999999994 111.46 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.04 149.38 12.91 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.295 1.038 . . . . 73.439999999999998 109.164 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.31 178.26 7.73 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.585 2.857 . . . . 71.140000000000001 110.725 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.96 175.76 44.56 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.829 -0.908 . . . . 51.210000000000001 110.829 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.68 -178.66 48.71 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.218 -1.153 . . . . 44.009999999999998 110.218 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.2 -164.6 37.93 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.594 -1.003 . . . . 72.439999999999998 110.594 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 t 58.26 58.76 3.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.994 1.318 . . . . 75.0 111.297 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -133.5 70.09 1.47 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.67 1.188 . . . . 63.450000000000003 108.18 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -162.41 152.64 16.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.305 1.042 . . . . 75.049999999999997 109.542 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -150.71 151.49 32.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.522 1.129 . . . . 72.409999999999997 108.885 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.12 99.59 2.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.386 1.074 . . . . 75.200000000000003 108.282 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.62 132.58 45.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.19 -1.041 . . . . 71.120000000000005 108.19 167.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.8 m80 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 107.589 -1.263 . . . . 51.420000000000002 107.589 175.059 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 119.088 -0.482 . . . . 64.239999999999995 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -70.51 154.44 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.034 2.489 . . . . 62.020000000000003 110.39 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -158.84 -171.85 3.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.221 1.009 . . . . 71.519999999999996 109.29 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -136.82 172.33 13.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.874 1.27 . . . . 71.120000000000005 108.606 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 p -155.62 158.87 39.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.587 1.155 . . . . 75.209999999999994 108.973 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -152.58 155.17 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.102 0.961 . . . . 75.510000000000005 109.076 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -127.63 147.68 50.36 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.088 1.355 . . . . 73.540000000000006 108.777 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 p -162.73 169.55 19.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.412 1.085 . . . . 63.200000000000003 109.473 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.38 173.48 46.26 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.478 -1.049 . . . . 61.509999999999998 110.478 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.97 170.0 18.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.499 1.12 . . . . 72.200000000000003 109.531 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 175.18 47.15 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.702 -0.959 . . . . 52.030000000000001 110.702 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 166.72 34.64 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.416 -1.074 . . . . 71.439999999999998 110.416 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tt -159.63 133.69 7.47 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.213 1.005 . . . . 73.519999999999996 108.92 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -101.68 -68.46 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.546 1.138 . . . . 72.0 109.269 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -144.96 160.93 40.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.525 1.53 . . . . 63.450000000000003 108.68 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.29 61.77 6.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.922 0.889 . . . . 75.150000000000006 109.177 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.9 -107.54 1.35 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.492 1.044 . . . . 64.200000000000003 111.283 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.24 71.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.467 -1.453 . . . . 74.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 167.36 15.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.327 1.051 . . . . 71.319999999999993 112.572 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -73.72 125.46 28.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.769 0.828 . . . . 74.530000000000001 108.898 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.7 t -71.38 -35.55 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.23 0.612 . . . . 64.209999999999994 111.55 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 64.25 77.3 0.32 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.994 1.318 . . . . 54.329999999999998 108.486 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.16 -41.46 0.64 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.296 -1.922 . . . . 73.400000000000006 108.296 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -54.79 153.19 11.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.62 1.168 . . . . 72.430000000000007 110.851 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.24 160.25 42.59 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.902 2.401 . . . . 62.399999999999999 110.152 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -119.45 70.64 12.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 74.310000000000002 110.449 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.03 -165.34 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.066 2.51 . . . . 62.020000000000003 109.844 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -54.66 -21.41 10.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.436 1.495 . . . . 74.549999999999997 113.285 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -54.96 -26.64 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.527 1.131 . . . . 54.240000000000002 112.411 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -56.13 -56.06 15.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 123.665 0.786 . . . . 44.030000000000001 110.289 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -46.31 -56.94 5.07 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.661 0.784 . . . . 62.229999999999997 110.28 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -56.36 -46.07 80.17 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.111 0.964 . . . . 74.430000000000007 111.724 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -64.91 -44.91 88.01 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.973 0.909 . . . . 74.430000000000007 111.605 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.26 -40.74 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.174 0.443 . . . . 64.239999999999995 110.766 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.96 -50.09 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.197 0.599 . . . . 70.209999999999994 110.116 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.66 -49.05 78.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.286 1.034 . . . . 61.030000000000001 111.105 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.55 -56.33 21.59 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.967 0.907 . . . . 73.400000000000006 109.772 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.21 -38.52 65.75 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.512 1.125 . . . . 75.530000000000001 112.304 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.24 -29.28 67.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.682 1.193 . . . . 74.510000000000005 112.962 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.35 -21.81 66.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.292 0.951 . . . . 71.230000000000004 111.881 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.47 70.7 0.37 Allowed Glycine 0 C--N 1.343 0.923 0 C-N-CA 125.539 1.542 . . . . 65.409999999999997 109.836 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.89 128.46 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.879 0.872 . . . . 72.109999999999999 109.921 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -69.73 159.35 84.25 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.028 1.331 . . . . 71.230000000000004 109.115 170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -57.02 -37.12 99.23 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.205 1.937 . . . . 75.530000000000001 111.447 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.51 -44.07 97.26 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.078 0.951 . . . . 65.109999999999999 111.333 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.73 -15.85 60.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.645 0.609 . . . . 71.349999999999994 112.645 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.4 mt -77.05 -48.62 24.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.94 -1.133 . . . . 60.399999999999999 107.94 164.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -51.87 -38.83 57.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.615 1.166 . . . . 63.409999999999997 112.481 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -69.05 -45.81 69.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.194 -0.431 . . . . 73.340000000000003 111.284 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.21 -39.65 93.49 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.637 0.653 . . . . 75.409999999999997 111.725 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.76 -12.37 59.97 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.557 0.743 . . . . 73.219999999999999 111.298 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 47.63 62.44 2.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.031 2.132 . . . . 73.420000000000002 112.561 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.19 -179.93 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.02 1.328 . . . . 74.150000000000006 110.28 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 p -93.52 -88.9 0.22 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.719 1.208 . . . . 65.129999999999995 111.696 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -159.89 -44.4 0.05 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.404 1.082 . . . . 74.409999999999997 111.015 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.96 93.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.953 -0.859 . . . . 71.420000000000002 110.953 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.54 -46.23 63.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.638 0.775 . . . . 64.230000000000004 109.792 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.61 -44.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 123.884 0.873 . . . . 60.240000000000002 110.349 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -48.62 -47.76 39.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.746 1.218 . . . . 71.209999999999994 112.282 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -82.77 -29.07 29.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.26 -51.6 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.973 0.806 . . . . 73.109999999999999 109.787 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 -59.98 2.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.867 0.867 . . . . 75.030000000000001 109.699 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.49 80.64 0.33 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.175 -1.17 . . . . 71.519999999999996 110.175 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.73 -31.95 73.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.23 0.612 . . . . 74.25 109.652 173.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 78.11 -66.84 0.2 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 127.094 2.158 . . . . 71.209999999999994 109.764 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -110.14 69.59 0.7 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.156 0.983 . . . . 74.310000000000002 108.496 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -67.03 179.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.08 -1.082 . . . . 71.0 108.08 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -52.75 -30.99 35.8 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.536 -0.727 . . . . 72.5 111.232 167.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.8 -122.94 1.32 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.456 -1.058 . . . . 52.299999999999997 110.456 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.0 t -164.93 90.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.698 0.799 . . . . 72.209999999999994 109.659 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.12 -1.437 . . . . 72.109999999999999 107.12 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -132.89 66.59 76.62 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.529 0.732 . . . . 70.519999999999996 110.857 -167.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.62 117.24 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.276 2.651 . . . . 73.010000000000005 110.527 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.01 0.22 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.761 -0.936 . . . . 71.239999999999995 110.761 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.88 56.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.272 1.029 . . . . 60.119999999999997 110.608 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.69 129.54 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.081 0.952 . . . . 71.25 109.005 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.01 -178.96 43.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.899 -0.88 . . . . 74.209999999999994 110.899 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.24 115.09 3.39 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.584 1.088 . . . . 74.200000000000003 111.084 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -160.67 167.49 26.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.542 1.137 . . . . 72.549999999999997 109.773 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.36 75.05 5.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.883 0.873 . . . . 63.340000000000003 109.243 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.52 178.23 6.35 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.571 2.847 . . . . 70.519999999999996 111.527 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -142.99 146.98 34.4 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.475 1.91 . . . . 65.319999999999993 106.483 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -86.43 141.66 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.86 1.264 . . . . 54.240000000000002 110.801 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.59 138.19 31.69 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 108.806 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 t -156.45 143.86 13.85 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.337 -0.616 . . . . 75.349999999999994 109.337 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.35 -12.77 30.14 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.845 2.363 . . . . 73.299999999999997 111.891 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -53.78 -22.29 9.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.653 1.581 . . . . 44.119999999999997 112.93 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.13 -33.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.086 0.954 . . . . 62.130000000000003 112.581 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.22 -41.43 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.844 0.747 . . . . 73.519999999999996 111.13 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.21 -39.01 75.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.373 0.669 . . . . 62.009999999999998 110.074 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.0 -39.52 92.54 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.305 -0.855 . . . . 73.519999999999996 112.057 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.77 -41.84 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.5 1.046 . . . . 72.329999999999998 109.965 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.16 -54.27 39.36 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.761 0.696 . . . . 54.140000000000001 112.281 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -56.9 -47.98 79.26 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.974 0.887 . . . . 71.120000000000005 110.907 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -63.85 -42.3 97.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 111.515 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -56.14 -46.24 79.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.658 0.783 . . . . 62.310000000000002 110.795 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -65.24 -34.0 77.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.945 0.898 . . . . 75.109999999999999 112.017 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -71.46 -60.36 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.391 0.676 . . . . 62.0 110.383 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.63 -179.87 1.6 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.282 1.433 . . . . 75.409999999999997 110.838 -170.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.35 -148.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.124 2.549 . . . . 73.150000000000006 109.786 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.5 p -78.66 61.16 2.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.18 0.992 . . . . 64.409999999999997 111.012 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 175.71 6.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.956 1.302 . . . . 75.349999999999994 109.535 172.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -143.14 169.67 17.17 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.267 1.027 . . . . 75.099999999999994 109.828 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.21 -29.02 1.41 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.822 1.649 . . . . 51.240000000000002 115.439 -161.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -47.15 -63.28 1.08 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.017 0.927 . . . . 71.209999999999994 111.769 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -56.86 -49.57 75.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.284 1.434 . . . . 75.329999999999998 110.364 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.01 -27.3 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.511 -169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -62.15 -59.43 5.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.653 0.781 . . . . 74.129999999999995 110.351 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.27 -22.8 66.32 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 119.286 -0.388 . . . . 65.239999999999995 111.969 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.86 -33.14 64.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.715 0.806 . . . . 74.030000000000001 111.908 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.5 mt -55.76 -50.1 71.34 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.214 0.606 . . . . 52.020000000000003 110.288 172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.01 -35.36 74.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.879 0.871 . . . . 72.019999999999996 111.118 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.34 98.17 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.347 0.659 . . . . 73.349999999999994 110.777 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.92 -30.9 64.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.043 0.537 . . . . 63.119999999999997 110.619 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 34.58 5.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.815 1.198 . . . . 61.310000000000002 111.449 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.33 -62.82 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.557 1.143 . . . . 74.310000000000002 108.845 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.7 m -97.2 -167.1 1.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.99 1.316 . . . . 72.129999999999995 110.67 -172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.64 -74.7 0.38 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.254 1.422 . . . . 71.409999999999997 110.304 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -149.07 -56.14 0.19 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.912 0.885 . . . . 65.439999999999998 111.995 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.94 -42.96 37.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.889 -0.782 . . . . 75.340000000000003 108.889 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.7 p -64.39 -31.35 72.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.53 1.532 . . . . 70.109999999999999 112.095 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.38 119.32 76.47 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.247 -1.02 . . . . 63.109999999999999 108.247 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.81 167.35 26.45 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.768 2.978 . . . . 73.030000000000001 110.374 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.6 p -69.33 149.47 48.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.738 0.304 . . . . 73.010000000000005 110.357 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.49 -42.42 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.811 0.844 . . . . 72.510000000000005 110.011 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -43.01 99.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.102 1.361 . . . . 63.32 111.596 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.2 t -56.85 -65.06 0.68 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.248 0.476 . . . . 74.329999999999998 111.077 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.69 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 120.262 -0.575 . . . . 73.109999999999999 110.796 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -54.84 -57.74 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.38 0.272 . . . . 74.319999999999993 110.744 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -40.75 86.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.902 0.881 . . . . 72.010000000000005 111.621 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.4 -56.94 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.697 0.799 . . . . 63.439999999999998 109.427 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 mm -55.15 -40.59 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 73.140000000000001 111.489 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.68 -52.3 64.87 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.144 0.578 . . . . 71.049999999999997 110.582 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 p -61.19 -27.89 68.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.866 -0.588 . . . . 73.109999999999999 112.427 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -67.53 -71.99 0.19 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.784 0.72 . . . . 54.409999999999997 109.558 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.2 t -144.52 89.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.594 1.157 . . . . 71.400000000000006 108.658 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 148.62 41.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.501 0.721 . . . . 70.049999999999997 111.118 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -115.62 93.39 36.81 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.389 1.476 . . . . 74.340000000000003 107.574 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.25 155.85 14.6 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.059 2.506 . . . . 72.450000000000003 110.979 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.08 123.03 29.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.483 -0.932 . . . . 71.219999999999999 108.483 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -151.82 147.72 26.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.729 0.812 . . . . 71.450000000000003 109.712 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.4 tp -151.99 127.83 5.05 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.474 -1.306 . . . . 73.409999999999997 107.474 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.11 163.88 35.64 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.991 2.461 . . . . 65.530000000000001 110.889 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.8 ttm -153.74 145.26 23.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.995 0.918 . . . . 71.5 108.987 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -148.01 160.7 42.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.567 1.547 . . . . 75.150000000000006 108.429 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t -158.54 144.35 16.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.651 0.78 . . . . 64.140000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.46 152.2 10.13 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.591 -1.404 . . . . 54.350000000000001 109.591 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -161.99 149.51 11.74 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.842 . . . . 74.439999999999998 109.366 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.2 172.59 16.06 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.387 2.725 . . . . 73.120000000000005 110.505 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.67 164.84 37.65 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.688 -0.965 . . . . 73.239999999999995 110.688 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.44 39.46 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.068 -1.213 . . . . 64.329999999999998 110.068 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.36 173.78 40.63 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.991 -0.843 . . . . 44.310000000000002 110.991 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 76.0 p -163.97 170.07 17.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.107 1.363 . . . . 74.209999999999994 108.874 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -151.13 155.03 38.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.699 0.8 . . . . 70.420000000000002 109.275 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.33 171.65 14.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.114 0.966 . . . . 51.210000000000001 111.252 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -154.95 121.57 5.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.13 0.972 . . . . 74.409999999999997 108.615 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.37 113.83 10.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.407 -0.96 . . . . 61.240000000000002 108.407 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -62.27 162.93 9.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.846 0.858 . . . . 72.319999999999993 111.946 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.037 -1.459 . . . . 74.430000000000007 110.184 171.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.393 -0.336 . . . . 72.530000000000001 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.7 142.5 35.96 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.588 2.192 . . . . 42.039999999999999 110.05 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -162.9 161.79 25.98 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.263 1.025 . . . . 62.32 109.569 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -144.55 172.76 12.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.953 1.301 . . . . 75.430000000000007 109.285 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.4 t -146.22 151.47 37.65 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.537 1.135 . . . . 73.329999999999998 108.695 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -137.76 160.15 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.947 1.299 . . . . 73.109999999999999 109.657 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -142.06 152.14 43.06 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.72 1.208 . . . . 74.040000000000006 108.866 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.5 t -158.8 157.02 30.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 64.129999999999995 109.114 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.8 75.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.884 -1.286 . . . . 55.450000000000003 109.884 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -158.26 153.95 26.41 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 74.510000000000005 109.991 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.99 178.93 42.02 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.599 -1.4 . . . . 70.239999999999995 109.599 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.32 65.35 0.18 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.579 -1.008 . . . . 72.319999999999993 110.579 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.53 92.21 5.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.389 -0.967 . . . . 73.040000000000006 108.389 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -152.77 140.71 20.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.595 0.758 . . . . 73.239999999999995 109.733 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -162.15 153.06 17.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.141 1.376 . . . . 72.319999999999993 108.877 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -162.95 161.1 25.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.393 1.077 . . . . 63.329999999999998 109.998 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.5 -171.43 41.45 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.845 -0.902 . . . . 54.409999999999997 110.845 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.1 110.72 0.9 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.96 0.79 . . . . 51.32 111.533 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.25 62.14 7.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.837 0.855 . . . . 65.030000000000001 109.982 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -87.22 142.65 27.75 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.701 0.8 . . . . 73.549999999999997 109.877 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.0 t 70.39 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.144 2.177 . . . . 64.239999999999995 112.833 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.78 65.57 1.48 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.581 1.553 . . . . 71.239999999999995 110.921 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.33 71.15 0.49 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 108.865 -1.694 . . . . 44.240000000000002 108.865 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.16 58.61 9.29 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.785 0.661 . . . . 71.209999999999994 112.785 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.69 67.4 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.679 2.92 . . . . 72.219999999999999 109.732 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.65 164.94 18.36 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 126.153 1.781 . . . . 64.140000000000001 108.26 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.16 -153.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.106 2.537 . . . . 74.230000000000004 111.426 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -47.55 -32.63 5.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.918 1.687 . . . . 62.149999999999999 112.591 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.28 -29.3 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.655 1.582 . . . . 71.120000000000005 113.58 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.66 -51.59 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.739 0.816 . . . . 72.049999999999997 110.437 170.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -54.15 36.86 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.515 1.126 . . . . 75.409999999999997 110.001 177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.86 -41.58 96.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.121 0.969 . . . . 71.150000000000006 111.924 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -68.53 -41.15 80.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.136 0.574 . . . . 71.439999999999998 111.556 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.27 -48.49 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.593 -0.521 . . . . 74.120000000000005 109.593 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.11 -48.86 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.956 0.902 . . . . 74.310000000000002 110.461 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -57.79 -52.55 65.01 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.76 0.824 . . . . 73.450000000000003 111.098 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.88 -51.13 71.01 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.28 0.632 . . . . 74.340000000000003 110.465 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.32 -36.53 75.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.145 0.578 . . . . 73.510000000000005 112.382 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.56 -26.64 67.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.352 1.061 . . . . 73.5 112.773 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -63.31 -23.25 67.34 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.957 0.799 . . . . 74.150000000000006 111.84 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.27 51.02 4.56 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.742 1.163 . . . . 74.409999999999997 110.411 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.55 138.53 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 110.784 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -71.39 149.92 93.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.435 1.094 . . . . 73.310000000000002 110.834 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -56.41 -31.78 86.61 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.738 2.959 . . . . 71.439999999999998 112.803 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.6 m -55.98 -34.75 66.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.923 0.889 . . . . 74.530000000000001 112.119 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.42 -29.26 15.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.725 1.21 . . . . 72.109999999999999 111.119 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.88 -41.51 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 64.540000000000006 109.469 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -51.91 -38.53 56.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.477 0.711 . . . . 73.409999999999997 111.701 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -70.1 -52.81 20.77 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.99 0.516 . . . . 73.030000000000001 109.664 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -56.02 -39.59 72.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.175 0.99 . . . . 72.219999999999999 112.563 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.16 -19.19 27.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.252 1.021 . . . . 74.540000000000006 111.547 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.27 62.73 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.948 1.699 . . . . 72.230000000000004 110.794 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.28 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.03 1.732 . . . . 75.120000000000005 108.73 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -132.33 172.43 12.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.292 1.437 . . . . 50.439999999999998 110.099 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -54.28 -45.31 72.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.647 1.179 . . . . 74.219999999999999 113.092 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.29 -41.04 86.43 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.445 -0.662 . . . . 63.240000000000002 111.445 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m -72.2 -45.11 61.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.593 0.757 . . . . 70.239999999999995 110.833 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -44.53 -47.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 124.686 1.194 . . . . 71.25 111.496 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.2 t -46.29 -41.92 13.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.058 0.943 . . . . 74.099999999999994 112.863 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -93.66 -52.65 4.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.107 0.963 . . . . 75.409999999999997 111.128 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.56 -35.04 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.499 1.52 . . . . 65.140000000000001 111.762 -170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -48.66 80.79 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.783 -0.821 . . . . 73.25 108.783 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.37 108.14 1.05 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.321 -1.912 . . . . 74.230000000000004 108.321 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -53.57 -47.12 70.38 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.212 0.605 . . . . 70.219999999999999 111.406 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -141.52 -55.9 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.295 1.038 . . . . 75.25 110.365 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -139.42 -61.27 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.339 1.056 . . . . 74.409999999999997 111.703 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 102.85 178.3 0.0 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.957 3.303 . . . . 61.149999999999999 109.553 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -66.64 -66.97 0.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.986 -0.746 . . . . 51.409999999999997 108.986 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -125.62 32.42 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.15 -1.18 . . . . 53.539999999999999 110.15 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t -130.15 56.19 1.76 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.238 -1.393 . . . . 52.299999999999997 107.238 155.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.06 27.62 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.744 1.618 . . . . 72.420000000000002 108.307 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -139.35 66.5 37.01 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.039 -166.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.01 83.16 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.857 3.038 . . . . 70.019999999999996 110.026 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.12 4.91 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.841 0.734 . . . . 63.0 111.753 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -85.76 55.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.128 0.971 . . . . 52.439999999999998 110.167 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.9 mt -85.3 135.38 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.396 1.078 . . . . 75.019999999999996 109.404 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 -69.62 2.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.087 0.851 . . . . 63.229999999999997 111.633 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.66 -71.81 2.49 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.339 -1.105 . . . . 74.0 110.339 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.6 p -160.63 165.36 30.78 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.762 1.225 . . . . 62.240000000000002 109.287 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -155.49 75.44 5.16 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.927 0.891 . . . . 73.420000000000002 108.771 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.07 158.42 45.7 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.119 2.546 . . . . 63.32 110.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -133.55 92.98 3.06 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.24 1.416 . . . . 75.030000000000001 108.681 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.37 135.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.59 0.756 . . . . 74.150000000000006 109.255 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.28 157.22 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.361 1.064 . . . . 53.100000000000001 110.841 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 t -128.09 99.53 24.98 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.997 1.319 . . . . 73.530000000000001 108.341 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -74.42 -28.59 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.086 2.524 . . . . 74.209999999999994 112.285 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.0 -22.24 48.58 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.439 0.696 . . . . 72.319999999999993 112.491 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.0 t -40.64 -44.77 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 71.340000000000003 112.011 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.23 -42.06 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.974 0.91 . . . . 41.109999999999999 111.007 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.46 -30.77 70.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.745 1.218 . . . . 74.150000000000006 112.51 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -50.52 -57.78 7.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.458 1.103 . . . . 74.450000000000003 111.338 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -38.48 -57.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.8 1.24 . . . . 54.020000000000003 110.973 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.27 -54.97 17.63 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.793 1.187 . . . . 72.019999999999996 112.081 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -55.18 -48.35 73.91 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.936 0.894 . . . . 74.120000000000005 111.055 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -58.77 -32.27 69.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.62 0.6 . . . . 72.030000000000001 112.62 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -75.22 -35.61 61.44 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.988 0.813 . . . . 61.009999999999998 111.79 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.53 -43.58 96.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.926 0.784 . . . . 65.25 110.248 171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.72 -66.69 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.702 1.201 . . . . 64.310000000000002 109.985 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -122.41 83.79 47.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.748 2.019 . . . . 51.450000000000003 109.289 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.83 -43.27 5.41 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.385 2.723 . . . . 65.0 111.724 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -55.57 -31.43 62.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.444 1.497 . . . . 53.020000000000003 113.813 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 179.82 2.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.758 0.823 . . . . 74.400000000000006 112.017 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -137.94 161.86 35.58 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.994 1.318 . . . . 73.340000000000003 110.053 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.83 -40.71 2.16 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.84 2.056 . . . . 72.319999999999993 114.479 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -47.84 -58.02 4.9 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.215 1.006 . . . . 74.409999999999997 111.515 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -67.94 -34.7 77.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.616 0.366 . . . . 74.349999999999994 111.051 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.6 mm -59.67 -38.85 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.577 0.626 . . . . 65.120000000000005 110.915 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -60.39 -53.81 53.17 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.278 0.49 . . . . 74.030000000000001 110.059 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -59.09 -29.53 67.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.39 0.676 . . . . 62.039999999999999 112.07 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -63.64 -37.97 89.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.237 1.015 . . . . 64.030000000000001 111.805 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.95 -44.63 97.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.193 0.597 . . . . 72.019999999999996 110.543 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.94 -48.36 74.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.352 0.661 . . . . 71.409999999999997 110.273 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.49 -43.86 96.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.856 1.262 . . . . 51.229999999999997 111.386 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 -15.82 63.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.436 1.094 . . . . 74.430000000000007 111.296 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.42 38.64 28.23 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.112 -0.795 . . . . 43.119999999999997 111.112 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.76 -47.44 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.222 1.009 . . . . 72.140000000000001 109.843 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.7 p -160.12 175.21 13.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.016 0.926 . . . . 74.209999999999994 110.528 -169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.59 165.84 15.87 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.165 1.386 . . . . 70.319999999999993 110.957 -171.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -58.37 -26.73 63.51 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.494 1.117 . . . . 75.219999999999999 112.77 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -92.33 -46.86 7.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.109 0.964 . . . . 72.409999999999997 109.982 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.3 p -73.03 -25.37 60.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.166 0.986 . . . . 61.020000000000003 112.353 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.88 141.91 46.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.579 1.151 . . . . 74.25 110.857 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.45 145.04 98.41 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.99 1.793 . . . . 64.430000000000007 110.293 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.5 p -69.6 160.03 32.29 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.833 0.853 . . . . 64.150000000000006 112.098 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.52 -47.2 60.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.999 0.92 . . . . 61.240000000000002 108.637 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.2 m -55.03 -46.23 75.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.773 1.229 . . . . 63.109999999999999 112.0 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.6 p -69.83 -60.27 2.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.037 -0.506 . . . . 52.310000000000002 110.015 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.56 -36.83 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.871 0.76 . . . . 73.239999999999995 111.604 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -54.81 -56.64 17.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.104 0.561 . . . . 74.310000000000002 110.865 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.58 75.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.623 0.647 . . . . 70.409999999999997 112.232 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.0 mp -53.83 -60.13 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.319 0.963 . . . . 72.519999999999996 109.284 167.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -50.16 -51.41 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.053 0.941 . . . . 71.030000000000001 111.212 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -55.89 -53.65 54.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.322 0.649 . . . . 73.299999999999997 111.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 p -60.77 -27.74 68.21 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.598 0.592 . . . . 74.230000000000004 112.598 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.32 -50.9 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.737 0.699 . . . . 74.319999999999993 110.288 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 p -159.09 114.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.0 0.92 . . . . 65.239999999999995 109.299 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -139.36 153.65 47.72 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.7 1.6 . . . . 74.25 110.461 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -136.65 70.45 59.17 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.98 1.312 . . . . 73.209999999999994 108.268 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.47 166.91 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.549 2.833 . . . . 72.349999999999994 111.46 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 61.53 32.67 18.71 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.325 1.45 . . . . 73.420000000000002 112.151 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -76.77 137.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.535 0.734 . . . . 62.32 109.888 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 tp -163.34 127.32 1.87 Allowed Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.303 -1.369 . . . . 74.299999999999997 107.303 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.28 146.08 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.565 2.176 . . . . 63.119999999999997 109.834 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mtp -81.91 69.18 8.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.336 -0.616 . . . . 71.439999999999998 109.336 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -76.02 75.77 2.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.058 0.943 . . . . 62.340000000000003 109.027 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.6 p -151.4 76.83 1.23 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.332 1.053 . . . . 73.299999999999997 109.315 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.5 78.28 0.23 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.414 -1.474 . . . . 41.140000000000001 109.414 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.16 76.08 15.73 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.788 1.235 . . . . 72.200000000000003 109.536 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.8 170.17 20.27 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.029 2.486 . . . . 54.530000000000001 110.552 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.46 167.38 40.52 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.081 -1.207 . . . . 73.400000000000006 110.081 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 174.92 -177.21 47.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.349 -1.1 . . . . 61.539999999999999 110.349 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.88 167.9 40.28 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.289 -1.124 . . . . 71.129999999999995 110.289 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.3 p -162.65 168.29 21.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.371 1.068 . . . . 71.439999999999998 109.248 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -158.33 163.29 37.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.279 1.032 . . . . 73.25 109.22 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -164.95 174.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.605 1.162 . . . . 71.219999999999999 109.001 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -147.89 116.52 6.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.33 -1.359 . . . . 65.409999999999997 107.33 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -69.71 162.68 27.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.059 0.457 . . . . 74.329999999999998 111.368 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -64.9 -41.87 95.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.524 0.729 . . . . 52.450000000000003 110.167 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.804 -1.57 . . . . 70.129999999999995 110.745 176.603 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 117.905 -1.045 . . . . 71.310000000000002 112.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.54 -41.66 6.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.084 1.856 . . . . 65.129999999999995 111.684 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.5 64.22 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.959 1.304 . . . . 75.420000000000002 110.586 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.86 125.14 28.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.381 -0.97 . . . . 71.310000000000002 108.381 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -155.6 139.44 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.657 0.783 . . . . 74.409999999999997 109.877 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -154.48 154.44 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.077 1.351 . . . . 55.119999999999997 108.664 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -133.71 143.01 48.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.589 1.156 . . . . 73.549999999999997 109.432 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.7 m -153.68 151.68 29.95 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.555 1.142 . . . . 74.019999999999996 108.759 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.28 77.29 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.773 -1.731 . . . . 71.530000000000001 108.773 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -116.14 124.9 51.47 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.228 1.011 . . . . 75.409999999999997 109.792 -167.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.5 175.15 44.49 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.424 -1.07 . . . . 71.510000000000005 110.424 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.95 155.15 14.69 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.317 -1.113 . . . . 74.329999999999998 110.317 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.16 164.16 28.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 54.439999999999998 109.063 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -155.32 160.64 40.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.095 0.958 . . . . 75.409999999999997 110.245 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -164.39 167.16 19.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.296 1.438 . . . . 75.349999999999994 108.738 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.87 -7.16 0.38 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.125 1.157 . . . . 74.209999999999994 114.125 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 65.8 -105.67 1.32 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.418 -1.073 . . . . 44.439999999999998 110.418 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.71 67.75 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.882 0.753 . . . . 54.310000000000002 111.295 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.49 173.32 16.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.723 0.809 . . . . 60.530000000000001 110.5 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -71.44 144.97 49.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.213 0.605 . . . . 74.030000000000001 109.82 173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -128.69 137.56 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.459 -1.311 . . . . 74.030000000000001 107.459 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -71.44 78.09 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.079 0.951 . . . . 73.219999999999999 109.323 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.31 -25.97 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.051 -0.86 . . . . 72.019999999999996 112.314 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.5 148.01 96.9 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 118.564 1.182 . . . . 70.219999999999999 111.035 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.17 171.25 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.225 2.617 . . . . 54.439999999999998 110.904 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.47 71.74 3.45 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.609 1.164 . . . . 75.230000000000004 110.648 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.23 -164.67 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.053 2.502 . . . . 52.219999999999999 109.754 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.77 -6.56 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.234 1.014 . . . . 74.109999999999999 113.61 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -35.06 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 121.499 -0.75 . . . . 64.319999999999993 110.761 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.06 -35.64 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.852 0.861 . . . . 63.530000000000001 110.76 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -63.09 1.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.04 0.936 . . . . 65.209999999999994 108.89 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -28.65 69.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.148 -0.453 . . . . 72.129999999999995 111.81 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -44.3 96.18 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.868 0.758 . . . . 71.140000000000001 111.23 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.0 -49.22 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.548 0.613 . . . . 72.519999999999996 109.788 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.56 -63.02 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.229 1.012 . . . . 74.209999999999994 110.007 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.29 -48.99 77.48 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.891 1.676 . . . . 73.409999999999997 111.895 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.22 -45.55 90.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.285 0.634 . . . . 65.209999999999994 110.542 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.76 91.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.177 0.444 . . . . 73.299999999999997 111.524 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -58.7 -29.25 66.51 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.02 1.328 . . . . 74.349999999999994 112.561 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.86 -23.96 63.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.632 0.651 . . . . 74.530000000000001 111.928 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.35 69.04 1.21 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.002 -1.639 . . . . 71.109999999999999 109.002 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.91 141.7 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.375 1.07 . . . . 71.209999999999994 109.143 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -86.28 152.63 55.66 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 74.239999999999995 108.69 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -55.51 -40.24 86.56 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.225 2.617 . . . . 75.040000000000006 111.979 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -67.03 -27.77 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.339 0.656 . . . . 74.109999999999999 112.751 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.8 -32.79 21.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.137 0.975 . . . . 63.219999999999999 112.124 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.6 mt -50.12 -41.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 C-N-CA 123.546 0.738 . . . . 63.530000000000001 111.025 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -38.18 -56.26 1.21 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.082 1.753 . . . . 51.439999999999998 112.98 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -15.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.853 1.057 . . . . 61.240000000000002 113.853 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -67.87 -47.0 70.12 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.562 1.074 . . . . 75.109999999999999 110.4 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.67 -15.24 25.5 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.012 1.325 . . . . 72.010000000000005 111.214 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.83 71.17 0.53 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.586 1.954 . . . . 71.409999999999997 110.627 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.5 t -114.67 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.545 1.138 . . . . 63.009999999999998 109.471 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -150.25 -112.18 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.884 0.874 . . . . 75.439999999999998 110.336 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -162.53 -59.58 0.04 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.668 0.787 . . . . 75.019999999999996 110.186 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.44 58.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.549 -0.62 . . . . 50.119999999999997 111.549 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 60.2 m -63.5 -44.14 95.22 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.595 0.758 . . . . 74.109999999999999 110.011 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.05 -46.83 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.056 1.342 . . . . 72.310000000000002 110.513 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -61.31 -35.49 77.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.689 0.796 . . . . 71.430000000000007 111.47 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -75.6 -49.21 19.2 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.932 -0.556 . . . . 52.25 111.914 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -60.53 -29.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.097 0.862 . . . . 71.230000000000004 111.864 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.14 -73.49 0.16 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.956 -0.757 . . . . 73.140000000000001 108.956 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.55 99.35 1.15 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.573 -1.411 . . . . 61.140000000000001 109.573 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -43.43 64.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.124 0.57 . . . . 64.409999999999997 110.073 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 55.51 41.24 31.01 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.899 1.279 . . . . 73.530000000000001 110.097 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -157.23 -63.58 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.836 1.655 . . . . 72.310000000000002 108.265 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 55.06 34.59 22.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.518 1.127 . . . . 73.420000000000002 111.876 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -82.75 68.53 9.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.134 1.374 . . . . 74.319999999999993 108.998 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.32 -157.6 13.59 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.604 -1.399 . . . . 53.450000000000003 109.604 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 m -81.34 47.24 1.01 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.728 0.811 . . . . 65.549999999999997 111.739 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -143.77 40.12 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.781 1.232 . . . . 74.150000000000006 109.734 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -156.58 70.85 4.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.175 -0.676 . . . . 72.230000000000004 109.175 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.97 94.51 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.253 2.636 . . . . 71.409999999999997 110.448 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.65 73.18 0.07 OUTLIER Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.771 -1.332 . . . . 63.240000000000002 109.771 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -84.26 56.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.284 1.034 . . . . 73.219999999999999 109.61 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.7 mm -77.32 136.54 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.402 1.081 . . . . 63.130000000000003 109.588 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.93 -115.09 1.17 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.164 -1.174 . . . . 63.119999999999997 110.164 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.93 -166.07 36.57 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.293 -1.123 . . . . 64.319999999999993 110.293 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.1 p -157.21 171.06 21.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.268 1.027 . . . . 51.549999999999997 109.575 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -145.8 71.52 13.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.949 0.899 . . . . 74.200000000000003 109.362 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.26 169.78 17.0 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.503 2.802 . . . . 71.519999999999996 111.572 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -143.35 111.42 6.12 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.596 1.559 . . . . 71.010000000000005 107.483 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.89 138.75 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.965 1.306 . . . . 45.229999999999997 108.248 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.95 152.6 41.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.628 0.771 . . . . 73.519999999999996 111.057 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p -75.03 152.06 86.36 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.666 0.786 . . . . 64.010000000000005 109.059 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.3 -29.73 38.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.123 2.549 . . . . 71.129999999999995 112.255 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -56.45 -27.28 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.248 1.019 . . . . 74.420000000000002 113.086 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 m -52.34 -34.47 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 112.081 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -70.7 -40.83 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.714 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -59.5 -34.35 72.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.059 0.944 . . . . 63.130000000000003 111.433 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -46.48 -59.25 3.09 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.59 1.156 . . . . 63.229999999999997 111.303 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mp -42.18 -55.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 124.932 1.293 . . . . 60.539999999999999 110.514 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.75 -53.81 16.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.378 0.99 . . . . 65.430000000000007 111.706 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -59.17 -58.08 10.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.123 0.569 . . . . 63.520000000000003 111.519 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.56 -32.38 73.83 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.858 0.688 . . . . 75.340000000000003 112.858 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -65.21 -47.57 76.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.896 0.771 . . . . 74.439999999999998 110.61 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.75 -47.56 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.837 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.43 -38.91 88.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.802 0.841 . . . . 34.100000000000001 111.009 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -73.34 160.52 82.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.209 1.004 . . . . 64.230000000000004 109.458 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.51 -83.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.7 2.267 . . . . 70.420000000000002 110.879 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.7 p -137.45 49.69 1.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 75.120000000000005 109.826 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.97 174.31 10.44 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.275 0.63 . . . . 44.530000000000001 111.655 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 125.101 1.36 . . . . 74.140000000000001 109.934 -169.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -36.53 -46.11 0.55 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.427 2.291 . . . . 53.310000000000002 114.334 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -49.14 -53.1 22.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.741 1.216 . . . . 74.400000000000006 111.843 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.38 -38.69 71.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.852 -0.594 . . . . 70.439999999999998 110.73 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.45 -35.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.533 0.606 . . . . 62.43 112.073 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -49.11 -57.36 6.77 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.873 0.469 . . . . 74.319999999999993 110.218 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -70.06 -29.91 67.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.301 1.041 . . . . 53.109999999999999 111.925 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -57.46 -44.33 84.74 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.772 0.829 . . . . 75.349999999999994 110.757 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.77 -42.8 94.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.1 0.96 . . . . 74.109999999999999 111.39 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.5 -49.49 71.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 109.833 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.618 1.167 . . . . 55.409999999999997 111.855 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.8 -38.47 89.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.626 0.771 . . . . 62.340000000000003 110.114 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.29 54.41 1.47 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.421 -1.472 . . . . 73.010000000000005 109.421 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.57 -55.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 125.147 1.379 . . . . 73.409999999999997 108.912 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.44 166.0 11.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.254 1.022 . . . . 71.239999999999995 110.262 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.72 161.24 13.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.619 1.568 . . . . 74.510000000000005 107.971 165.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -54.29 -25.19 22.31 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.924 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.31 -55.11 4.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.462 0.705 . . . . 72.019999999999996 109.618 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -72.26 -23.48 61.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.173 0.805 . . . . 74.120000000000005 113.173 -165.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -47.53 131.94 10.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.414 1.485 . . . . 75.209999999999994 111.165 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.77 162.04 43.25 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.042 2.494 . . . . 71.340000000000003 111.765 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 m -57.32 130.77 47.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.256 1.422 . . . . 61.350000000000001 111.554 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.16 -49.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 125.623 1.569 . . . . 63.149999999999999 109.992 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.7 p -58.79 -37.78 77.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.471 0.708 . . . . 53.310000000000002 111.617 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 t -73.9 -44.01 56.64 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 119.06 -0.495 . . . . 64.120000000000005 110.557 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.4 pt -69.12 -32.85 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.946 0.339 . . . . 63.329999999999998 111.708 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.52 -56.94 13.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.351 0.66 . . . . 54.5 111.299 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -62.28 -13.48 28.84 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.479 1.289 . . . . 75.299999999999997 114.479 -172.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.25 -47.01 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.056 0.844 . . . . 72.329999999999998 109.916 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.07 -32.44 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.813 1.245 . . . . 60.409999999999997 111.921 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -53.97 -45.05 71.26 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.058 0.543 . . . . 73.109999999999999 111.998 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 43.8 p -67.11 -26.06 66.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.33 -0.367 . . . . 71.209999999999994 111.66 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -67.9 0.71 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.45 -0.574 . . . . 71.299999999999997 109.45 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -168.61 105.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.463 1.105 . . . . 74.030000000000001 109.609 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -108.59 58.12 0.61 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.47 1.108 . . . . 43.219999999999999 109.565 166.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -122.48 75.31 43.96 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.178 0.991 . . . . 55.119999999999997 110.101 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.621 2.214 . . . . 75.329999999999998 109.798 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.32 134.03 43.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.066 0.946 . . . . 74.519999999999996 110.145 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -155.74 152.71 28.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.533 1.133 . . . . 63.119999999999997 109.004 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 tt -151.16 108.82 3.01 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.743 -1.577 . . . . 62.439999999999998 106.743 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.59 84.9 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.105 2.537 . . . . 65.140000000000001 110.22 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.75 140.55 58.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.921 0.889 . . . . 75.510000000000005 110.301 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -149.43 158.87 44.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.662 1.185 . . . . 73.409999999999997 109.21 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -158.69 144.19 16.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.262 1.025 . . . . 70.430000000000007 109.005 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.97 68.39 0.07 OUTLIER Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.716 -1.354 . . . . 63.340000000000003 109.716 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.51 69.85 81.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.436 1.094 . . . . 64.200000000000003 109.837 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.04 173.33 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.269 2.646 . . . . 75.239999999999995 110.677 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.34 164.18 35.88 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.248 -1.141 . . . . 62.340000000000003 110.248 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.93 41.0 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.341 -1.104 . . . . 72.209999999999994 110.341 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.92 166.18 34.01 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.202 -1.159 . . . . 73.340000000000003 110.202 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.7 m -144.71 137.67 26.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.46 1.104 . . . . 71.219999999999999 108.831 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -148.7 129.08 13.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.949 -1.13 . . . . 73.450000000000003 107.949 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -166.1 115.4 0.96 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.489 -0.93 . . . . 74.349999999999994 108.489 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.48 148.25 32.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.529 1.131 . . . . 74.310000000000002 108.862 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.25 166.65 32.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.646 1.178 . . . . 53.350000000000001 108.792 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -152.55 165.68 34.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.395 1.078 . . . . 74.519999999999996 109.237 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.174 -1.393 . . . . 62.130000000000003 109.963 175.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.584 -0.246 . . . . 72.129999999999995 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.71 73.31 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.427 2.751 . . . . 63.43 110.179 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -64.96 143.96 57.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.592 0.757 . . . . 75.349999999999994 110.58 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -129.64 162.6 27.94 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 109.575 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.6 t -69.01 -46.75 67.21 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.555 0.742 . . . . 71.430000000000007 110.882 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mt 61.27 72.83 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.41 1.484 . . . . 73.120000000000005 109.626 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.74 161.64 38.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.988 1.315 . . . . 74.329999999999998 109.079 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -160.72 -171.7 3.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.831 0.852 . . . . 74.510000000000005 109.999 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.4 -176.42 48.82 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.619 1.104 . . . . 54.219999999999999 112.187 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -155.72 158.49 38.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.573 1.149 . . . . 61.130000000000003 109.637 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.01 156.18 26.65 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.932 -1.667 . . . . 73.140000000000001 108.932 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 67.67 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.878 -1.289 . . . . 53.240000000000002 109.878 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.48 121.42 15.77 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.006 0.922 . . . . 61.43 109.568 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -151.88 166.22 32.12 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.895 0.878 . . . . 72.530000000000001 110.576 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -157.18 161.22 39.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.276 1.43 . . . . 71.349999999999994 108.807 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.52 107.45 2.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.994 0.518 . . . . 51.140000000000001 109.623 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.42 137.49 4.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.422 -0.671 . . . . 74.230000000000004 111.422 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.82 159.8 20.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.625 -0.99 . . . . 74.420000000000002 110.625 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.99 41.12 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.413 0.685 . . . . 74.420000000000002 110.918 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.6 t80 77.55 -29.99 0.17 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.907 1.683 . . . . 75.439999999999998 113.164 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 22' ' ' ASN . 13.0 p -109.81 -177.61 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 127.424 2.289 . . . . 33.420000000000002 107.81 172.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 21' ' ' VAL . 19.2 t-20 60.39 76.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.424 1.09 . . . . 71.129999999999995 110.638 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.66 -52.79 2.67 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.14 -1.184 . . . . 54.43 110.14 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.68 121.86 64.11 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.991 -1.114 . . . . 74.209999999999994 107.991 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.84 141.88 21.96 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.059 2.506 . . . . 64.25 111.427 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 26' ' ' LEU . 1.8 mm? -86.88 -45.99 0.53 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 117.471 -1.252 . . . . 74.010000000000005 112.03 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -89.37 176.29 3.09 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.718 2.279 . . . . 73.150000000000006 111.422 -171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 15.17 -71.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 131.005 3.722 . . . . 71.230000000000004 116.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.11 -19.92 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.105 1.362 . . . . 61.229999999999997 113.456 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.03 -35.88 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.386 1.474 . . . . 74.329999999999998 111.749 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.1 ttp85 -39.84 -51.17 2.43 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.142 1.777 . . . . 64.239999999999995 111.961 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.67 -41.96 82.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.457 0.703 . . . . 62.520000000000003 111.325 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -65.93 -46.1 79.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.303 -0.379 . . . . 74.329999999999998 110.673 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -60.88 -48.21 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.148 0.431 . . . . 75.150000000000006 110.838 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.16 -56.35 15.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.285 1.034 . . . . 71.230000000000004 109.991 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.03 -51.26 66.84 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.669 1.187 . . . . 72.420000000000002 111.236 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.27 -54.14 48.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.162 0.985 . . . . 45.32 110.361 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.59 89.12 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.119 0.414 . . . . 71.319999999999993 112.119 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.97 -24.83 68.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.14 1.376 . . . . 71.150000000000006 112.614 -174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.98 -26.14 65.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.013 0.824 . . . . 64.310000000000002 111.367 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 72.31 1.26 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 108.772 -1.731 . . . . 53.5 108.772 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.3 149.8 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.051 0.941 . . . . 62.520000000000003 110.503 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -78.1 146.14 70.71 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.218 1.007 . . . . 74.329999999999998 109.451 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.02 -32.99 84.18 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.998 . . . . 75.340000000000003 110.682 171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.06 -27.77 69.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.984 0.913 . . . . 55.039999999999999 112.108 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.14 -37.5 20.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.279 0.632 . . . . 31.210000000000001 110.933 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -37.16 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.541 0.61 . . . . 65.340000000000003 109.68 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -54.36 -39.29 66.99 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.076 0.55 . . . . 61.240000000000002 111.516 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -67.7 -52.95 31.7 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 110.066 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -51.39 -49.79 60.88 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.807 0.843 . . . . 74.099999999999994 112.149 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.81 -8.47 59.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.911 0.884 . . . . 75.549999999999997 111.263 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 47.91 62.93 2.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.909 2.083 . . . . 72.430000000000007 112.219 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 m -133.52 -178.9 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.439 1.896 . . . . 52.520000000000003 109.26 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -69.88 -84.51 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.424 1.09 . . . . 63.210000000000001 111.309 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -177.91 -38.44 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.725 2.01 . . . . 75.019999999999996 109.43 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.9 -35.17 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.407 -0.677 . . . . 64.450000000000003 111.407 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.82 -42.71 97.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.207 0.603 . . . . 61.409999999999997 110.109 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.26 -44.09 97.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 122.889 0.475 . . . . 64.439999999999998 110.243 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 t -55.1 -41.21 71.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.901 0.48 . . . . 65.310000000000002 111.19 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.39 -35.17 68.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.707 0.803 . . . . 73.420000000000002 112.291 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.05 -42.92 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.27 0.628 . . . . 71.510000000000005 110.447 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.02 -52.51 62.63 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.419 -0.585 . . . . 75.099999999999994 109.419 170.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.93 58.78 5.03 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.378 0.99 . . . . 71.319999999999993 111.221 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -80.65 -57.34 3.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.182 0.993 . . . . 63.140000000000001 111.359 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -165.09 132.93 3.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.631 -1.618 . . . . 75.219999999999999 106.631 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.3 t80 71.23 -49.18 0.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.859 2.064 . . . . 71.150000000000006 111.845 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 69.79 11.71 7.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.802 1.641 . . . . 74.519999999999996 113.44 159.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 p -145.61 -177.89 5.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.146 1.379 . . . . 73.129999999999995 109.433 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 -87.53 0.58 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.296 0.95 . . . . 72.120000000000005 111.747 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 m -141.4 50.77 1.58 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.195 0.998 . . . . 73.040000000000006 110.273 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.75 31.92 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.992 -1.114 . . . . 62.140000000000001 107.992 166.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -155.23 156.03 30.63 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.274 1.83 . . . . 75.209999999999994 107.479 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.49 79.27 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.169 2.58 . . . . 65.420000000000002 109.99 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.79 144.93 5.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.032 -1.227 . . . . 51.009999999999998 110.032 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.7 p -165.52 129.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.261 1.424 . . . . 75.420000000000002 107.459 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.68 135.43 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.523 -0.917 . . . . 75.099999999999994 108.523 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.31 84.16 0.11 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.181 -1.167 . . . . 73.219999999999999 110.181 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.4 153.98 23.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.458 -1.057 . . . . 73.209999999999994 110.458 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -162.88 166.66 23.74 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.838 1.255 . . . . 75.349999999999994 108.924 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -150.24 86.18 5.25 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.21 0.604 . . . . 75.200000000000003 109.619 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.64 166.3 25.77 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.202 2.602 . . . . 74.510000000000005 110.892 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -160.42 116.44 2.35 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.348 1.059 . . . . 74.25 108.548 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.73 147.93 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.236 1.415 . . . . 71.450000000000003 108.859 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.33 127.12 32.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.517 0.727 . . . . 74.349999999999994 109.631 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.3 p -82.64 143.44 47.2 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 122.875 0.47 . . . . 62.030000000000001 110.436 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.68 -27.09 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.499 2.799 . . . . 74.120000000000005 112.12 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -49.1 -41.91 37.26 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.258 1.023 . . . . 71.430000000000007 112.676 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.59 -46.86 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.332 1.053 . . . . 74.049999999999997 110.153 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.28 -38.85 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 110.796 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.89 -34.05 72.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.129 0.572 . . . . 61.020000000000003 111.997 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -63.48 -39.4 94.35 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.05 0.759 . . . . 62.119999999999997 113.05 -168.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 128' ' ' ILE . 3.1 mp -38.63 -55.14 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.688 1.195 . . . . 72.549999999999997 110.586 165.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.61 -62.59 4.68 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.157 -0.777 . . . . 63.119999999999997 111.157 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -51.89 -50.26 61.4 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.385 1.074 . . . . 70.209999999999994 112.603 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -69.46 -34.42 74.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.226 -0.416 . . . . 74.450000000000003 110.986 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -67.2 -40.34 86.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.204 0.456 . . . . 73.129999999999995 110.953 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -62.81 -45.32 93.16 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.658 0.783 . . . . 75.319999999999993 110.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -66.94 -54.52 21.19 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.922 0.889 . . . . 63.030000000000001 110.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -118.23 87.42 29.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.791 1.636 . . . . 74.519999999999996 108.874 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.19 -44.31 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.771 2.314 . . . . 63.140000000000001 110.564 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 p -46.24 -46.94 18.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.367 1.867 . . . . 51.539999999999999 113.172 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 95.3 mmm -77.18 174.96 10.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.952 0.882 . . . . 71.299999999999997 112.045 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.55 -175.76 5.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.223 1.409 . . . . 55.229999999999997 111.457 -168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.28 79.61 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.54 1.136 . . . . 63.420000000000002 112.022 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -63.87 -31.9 73.24 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.706 0.684 . . . . 72.25 111.429 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -57.86 -38.22 75.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.479 0.712 . . . . 74.150000000000006 111.018 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.96 -45.71 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.114 0.966 . . . . 73.420000000000002 110.419 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.74 -49.81 75.98 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.631 0.372 . . . . 71.549999999999997 110.442 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.4 -41.79 98.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 74.510000000000005 111.149 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -57.87 -38.94 76.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 112.341 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.47 -46.93 73.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.317 0.508 . . . . 74.030000000000001 110.949 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.14 -37.05 64.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.814 0.845 . . . . 62.439999999999998 111.247 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.34 86.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.572 0.749 . . . . 74.439999999999998 110.831 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -74.38 -27.29 60.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.468 0.707 . . . . 64.120000000000005 110.955 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.82 58.22 2.41 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.384 -1.086 . . . . 63.409999999999997 110.384 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.52 -44.79 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.717 1.207 . . . . 44.329999999999998 110.894 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.8 t -152.44 162.25 41.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.506 1.122 . . . . 73.219999999999999 108.373 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.0 154.79 40.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.738 0.815 . . . . 70.340000000000003 112.715 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -38.45 -50.33 1.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.843 2.457 . . . . 73.430000000000007 114.937 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.81 -51.28 6.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.659 0.784 . . . . 63.119999999999997 109.912 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.8 p -54.35 -36.09 63.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.096 1.758 . . . . 74.439999999999998 113.979 -166.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 m -44.92 143.75 2.17 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.853 0.861 . . . . 75.329999999999998 111.709 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.68 146.07 91.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.089 2.526 . . . . 71.439999999999998 111.582 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 76.2 p -61.96 155.31 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.377 1.071 . . . . 63.009999999999998 111.937 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.47 -39.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.162 0.585 . . . . 75.400000000000006 109.822 170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.2 m -60.01 -47.93 83.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.949 0.899 . . . . 74.120000000000005 110.773 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t -59.82 -68.11 0.32 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 92' ' ' ILE . 1.7 pt -51.67 -40.43 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.944 0.898 . . . . 54.109999999999999 112.235 -173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -56.78 -61.45 2.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.349 0.66 . . . . 45.219999999999999 110.915 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -55.62 -37.65 68.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.649 1.179 . . . . 71.219999999999999 112.357 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mm -57.8 -43.41 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.619 0.645 . . . . 73.310000000000002 109.413 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.7 mt -80.52 -26.94 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.935 0.894 . . . . 70.129999999999995 111.132 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -58.16 -33.89 69.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.871 1.214 . . . . 73.239999999999995 111.649 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.4 p -62.29 -29.8 70.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.48 0.582 . . . . 74.420000000000002 111.369 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -112.21 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.446 -1.316 . . . . 51.100000000000001 107.446 167.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.3 t -145.36 71.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 64.540000000000006 109.437 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -80.53 115.99 20.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.489 -0.93 . . . . 74.409999999999997 108.489 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -124.99 119.62 25.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.429 1.091 . . . . 73.049999999999997 108.086 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 129.28 11.63 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.282 1.988 . . . . 64.239999999999995 109.316 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -74.59 98.46 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.869 0.868 . . . . 74.230000000000004 110.497 -169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -141.29 139.12 33.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.202 1.401 . . . . 63.329999999999998 107.393 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.6 tp -153.02 76.53 6.46 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.193 -1.04 . . . . 73.219999999999999 108.193 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.36 66.35 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.641 2.894 . . . . 54.119999999999997 109.42 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.9 mtp -136.39 133.37 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.047 1.339 . . . . 61.509999999999998 108.863 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.17 159.4 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.827 1.251 . . . . 73.510000000000005 109.324 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -159.02 147.93 18.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.536 1.134 . . . . 73.25 108.949 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.5 70.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.113 -1.195 . . . . 55.520000000000003 110.113 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.68 71.41 80.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.41 1.084 . . . . 71.209999999999994 110.116 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.94 171.95 17.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.348 2.699 . . . . 64.219999999999999 110.705 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.94 161.43 31.77 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.682 -0.967 . . . . 73.340000000000003 110.682 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.57 179.38 40.8 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.425 -1.07 . . . . 62.420000000000002 110.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 178.05 176.56 46.12 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.469 -1.052 . . . . 54.030000000000001 110.469 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.3 m -147.4 157.52 43.61 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.658 1.183 . . . . 64.200000000000003 109.947 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -163.21 173.43 13.4 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.74 1.216 . . . . 62.0 109.519 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -158.28 177.95 10.71 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.618 1.167 . . . . 74.150000000000006 109.273 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -158.73 153.85 25.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.868 0.867 . . . . 75.25 109.61 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -155.55 155.94 34.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.757 1.223 . . . . 55.539999999999999 108.916 173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.11 -127.18 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.81 0.844 . . . . 72.510000000000005 108.959 172.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.988 -1.482 . . . . 71.530000000000001 110.906 168.313 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 119.342 -0.361 . . . . 64.109999999999999 110.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 134.82 21.63 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.679 2.253 . . . . 73.219999999999999 110.173 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.78 166.66 23.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.614 1.165 . . . . 73.340000000000003 109.095 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.15 168.35 25.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.125 0.97 . . . . 75.140000000000001 109.651 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 m -150.49 141.85 23.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.16 0.984 . . . . 73.120000000000005 108.703 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.92 139.12 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.285 1.034 . . . . 74.120000000000005 108.487 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -135.07 154.1 51.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.093 1.357 . . . . 75.430000000000007 108.356 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.7 m -143.69 152.5 41.4 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.727 1.211 . . . . 65.230000000000004 109.217 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 169.16 40.66 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.754 -0.938 . . . . 52.450000000000003 110.754 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -165.05 167.24 18.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.947 1.299 . . . . 72.540000000000006 109.099 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.89 -173.02 45.32 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.47 -1.052 . . . . 71.430000000000007 110.47 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.64 168.27 40.56 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.102 -1.199 . . . . 74.409999999999997 110.102 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -137.44 160.82 38.04 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.755 1.222 . . . . 52.299999999999997 109.571 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -157.88 147.06 19.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.009 1.324 . . . . 70.230000000000004 108.418 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -137.58 140.54 41.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.472 1.109 . . . . 74.120000000000005 108.77 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.98 148.27 22.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.249 1.02 . . . . 65.5 108.923 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.71 176.38 47.91 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.236 -1.145 . . . . 71.230000000000004 110.236 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.38 64.84 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.48 -1.048 . . . . 70.040000000000006 110.48 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 140.73 18.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.139 0.975 . . . . 64.099999999999994 108.631 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.3 t80 55.5 64.13 1.86 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.09 0.956 . . . . 64.219999999999999 109.425 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.02 -54.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.934 1.294 . . . . 70.549999999999997 109.199 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -121.42 143.8 49.03 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.902 1.281 . . . . 53.229999999999997 109.388 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.89 -58.65 4.53 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.907 0.765 . . . . 74.310000000000002 111.976 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -52.06 151.66 6.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.976 1.711 . . . . 73.010000000000005 111.97 -174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.27 83.53 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.734 2.956 . . . . 74.150000000000006 110.543 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.18 167.82 25.26 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.615 1.166 . . . . 74.340000000000003 109.965 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 -152.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.707 2.938 . . . . 64.340000000000003 110.26 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -49.35 -29.99 6.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.58 1.552 . . . . 64.25 114.369 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.9 -24.78 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.933 0.893 . . . . 61.130000000000003 112.538 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -47.25 -41.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 C-N-CA 124.159 0.984 . . . . 71.219999999999999 111.254 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -47.48 -49.64 25.19 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.199 1.0 . . . . 71.340000000000003 110.999 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -64.35 -33.44 75.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.349 0.659 . . . . 74.140000000000001 111.291 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -65.16 -38.81 91.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.373 0.533 . . . . 73.299999999999997 110.605 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 mm -63.74 -46.35 94.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 109.297 -0.631 . . . . 65.230000000000004 109.297 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.8 -55.73 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.155 0.982 . . . . 63.329999999999998 109.939 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.29 -50.0 65.81 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 71.340000000000003 112.059 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.99 -45.09 75.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.485 0.714 . . . . 73.25 111.452 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.84 76.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.503 0.321 . . . . 75.129999999999995 110.394 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -56.55 -49.88 73.54 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.967 1.307 . . . . 62.509999999999998 112.496 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.47 -18.26 65.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.21 84.22 1.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.449 -1.06 . . . . 70.120000000000005 110.449 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.99 114.16 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.013 0.925 . . . . 73.299999999999997 108.686 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -65.35 158.93 70.3 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.964 0.905 . . . . 73.109999999999999 109.692 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -54.26 -37.42 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.417 2.078 . . . . 70.430000000000007 111.406 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.1 m -57.25 -43.55 83.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.429 1.091 . . . . 65.329999999999998 111.503 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.18 -35.71 76.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.254 0.622 . . . . 74.340000000000003 111.124 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.03 -51.32 74.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.039 0.836 . . . . 72.209999999999994 109.05 171.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 m -48.86 -51.41 29.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.22 0.608 . . . . 72.200000000000003 112.002 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.58 -50.4 52.02 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.703 -0.665 . . . . 72.530000000000001 111.707 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.6 -34.01 76.14 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.459 1.027 . . . . 64.209999999999994 113.053 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.68 -13.36 29.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.469 1.108 . . . . 73.239999999999995 111.311 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 61.54 63.67 1.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.464 1.506 . . . . 75.120000000000005 110.573 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.91 176.04 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.566 1.547 . . . . 71.140000000000001 109.457 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 m -85.2 -74.61 0.39 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 72.239999999999995 110.996 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -175.86 -38.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.908 1.283 . . . . 75.310000000000002 110.841 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.62 92.99 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.345 -0.702 . . . . 63.109999999999999 111.345 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.9 m -65.49 -43.76 89.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.767 0.827 . . . . 74.329999999999998 110.443 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.44 -54.36 15.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.346 1.058 . . . . 51.509999999999998 110.541 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -50.63 -48.3 58.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.071 0.948 . . . . 64.5 111.842 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.81 -51.88 55.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.029 0.932 . . . . 72.5 111.799 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.05 -44.83 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.059 0.391 . . . . 64.140000000000001 111.187 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.14 -53.58 42.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.538 1.135 . . . . 64.230000000000004 110.335 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.02 89.95 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.049 -0.82 . . . . 42.350000000000001 111.049 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -49.79 66.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.737 -0.838 . . . . 72.400000000000006 108.737 164.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 71.05 -3.93 1.91 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.582 1.953 . . . . 71.510000000000005 112.738 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -156.95 55.37 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.705 1.202 . . . . 73.5 108.877 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 153.87 42.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.536 0.734 . . . . 72.329999999999998 109.212 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 p -73.74 72.8 1.52 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.342 1.057 . . . . 54.539999999999999 110.463 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.95 -137.96 5.22 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.452 -1.059 . . . . 40.450000000000003 110.452 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.41 41.57 0.63 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.064 0.946 . . . . 65.329999999999998 113.405 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.69 50.91 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.735 -1.579 . . . . 71.409999999999997 106.735 160.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -142.43 72.14 21.23 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 64.420000000000002 108.068 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 143.08 44.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.939 2.426 . . . . 73.239999999999995 110.907 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.05 -154.27 10.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.91 1.243 . . . . 50.329999999999998 110.845 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 -156.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.673 1.589 . . . . 71.010000000000005 107.664 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.43 -54.06 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 109.595 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.33 73.4 1.27 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.316 -1.113 . . . . 54.109999999999999 110.316 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.29 -175.62 53.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.774 0.702 . . . . 64.340000000000003 112.441 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.3 p -161.93 164.28 28.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.911 1.284 . . . . 54.140000000000001 109.397 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -131.82 76.34 74.36 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.381 1.072 . . . . 72.439999999999998 109.13 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.29 -42.48 3.85 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.994 2.462 . . . . 65.150000000000006 111.108 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? 58.09 53.11 6.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.737 1.215 . . . . 73.319999999999993 109.965 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.47 146.98 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.587 0.755 . . . . 65.430000000000007 110.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.76 172.98 13.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.128 0.971 . . . . 71.019999999999996 110.887 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -157.74 143.54 12.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.418 1.087 . . . . 72.040000000000006 108.663 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.66 -14.49 44.97 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.324 2.683 . . . . 74.310000000000002 112.624 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -56.48 -36.57 69.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.479 0.581 . . . . 75.109999999999999 111.14 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.18 -47.01 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.059 0.944 . . . . 71.439999999999998 110.413 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.73 -43.85 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.146 0.579 . . . . 70.540000000000006 110.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -60.73 -26.74 67.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.611 . . . . 64.400000000000006 112.651 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.51 -30.09 71.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.961 0.8 . . . . 74.319999999999993 112.703 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 92' ' ' ILE . 4.2 mp -64.26 -41.14 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.349 0.977 . . . . 52.32 109.48 172.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.79 -52.01 41.36 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.931 -0.867 . . . . 63.039999999999999 110.931 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.97 -43.87 94.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.498 0.719 . . . . 71.129999999999995 111.582 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -68.17 -25.95 65.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.283 -0.865 . . . . 73.5 112.869 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -13.98 62.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.333 0.969 . . . . 63.149999999999999 112.215 168.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -89.82 -52.77 4.82 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.691 0.797 . . . . 75.120000000000005 109.56 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.05 -58.43 7.29 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.979 0.912 . . . . 73.519999999999996 110.067 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -86.73 159.28 52.54 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 107.296 -1.372 . . . . 72.549999999999997 107.296 167.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.32 -176.15 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.093 1.862 . . . . 71.329999999999998 111.23 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -40.21 -67.24 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.745 2.018 . . . . 65.219999999999999 113.133 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 68.9 mtp 50.16 -177.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.949 2.5 . . . . 75.120000000000005 116.258 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -104.24 150.07 24.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.834 1.653 . . . . 73.230000000000004 110.8 -170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.72 -30.96 46.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.205 1.402 . . . . 70.319999999999993 113.26 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -67.11 -41.42 86.24 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.828 0.74 . . . . 73.409999999999997 111.405 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.67 -43.18 99.45 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.625 0.648 . . . . 73.420000000000002 109.428 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.58 -31.55 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 119.195 -0.431 . . . . 71.340000000000003 111.713 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -51.29 68.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.828 0.74 . . . . 73.120000000000005 109.707 172.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -59.83 -42.35 93.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.834 0.453 . . . . 74.129999999999995 110.577 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -55.51 -48.81 74.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.497 1.119 . . . . 74.5 111.471 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -57.6 -53.33 59.34 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.546 1.138 . . . . 72.120000000000005 111.267 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.56 -43.0 77.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.353 0.261 . . . . 73.109999999999999 110.887 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.22 85.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.631 1.173 . . . . 71.030000000000001 111.565 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -36.78 75.66 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.999 -0.371 . . . . 75.409999999999997 109.999 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.69 2.56 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.283 -1.127 . . . . 74.120000000000005 110.283 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.82 -53.0 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.114 0.965 . . . . 75.400000000000006 109.671 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 10.9 t -156.07 136.72 13.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.772 -1.196 . . . . 53.030000000000001 107.772 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.37 163.34 20.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.353 1.061 . . . . 70.140000000000001 112.894 -165.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -34.97 -51.73 0.53 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 128.167 2.587 . . . . 74.010000000000005 114.511 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.89 -42.39 9.53 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.048 0.939 . . . . 73.519999999999996 110.658 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.4 p -65.72 -28.92 69.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.118 0.967 . . . . 73.099999999999994 112.722 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.27 135.61 60.23 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.71 1.204 . . . . 53.539999999999999 110.419 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.98 164.95 29.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.272 2.648 . . . . 71.230000000000004 111.836 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.2 m -55.97 145.83 24.11 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.704 1.202 . . . . 64.219999999999999 113.216 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.17 -44.25 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.744 1.217 . . . . 61.530000000000001 109.535 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.1 m -54.96 -36.4 65.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.649 1.18 . . . . 65.209999999999994 112.133 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -73.0 -59.14 2.85 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.033 -0.508 . . . . 75.439999999999998 109.677 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.2 pt -50.74 -37.53 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 112.149 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -62.47 -56.04 21.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.281 0.632 . . . . 71.510000000000005 111.146 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -15.71 61.18 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.96 1.467 . . . . 71.230000000000004 114.96 -171.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.01 -39.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 120.285 1.402 . . . . 52.329999999999998 110.865 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.5 mm -46.85 -33.07 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.966 1.706 . . . . 51.140000000000001 112.689 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -49.84 -42.23 46.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.37 0.668 . . . . 73.120000000000005 112.126 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.5 p -63.05 -27.8 69.65 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.984 0.365 . . . . 61.109999999999999 111.984 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -85.11 -40.87 16.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.721 0.808 . . . . 44.32 110.511 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.32 96.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.751 0.82 . . . . 73.030000000000001 109.833 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -141.21 167.16 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.717 1.207 . . . . 72.420000000000002 109.799 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 39.89 65.16 3.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.452 1.901 . . . . 74.150000000000006 112.568 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.57 128.11 17.56 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.576 2.184 . . . . 72.040000000000006 110.828 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.38 67.96 6.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.379 1.072 . . . . 75.239999999999995 110.024 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -69.71 138.39 52.84 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.529 0.732 . . . . 54.229999999999997 109.863 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.4 tp -158.82 100.13 1.64 Allowed Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.851 0.86 . . . . 65.540000000000006 108.688 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 76.39 4.39 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.138 2.559 . . . . 73.219999999999999 109.44 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.5 tpt -79.02 75.61 5.53 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.213 1.005 . . . . 72.120000000000005 110.056 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.37 117.09 5.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.712 0.805 . . . . 72.310000000000002 109.513 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.6 p -166.06 146.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.982 0.913 . . . . 64.010000000000005 109.222 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.2 66.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.608 -1.397 . . . . 43.030000000000001 109.608 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -128.28 75.45 78.99 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.547 1.139 . . . . 71.019999999999996 109.898 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.12 159.7 37.05 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.104 2.536 . . . . 74.200000000000003 110.871 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.58 176.71 40.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.563 -1.015 . . . . 73.409999999999997 110.563 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.14 117.65 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.917 -0.873 . . . . 65.0 110.917 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.53 160.86 29.54 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.519 -1.032 . . . . 21.52 110.519 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.6 t -161.2 158.56 27.56 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.527 1.131 . . . . 71.409999999999997 108.986 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -164.2 153.27 13.6 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.457 1.103 . . . . 54.43 109.27 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -169.44 158.43 7.94 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.744 1.218 . . . . 74.25 109.312 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -164.54 154.14 13.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.677 1.191 . . . . 64.230000000000004 108.762 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.88 153.87 37.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.171 0.988 . . . . 70.319999999999993 109.1 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -155.76 164.93 37.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.057 1.343 . . . . 70.450000000000003 108.92 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.384 -1.293 . . . . 73.019999999999996 108.878 169.612 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 118.992 -0.528 . . . . 53.520000000000003 110.365 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.2 124.46 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.054 2.503 . . . . 73.409999999999997 110.064 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -157.15 150.86 24.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.124 0.97 . . . . 55.43 109.047 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.42 71.43 0.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.44 . . . . 73.420000000000002 110.776 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -144.53 55.6 1.27 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.595 0.758 . . . . 72.340000000000003 109.835 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.5 mp -83.13 74.94 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.464 -1.68 . . . . 51.100000000000001 106.464 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -110.99 65.13 0.61 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.732 1.213 . . . . 74.019999999999996 108.111 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 p -158.98 80.45 0.78 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.987 0.915 . . . . 62.299999999999997 109.387 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.01 122.82 0.99 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.834 -1.306 . . . . 74.040000000000006 109.834 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -162.09 157.08 22.87 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.659 1.184 . . . . 70.209999999999994 108.748 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.11 172.2 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.104 -1.199 . . . . 54.130000000000003 110.104 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 55.38 0.05 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.962 -1.255 . . . . 71.340000000000003 109.962 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -81.79 65.31 6.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 75.450000000000003 109.673 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -141.26 76.81 1.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.885 1.274 . . . . 71.340000000000003 108.494 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -79.65 -46.73 16.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.203 1.001 . . . . 73.310000000000002 111.239 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 64.16 -172.8 0.17 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.235 1.414 . . . . 72.319999999999993 110.252 -165.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.22 -179.94 48.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.006 -1.238 . . . . 34.210000000000001 110.006 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.71 65.19 0.14 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.838 -1.305 . . . . 61.310000000000002 109.838 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.38 -177.87 6.86 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.602 1.161 . . . . 75.420000000000002 109.154 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.7 t80 60.38 59.83 2.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.521 1.128 . . . . 73.319999999999993 110.885 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.53 142.82 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.792 1.237 . . . . 53.399999999999999 108.018 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.16 71.14 2.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.634 0.774 . . . . 54.530000000000001 110.26 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.67 43.12 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.885 1.231 . . . . 71.129999999999995 110.422 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -147.77 154.85 44.51 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.717 1.607 . . . . 65.140000000000001 108.067 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.86 103.58 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.104 2.536 . . . . 71.310000000000002 109.753 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -126.69 149.76 69.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 125.437 1.495 . . . . 71.319999999999993 108.603 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.04 -168.45 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.455 2.77 . . . . 74.140000000000001 111.318 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -48.16 -27.49 2.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.255 1.822 . . . . 52.240000000000002 114.401 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -47.8 -32.29 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.59 1.156 . . . . 71.420000000000002 112.583 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -51.21 -40.41 22.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.49 1.116 . . . . 73.540000000000006 111.959 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -58.67 -37.08 75.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.01 0.368 . . . . 75.209999999999994 111.121 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.5 -24.49 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.853 0.861 . . . . 64.150000000000006 111.769 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -68.72 -43.46 75.91 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.005 -0.739 . . . . 54.049999999999997 109.005 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -57.74 -43.72 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.045 -0.979 . . . . 73.420000000000002 111.098 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.54 -57.73 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.201 0.91 . . . . 74.230000000000004 110.962 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -49.88 -60.53 2.83 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 111.806 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp -66.2 -43.98 85.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.299 -0.382 . . . . 72.209999999999994 110.889 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.84 -39.28 68.41 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.943 0.897 . . . . 71.299999999999997 111.932 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -68.36 -10.32 54.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.997 1.11 . . . . 73.299999999999997 113.997 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -71.95 -26.14 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.572 1.078 . . . . 70.340000000000003 111.152 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.19 79.36 1.39 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.029 -1.628 . . . . 70.319999999999993 109.029 -173.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.68 154.8 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.499 1.12 . . . . 71.510000000000005 110.454 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -119.03 152.43 51.88 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.336 1.854 . . . . 74.239999999999995 108.373 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -56.08 -36.1 95.77 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.625 2.883 . . . . 62.340000000000003 113.584 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.83 -36.67 72.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.38 0.672 . . . . 61.409999999999997 111.656 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.07 -30.68 23.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.307 1.043 . . . . 70.239999999999995 111.906 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.1 mt -51.3 -48.56 32.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 109.048 -0.723 . . . . 64.219999999999999 109.048 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 m -49.92 -49.77 48.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 112.517 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ptp85 -77.36 -44.7 28.47 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.324 0.511 . . . . 72.439999999999998 112.005 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -61.41 -48.53 80.77 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.801 0.728 . . . . 72.200000000000003 111.342 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.64 -3.42 56.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.303 0.641 . . . . 74.439999999999998 110.493 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 47.07 64.95 1.37 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.654 1.981 . . . . 63.340000000000003 112.134 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.21 161.55 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 126.167 1.787 . . . . 73.310000000000002 109.285 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -66.32 0.88 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.577 -0.897 . . . . 50.439999999999998 108.577 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -146.41 54.27 1.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.001 . . . . 65.439999999999998 110.151 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.47 -83.07 1.71 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.915 -1.274 . . . . 60.25 109.915 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.33 -19.55 47.45 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.893 1.277 . . . . 30.52 112.432 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -48.59 -26.43 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 73.329999999999998 112.263 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.2 t -49.05 -22.23 0.86 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.21 1.404 . . . . 74.239999999999995 113.729 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -53.76 -22.09 8.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.535 1.134 . . . . 72.340000000000003 112.956 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mt -43.62 -39.82 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.178 1.391 . . . . 73.219999999999999 111.762 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.7 -64.05 0.86 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.047 1.739 . . . . 74.540000000000006 111.728 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.43 -40.05 49.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.664 -0.574 . . . . 62.450000000000003 111.664 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -18.12 64.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.495 0.647 . . . . 71.109999999999999 112.716 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -53.58 -53.03 57.6 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 118.962 0.801 . . . . 62.229999999999997 110.057 166.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.02 -35.51 23.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.446 1.099 . . . . 71.340000000000003 110.842 -166.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 59.39 33.81 22.51 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.098 1.759 . . . . 74.510000000000005 111.954 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.2 p -84.53 -179.14 7.08 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 75.129999999999995 110.219 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.92 -93.44 0.27 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.058 -1.217 . . . . 74.019999999999996 110.058 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -150.8 32.77 0.61 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.546 0.738 . . . . 73.409999999999997 111.048 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.96 61.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 108.324 -0.991 . . . . 73.319999999999993 108.324 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -148.86 78.21 9.03 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 108.174 -1.047 . . . . 75.530000000000001 108.174 -174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.87 75.74 4.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.384 2.723 . . . . 73.319999999999993 109.636 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.91 71.25 0.04 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.964 -1.255 . . . . 65.349999999999994 109.964 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.05 49.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.698 1.199 . . . . 61.039999999999999 109.385 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.64 133.82 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.361 -0.978 . . . . 75.129999999999995 108.361 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.28 -171.1 38.98 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.603 -0.999 . . . . 64.530000000000001 110.603 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.93 -163.34 29.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.108 -1.197 . . . . 62.310000000000002 110.108 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.9 m -155.95 145.76 21.21 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.47 1.108 . . . . 55.420000000000002 109.059 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.13 153.58 95.87 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.847 0.859 . . . . 73.340000000000003 109.763 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.98 -26.87 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.795 2.997 . . . . 74.120000000000005 112.785 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 63.61 69.16 0.56 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.517 1.527 . . . . 74.019999999999996 108.885 -171.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.66 145.26 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.391 0.676 . . . . 64.010000000000005 110.535 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.06 150.51 48.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.627 0.771 . . . . 72.439999999999998 110.827 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 t -160.14 144.55 10.78 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.954 0.902 . . . . 65.319999999999993 109.054 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.81 -15.3 46.83 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.818 2.346 . . . . 74.239999999999995 112.15 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -58.96 -20.92 56.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.669 0.788 . . . . 71.209999999999994 112.876 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.63 -39.34 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.27 0.628 . . . . 70.140000000000001 110.939 170.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.66 -47.42 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.748 0.819 . . . . 63.149999999999999 110.806 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.75 -30.26 71.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.516 0.726 . . . . 62.539999999999999 111.335 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -69.8 -37.72 76.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.472 -0.775 . . . . 65.409999999999997 111.695 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.9 -43.81 89.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 108.233 -1.025 . . . . 75.319999999999993 108.233 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.1 -59.55 5.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.553 1.073 . . . . 55.439999999999998 111.983 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -67.42 -43.83 80.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.751 0.775 . . . . 73.129999999999995 112.709 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -59.06 -40.04 83.93 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.701 0.682 . . . . 74.319999999999993 111.071 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -68.78 -45.75 70.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.855 0.752 . . . . 64.420000000000002 111.722 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -53.11 -53.9 43.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 111.103 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -69.16 -38.52 78.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.998 0.519 . . . . 65.450000000000003 111.248 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -125.66 88.48 54.15 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.942 1.297 . . . . 60.539999999999999 109.309 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.82 -24.8 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.475 2.783 . . . . 72.409999999999997 113.034 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.0 p -68.23 -40.82 81.94 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.342 0.519 . . . . 63.130000000000003 110.969 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 72.4 mtp -62.86 119.42 9.35 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 121.129 0.49 . . . . 52.229999999999997 109.963 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -84.08 177.8 8.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.987 1.315 . . . . 64.040000000000006 110.406 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.91 -59.15 2.1 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.035 1.334 . . . . 50.539999999999999 113.396 -174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.34 -37.91 82.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.186 0.995 . . . . 63.039999999999999 112.139 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -65.37 -48.03 74.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.319 0.647 . . . . 75.109999999999999 109.453 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.87 -41.25 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.268 1.027 . . . . 73.409999999999997 111.22 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -53.11 -51.5 61.69 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.932 0.893 . . . . 70.150000000000006 109.484 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.64 -31.12 72.19 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.045 0.938 . . . . 73.140000000000001 112.402 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -41.22 72.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.376 1.07 . . . . 73.239999999999995 110.889 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.09 -37.98 87.12 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.649 0.78 . . . . 52.409999999999997 111.832 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.24 -43.64 81.43 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.286 -0.635 . . . . 71.510000000000005 109.286 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.26 87.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.626 1.17 . . . . 74.129999999999995 111.61 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -67.5 -35.66 79.56 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.276 0.631 . . . . 62.350000000000001 110.187 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.04 43.72 5.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.026 -1.23 . . . . 72.319999999999993 110.026 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.25 -45.61 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.979 1.312 . . . . 73.230000000000004 109.776 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.6 p -150.82 176.16 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.226 1.011 . . . . 63.109999999999999 110.223 -173.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.87 155.43 16.75 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.319 1.447 . . . . 74.129999999999995 110.614 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.53 -30.78 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.124 2.17 . . . . 61.229999999999997 114.812 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -95.51 -44.02 7.71 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.909 0.777 . . . . 72.510000000000005 110.24 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.4 p -62.31 -34.9 77.5 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.883 0.873 . . . . 75.200000000000003 112.324 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.95 134.39 38.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.429 1.092 . . . . 62.030000000000001 109.617 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.93 157.01 61.49 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.016 2.477 . . . . 74.420000000000002 112.664 -169.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.6 m -54.37 136.52 43.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.836 1.655 . . . . 64.129999999999995 112.831 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 t -53.7 -42.86 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.381 1.473 . . . . 74.530000000000001 110.404 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 p -62.96 -37.06 85.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.303 0.641 . . . . 72.120000000000005 111.692 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.6 t -69.62 -62.58 1.33 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.407 -0.59 . . . . 72.319999999999993 109.407 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -51.49 -39.83 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.415 0.686 . . . . 71.430000000000007 111.773 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.71 -54.25 49.05 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.301 0.501 . . . . 71.099999999999994 110.399 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -57.04 -36.67 70.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.578 -0.725 . . . . 63.020000000000003 112.038 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.12 -62.16 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.189 0.904 . . . . 74.310000000000002 108.812 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.22 -35.85 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.576 1.55 . . . . 65.319999999999993 112.198 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -74.43 -60.33 2.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.396 0.544 . . . . 74.129999999999995 109.544 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.1 p -115.16 96.34 5.63 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.645 1.578 . . . . 74.150000000000006 106.872 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -51.48 -46.54 63.19 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.796 0.838 . . . . 55.219999999999999 111.994 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -84.74 55.68 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.937 0.895 . . . . 63.149999999999999 110.479 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.68 120.57 21.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.358 -0.979 . . . . 52.299999999999997 108.358 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -133.21 149.07 71.59 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.218 1.407 . . . . 64.329999999999998 108.321 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.79 147.63 85.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.022 2.482 . . . . 75.430000000000007 110.91 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -64.95 128.48 35.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.598 0.759 . . . . 73.129999999999995 109.966 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -155.23 158.99 39.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.832 0.853 . . . . 72.519999999999996 109.804 -172.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 tp 59.98 70.18 1.09 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.813 1.645 . . . . 74.239999999999995 111.184 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.43 171.03 18.33 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.234 2.623 . . . . 71.129999999999995 110.177 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -149.48 87.81 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.585 -0.894 . . . . 70.25 108.585 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.05 110.35 1.78 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 62.210000000000001 109.247 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.6 p -163.36 144.92 9.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.974 0.909 . . . . 52.439999999999998 109.209 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.25 111.41 0.3 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.849 -1.3 . . . . 72.049999999999997 109.849 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.8 68.27 18.89 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.807 0.843 . . . . 34.109999999999999 110.146 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.98 177.21 9.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.5 2.8 . . . . 60.5 110.856 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.19 65.11 2.25 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.969 -0.852 . . . . 74.329999999999998 110.969 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.67 74.1 0.45 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.614 -1.394 . . . . 51.450000000000003 109.614 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.37 144.79 9.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.423 -1.071 . . . . 74.430000000000007 110.423 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.9 t -157.88 120.31 3.79 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.511 -1.292 . . . . 72.209999999999994 107.511 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -146.03 97.42 2.95 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.006 0.922 . . . . 73.219999999999999 108.577 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -141.53 156.44 45.72 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.406 1.083 . . . . 72.439999999999998 109.432 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -155.76 -57.5 0.09 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.288 0.635 . . . . 64.430000000000007 110.425 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 71.0 151.33 0.1 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.099 1.76 . . . . 75.030000000000001 110.925 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -66.8 104.06 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.54 -0.541 . . . . 65.439999999999998 109.54 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.35 -1.31 . . . . 75.530000000000001 109.192 176.494 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 119.413 -0.327 . . . . 72.409999999999997 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.7 147.71 40.48 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.011 2.474 . . . . 72.049999999999997 110.798 -175.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -167.02 167.18 14.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.153 1.381 . . . . 75.299999999999997 108.668 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -158.58 147.97 19.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.946 0.898 . . . . 65.310000000000002 109.075 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.5 p -131.02 56.17 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.404 1.082 . . . . 72.530000000000001 109.527 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.9 mm -83.61 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.752 -0.833 . . . . 65.340000000000003 108.752 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 116.93 21.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.56 1.544 . . . . 75.099999999999994 106.856 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -148.71 130.24 14.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.917 0.887 . . . . 70.409999999999997 110.003 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.65 164.73 53.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.265 -1.134 . . . . 71.430000000000007 110.265 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -167.89 158.71 10.91 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.283 0.633 . . . . 74.129999999999995 110.166 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.57 -166.47 34.3 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.048 -1.221 . . . . 75.150000000000006 110.048 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.78 68.79 0.25 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.254 -1.138 . . . . 43.219999999999999 110.254 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.21 74.84 4.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.569 1.148 . . . . 73.239999999999995 109.549 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.5 164.96 22.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.196 1.398 . . . . 75.310000000000002 110.968 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.28 159.85 41.27 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.592 1.157 . . . . 71.219999999999999 109.968 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.6 tp -70.5 127.69 33.57 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.371 1.068 . . . . 74.450000000000003 110.93 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 117.29 4.46 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.939 -1.664 . . . . 54.509999999999998 108.939 168.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.31 64.69 3.46 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.974 0.797 . . . . 75.230000000000004 111.841 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.67 -168.02 2.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.96 1.304 . . . . 71.430000000000007 110.664 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.9 t80 67.03 98.53 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.943 1.697 . . . . 72.450000000000003 111.265 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.5 t 56.93 54.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.054 1.342 . . . . 72.420000000000002 109.262 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -153.31 90.62 1.44 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.61 -1.626 . . . . 72.319999999999993 106.61 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.41 -48.6 3.99 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.527 0.584 . . . . 51.32 111.748 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -45.9 -50.74 33.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.078 1.351 . . . . 52.520000000000003 114.372 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.48 77.91 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.816 1.677 . . . . 71.239999999999995 110.502 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -146.88 -63.5 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.855 -1.069 . . . . 73.310000000000002 110.048 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.137 1.891 . . . . 55.340000000000003 110.63 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -34.49 -45.81 0.25 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.179 2.591 . . . . 75.5 114.89 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.18 -18.41 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 72.010000000000005 113.781 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.94 -40.62 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.735 1.214 . . . . 65.0 111.479 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -49.75 -54.64 17.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.03 1.332 . . . . 71.329999999999998 110.888 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -78.7 -24.29 45.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.668 1.187 . . . . 62.030000000000001 112.035 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -42.72 92.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.921 0.782 . . . . 74.400000000000006 110.865 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mt -54.5 -51.17 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.36 -0.607 . . . . 73.430000000000007 109.36 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.42 -58.56 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 73.019999999999996 110.431 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.45 -47.47 76.0 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 125.524 1.53 . . . . 63.210000000000001 111.7 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.88 -58.33 7.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.157 -0.449 . . . . 74.349999999999994 109.86 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.73 63.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 54.310000000000002 112.289 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -51.82 -40.89 61.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.996 1.318 . . . . 73.510000000000005 112.988 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.91 -18.9 65.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.043 0.838 . . . . 74.400000000000006 112.461 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.68 75.14 0.79 Allowed Glycine 0 C--N 1.342 0.885 0 C-N-CA 125.393 1.473 . . . . 75.209999999999994 109.698 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.98 110.32 17.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.701 0.8 . . . . 63.109999999999999 110.126 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.55 158.97 80.76 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.112 0.965 . . . . 75.349999999999994 109.268 168.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -52.91 -45.93 37.42 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.983 2.456 . . . . 73.450000000000003 112.274 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -60.18 -35.93 76.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.311 0.644 . . . . 54.5 111.832 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.26 -29.43 61.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.162 0.585 . . . . 75.340000000000003 111.286 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.57 -58.01 8.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.021 -1.103 . . . . 71.329999999999998 108.021 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -57.45 -38.67 74.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.853 0.686 . . . . 72.340000000000003 112.853 -167.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -63.78 -40.6 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.115 -0.469 . . . . 73.140000000000001 111.877 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.52 -45.67 91.93 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.514 0.597 . . . . 74.209999999999994 111.515 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.28 -26.24 42.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.081 0.552 . . . . 65.040000000000006 110.295 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 76.69 65.03 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.768 2.427 . . . . 72.349999999999994 109.297 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.68 -20.54 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 73.409999999999997 112.271 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 t 73.52 -64.15 0.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.315 1.846 . . . . 45.130000000000003 110.851 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -167.02 -8.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.729 1.011 . . . . 72.420000000000002 113.729 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -42.42 -59.11 3.2 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.2 1.381 . . . . 44.020000000000003 114.577 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.2 m -73.91 -40.08 63.41 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.892 0.477 . . . . 64.200000000000003 110.419 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.9 -39.55 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 64.239999999999995 111.143 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -48.46 -54.42 14.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.603 1.161 . . . . 44.549999999999997 111.896 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.82 -50.37 57.15 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.215 1.006 . . . . 75.329999999999998 110.47 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.38 -50.62 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.16 0.984 . . . . 72.519999999999996 110.775 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.17 -29.02 67.79 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.006 -0.521 . . . . 74.340000000000003 111.033 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.62 52.05 4.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.519 -0.633 . . . . 44.0 111.519 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -8.4 53.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.547 1.139 . . . . 73.140000000000001 112.831 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -69.47 -31.95 70.56 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.667 1.587 . . . . 74.150000000000006 110.142 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.1 -15.08 62.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.819 0.848 . . . . 65.109999999999999 111.559 171.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 59.95 57.43 3.07 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.508 1.523 . . . . 75.329999999999998 109.753 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.9 p -57.63 -42.23 82.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.939 1.295 . . . . 62.310000000000002 111.825 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.53 -92.12 0.39 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 72.140000000000001 110.402 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 p -164.17 52.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.536 1.134 . . . . 35.32 108.265 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 mt -90.95 53.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.439 0.696 . . . . 64.150000000000006 109.766 -163.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -144.32 68.22 15.22 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 125.079 1.351 . . . . 71.439999999999998 108.866 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.65 77.7 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.44 2.76 . . . . 72.219999999999999 110.372 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.36 152.52 6.29 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.161 -0.776 . . . . 54.219999999999999 111.161 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -159.5 118.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.097 1.359 . . . . 74.409999999999997 108.453 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.75 135.95 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.603 1.161 . . . . 73.340000000000003 108.803 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.68 -166.3 38.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.982 -0.847 . . . . 71.140000000000001 110.982 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.34 1.47 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.007 0.813 . . . . 54.049999999999997 111.735 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.7 p -79.28 164.38 24.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.423 0.689 . . . . 60.119999999999997 110.601 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -152.65 76.21 6.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.691 0.796 . . . . 65.439999999999998 109.173 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.35 164.97 31.73 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.337 2.691 . . . . 72.530000000000001 111.348 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -159.26 99.91 1.5 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.079 0.952 . . . . 72.150000000000006 108.837 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -92.69 139.24 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.899 0.88 . . . . 75.030000000000001 109.363 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.97 163.02 32.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.43 1.492 . . . . 62.109999999999999 108.4 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -161.7 141.48 7.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.066 0.546 . . . . 73.409999999999997 109.932 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.72 -11.82 26.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.272 2.648 . . . . 75.439999999999998 112.298 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -57.52 -24.08 53.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.766 0.826 . . . . 73.109999999999999 112.209 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.49 -49.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.885 1.274 . . . . 64.019999999999996 110.468 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.88 -45.5 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.041 0.536 . . . . 54.0 109.834 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.44 12.25 2.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.105 0.78 . . . . 72.329999999999998 113.105 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.96 -57.54 5.35 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.018 -1.475 . . . . 74.450000000000003 107.018 161.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.13 -39.79 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.459 1.104 . . . . 55.340000000000003 110.092 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.52 -78.05 0.12 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.791 -0.924 . . . . 73.25 110.791 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -49.25 -37.61 23.96 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.811 1.245 . . . . 73.310000000000002 113.483 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -49.85 -62.05 1.78 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.294 0.637 . . . . 72.400000000000006 110.973 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -76.86 -34.16 57.83 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 112.066 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.19 -52.95 62.53 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 110.117 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -76.66 -52.37 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.779 0.432 . . . . 70.519999999999996 110.171 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -117.35 82.07 14.45 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.207 1.403 . . . . 62.130000000000003 110.034 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.27 -35.5 13.96 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.799 2.332 . . . . 74.409999999999997 111.185 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.2 p -64.02 -58.3 7.11 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.413 1.485 . . . . 44.140000000000001 111.947 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 66.5 mmm -70.59 175.64 4.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.08 0.952 . . . . 72.519999999999996 112.011 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -104.82 160.82 14.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.172 0.989 . . . . 72.450000000000003 111.747 -163.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.88 -48.46 64.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.596 1.158 . . . . 75.25 111.478 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -47.71 -57.32 5.69 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.222 1.409 . . . . 72.400000000000006 111.08 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -62.79 -50.41 71.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.048 1.339 . . . . 75.030000000000001 110.719 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.7 mt -78.36 -18.0 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.073 0.549 . . . . 60.240000000000002 111.821 -167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -33.79 62.97 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.165 -0.96 . . . . 62.530000000000001 110.956 166.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.92 -1.3 19.09 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.253 0.834 . . . . 62.439999999999998 113.253 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -49.05 -47.71 44.55 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.868 0.867 . . . . 74.409999999999997 109.531 166.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.2 mt -57.04 -47.13 81.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.677 0.791 . . . . 62.520000000000003 110.727 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.72 -44.14 74.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.814 0.445 . . . . 60.109999999999999 110.772 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.13 75.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.158 0.983 . . . . 43.32 111.358 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -70.5 -29.67 66.24 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.551 0.74 . . . . 63.520000000000003 111.368 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.23 56.62 2.13 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.409 -1.077 . . . . 73.129999999999995 110.409 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.2 -46.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.67 1.588 . . . . 62.32 109.518 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.0 p -143.28 176.88 8.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.052 0.941 . . . . 70.340000000000003 110.69 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.39 163.94 18.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.834 1.254 . . . . 55.240000000000002 110.647 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -58.39 -23.81 58.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.653 1.181 . . . . 64.099999999999994 113.081 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -93.36 -47.25 6.98 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.55 1.14 . . . . 65.510000000000005 109.724 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.5 p -74.1 -17.89 60.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.739 1.216 . . . . 73.340000000000003 112.604 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.55 136.18 9.85 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.153 1.381 . . . . 62.200000000000003 110.853 168.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.96 170.21 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.106 2.537 . . . . 73.010000000000005 111.892 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 m -63.79 140.01 58.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.628 1.171 . . . . 72.549999999999997 110.842 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.81 -40.71 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.012 -0.736 . . . . 63.420000000000002 109.012 167.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -52.92 -39.92 63.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.418 1.087 . . . . 71.450000000000003 112.315 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -69.05 -64.49 0.86 Allowed 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.132 -0.692 . . . . 72.040000000000006 109.132 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 pt -50.01 -40.12 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.643 1.177 . . . . 72.109999999999999 111.791 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -58.0 -53.86 53.43 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.856 0.863 . . . . 65.519999999999996 110.703 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -57.0 -37.8 72.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.101 -0.476 . . . . 75.129999999999995 111.719 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.81 -50.5 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.795 0.725 . . . . 70.120000000000005 109.172 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.09 -41.61 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.599 1.16 . . . . 73.329999999999998 110.996 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -53.99 -51.28 64.44 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.127 0.876 . . . . 74.209999999999994 112.441 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.5 p -60.87 -28.5 68.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.136 0.426 . . . . 71.400000000000006 112.093 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -73.74 -62.05 1.63 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.7 -0.482 . . . . 72.400000000000006 109.7 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.4 p -165.08 103.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.489 1.115 . . . . 64.209999999999994 109.814 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.89 69.68 0.69 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.098 0.959 . . . . 62.039999999999999 109.154 161.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -121.15 68.2 17.71 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.435 1.094 . . . . 53.409999999999997 110.186 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.53 153.5 49.64 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.951 2.434 . . . . 71.519999999999996 110.165 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.25 150.52 22.46 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.086 0.954 . . . . 74.230000000000004 110.268 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -157.07 155.19 30.73 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.531 1.133 . . . . 70.040000000000006 108.528 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.5 tp -148.39 89.41 5.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.843 -1.169 . . . . 73.439999999999998 107.843 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.63 147.72 32.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.856 2.371 . . . . 72.099999999999994 110.065 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.8 ptp -163.28 168.57 20.38 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.854 0.861 . . . . 71.340000000000003 110.294 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -147.2 162.85 38.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.062 1.345 . . . . 64.129999999999995 109.069 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -80.97 67.54 6.92 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.316 1.046 . . . . 50.240000000000002 109.903 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.86 68.83 3.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.057 -1.217 . . . . 50.200000000000003 110.057 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.9 79.43 64.52 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.051 1.341 . . . . 43.439999999999998 110.026 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.9 171.34 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.301 2.668 . . . . 73.150000000000006 110.966 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.96 168.05 40.47 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.001 -0.84 . . . . 32.310000000000002 111.001 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.92 -178.75 47.35 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.426 -1.069 . . . . 61.420000000000002 110.426 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.38 166.32 36.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.369 -0.693 . . . . 64.030000000000001 111.369 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 p -161.89 139.73 8.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 41.039999999999999 109.21 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -78.65 116.41 19.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.75 0.82 . . . . 75.319999999999993 109.808 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -103.12 132.44 49.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.464 1.106 . . . . 54.299999999999997 109.231 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -172.37 175.19 3.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 71.209999999999994 109.567 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -150.8 156.57 41.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.214 1.006 . . . . 64.310000000000002 109.515 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -71.93 156.27 39.44 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.182 0.593 . . . . 73.239999999999995 110.816 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 116.885 -1.531 . . . . 74.510000000000005 109.711 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 119.041 -0.504 . . . . 75.209999999999994 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.76 159.76 49.89 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.048 2.499 . . . . 71.439999999999998 110.822 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -72.94 -45.6 57.17 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.676 0.79 . . . . 62.329999999999998 110.474 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 71.54 -179.73 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.754 1.622 . . . . 72.420000000000002 110.967 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 t -152.5 -43.16 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.988 0.915 . . . . 54.009999999999998 110.1 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm 56.09 72.58 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.508 1.523 . . . . 73.340000000000003 110.632 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -87.12 141.27 28.78 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.344 -0.614 . . . . 75.129999999999995 109.344 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -132.11 168.84 17.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.469 1.108 . . . . 42.439999999999998 110.531 -173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.86 -173.7 24.69 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.798 0.713 . . . . 44.210000000000001 111.684 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -134.53 -58.86 0.82 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.156 0.982 . . . . 72.120000000000005 109.649 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 169.18 176.78 39.44 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.827 -0.909 . . . . 44.43 110.827 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 140.67 5.96 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.023 -1.631 . . . . 74.420000000000002 109.023 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.17 163.36 28.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.627 1.171 . . . . 71.510000000000005 109.328 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -151.73 152.25 32.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.537 1.135 . . . . 65.549999999999997 109.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -154.98 164.59 38.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.837 1.255 . . . . 75.219999999999999 109.0 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.99 89.36 2.56 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.47 -1.307 . . . . 73.25 107.47 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.87 160.09 53.95 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.596 0.617 . . . . 55.240000000000002 111.59 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.06 -58.84 4.99 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.894 -0.882 . . . . 71.439999999999998 110.894 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.5 178.4 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.651 1.58 . . . . 73.340000000000003 112.121 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.16 71.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.951 1.301 . . . . 72.109999999999999 108.585 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -106.63 147.83 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.725 1.21 . . . . 65.430000000000007 110.586 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -65.33 102.3 0.66 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.291 1.036 . . . . 75.25 109.408 172.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.25 -46.02 0.96 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.753 -1.339 . . . . 73.319999999999993 109.753 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -62.0 142.21 95.35 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.924 1.29 . . . . 72.109999999999999 109.821 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.42 91.02 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.145 2.563 . . . . 64.140000000000001 110.03 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.0 139.89 85.6 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 122.999 0.52 . . . . 62.299999999999997 110.892 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.24 -153.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.298 3.332 . . . . 43.310000000000002 109.691 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -28.26 -53.58 0.1 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 127.985 2.514 . . . . 74.219999999999999 114.334 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 p -40.2 -35.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.053 2.141 . . . . 70.239999999999995 114.541 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -52.59 -36.6 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.563 0.745 . . . . 64.120000000000005 112.031 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -24.87 63.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.457 1.103 . . . . 73.150000000000006 113.083 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -32.22 8.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.945 1.298 . . . . 74.439999999999998 111.084 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -60.49 -47.45 86.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.683 0.674 . . . . 74.439999999999998 111.203 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.91 -34.16 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.267 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.05 -56.2 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 109.391 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.95 -46.99 84.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.139 0.975 . . . . 54.409999999999997 111.345 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -56.66 -54.93 40.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.16 0.984 . . . . 52.049999999999997 110.159 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.74 73.5 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.876 0.87 . . . . 65.510000000000005 111.224 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.37 -14.98 45.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.335 1.454 . . . . 73.030000000000001 113.413 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.51 -27.82 67.9 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.647 1.112 . . . . 75.030000000000001 110.915 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.8 54.77 0.39 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 125.287 1.422 . . . . 71.049999999999997 109.912 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.76 133.68 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.153 0.981 . . . . 53.149999999999999 108.605 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp-105 -66.6 151.09 96.87 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.697 0.799 . . . . 53.310000000000002 109.529 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.92 -32.99 85.05 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.434 2.089 . . . . 70.310000000000002 110.857 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.67 -48.74 80.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.366 0.666 . . . . 63.350000000000001 110.444 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.763 0.825 . . . . 71.329999999999998 112.089 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.1 mt -50.97 -34.42 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.318 0.963 . . . . 74.120000000000005 111.667 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -48.18 -38.97 19.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 112.732 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -32.16 70.2 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.268 0.627 . . . . 54.229999999999997 112.32 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.47 -41.86 98.6 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.638 0.654 . . . . 72.040000000000006 110.762 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.14 -23.94 37.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.871 0.868 . . . . 71.230000000000004 110.201 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 68.37 56.16 0.49 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.188 1.795 . . . . 74.310000000000002 109.809 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.54 165.35 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.978 0.911 . . . . 74.329999999999998 111.167 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 p -83.44 -83.47 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.585 1.154 . . . . 72.239999999999995 112.205 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -150.32 -48.74 0.13 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.476 1.11 . . . . 74.129999999999995 111.141 -168.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -47.38 91.09 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.375 -0.69 . . . . 72.040000000000006 111.375 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.0 m -67.28 -42.89 83.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.755 0.822 . . . . 72.549999999999997 110.568 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -44.68 -51.19 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 125.725 1.61 . . . . 62.240000000000002 111.02 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 t -45.06 -58.32 3.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.064 0.945 . . . . 55.219999999999999 111.233 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -71.59 -39.25 70.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.071 0.949 . . . . 71.340000000000003 113.441 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.1 pt -65.16 -40.27 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.816 1.189 . . . . 61.130000000000003 110.972 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.39 -37.99 87.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.26 0.482 . . . . 74.310000000000002 110.218 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 176.13 145.12 5.43 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.452 -1.059 . . . . 64.209999999999994 110.452 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -65.57 -33.41 75.85 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.143 -0.622 . . . . 73.340000000000003 110.154 172.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 72.2 -67.96 0.24 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.717 2.407 . . . . 74.420000000000002 109.668 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -95.75 84.04 3.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.354 -0.98 . . . . 75.239999999999995 108.354 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 55.92 -92.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.929 1.292 . . . . 73.310000000000002 113.294 156.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p 36.88 70.79 0.16 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 127.117 2.167 . . . . 53.539999999999999 112.266 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.82 -57.77 4.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.851 -0.9 . . . . 63.009999999999998 110.851 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -82.65 -168.58 2.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.066 0.947 . . . . 54.520000000000003 110.091 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mt 40.31 55.06 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.792 2.437 . . . . 74.25 111.264 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -142.45 70.96 21.42 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.274 1.03 . . . . 74.030000000000001 109.787 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.05 69.69 7.39 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.187 2.591 . . . . 73.299999999999997 108.579 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.08 94.05 0.18 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.646 -1.382 . . . . 52.43 109.646 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -151.77 -47.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.124 0.97 . . . . 75.530000000000001 110.814 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.57 128.85 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.712 -0.848 . . . . 74.510000000000005 108.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.71 62.86 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.13 -1.588 . . . . 43.329999999999998 109.13 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.81 156.78 53.4 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.413 -0.675 . . . . 72.400000000000006 111.413 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -63.32 144.22 57.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.651 0.78 . . . . 71.5 110.551 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.33 79.05 19.7 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.7 1.2 . . . . 74.120000000000005 108.534 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.52 176.59 9.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.305 2.67 . . . . 73.439999999999998 111.364 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.73 -150.23 0.41 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.087 1.355 . . . . 74.099999999999994 107.886 175.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.71 151.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.626 1.57 . . . . 52.140000000000001 109.354 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.82 43.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.414 0.686 . . . . 75.5 110.637 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 t -135.81 108.98 9.98 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.748 1.219 . . . . 75.409999999999997 108.295 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.93 -27.17 7.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.04 2.494 . . . . 73.439999999999998 112.403 -172.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -59.2 -21.2 59.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.881 0.873 . . . . 72.109999999999999 112.579 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.12 -32.61 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.192 0.997 . . . . 74.400000000000006 111.65 174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.1 t -53.33 -43.23 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 51.439999999999998 111.41 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -61.15 -26.4 67.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.424 0.689 . . . . 72.150000000000006 112.119 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 119.012 -0.518 . . . . 72.329999999999998 111.576 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.85 -41.93 92.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 N-CA-C 108.554 -0.906 . . . . 62.229999999999997 108.554 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.58 -50.63 30.17 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.803 0.716 . . . . 63.539999999999999 111.59 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -59.83 -51.75 68.4 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.846 0.823 . . . . 63.119999999999997 110.73 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -62.05 -31.2 71.59 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.591 -0.719 . . . . 64.439999999999998 112.61 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.526 1.057 . . . . 63.32 112.043 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -78.28 -45.7 22.11 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.595 0.634 . . . . 73.409999999999997 110.239 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -64.07 -56.97 11.13 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.864 0.866 . . . . 44.299999999999997 110.339 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -75.81 164.51 60.04 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.359 1.464 . . . . 75.200000000000003 109.517 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.59 -179.05 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.681 2.254 . . . . 62.149999999999999 110.79 163.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.5 p -75.84 67.86 2.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.814 1.246 . . . . 73.239999999999995 110.793 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 61.7 mmm -89.96 170.67 10.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.133 1.373 . . . . 63.030000000000001 111.004 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -69.59 159.62 33.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.783 1.233 . . . . 74.219999999999999 112.837 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.72 98.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.121 0.968 . . . . 65.219999999999999 111.294 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -69.03 -46.08 68.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.167 0.44 . . . . 74.519999999999996 110.956 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -51.68 -49.93 61.42 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 122.948 0.499 . . . . 74.299999999999997 110.584 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.02 -28.22 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.557 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.75 -55.56 30.87 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.568 -0.901 . . . . 75.349999999999994 108.568 167.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -10.58 33.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 112.835 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -42.31 88.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.239 0.927 . . . . 72.010000000000005 110.596 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.2 mt -55.63 -45.2 77.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.284 0.634 . . . . 65.239999999999995 111.566 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.36 -44.54 71.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.522 0.729 . . . . 62.100000000000001 110.361 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.427 1.091 . . . . 72.450000000000003 111.609 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.63 -44.07 82.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.964 1.306 . . . . 64.5 110.017 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.17 54.01 1.66 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.952 1.263 . . . . 52.229999999999997 109.953 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.71 -43.91 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 124.729 1.212 . . . . 75.010000000000005 110.573 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.3 p -148.89 173.46 13.29 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.643 0.777 . . . . 74.209999999999994 110.885 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.5 157.85 26.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.182 0.993 . . . . 74.25 111.332 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.46 -27.44 37.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.393 1.877 . . . . 75.439999999999998 113.466 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.15 -51.13 5.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.431 0.693 . . . . 74.219999999999999 109.687 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.0 p -65.13 -31.07 72.08 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.594 1.157 . . . . 70.140000000000001 112.352 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.39 135.4 24.31 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 124.92 1.288 . . . . 71.200000000000003 110.755 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.53 154.94 67.97 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.509 2.139 . . . . 64.340000000000003 111.264 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -70.85 148.58 47.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.261 1.024 . . . . 71.329999999999998 112.038 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.86 -42.35 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.054 1.342 . . . . 63.229999999999997 110.148 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.6 p -61.03 -43.46 98.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.486 0.714 . . . . 72.230000000000004 110.866 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.6 t -64.97 -59.64 3.94 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 119.123 -0.465 . . . . 75.420000000000002 110.266 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.7 pt -50.35 -43.71 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.695 0.798 . . . . 75.140000000000001 111.339 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.3 -48.67 74.75 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.391 0.676 . . . . 61.140000000000001 111.302 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.27 -35.58 62.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.519 1.128 . . . . 71.120000000000005 111.949 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.1 -52.29 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.122 -0.695 . . . . 65.010000000000005 109.122 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.1 mm -62.38 -30.66 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.951 0.9 . . . . 63.140000000000001 111.908 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -48.69 -46.69 40.77 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.279 0.945 . . . . 73.25 112.023 172.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.6 p -72.01 -19.71 61.82 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.089 -0.481 . . . . 52.229999999999997 112.061 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.98 -100.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.96 0.904 . . . . 64.319999999999993 108.933 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.1 t -149.47 95.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.328 1.451 . . . . 71.439999999999998 107.668 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -70.26 151.49 45.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.514 0.726 . . . . 71.409999999999997 110.677 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -131.33 77.25 74.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.566 1.546 . . . . 64.329999999999998 107.628 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.19 154.62 46.78 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.956 2.437 . . . . 62.32 110.915 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -83.25 60.0 5.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.575 1.15 . . . . 73.439999999999998 109.509 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.73 165.19 11.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.216 1.407 . . . . 61.140000000000001 110.629 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.14 150.0 36.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.119 1.368 . . . . 71.239999999999995 109.279 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.61 160.51 38.06 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.224 2.616 . . . . 71.420000000000002 110.626 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.1 mtt -141.72 160.77 39.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.03 1.332 . . . . 64.439999999999998 108.873 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.4 160.36 43.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.901 0.88 . . . . 72.409999999999997 110.75 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.9 m -148.08 46.17 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.413 1.085 . . . . 60.210000000000001 110.05 171.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.05 86.71 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.499 -1.04 . . . . 42.020000000000003 110.499 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.19 70.52 61.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.326 1.05 . . . . 63.130000000000003 111.529 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.1 169.04 22.87 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.472 2.781 . . . . 70.010000000000005 111.167 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.56 170.15 42.01 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.416 -1.073 . . . . 64.340000000000003 110.416 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.82 45.06 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.054 -0.818 . . . . 70.549999999999997 111.054 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.45 166.08 36.82 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.339 -1.105 . . . . 73.329999999999998 110.339 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.9 t -161.38 159.77 28.7 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.126 0.97 . . . . 71.120000000000005 109.681 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -152.33 153.42 33.62 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.189 . . . . 54.520000000000003 109.45 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -152.98 155.39 36.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.63 1.172 . . . . 72.200000000000003 109.134 173.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -159.45 169.24 24.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.212 1.405 . . . . 74.209999999999994 108.697 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -147.43 146.37 29.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.042 -1.095 . . . . 61.119999999999997 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -144.24 149.61 36.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.838 1.255 . . . . 71.040000000000006 108.557 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.319 -1.324 . . . . 72.439999999999998 109.018 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 118.758 -0.639 . . . . 74.230000000000004 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.9 130.62 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.549 2.166 . . . . 75.209999999999994 110.074 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -136.08 136.1 39.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.701 1.2 . . . . 64.140000000000001 108.61 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -166.86 155.58 10.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.148 0.979 . . . . 70.030000000000001 109.417 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -76.24 150.91 36.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.366 0.666 . . . . 60.109999999999999 110.034 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.65 141.77 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.814 1.245 . . . . 75.230000000000004 108.295 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -133.69 167.49 20.41 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.053 1.341 . . . . 75.319999999999993 109.374 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -65.99 152.32 44.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.504 0.722 . . . . 71.409999999999997 110.506 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.34 162.13 32.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.979 -1.248 . . . . 74.140000000000001 109.979 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -75.62 145.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.339 0.656 . . . . 65.109999999999999 110.353 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 72.6 2.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.943 -1.263 . . . . 40.509999999999998 109.943 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.82 48.66 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.719 1.152 . . . . 70.140000000000001 113.505 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -56.41 -42.22 77.64 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.392 1.077 . . . . 73.150000000000006 111.638 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -95.47 149.24 21.61 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.777 0.831 . . . . 62.030000000000001 110.529 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -167.26 159.43 12.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.181 1.392 . . . . 71.540000000000006 108.801 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 tp 70.32 -68.89 0.19 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.745 2.018 . . . . 64.219999999999999 112.49 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 -72.12 2.29 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 109.608 -1.397 . . . . 73.450000000000003 109.608 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 70.63 0.98 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.202 0.906 . . . . 72.310000000000002 111.381 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.17 43.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.811 0.844 . . . . 61.140000000000001 110.205 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -74.76 148.94 39.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.519 0.728 . . . . 74.299999999999997 109.234 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -142.8 -72.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.917 0.887 . . . . 74.450000000000003 108.774 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -167.6 121.88 0.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.109 0.963 . . . . 63.009999999999998 108.732 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.84 35.32 91.77 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.416 0.531 . . . . 64.420000000000002 112.652 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 158.64 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.93 169.62 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.282 2.655 . . . . 70.530000000000001 110.947 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -122.77 71.05 39.52 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.322 1.049 . . . . 72.200000000000003 111.051 -171.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.89 163.04 36.32 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.717 2.278 . . . . 63.140000000000001 109.752 165.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.21 -33.8 67.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.997 0.74 . . . . 74.400000000000006 112.997 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.33 -28.77 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.842 0.682 . . . . 74.319999999999993 112.842 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -56.93 -26.97 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.466 0.706 . . . . 65.409999999999997 112.158 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -39.96 -46.9 2.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 75.239999999999995 111.043 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -57.75 -52.41 65.58 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 73.310000000000002 111.757 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -69.16 -29.57 67.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.022 -0.514 . . . . 64.219999999999999 112.05 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.69 -47.95 88.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 118.782 0.719 . . . . 64.209999999999994 109.812 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -55.91 -51.63 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.885 0.874 . . . . 74.540000000000006 109.916 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.94 -51.31 69.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.06 0.944 . . . . 74.040000000000006 111.623 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.91 -52.76 64.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.274 1.03 . . . . 74.150000000000006 110.154 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.92 86.12 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 62.43 111.394 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -62.66 -20.33 64.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.516 1.126 . . . . 72.129999999999995 112.959 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -61.02 -25.65 67.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.382 0.992 . . . . 54.439999999999998 111.23 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.45 69.51 1.21 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 108.789 -1.724 . . . . 55.049999999999997 108.789 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.85 143.89 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.053 0.941 . . . . 64.049999999999997 110.529 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -81.34 149.61 65.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 74.430000000000007 110.647 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -62.08 -31.58 83.47 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.453 2.769 . . . . 70.010000000000005 112.382 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.3 t -56.52 -30.85 63.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.825 0.85 . . . . 44.219999999999999 111.825 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 -32.66 15.25 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.905 0.882 . . . . 72.430000000000007 111.694 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.06 -37.13 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.623 0.647 . . . . 64.129999999999995 109.831 167.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -48.36 -56.09 9.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.679 0.792 . . . . 54.119999999999997 111.099 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -75.48 -36.66 60.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.505 -0.76 . . . . 74.230000000000004 112.892 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -54.82 -45.88 74.5 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.245 0.929 . . . . 71.409999999999997 111.961 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.98 -16.25 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 74.129999999999995 111.075 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 68.72 54.78 0.48 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.505 1.922 . . . . 74.310000000000002 110.014 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.83 166.82 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.586 1.554 . . . . 64.420000000000002 109.976 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -71.88 148.69 45.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.205 0.602 . . . . 60.310000000000002 109.538 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.36 -33.66 71.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.378 0.671 . . . . 70.099999999999994 111.944 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.88 -38.74 85.97 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.966 -0.454 . . . . 61.299999999999997 111.966 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.8 m -72.7 -29.83 63.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.62 0.768 . . . . 74.5 111.61 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -53.52 -33.12 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.348 0.659 . . . . 74.219999999999999 111.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 t -51.44 -45.73 62.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.4 0.68 . . . . 73.420000000000002 111.5 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -77.46 -34.31 54.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.028 0.931 . . . . 72.540000000000006 112.269 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.11 -48.64 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.335 -0.617 . . . . 64.040000000000006 109.335 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.0 -25.76 67.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.574 1.149 . . . . 75.519999999999996 111.704 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.37 113.25 1.8 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.912 -1.675 . . . . 61.299999999999997 108.912 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -53.15 -49.89 65.67 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.495 0.718 . . . . 74.010000000000005 111.256 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.31 -59.45 0.09 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.617 1.167 . . . . 75.430000000000007 109.633 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.47 81.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.939 -2.245 . . . . 72.319999999999993 104.939 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.84 -60.48 1.9 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.748 -0.464 . . . . 72.349999999999994 109.748 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.4 p -104.97 -81.36 0.53 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.612 -1.255 . . . . 70.340000000000003 107.612 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.13 179.28 53.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.582 -1.007 . . . . 44.43 110.582 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -61.68 -64.75 0.84 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.118 0.967 . . . . 71.219999999999999 111.309 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 mt 58.17 30.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.101 1.76 . . . . 75.409999999999997 110.362 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.4 mmt-85 -152.44 100.05 2.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 75.439999999999998 106.831 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.67 147.51 40.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.467 2.112 . . . . 70.129999999999995 110.635 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.7 170.05 42.28 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.248 -1.541 . . . . 41.310000000000002 109.248 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.63 124.11 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 124.788 1.235 . . . . 73.409999999999997 108.575 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.39 140.43 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.419 1.088 . . . . 61.009999999999998 109.241 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.13 76.53 0.19 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.936 -1.266 . . . . 71.430000000000007 109.936 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.89 64.54 0.23 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.497 -1.041 . . . . 71.319999999999993 110.497 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -148.86 50.04 0.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.11 0.964 . . . . 75.540000000000006 109.431 177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -77.07 125.14 87.14 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 109.856 -175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.65 170.86 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.34 2.693 . . . . 74.430000000000007 110.785 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -149.57 104.27 3.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.632 0.773 . . . . 63.109999999999999 109.307 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.49 152.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.865 0.866 . . . . 75.430000000000007 110.384 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.7 164.15 36.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.911 1.284 . . . . 74.030000000000001 109.159 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.12 109.24 1.26 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.436 0.694 . . . . 44.130000000000003 109.785 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.59 -19.03 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.094 2.529 . . . . 23.210000000000001 112.252 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -55.09 -24.84 27.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.92 1.288 . . . . 61.439999999999998 112.696 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.6 t -45.54 -41.75 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.005 1.322 . . . . 73.540000000000006 111.879 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.0 t -60.07 -48.11 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.155 0.582 . . . . 74.340000000000003 110.151 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.11 33.59 0.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.822 0.675 . . . . 74.400000000000006 112.822 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.16 -59.06 2.92 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 107.259 -1.385 . . . . 70.140000000000001 107.259 163.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -39.89 -48.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 124.711 1.204 . . . . 71.450000000000003 109.744 159.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.72 -59.98 5.7 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 124.681 1.134 . . . . 40.5 112.13 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -53.06 -53.14 54.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.408 1.104 . . . . 75.239999999999995 111.759 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -67.35 -33.55 75.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.447 0.536 . . . . 74.0 112.447 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.16 -38.32 85.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.39 0.541 . . . . 72.519999999999996 111.502 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -67.55 -38.57 84.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.531 0.605 . . . . 74.109999999999999 110.791 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -62.96 -51.32 67.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.16 0.984 . . . . 72.299999999999997 109.918 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -137.79 111.63 8.86 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.559 1.143 . . . . 64.519999999999996 108.622 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.42 -36.18 27.93 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.657 2.238 . . . . 60.020000000000003 111.686 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.8 p -81.85 66.11 7.27 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.798 0.839 . . . . 72.439999999999998 109.493 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 76.8 mmm -125.18 162.98 23.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.187 1.795 . . . . 72.209999999999994 108.593 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -145.69 163.87 33.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.441 -1.254 . . . . 71.420000000000002 109.465 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.98 -59.07 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.509 1.524 . . . . 62.140000000000001 113.173 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -52.13 -48.2 64.97 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.462 0.705 . . . . 73.420000000000002 112.043 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.35 -42.6 98.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.519 1.128 . . . . 73.409999999999997 110.361 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 mm -59.31 -49.22 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.218 1.007 . . . . 70.209999999999994 110.508 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -62.35 -46.62 87.87 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.788 0.267 . . . . 74.540000000000006 110.372 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.78 -42.01 78.66 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.261 0.624 . . . . 61.420000000000002 110.564 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.5 ttt-85 -80.87 21.56 0.67 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.35 0.66 . . . . 73.150000000000006 112.773 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.94 -49.52 2.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.407 1.483 . . . . 73.120000000000005 109.089 159.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.5 mt -66.84 -63.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.652 0.781 . . . . 62.149999999999999 111.0 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -29.73 69.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.823 0.849 . . . . 71.010000000000005 111.745 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -63.62 -27.71 69.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.131 0.572 . . . . 61.140000000000001 110.472 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.55 48.77 4.62 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 109.941 -1.264 . . . . 74.129999999999995 109.941 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.5 -46.69 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.265 1.426 . . . . 70.420000000000002 109.394 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.59 165.66 26.97 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.18 0.992 . . . . 74.519999999999996 110.955 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.51 159.19 17.36 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.14 1.776 . . . . 62.109999999999999 110.949 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -38.65 -49.05 1.53 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.312 2.645 . . . . 54.100000000000001 114.054 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.1 -32.58 22.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.592 0.757 . . . . 73.140000000000001 110.793 -173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.4 p -72.87 -39.53 66.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.662 0.785 . . . . 73.120000000000005 112.432 -173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.16 149.94 33.59 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.819 0.736 . . . . 54.310000000000002 111.134 174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.78 150.13 88.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 110.15 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 81.8 p -69.42 163.49 25.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.415 0.686 . . . . 55.25 112.321 -169.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -39.41 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.424 1.09 . . . . 63.450000000000003 110.211 173.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.0 t -63.51 -49.28 74.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.131 0.572 . . . . 72.329999999999998 110.36 174.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.9 m -58.86 -62.07 2.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.801 0.441 . . . . 74.219999999999999 110.213 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -52.64 -40.27 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.071 0.549 . . . . 73.540000000000006 111.673 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -58.59 -48.24 81.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.731 0.413 . . . . 74.040000000000006 111.444 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -58.54 -43.63 89.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.819 -0.61 . . . . 73.340000000000003 111.724 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.96 -55.11 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.962 0.801 . . . . 75.209999999999994 109.622 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -46.63 -56.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 71.439999999999998 111.619 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -51.25 -47.85 62.32 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.844 0.858 . . . . 71.239999999999995 112.703 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.3 p -74.28 -7.04 51.38 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.862 . . . . 72.349999999999994 113.329 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -7.5 53.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.622 1.101 . . . . 64.340000000000003 111.274 164.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t 69.15 69.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.107 2.163 . . . . 73.25 108.405 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.96 78.52 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.898 1.279 . . . . 74.409999999999997 110.687 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -63.6 145.64 97.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 75.439999999999998 110.564 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.0 164.33 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.239 2.626 . . . . 73.329999999999998 110.331 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -82.16 55.13 2.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.728 0.811 . . . . 71.010000000000005 110.232 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -166.24 145.1 5.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.713 1.205 . . . . 73.019999999999996 109.122 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.33 103.76 48.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.019 -1.474 . . . . 55.219999999999999 107.019 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.42 78.18 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.032 2.488 . . . . 72.319999999999993 110.216 -175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.5 mtp -69.01 136.61 52.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.52 0.728 . . . . 65.099999999999994 110.222 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.28 170.72 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.596 1.158 . . . . 72.329999999999998 110.998 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 m -146.78 149.66 33.78 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.559 1.144 . . . . 74.150000000000006 109.503 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.84 134.35 2.11 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.811 -1.316 . . . . 64.420000000000002 109.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.62 10.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.177 0.991 . . . . 62.420000000000002 109.455 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.63 177.79 8.39 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.573 2.848 . . . . 74.0 110.904 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -167.4 176.35 42.24 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.798 -0.921 . . . . 75.439999999999998 110.798 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 178.54 -169.57 41.21 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.568 -1.013 . . . . 41.439999999999998 110.568 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.75 66.84 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.303 -1.119 . . . . 52.140000000000001 110.303 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -74.1 146.32 43.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.74 0.816 . . . . 55.210000000000001 111.054 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -162.72 170.97 17.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.649 1.18 . . . . 72.409999999999997 109.559 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.41 173.32 7.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.323 1.049 . . . . 62.219999999999999 111.869 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -121.26 143.23 49.27 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.073 1.349 . . . . 71.129999999999995 108.3 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.3 t60 47.84 -108.98 0.26 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.482 1.513 . . . . 65.450000000000003 111.463 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -173.97 -61.23 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.17 1.388 . . . . 75.200000000000003 108.056 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.378 -1.296 . . . . 65.200000000000003 109.651 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 118.063 -0.97 . . . . 74.120000000000005 112.338 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.3 147.59 53.5 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.877 1.718 . . . . 65.030000000000001 110.765 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -70.04 134.58 48.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.517 0.727 . . . . 62.310000000000002 110.032 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -144.31 145.1 31.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.754 1.222 . . . . 61.310000000000002 108.378 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -159.44 163.25 35.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.432 1.093 . . . . 64.420000000000002 109.141 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.14 144.73 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.023 1.329 . . . . 71.349999999999994 108.167 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -141.85 164.37 30.38 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.278 1.031 . . . . 64.430000000000007 109.688 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -157.64 163.59 38.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.772 1.229 . . . . 52.439999999999998 109.237 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.02 111.83 0.28 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.826 -1.31 . . . . 53.009999999999998 109.826 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -155.49 155.93 34.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.077 0.951 . . . . 75.439999999999998 109.325 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.16 -168.97 38.4 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.361 -1.095 . . . . 53.229999999999997 110.361 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.42 156.33 27.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.725 -1.35 . . . . 53.109999999999999 109.725 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.78 98.69 4.25 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.521 1.129 . . . . 73.129999999999995 109.129 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -68.79 153.48 43.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.235 0.614 . . . . 74.099999999999994 110.126 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -142.01 156.9 45.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.648 1.179 . . . . 74.340000000000003 109.582 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.46 167.0 21.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 75.030000000000001 109.189 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 162.0 32.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.867 -0.893 . . . . 52.219999999999999 110.867 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.98 130.11 1.67 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.258 -1.137 . . . . 54.409999999999997 110.258 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.78 4.44 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.873 0.869 . . . . 75.340000000000003 110.315 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.42 68.65 1.39 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.992 1.317 . . . . 74.310000000000002 108.456 -174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.71 172.24 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.551 1.54 . . . . 54.119999999999997 109.473 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -59.69 127.56 32.58 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.968 -0.458 . . . . 73.209999999999994 110.099 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 37.14 92.7 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 123.295 0.474 . . . . 72.120000000000005 112.107 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -59.56 147.56 76.94 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.413 0.685 . . . . 71.329999999999998 110.087 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.16 147.98 93.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.359 2.706 . . . . 71.409999999999997 110.92 -175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.49 62.05 52.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.968 0.907 . . . . 75.219999999999999 112.16 -172.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -76.66 -165.97 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.935 2.423 . . . . 73.140000000000001 108.915 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.06 -34.7 4.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.91 1.684 . . . . 63.130000000000003 113.732 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.66 -20.88 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.668 1.187 . . . . 75.150000000000006 112.846 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.03 -45.13 29.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 123.879 0.872 . . . . 65.030000000000001 110.895 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -56.82 -54.35 47.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.194 0.598 . . . . 71.420000000000002 109.747 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -56.5 -49.17 75.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 72.230000000000004 111.429 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -61.91 -52.52 63.73 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.282 0.633 . . . . 75.030000000000001 111.024 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.2 -46.75 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.227 0.611 . . . . 71.329999999999998 110.796 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.67 -56.75 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.464 0.705 . . . . 70.510000000000005 110.398 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.83 -47.3 77.45 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.254 1.022 . . . . 71.420000000000002 111.154 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.42 -57.16 8.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.482 0.713 . . . . 72.450000000000003 110.327 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.13 -32.35 54.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.306 1.042 . . . . 65.099999999999994 112.452 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -52.53 -36.21 55.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.267 1.027 . . . . 75.340000000000003 112.7 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.77 -23.3 66.06 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.874 0.761 . . . . 74.019999999999996 112.387 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.78 85.34 1.74 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.543 -1.423 . . . . 70.230000000000004 109.543 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.34 124.19 61.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 124.195 0.998 . . . . 62.119999999999997 109.888 -171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -66.59 146.77 99.1 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 123.68 0.792 . . . . 63.100000000000001 109.397 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -58.66 -35.98 97.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.789 2.326 . . . . 73.409999999999997 112.008 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.72 -38.24 77.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.194 0.442 . . . . 62.539999999999999 112.194 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -75.84 -38.68 57.78 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.952 0.901 . . . . 75.209999999999994 110.898 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -52.75 -44.75 48.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.874 -0.787 . . . . 55.32 108.874 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -54.06 -37.15 63.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.058 0.543 . . . . 51.119999999999997 112.249 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -67.36 -55.42 13.89 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.114 0.566 . . . . 74.430000000000007 110.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.03 -40.35 90.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.328 1.051 . . . . 65.129999999999995 112.247 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.09 -28.69 62.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.441 1.096 . . . . 64.430000000000007 109.485 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 65.33 62.02 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.902 1.681 . . . . 72.219999999999999 109.436 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.1 m -147.03 179.95 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.521 1.928 . . . . 74.400000000000006 108.941 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -76.06 151.7 37.04 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.545 0.738 . . . . 62.200000000000003 110.653 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -59.75 -30.76 69.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.735 0.814 . . . . 64.349999999999994 110.651 170.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -40.71 95.64 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.694 0.664 . . . . 43.210000000000001 111.601 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.58 -44.7 66.84 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.402 0.601 . . . . 73.329999999999998 110.239 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.58 -52.56 25.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 C-N-CA 123.23 0.612 . . . . 50.439999999999998 110.508 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 t -50.6 -42.74 56.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.205 1.002 . . . . 55.219999999999999 111.674 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -69.16 -62.32 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.012 0.525 . . . . 51.409999999999997 111.018 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.8 -25.48 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.705 1.002 . . . . 62.450000000000003 113.705 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.49 -40.88 39.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.28 0.632 . . . . 65.349999999999994 111.783 169.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.98 83.05 0.06 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.479 -1.048 . . . . 74.140000000000001 110.479 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.39 -32.35 68.35 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.089 0.444 . . . . 65.209999999999994 110.111 166.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 66.37 25.51 10.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.353 1.861 . . . . 73.549999999999997 111.555 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -169.5 48.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.833 1.253 . . . . 73.109999999999999 110.203 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.09 -170.78 2.63 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.821 -0.55 . . . . 73.540000000000006 110.572 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 p -53.27 -40.52 64.72 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.896 1.278 . . . . 62.520000000000003 111.489 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.05 -86.44 0.4 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.822 -1.311 . . . . 70.450000000000003 109.822 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -168.35 -71.34 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.13 0.972 . . . . 71.0 109.488 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mt 60.62 41.13 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.527 1.931 . . . . 71.140000000000001 109.302 -171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.53 83.82 22.48 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.179 1.392 . . . . 73.219999999999999 108.482 175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.1 93.95 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.2 2.6 . . . . 63.100000000000001 110.852 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.27 -112.09 0.5 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.923 -1.271 . . . . 63.130000000000003 109.923 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m 44.85 43.6 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.572 1.949 . . . . 63.530000000000001 113.466 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.41 -48.86 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.908 0.883 . . . . 73.340000000000003 109.758 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.68 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.819 -1.312 . . . . 51.210000000000001 109.819 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.49 39.22 14.8 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.394 1.473 . . . . 65.109999999999999 113.361 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.4 m -95.6 89.26 5.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.898 0.879 . . . . 71.129999999999995 110.266 -168.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -118.69 69.62 8.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.431 1.492 . . . . 72.230000000000004 109.785 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.64 173.45 14.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.339 2.693 . . . . 73.430000000000007 111.35 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? 61.46 76.76 0.36 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.098 1.359 . . . . 74.019999999999996 110.421 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 t -84.32 127.16 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.51 124.29 31.22 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.694 0.798 . . . . 75.329999999999998 109.031 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.276 0.2 OUTLIER -144.69 -67.29 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.792 -1.099 . . . . 64.099999999999994 112.152 -178.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.76 -46.25 1.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 71.439999999999998 111.915 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.55 -31.45 72.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.648 0.379 . . . . 75.239999999999995 111.829 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.23 -36.8 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.092 0.957 . . . . 73.209999999999994 110.737 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.43 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 123.224 0.61 . . . . 73.319999999999993 111.046 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.1 -37.96 84.62 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.131 0.572 . . . . 61.509999999999998 111.373 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -55.67 -50.48 70.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.907 0.883 . . . . 73.109999999999999 112.643 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -40.32 -61.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 123.841 0.857 . . . . 72.239999999999995 110.627 168.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.21 -55.15 20.39 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.506 1.05 . . . . 73.439999999999998 111.526 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.05 -52.48 63.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.531 0.732 . . . . 53.450000000000003 111.032 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -66.02 -31.3 72.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.717 -0.658 . . . . 72.400000000000006 112.579 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.66 -42.67 86.26 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.284 0.947 . . . . 63.32 110.544 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -64.34 -47.94 77.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.556 0.617 . . . . 75.329999999999998 110.7 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -64.14 -45.41 88.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.12 1.368 . . . . 73.010000000000005 110.939 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -136.72 75.6 49.45 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.519 1.127 . . . . 73.239999999999995 109.464 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.25 -24.32 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.529 2.819 . . . . 71.209999999999994 111.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -65.21 -49.36 70.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.915 0.886 . . . . 73.319999999999993 111.047 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 96.2 mmm -78.56 172.71 13.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.903 0.859 . . . . 64.200000000000003 111.945 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -105.46 174.78 5.73 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.162 -1.381 . . . . 72.010000000000005 112.033 -160.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.02 -47.13 68.56 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.3 1.04 . . . . 74.319999999999993 111.256 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -46.19 -53.21 10.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.514 1.126 . . . . 73.400000000000006 111.872 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.72 -47.8 81.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.246 1.019 . . . . 75.310000000000002 110.619 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.9 mt -76.68 -29.01 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.763 1.225 . . . . 70.310000000000002 112.084 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -57.78 -56.71 18.37 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.087 -1.079 . . . . 74.540000000000006 108.087 165.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -69.92 -12.81 61.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.5 0.72 . . . . 62.200000000000003 112.533 -175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -65.42 -36.16 83.09 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.452 0.701 . . . . 72.450000000000003 111.409 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 mt -60.14 -44.65 94.77 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.007 0.367 . . . . 61.130000000000003 110.379 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.16 -46.56 76.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.546 0.738 . . . . 75.109999999999999 110.321 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.03 -46.48 89.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.757 1.223 . . . . 43.43 111.619 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.08 -32.85 74.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.799 0.44 . . . . 74.140000000000001 110.424 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.05 59.13 1.41 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.776 -1.33 . . . . 72.340000000000003 109.776 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.22 -60.98 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 109.722 -173.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.17 150.24 32.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.801 1.24 . . . . 62.450000000000003 109.887 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.3 150.74 41.68 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.786 0.435 . . . . 74.310000000000002 110.405 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -38.62 -48.3 1.43 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.602 2.361 . . . . 73.420000000000002 114.072 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.2 -36.35 16.84 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.677 0.791 . . . . 63.020000000000003 110.538 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.0 p -72.68 -21.36 61.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.723 0.809 . . . . 62.439999999999998 112.451 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.89 133.42 21.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.151 1.38 . . . . 62.329999999999998 110.834 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.64 141.82 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.502 2.135 . . . . 72.439999999999998 110.244 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.8 m -68.03 160.52 28.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.132 0.973 . . . . 74.5 112.289 -167.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.8 t -54.34 -50.94 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.078 1.351 . . . . 75.109999999999999 109.338 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.2 t -61.44 -37.18 82.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.918 0.887 . . . . 65.239999999999995 111.36 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -66.41 -62.38 1.5 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.132 0.424 . . . . 71.530000000000001 110.305 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -56.17 -35.6 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.35 0.66 . . . . 74.439999999999998 112.238 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -62.42 -60.33 3.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.713 0.405 . . . . 73.239999999999995 110.752 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -58.85 -37.24 76.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.104 0.961 . . . . 64.510000000000005 112.489 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.78 -28.9 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.883 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.09 -27.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.02 1.328 . . . . 73.430000000000007 111.969 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -51.81 -46.75 64.39 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.426 1.012 . . . . 64.239999999999995 110.754 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.3 p -57.41 -15.05 5.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.584 1.153 . . . . 71.519999999999996 113.592 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -104.78 -54.08 2.57 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.678 1.191 . . . . 53.420000000000002 111.551 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.09 106.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.154 0.582 . . . . 74.310000000000002 109.55 -165.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -156.58 166.62 32.88 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.842 1.257 . . . . 65.329999999999998 111.85 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.75 138.97 33.1 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.378 1.071 . . . . 71.200000000000003 109.192 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.19 161.84 44.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.653 2.902 . . . . 71.109999999999999 112.34 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.08 130.56 38.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.191 1.397 . . . . 75.510000000000005 108.64 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -145.77 160.54 41.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.764 0.826 . . . . 72.319999999999993 110.387 -175.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -149.76 80.05 7.62 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 107.901 -1.148 . . . . 61.030000000000001 107.901 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.72 74.96 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.526 2.817 . . . . 73.409999999999997 110.878 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -87.04 152.54 22.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.501 0.72 . . . . 73.200000000000003 111.438 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.91 153.89 19.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.162 1.385 . . . . 70.540000000000006 109.325 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.5 m -136.37 33.51 2.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.252 1.021 . . . . 75.349999999999994 110.62 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -89.79 134.63 12.48 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.156 -1.178 . . . . 50.399999999999999 110.156 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.44 70.55 3.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.703 0.801 . . . . 70.129999999999995 109.907 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.59 170.95 18.34 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.434 2.756 . . . . 70.430000000000007 111.238 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.45 169.8 39.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.415 -1.074 . . . . 74.329999999999998 110.415 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 172.31 -179.58 43.8 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.303 -0.719 . . . . 52.229999999999997 111.303 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.92 161.83 29.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.247 -1.141 . . . . 31.199999999999999 110.247 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 78.4 p -163.74 167.31 21.15 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.57 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -147.8 154.6 40.69 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.24 1.416 . . . . 64.230000000000004 109.187 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -151.1 52.18 0.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 71.120000000000005 108.534 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -88.05 68.25 9.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.696 0.798 . . . . 71.019999999999996 109.036 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.01 116.03 20.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.553 0.741 . . . . 75.329999999999998 109.338 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -77.74 151.51 34.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.204 1.002 . . . . 61.450000000000003 110.528 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.295 -1.336 . . . . 73.409999999999997 108.565 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.798 -0.445 . . . . 70.219999999999999 109.798 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.17 175.06 11.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.152 2.568 . . . . 62.409999999999997 110.877 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -137.05 145.36 43.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.806 1.242 . . . . 73.109999999999999 108.969 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -145.27 161.23 40.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.262 1.425 . . . . 75.540000000000006 108.228 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 p -151.33 -55.97 0.15 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.648 0.779 . . . . 72.349999999999994 109.807 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.3 mt 61.19 75.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.32 1.448 . . . . 73.540000000000006 109.944 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -105.08 143.0 33.86 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.085 1.354 . . . . 74.150000000000006 109.42 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -157.33 150.6 23.78 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.255 1.022 . . . . 64.099999999999994 109.347 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.01 175.69 48.51 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.01 -0.836 . . . . 52.329999999999998 111.01 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -161.03 158.82 28.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.922 1.289 . . . . 74.150000000000006 109.12 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.84 38.33 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.385 -1.086 . . . . 43.200000000000003 110.385 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.43 172.21 40.14 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.55 -1.02 . . . . 65.109999999999999 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.24 150.06 50.78 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.78 1.232 . . . . 74.530000000000001 110.221 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -87.06 166.87 14.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.867 1.267 . . . . 72.030000000000001 110.359 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.86 -64.29 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.386 1.074 . . . . 71.099999999999994 111.454 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 63.91 178.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.379 1.472 . . . . 55.009999999999998 111.659 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.59 173.17 45.36 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.397 -0.681 . . . . 31.329999999999998 111.397 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.53 -167.5 42.87 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.394 0.997 . . . . 72.140000000000001 112.103 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.95 154.82 33.18 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.727 0.811 . . . . 74.109999999999999 110.771 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -83.08 59.81 5.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.213 1.405 . . . . 72.430000000000007 110.432 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -166.84 -36.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.648 1.179 . . . . 71.430000000000007 111.159 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -49.45 -47.76 48.0 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.164 1.386 . . . . 64.0 112.046 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.84 56.77 0.11 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.877 -1.689 . . . . 50.109999999999999 108.877 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -123.21 79.08 52.54 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.65 1.18 . . . . 73.420000000000002 110.022 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.33 69.61 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.436 3.424 . . . . 62.119999999999997 110.289 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.99 166.84 14.11 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.409 1.484 . . . . 71.530000000000001 110.206 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.14 -158.95 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.864 3.043 . . . . 52.229999999999997 110.805 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -51.6 -19.84 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 115.31 1.596 . . . . 71.120000000000005 115.31 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.41 -33.85 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.072 0.851 . . . . 74.109999999999999 111.995 170.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -48.67 -49.29 14.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.77 1.228 . . . . 40.049999999999997 110.841 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -48.4 -49.12 36.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.921 0.888 . . . . 74.019999999999996 110.914 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.22 -36.22 77.2 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.217 1.007 . . . . 63.420000000000002 111.22 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.1 mmt-85 -75.69 -34.23 60.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.173 0.589 . . . . 72.25 112.063 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.28 -50.05 81.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 N-CA-C 108.914 -0.773 . . . . 72.150000000000006 108.914 170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.3 -50.69 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.139 0.976 . . . . 55.229999999999997 110.361 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.31 -52.79 42.03 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.856 1.262 . . . . 72.120000000000005 111.772 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.39 -49.63 21.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.531 -0.271 . . . . 73.209999999999994 111.026 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.49 -26.89 55.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.397 1.079 . . . . 22.329999999999998 112.799 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -49.09 -37.68 22.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.777 1.231 . . . . 74.230000000000004 112.054 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -63.29 -23.46 67.43 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.656 0.613 . . . . 71.430000000000007 112.656 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.28 79.73 1.32 Allowed Glycine 0 C--N 1.34 0.789 0 N-CA-C 109.643 -1.383 . . . . 45.210000000000001 109.643 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.05 149.12 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.001 0.921 . . . . 74.510000000000005 110.042 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -76.18 155.08 84.44 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.038 0.935 . . . . 73.150000000000006 109.881 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.86 57.81 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.4 2.733 . . . . 71.439999999999998 111.144 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -140.95 -58.43 0.5 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.606 1.563 . . . . 52.420000000000002 108.27 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.46 -14.5 51.4 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.492 1.117 . . . . 72.129999999999995 112.768 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.2 mt -52.72 -37.85 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.531 -0.73 . . . . 54.140000000000001 109.73 167.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -57.53 -59.99 4.34 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.031 0.933 . . . . 71.239999999999995 111.852 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -36.59 80.92 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.658 0.614 . . . . 71.310000000000002 112.658 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -59.1 -56.31 23.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.633 0.651 . . . . 43.149999999999999 112.179 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.28 -6.5 59.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.996 0.518 . . . . 74.209999999999994 111.345 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.33 58.95 1.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.363 1.865 . . . . 72.040000000000006 110.725 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.42 -118.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.912 1.285 . . . . 63.420000000000002 107.688 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -148.17 -79.48 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.579 1.152 . . . . 74.140000000000001 108.591 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.3 p80 179.2 -47.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.602 1.561 . . . . 63.130000000000003 109.726 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -54.43 33.39 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.005 0.812 . . . . 33.109999999999999 111.407 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.09 -45.35 87.31 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.277 0.631 . . . . 62.240000000000002 110.285 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.79 -60.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.694 0.798 . . . . 63.420000000000002 109.704 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -48.13 -45.25 32.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.238 1.015 . . . . 74.019999999999996 111.756 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -63.6 -56.81 12.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.151 0.581 . . . . 74.150000000000006 111.453 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.5 mm -63.33 -37.03 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.755 0.707 . . . . 74.519999999999996 111.736 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.02 -54.93 38.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.178 0.591 . . . . 71.239999999999995 109.587 170.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.93 119.42 0.53 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.977 -1.249 . . . . 75.150000000000006 109.977 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -61.3 -46.88 88.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.562 0.681 . . . . 71.239999999999995 109.81 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -159.39 39.97 0.21 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.703 0.801 . . . . 74.319999999999993 110.647 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 60.48 71.46 0.57 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.291 -1.003 . . . . 71.140000000000001 108.291 -165.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.46 136.66 20.33 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.579 1.552 . . . . 74.549999999999997 113.604 -160.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -79.03 -34.95 43.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.776 0.831 . . . . 45.420000000000002 111.292 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -83.36 0.17 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.767 -0.933 . . . . 72.239999999999995 110.767 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -77.83 173.01 12.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.001 0.521 . . . . 74.519999999999996 109.671 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mt 60.8 35.77 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.134 1.373 . . . . 55.32 111.138 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -144.14 67.67 15.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.501 1.121 . . . . 71.040000000000006 110.579 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.21 124.81 9.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.798 2.332 . . . . 45.100000000000001 109.919 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.39 159.57 20.21 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.729 -0.949 . . . . 74.430000000000007 110.729 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.63 125.88 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.644 1.577 . . . . 75.150000000000006 108.344 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.81 136.03 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.269 1.427 . . . . 75.219999999999999 109.028 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.39 164.5 33.18 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.559 -1.016 . . . . 75.150000000000006 110.559 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.58 164.61 27.5 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.185 -0.766 . . . . 53.119999999999997 111.185 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.6 m -154.73 143.45 20.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.626 1.17 . . . . 75.010000000000005 109.274 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -159.5 79.12 2.77 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 64.540000000000006 109.387 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.23 160.62 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.253 2.635 . . . . 74.329999999999998 111.966 -173.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -147.93 109.4 4.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.802 1.641 . . . . 72.200000000000003 108.089 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -139.4 135.55 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 73.349999999999994 108.912 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.97 132.03 34.4 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.284 1.034 . . . . 74.340000000000003 109.735 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER -154.84 -67.64 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.122 -0.942 . . . . 73.239999999999995 112.417 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.07 -41.62 7.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.335 2.023 . . . . 74.239999999999995 112.01 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.35 -26.34 63.02 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.692 0.797 . . . . 64.299999999999997 112.154 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.26 -25.54 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 122.792 0.437 . . . . 74.219999999999999 111.528 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.82 -42.81 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.359 0.664 . . . . 73.299999999999997 110.66 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.13 -39.47 82.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.171 0.588 . . . . 73.239999999999995 110.165 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.53 -33.44 66.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.426 0.69 . . . . 72.129999999999995 111.654 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 -45.25 98.99 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 108.228 -1.027 . . . . 73.430000000000007 108.228 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.88 -54.64 17.37 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.249 0.928 . . . . 72.219999999999999 112.228 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -60.27 -48.94 79.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.905 0.853 . . . . 75.049999999999997 111.461 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -64.36 -39.18 93.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.394 -0.336 . . . . 72.329999999999998 111.376 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -57.97 -47.0 84.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.641 0.776 . . . . 71.019999999999996 110.779 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.219 1.008 . . . . 75.200000000000003 111.255 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.44 -53.7 54.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.734 0.814 . . . . 74.120000000000005 110.154 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -71.67 163.48 66.04 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.625 . . . . 60.5 110.838 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.3 -159.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.102 2.534 . . . . 64.209999999999994 109.881 168.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.1 p -76.96 63.56 2.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.74 1.216 . . . . 54.539999999999999 111.382 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 55.8 mtp -81.22 172.95 13.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.319 1.448 . . . . 71.140000000000001 110.483 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.86 145.52 24.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.342 1.057 . . . . 72.329999999999998 110.084 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.82 -35.8 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.824 1.249 . . . . 51.219999999999999 112.251 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -53.97 -36.09 62.5 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.25 1.02 . . . . 74.420000000000002 112.31 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.49 -37.57 50.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.44 0.696 . . . . 75.310000000000002 109.959 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.8 mm -67.94 -37.67 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.699 0.4 . . . . 65.310000000000002 111.093 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -49.02 -55.95 10.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.164 0.985 . . . . 74.510000000000005 109.09 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -67.15 -20.93 65.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.483 0.713 . . . . 70.329999999999998 112.669 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -45.73 92.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 73.420000000000002 110.404 175.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.12 -44.76 92.02 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.153 0.581 . . . . 64.230000000000004 111.061 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.217 0.607 . . . . 45.229999999999997 110.415 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.04 99.78 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.8 1.24 . . . . 72.040000000000006 111.463 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.71 -32.12 73.5 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.284 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.0 45.77 4.38 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 109.939 -1.264 . . . . 53.340000000000003 109.939 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.03 -56.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.162 1.385 . . . . 73.540000000000006 108.12 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 89.3 m -104.08 157.69 16.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.47 1.108 . . . . 63.229999999999997 109.927 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.37 168.83 10.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.334 1.454 . . . . 74.120000000000005 109.177 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -34.09 -56.11 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.627 2.371 . . . . 64.209999999999994 113.811 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.25 75.46 1.65 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 123.649 1.69 . . . . 74.010000000000005 109.791 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.2 p -148.28 -43.82 0.16 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 110.932 -2.849 . . . . 72.129999999999995 108.072 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -42.45 134.83 2.63 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.338 2.255 . . . . 74.329999999999998 111.358 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.37 146.6 50.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.227 1.951 . . . . 73.209999999999994 111.228 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.2 m -68.1 159.32 31.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.934 1.294 . . . . 60.25 111.643 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.96 -36.86 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.897 0.879 . . . . 64.040000000000006 109.751 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.9 t -61.25 -36.54 80.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.229 0.612 . . . . 70.109999999999999 111.444 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -83.06 -19.19 37.33 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.175 -0.916 . . . . 64.120000000000005 112.624 -170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.76 -44.72 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.082 0.855 . . . . 61.409999999999997 109.398 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -52.8 -48.8 66.65 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.225 1.41 . . . . 71.200000000000003 112.157 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -52.86 -28.11 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.674 0.991 . . . . 74.019999999999996 113.674 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.25 -55.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.924 -0.769 . . . . 74.430000000000007 108.924 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 65.2 mt -53.65 -39.01 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.432 1.093 . . . . 64.129999999999995 110.888 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -48.03 -51.8 22.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.118 1.367 . . . . 64.219999999999999 111.712 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.6 p -66.32 -29.61 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.291 -0.385 . . . . 72.329999999999998 111.879 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.63 -78.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.936 -0.764 . . . . 60.009999999999998 108.936 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -170.36 101.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.542 1.537 . . . . 64.219999999999999 108.967 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -83.25 171.2 13.85 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.17 0.588 . . . . 55.32 109.839 166.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -121.22 82.46 38.07 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 125.319 1.448 . . . . 75.540000000000006 108.299 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.15 128.67 17.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.539 2.16 . . . . 73.409999999999997 110.916 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.89 67.85 7.27 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.236 1.014 . . . . 71.540000000000006 109.642 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.35 145.81 22.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.231 1.013 . . . . 71.430000000000007 109.237 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.9 tp -118.35 93.07 44.6 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 125.132 1.373 . . . . 73.120000000000005 107.408 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.67 158.1 39.7 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.709 2.273 . . . . 65.040000000000006 110.169 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 27.9 ttt -155.89 120.36 4.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.599 0.76 . . . . 52.350000000000001 109.244 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.35 155.46 30.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.996 0.919 . . . . 53.43 109.729 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -158.29 163.06 37.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.806 0.842 . . . . 75.140000000000001 109.757 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.39 177.19 42.55 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.344 -1.102 . . . . 32.329999999999998 110.344 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 69.83 6.15 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.705 0.802 . . . . 74.310000000000002 110.132 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.85 167.44 27.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.246 2.63 . . . . 55.25 110.855 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.66 179.51 48.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.515 -1.034 . . . . 75.430000000000007 110.515 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.5 -175.25 47.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.75 -0.94 . . . . 64.239999999999995 110.75 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.89 169.9 42.44 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.359 -1.096 . . . . 60.420000000000002 110.359 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.3 m -153.18 164.43 38.08 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.328 1.051 . . . . 75.349999999999994 109.411 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -162.89 171.49 16.56 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.231 1.012 . . . . 43.210000000000001 109.649 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -155.3 -171.36 3.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.662 1.185 . . . . 75.310000000000002 108.928 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -130.13 -178.61 4.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.023 1.329 . . . . 74.329999999999998 109.811 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.71 153.34 41.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.826 1.25 . . . . 62.109999999999999 109.08 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -150.36 148.6 29.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.986 1.315 . . . . 70.109999999999999 107.754 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.247 -1.358 . . . . 73.120000000000005 109.269 178.043 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 119.271 -0.395 . . . . 74.430000000000007 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.79 -45.96 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.7 2.267 . . . . 73.299999999999997 111.009 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.8 t60 58.44 72.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 74.319999999999993 111.491 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -138.45 155.02 48.85 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.61 1.164 . . . . 62.299999999999997 109.209 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 m -152.58 -52.24 0.11 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.482 1.113 . . . . 54.520000000000003 109.228 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mt 60.97 73.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.203 1.401 . . . . 72.129999999999995 110.186 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 97.18 10.42 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.212 -1.403 . . . . 71.0 107.212 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.2 p -152.44 137.25 17.08 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 109.481 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.49 177.13 46.94 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.794 -0.923 . . . . 70.099999999999994 110.794 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -160.72 153.05 20.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.374 1.07 . . . . 72.230000000000004 109.681 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.72 152.09 23.58 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.902 -1.679 . . . . 43.130000000000003 108.902 170.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.01 96.06 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.279 -1.129 . . . . 51.539999999999999 110.279 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.64 148.37 42.79 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.859 1.264 . . . . 75.0 109.406 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -155.55 137.61 14.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.661 1.184 . . . . 74.140000000000001 108.464 -175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -90.2 -61.77 1.61 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.559 0.744 . . . . 60.520000000000003 112.032 -168.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.3 mt 56.19 -146.34 0.57 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.459 1.104 . . . . 74.439999999999998 110.792 -169.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.98 63.83 4.1 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.083 -1.207 . . . . 53.109999999999999 110.083 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.79 65.38 0.27 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.898 -0.39 . . . . 62.140000000000001 112.195 -168.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.11 142.2 21.36 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.173 0.989 . . . . 71.340000000000003 109.448 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -86.72 135.53 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.482 0.713 . . . . 75.519999999999996 109.934 -173.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 147.52 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.713 -0.847 . . . . 62.310000000000002 108.713 174.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -50.97 120.39 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 74.430000000000007 111.563 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.92 84.04 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.806 -0.997 . . . . 75.409999999999997 114.079 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -101.81 116.43 63.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.804 1.302 . . . . 72.120000000000005 108.545 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.86 115.04 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.984 2.456 . . . . 61.420000000000002 109.832 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 32.94 62.96 1.44 Allowed Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 71.409999999999997 114.571 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.94 170.84 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.538 2.158 . . . . 73.030000000000001 110.128 174.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.16 -21.26 21.7 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.497 1.295 . . . . 70.129999999999995 114.497 -167.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 p -49.94 -29.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.788 1.235 . . . . 75.310000000000002 112.447 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.56 -36.98 29.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 124.475 1.11 . . . . 75.549999999999997 111.892 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -54.5 38.67 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.726 -0.842 . . . . 73.340000000000003 108.726 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -67.31 -30.62 70.51 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.22 1.008 . . . . 74.420000000000002 112.053 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.6 -40.79 97.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.019 0.827 . . . . 63.340000000000003 110.696 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -68.39 -33.23 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.84 -0.6 . . . . 74.120000000000005 111.199 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.09 -50.37 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.234 0.925 . . . . 44.340000000000003 110.416 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.51 -48.98 68.51 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.661 1.184 . . . . 64.329999999999998 110.852 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.57 -56.35 19.87 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 109.868 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.57 68.7 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.417 1.087 . . . . 75.140000000000001 112.711 -172.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -59.53 -22.37 61.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.766 0.826 . . . . 65.0 112.73 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -64.48 -27.83 69.25 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.442 1.019 . . . . 73.109999999999999 111.516 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.84 61.61 1.5 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.317 -1.113 . . . . 73.099999999999994 110.317 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.9 151.02 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.948 0.899 . . . . 73.209999999999994 108.895 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -61.83 150.71 81.66 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 111.18 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.27 -39.01 18.81 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.375 2.717 . . . . 60.039999999999999 111.218 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.4 p -65.97 -39.7 90.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 75.430000000000007 111.848 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -58.37 -22.01 52.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.626 1.571 . . . . 52.299999999999997 112.779 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mt -53.74 -26.71 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.009 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -43.6 -60.17 1.88 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.985 1.314 . . . . 62.409999999999997 113.02 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -72.4 -32.17 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.351 0.523 . . . . 54.109999999999999 111.907 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.96 -47.88 84.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.265 0.484 . . . . 75.450000000000003 111.414 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.33 -9.6 38.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.663 0.785 . . . . 54.350000000000001 111.431 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 58.31 77.56 0.29 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.766 1.626 . . . . 61.210000000000001 110.56 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.37 -109.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.576 1.15 . . . . 73.430000000000007 108.869 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t -162.29 -96.98 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.023 0.929 . . . . 72.409999999999997 109.4 -174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -169.79 -53.8 0.02 OUTLIER 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.081 0.952 . . . . 74.510000000000005 109.822 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.63 -41.97 99.75 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.962 -0.855 . . . . 65.319999999999993 110.962 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -74.82 -16.15 60.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.501 0.72 . . . . 73.25 111.715 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.32 -41.5 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.021 0.928 . . . . 71.510000000000005 109.557 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.9 t -49.31 -42.04 40.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.634 1.174 . . . . 64.030000000000001 112.107 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.69 -38.14 86.73 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.741 0.645 . . . . 73.319999999999993 112.741 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.93 -42.02 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 110.221 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.51 -57.43 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.985 -0.746 . . . . 75.129999999999995 108.985 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.6 73.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.302 -0.719 . . . . 74.430000000000007 111.302 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -81.91 -55.46 4.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.827 -0.805 . . . . 54.399999999999999 108.827 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -132.7 34.66 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.597 1.159 . . . . 64.120000000000005 109.882 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 57.96 46.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.669 1.587 . . . . 63.030000000000001 111.138 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 53.14 -142.18 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.232 1.013 . . . . 71.349999999999994 109.585 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -79.66 54.7 1.85 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.869 0.868 . . . . 71.209999999999994 109.033 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 44.32 36.92 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.743 1.163 . . . . 25.32 112.581 -171.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -104.37 -22.48 13.33 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.749 1.22 . . . . 73.129999999999995 113.31 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.68 62.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.521 1.128 . . . . 71.439999999999998 109.556 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -119.04 77.39 15.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.139 1.376 . . . . 65.209999999999994 108.759 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.5 78.96 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.306 2.671 . . . . 72.129999999999995 109.984 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.91 74.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.413 -1.475 . . . . 72.310000000000002 109.413 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 p -150.82 87.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.014 0.926 . . . . 72.340000000000003 108.756 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.64 135.63 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.365 -0.976 . . . . 72.150000000000006 108.365 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.07 175.78 42.18 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.967 -0.853 . . . . 73.019999999999996 110.967 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.38 115.26 0.33 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.128 -1.589 . . . . 71.319999999999993 109.128 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -70.99 146.31 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.238 0.615 . . . . 54.149999999999999 110.991 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -103.7 151.95 38.85 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.567 1.547 . . . . 64.409999999999997 108.395 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.44 154.41 69.04 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.061 2.507 . . . . 72.230000000000004 110.476 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -101.65 66.59 1.08 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.134 0.974 . . . . 52.020000000000003 109.162 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.53 137.18 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.76 0.824 . . . . 74.239999999999995 108.807 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.4 126.27 32.56 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.812 0.845 . . . . 74.340000000000003 109.5 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 p 44.21 62.76 9.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.62 1.568 . . . . 75.129999999999995 112.17 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.47 -81.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.262 2.641 . . . . 55.140000000000001 111.752 -171.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.539 0.736 . . . . 74.409999999999997 111.756 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.6 t -45.65 -46.09 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.314 1.446 . . . . 71.239999999999995 110.691 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.67 -47.77 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.675 1.19 . . . . 71.340000000000003 110.579 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.61 -42.34 99.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.439 0.696 . . . . 62.240000000000002 110.793 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -59.8 -58.08 10.11 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.48 0.582 . . . . 70.400000000000006 111.062 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.9 mt -41.71 -54.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 124.498 1.119 . . . . 73.310000000000002 109.539 171.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.04 -61.22 4.55 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.995 1.284 . . . . 55.43 111.915 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -54.78 -55.86 25.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.639 0.719 . . . . 74.140000000000001 111.145 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -52.01 -43.81 63.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.237 0.829 . . . . 72.530000000000001 113.237 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.12 -42.44 96.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.209 0.459 . . . . 72.310000000000002 111.448 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -65.8 -48.39 71.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.76 0.824 . . . . 64.219999999999999 110.842 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.86 -28.2 65.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.881 0.473 . . . . 74.430000000000007 111.636 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -74.46 151.17 87.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.879 0.472 . . . . 41.329999999999998 109.803 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.15 -57.12 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.544 2.163 . . . . 62.32 109.704 168.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.4 p -130.85 -89.41 0.47 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.803 1.641 . . . . 55.43 108.287 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.25 -175.24 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.677 2.391 . . . . 63.43 113.83 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.6 167.7 21.92 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.581 1.152 . . . . 71.420000000000002 110.599 -164.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.13 -28.23 66.36 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.07 1.348 . . . . 70.25 113.708 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -55.44 34.45 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.641 0.777 . . . . 73.530000000000001 110.537 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -50.22 -49.04 54.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.892 1.277 . . . . 61.439999999999998 111.014 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.57 -41.08 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.646 1.178 . . . . 63.539999999999999 111.352 -163.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -42.39 98.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.788 0.267 . . . . 75.530000000000001 110.78 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -64.64 -42.61 95.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.59 0.356 . . . . 75.120000000000005 111.097 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -60.42 -35.37 75.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.835 0.68 . . . . 63.240000000000002 112.835 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -52.73 -42.77 65.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.802 0.841 . . . . 42.310000000000002 111.88 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 mt -78.75 -47.86 15.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.456 0.702 . . . . 62.130000000000003 110.563 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.21 62.15 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.298 1.439 . . . . 72.019999999999996 111.709 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -74.06 -10.92 60.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.737 0.643 . . . . 62.130000000000003 112.737 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.07 47.4 45.96 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.582 -1.007 . . . . 54.140000000000001 110.582 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -104.04 -27.4 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.643 1.577 . . . . 61.350000000000001 110.459 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 t -140.05 150.26 44.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.103 0.961 . . . . 73.25 109.226 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.31 155.43 32.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.412 0.685 . . . . 62.509999999999998 111.081 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -33.81 46.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.129 1.771 . . . . 75.209999999999994 113.705 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 -50.15 7.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.03 0.532 . . . . 73.299999999999997 109.615 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.5 p -71.1 -22.17 62.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.833 0.853 . . . . 64.439999999999998 112.855 -167.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 p -50.99 131.48 30.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.858 1.263 . . . . 74.310000000000002 111.73 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.77 160.46 43.62 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.215 2.61 . . . . 55.149999999999999 110.916 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m -61.45 151.55 32.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.144 0.977 . . . . 75.540000000000006 111.381 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.23 -41.61 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.312 1.045 . . . . 74.040000000000006 109.95 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -66.08 -33.71 76.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.383 1.073 . . . . 70.319999999999993 112.121 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.7 m -80.08 -26.04 39.76 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.308 -0.853 . . . . 70.340000000000003 111.913 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.7 pt -79.51 -40.16 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.615 0.643 . . . . 44.25 110.778 166.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.26 -48.92 79.69 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.586 0.754 . . . . 70.129999999999995 111.538 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -24.16 36.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.222 1.193 . . . . 75.319999999999993 114.222 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.99 -65.0 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.174 . . . . 74.0 107.832 170.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.99 -42.56 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.959 1.304 . . . . 74.519999999999996 110.306 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.9 mmm-85 -60.45 -55.47 33.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.239 0.472 . . . . 75.340000000000003 111.235 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 p -57.9 -34.84 70.25 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.199 -0.429 . . . . 75.299999999999997 111.863 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -72.65 -69.11 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.759 -0.46 . . . . 70.439999999999998 109.759 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -146.21 92.45 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.129 1.372 . . . . 72.329999999999998 108.077 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 165.25 20.71 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.041 0.537 . . . . 72.430000000000007 111.471 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -112.42 135.97 21.45 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.791 1.236 . . . . 74.420000000000002 107.689 171.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 154.29 52.39 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.987 2.458 . . . . 71.049999999999997 110.301 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.66 138.97 32.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.102 0.961 . . . . 72.209999999999994 109.231 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.35 162.79 30.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.256 1.022 . . . . 71.540000000000006 109.445 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.84 75.79 9.05 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.238 -1.023 . . . . 71.439999999999998 108.238 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.69 128.03 18.24 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.519 2.146 . . . . 74.239999999999995 108.951 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -150.8 140.57 21.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.604 -0.887 . . . . 44.229999999999997 108.604 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -146.25 159.55 43.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.949 1.299 . . . . 75.239999999999995 108.644 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -165.46 130.31 2.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.044 0.937 . . . . 75.420000000000002 109.115 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.72 146.03 11.12 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.672 -1.371 . . . . 54.149999999999999 109.672 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.72 74.26 10.36 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 124.14 0.976 . . . . 63.409999999999997 109.371 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.69 162.66 37.32 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.958 2.439 . . . . 71.329999999999998 110.646 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.51 177.95 48.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.102 -1.199 . . . . 55.43 110.102 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.71 -175.75 46.32 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.441 -1.064 . . . . 74.120000000000005 110.441 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.4 166.74 39.22 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.14 -1.184 . . . . 73.109999999999999 110.14 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.8 t -161.63 161.49 29.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.505 1.122 . . . . 44.25 108.803 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -158.85 160.95 36.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 73.409999999999997 109.262 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -157.04 143.81 18.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.154 0.981 . . . . 73.540000000000006 109.087 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -106.58 109.67 21.65 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.855 1.262 . . . . 65.310000000000002 109.031 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -70.4 93.85 0.9 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.066 -1.087 . . . . 73.120000000000005 108.066 167.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -72.46 140.8 48.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.286 0.634 . . . . 74.200000000000003 110.626 -174.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.935 -1.507 . . . . 74.0 109.95 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 117.614 -1.184 . . . . 52.329999999999998 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.33 76.95 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.648 2.232 . . . . 74.140000000000001 110.862 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -68.4 136.1 52.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.709 0.804 . . . . 72.349999999999994 110.22 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.31 91.22 1.49 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.714 0.806 . . . . 72.319999999999993 108.981 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -76.52 75.21 3.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.704 0.802 . . . . 74.329999999999998 109.397 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.51 153.83 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.895 0.878 . . . . 71.430000000000007 110.453 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -131.37 164.76 24.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 73.439999999999998 109.606 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -149.56 -177.06 5.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.835 1.254 . . . . 75.019999999999996 109.058 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.29 -170.31 36.0 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.938 -0.865 . . . . 52.299999999999997 110.938 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -157.3 -176.32 5.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.037 1.335 . . . . 70.040000000000006 109.018 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.25 20.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.228 -0.749 . . . . 73.120000000000005 111.228 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.09 -171.02 29.83 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.236 -1.146 . . . . 70.129999999999995 110.236 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.43 -179.31 7.57 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.086 0.954 . . . . 54.229999999999997 110.639 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.85 148.66 37.43 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.126 1.371 . . . . 65.099999999999994 108.976 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -121.06 -54.24 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.161 0.984 . . . . 75.129999999999995 111.275 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 63.29 179.58 0.15 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.181 1.392 . . . . 61.329999999999998 111.153 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.89 171.93 44.41 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.444 -1.062 . . . . 60.520000000000003 110.444 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.19 49.41 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.714 0.673 . . . . 65.219999999999999 112.06 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.69 154.92 33.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.318 1.047 . . . . 72.209999999999994 109.91 -174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.7 t80 69.21 1.77 3.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.816 1.647 . . . . 63.329999999999998 114.267 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.9 -48.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.543 1.137 . . . . 60.130000000000003 109.118 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.41 145.87 25.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.252 1.421 . . . . 71.230000000000004 107.388 168.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.07 -65.18 3.31 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.8 -1.32 . . . . 52.409999999999997 109.8 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -79.02 119.12 76.09 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.609 -0.886 . . . . 75.430000000000007 108.609 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.64 174.96 11.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.17 2.58 . . . . 71.129999999999995 111.501 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mp -124.28 71.56 55.56 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.826 1.25 . . . . 62.409999999999997 109.078 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.31 -156.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.417 2.745 . . . . 71.120000000000005 109.778 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -53.91 -20.31 5.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.914 1.286 . . . . 72.420000000000002 114.198 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.69 -16.08 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.482 1.113 . . . . 73.140000000000001 112.6 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.18 -35.42 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.554 1.141 . . . . 75.340000000000003 111.444 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -47.58 78.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 0.659 . . . . 75.219999999999999 110.806 172.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.05 -41.71 97.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.201 0.6 . . . . 74.319999999999993 110.952 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -56.63 -53.78 53.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.088 -0.338 . . . . 61.130000000000003 110.088 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.6 mt -53.88 -52.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.875 1.27 . . . . 65.140000000000001 110.233 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -56.15 -49.91 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.956 0.902 . . . . 63.030000000000001 110.536 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.08 -57.37 13.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.223 0.465 . . . . 74.129999999999995 111.266 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.51 -42.06 95.6 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.738 0.815 . . . . 54.509999999999998 111.837 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.39 87.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.783 0.433 . . . . 74.430000000000007 111.163 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -63.95 -49.97 70.47 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.578 0.751 . . . . 62.25 111.227 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.19 -28.1 68.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 117.858 0.299 . . . . 64.040000000000006 110.841 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 91.94 0.68 Allowed Glycine 0 C--N 1.342 0.869 0 C-N-CA 123.889 0.757 . . . . 62.310000000000002 111.291 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.03 144.88 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.565 0.746 . . . . 64.299999999999997 110.055 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -71.87 155.11 92.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.266 1.026 . . . . 74.010000000000005 110.783 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.24 48.31 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.888 3.059 . . . . 72.420000000000002 112.399 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.0 m -139.48 -49.94 0.5 Allowed 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.788 2.035 . . . . 70.019999999999996 107.794 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.0 -31.03 67.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.913 0.885 . . . . 75.420000000000002 110.982 171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.36 -43.17 70.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.23 0.468 . . . . 74.049999999999997 110.094 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.83 -34.81 68.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.861 0.464 . . . . 75.540000000000006 111.497 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -70.91 -52.66 18.71 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.083 0.553 . . . . 72.209999999999994 110.688 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -53.18 -38.1 62.49 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.944 0.72 . . . . 74.450000000000003 112.944 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.0 -16.13 28.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.01 0.924 . . . . 75.519999999999996 111.775 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.5 66.28 0.96 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.302 1.441 . . . . 75.430000000000007 110.956 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.02 177.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.953 1.301 . . . . 70.409999999999997 110.019 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 t -76.28 -70.0 0.47 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.375 1.07 . . . . 71.099999999999994 111.067 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -179.8 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.265 1.826 . . . . 64.439999999999998 109.638 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.39 -33.29 39.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.683 0.659 . . . . 64.299999999999997 112.762 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -70.97 -35.71 72.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.318 1.047 . . . . 73.329999999999998 111.322 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.5 t -53.53 -50.08 51.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 123.761 0.825 . . . . 70.349999999999994 111.433 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -56.75 -41.89 78.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.18 0.592 . . . . 44.329999999999998 111.466 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.05 -43.72 78.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.833 0.853 . . . . 71.200000000000003 110.397 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.9 -34.56 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.613 1.165 . . . . 72.209999999999994 110.456 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -19.46 40.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.104 1.362 . . . . 70.120000000000005 111.244 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.01 140.55 6.73 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.46 1.505 . . . . 72.430000000000007 109.507 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -15.2 60.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.043 0.422 . . . . 73.439999999999998 111.206 168.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 79.47 128.29 0.05 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 127.067 2.147 . . . . 74.430000000000007 111.32 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 62.92 55.15 2.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.787 1.635 . . . . 64.239999999999995 110.561 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -50.95 152.46 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.597 1.159 . . . . 75.310000000000002 110.71 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -31.28 -62.34 0.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.433 1.893 . . . . 73.400000000000006 112.799 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.49 49.05 0.94 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.052 0.835 . . . . 63.32 111.319 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -159.29 168.32 26.71 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.101 0.95 . . . . 73.230000000000004 109.983 173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mt 59.83 50.83 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.838 1.255 . . . . 44.450000000000003 109.018 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.33 55.42 1.06 Allowed Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.244 1.018 . . . . 72.519999999999996 110.965 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.93 151.51 68.12 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.057 2.504 . . . . 72.219999999999999 110.79 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.92 104.5 0.64 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.268 -1.133 . . . . 63.020000000000003 110.268 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -152.95 110.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.962 0.905 . . . . 72.239999999999995 109.303 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.5 mt -77.18 139.94 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 73.430000000000007 108.72 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.69 157.06 29.35 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.459 -1.057 . . . . 74.519999999999996 110.459 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.39 55.0 33.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.041 0.829 . . . . 73.430000000000007 111.483 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.1 p -155.27 81.27 1.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.367 0.667 . . . . 72.219999999999999 110.027 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.97 67.66 9.29 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.973 0.909 . . . . 70.549999999999997 109.341 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.78 161.05 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.472 2.781 . . . . 64.239999999999995 111.562 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -158.35 113.91 2.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.458 -1.312 . . . . 71.129999999999995 107.458 172.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.22 121.02 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.473 0.709 . . . . 62.049999999999997 109.922 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 166.61 149.0 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.066 2.546 . . . . 64.140000000000001 108.846 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -158.19 142.34 11.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.327 -1.36 . . . . 63.439999999999998 107.327 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.11 -21.34 36.65 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 71.340000000000003 111.895 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -60.48 -19.16 55.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.577 1.151 . . . . 72.439999999999998 113.219 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.13 -46.28 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 122.867 0.467 . . . . 71.329999999999998 111.042 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -56.88 -38.19 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.933 . . . . 65.5 110.734 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.57 -55.64 16.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.146 0.578 . . . . 63.240000000000002 110.209 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -4.14 48.63 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.462 1.282 . . . . 63.399999999999999 114.462 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mm -60.18 -36.36 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.014 0.824 . . . . 52.140000000000001 109.157 159.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.44 68.22 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.05 0.833 . . . . 40.32 111.811 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -62.97 -47.23 84.06 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.631 0.716 . . . . 75.450000000000003 110.753 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -58.69 -38.37 78.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.306 0.484 . . . . 51.420000000000002 112.306 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.78 -54.52 25.96 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.647 0.779 . . . . 53.5 111.899 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.23 -30.71 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.144 0.884 . . . . 62.409999999999997 112.198 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -71.14 -55.33 8.39 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.272 1.029 . . . . 71.209999999999994 110.197 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -127.44 85.58 60.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.498 1.519 . . . . 62.119999999999997 109.292 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.86 -31.77 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.249 2.633 . . . . 71.5 111.821 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 p -55.59 -40.45 72.04 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.068 . . . . 61.43 111.149 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 74.6 mtp -70.1 120.84 16.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.612 -0.514 . . . . 64.129999999999995 109.612 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -88.6 169.87 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.431 1.092 . . . . 73.209999999999994 110.619 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.27 -44.71 3.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.661 1.585 . . . . 71.530000000000001 113.879 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -71.6 -35.19 70.43 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.543 1.137 . . . . 60.539999999999999 111.954 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.93 -51.82 29.65 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.862 0.865 . . . . 74.400000000000006 109.571 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -34.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.599 1.56 . . . . 71.219999999999999 111.723 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -49.36 -42.41 41.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.724 0.81 . . . . 54.219999999999999 111.701 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -67.75 -23.04 65.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.676 0.991 . . . . 73.040000000000006 113.676 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -59.41 -28.64 67.11 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 64.549999999999997 112.241 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.07 -43.03 83.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.263 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.9 -42.75 84.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.926 -0.398 . . . . 70.439999999999998 109.926 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.06 91.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.877 0.871 . . . . 75.140000000000001 111.64 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.19 -37.28 85.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.649 0.78 . . . . 64.420000000000002 110.271 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.43 41.95 3.07 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.658 1.123 . . . . 72.129999999999995 110.428 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.09 -42.66 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.842 1.257 . . . . 63.229999999999997 109.184 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.09 -179.34 8.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.386 1.074 . . . . 63.140000000000001 110.375 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.63 -92.77 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.56 1.144 . . . . 55.030000000000001 112.357 -157.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.21 -60.6 2.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.799 -1.926 . . . . 74.329999999999998 105.799 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -174.34 162.76 3.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.574 1.55 . . . . 74.25 109.039 147.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.9 p -131.63 0.96 4.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.437 1.495 . . . . 72.010000000000005 110.214 161.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.48 149.16 97.53 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 73.349999999999994 109.609 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.42 -174.38 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.003 2.468 . . . . 54.140000000000001 112.947 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 m -54.08 134.79 43.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.201 1.8 . . . . 75.219999999999999 112.572 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.23 -33.18 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.712 1.205 . . . . 75.030000000000001 111.378 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -70.38 -31.64 68.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.083 0.553 . . . . 71.129999999999995 111.705 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.1 t -67.07 -49.88 63.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.488 0.585 . . . . 71.319999999999993 110.323 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 pt -58.56 -35.11 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.705 0.802 . . . . 63.439999999999998 112.195 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -67.68 -52.98 31.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.88 0.309 . . . . 72.030000000000001 110.583 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -64.67 -14.47 58.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.239 1.199 . . . . 72.340000000000003 114.239 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mm -59.67 -35.96 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.003 1.274 . . . . 65.439999999999998 109.705 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -27.58 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 125.269 1.428 . . . . 75.310000000000002 111.512 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -56.44 -36.58 69.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.775 0.716 . . . . 62.149999999999999 112.045 -177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.3 p -63.91 -29.58 70.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.136 0.574 . . . . 73.430000000000007 111.548 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -83.16 -46.93 12.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.704 0.802 . . . . 54.520000000000003 110.298 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.37 99.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.252 1.021 . . . . 74.319999999999993 109.238 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 165.55 12.04 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.598 1.159 . . . . 63.100000000000001 109.481 166.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -109.65 139.95 21.7 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 124.001 0.92 . . . . 65.329999999999998 109.358 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.32 165.28 33.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.079 2.519 . . . . 72.450000000000003 110.73 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -81.3 63.7 5.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.964 0.906 . . . . 63.229999999999997 110.294 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.62 154.75 23.04 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.311 1.444 . . . . 70.120000000000005 107.892 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.2 tp -147.83 77.32 10.29 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.221 1.008 . . . . 74.5 108.281 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -85.28 52.05 3.18 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.485 2.79 . . . . 73.439999999999998 110.553 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 38.5 mmt -86.64 67.88 9.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.942 0.897 . . . . 64.349999999999994 110.179 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.7 132.91 42.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.129 -0.693 . . . . 70.030000000000001 109.129 172.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.1 m -146.36 63.52 1.21 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.196 0.998 . . . . 74.319999999999993 109.26 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.26 127.06 2.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.642 -1.383 . . . . 61.420000000000002 109.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 147.26 14.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 70.420000000000002 109.312 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.38 170.96 18.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.531 2.821 . . . . 65.450000000000003 110.963 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.37 146.73 7.57 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.54 -1.424 . . . . 75.519999999999996 109.54 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.25 176.83 44.77 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.883 -0.887 . . . . 73.299999999999997 110.883 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.74 165.25 31.96 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.363 -1.095 . . . . 73.349999999999994 110.363 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.8 t -162.97 153.22 16.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.107 0.963 . . . . 73.209999999999994 109.372 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -163.23 153.71 16.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.576 1.15 . . . . 73.239999999999995 109.268 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -153.76 147.59 25.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.542 1.137 . . . . 63.420000000000002 108.384 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -153.92 164.04 39.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.577 1.151 . . . . 71.209999999999994 108.326 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -161.45 160.46 29.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.873 0.869 . . . . 73.439999999999998 109.262 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -69.57 146.78 51.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.359 0.663 . . . . 74.510000000000005 109.676 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.836 -1.078 . . . . 74.409999999999997 111.146 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.988 -1.006 . . . . 74.540000000000006 111.654 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.44 152.99 60.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.837 1.691 . . . . 71.230000000000004 109.712 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -138.79 74.8 1.49 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.064 -1.087 . . . . 73.439999999999998 108.064 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.43 136.68 53.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.667 0.787 . . . . 73.030000000000001 110.303 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -82.9 83.49 7.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.643 0.777 . . . . 54.009999999999998 110.195 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.42 129.86 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.903 -1.517 . . . . 75.340000000000003 106.903 168.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -136.26 152.07 50.34 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.446 1.098 . . . . 73.129999999999995 109.318 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -68.67 139.49 55.44 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.93 0.892 . . . . 63.0 111.648 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 175.8 52.61 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.723 -0.951 . . . . 72.129999999999995 110.723 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -163.68 155.95 17.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.974 0.91 . . . . 70.319999999999993 109.654 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.86 -170.54 43.66 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.195 -1.162 . . . . 64.439999999999998 110.195 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.87 155.08 23.16 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.539 -1.024 . . . . 63.240000000000002 110.539 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.82 137.68 32.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.066 0.946 . . . . 73.030000000000001 109.525 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -91.95 108.05 19.65 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.421 1.089 . . . . 71.420000000000002 109.246 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -70.1 142.34 52.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.073 -0.714 . . . . 63.520000000000003 109.073 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tt -151.75 102.02 2.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.063 -1.088 . . . . 65.430000000000007 108.063 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.15 177.2 53.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.683 0.659 . . . . 25.43 112.244 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.07 176.57 45.81 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.63 -0.988 . . . . 53.43 110.63 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.21 140.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.378 1.871 . . . . 71.209999999999994 111.924 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.8 t80 54.44 51.96 13.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.638 1.175 . . . . 62.549999999999997 111.216 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.2 t -101.24 142.27 16.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.596 1.158 . . . . 74.040000000000006 108.479 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -71.01 84.84 0.7 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.667 0.787 . . . . 75.530000000000001 108.882 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 -44.98 0.57 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.228 -1.549 . . . . 64.049999999999997 109.228 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -65.57 135.27 95.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 65.310000000000002 108.591 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.48 133.85 16.37 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.75 2.3 . . . . 72.239999999999995 109.603 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.32 89.6 12.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.135 . . . . 50.420000000000002 108.214 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.09 -160.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.365 2.71 . . . . 74.25 110.431 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -47.68 -26.8 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.75 1.62 . . . . 63.119999999999997 114.192 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.41 -26.22 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.135 1.374 . . . . 64.420000000000002 112.83 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -52.3 -30.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.643 1.177 . . . . 74.299999999999997 112.18 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -45.99 -42.14 12.75 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.918 0.887 . . . . 70.329999999999998 112.254 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.85 -39.09 87.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.18 0.992 . . . . 62.039999999999999 110.612 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -69.83 -40.45 75.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 74.510000000000005 111.227 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.06 -51.14 76.02 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 109.495 -0.557 . . . . 63.140000000000001 109.495 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -56.7 -56.09 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.951 1.3 . . . . 62.539999999999999 109.945 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.54 -55.33 19.67 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.958 1.303 . . . . 63.030000000000001 111.487 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.25 -49.16 78.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 110.457 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -37.64 67.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.49 0.716 . . . . 74.010000000000005 112.29 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -59.61 -27.54 66.4 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.761 1.224 . . . . 74.409999999999997 112.721 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.05 -25.21 60.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.73 0.695 . . . . 65.540000000000006 111.916 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.59 63.23 0.82 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 109.206 -1.558 . . . . 44.439999999999998 109.206 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.49 159.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.905 0.882 . . . . 63.229999999999997 110.251 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.44 153.04 80.24 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.086 2.154 . . . . 71.310000000000002 108.096 -175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.42 -36.25 87.22 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.718 2.945 . . . . 63.509999999999998 114.728 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.2 t -58.91 -41.15 86.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.929 0.492 . . . . 73.540000000000006 111.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.59 -46.06 27.72 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.476 1.11 . . . . 63.109999999999999 110.805 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.6 mt -46.66 -39.97 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.987 1.315 . . . . 71.25 111.1 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -52.14 -21.06 2.93 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.543 1.312 . . . . 71.209999999999994 114.543 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -43.52 64.61 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.998 1.272 . . . . 71.200000000000003 110.897 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.231 1.012 . . . . 73.450000000000003 110.821 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.26 -22.08 38.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 73.230000000000004 110.528 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 64.14 64.25 0.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.217 1.807 . . . . 54.420000000000002 110.663 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.69 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.197 0.999 . . . . 62.009999999999998 109.684 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -160.69 -81.63 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.776 0.831 . . . . 74.200000000000003 110.493 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -176.48 -61.34 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.889 1.276 . . . . 73.439999999999998 109.71 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.84 74.12 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.74 0.686 . . . . 75.299999999999997 112.225 -170.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.8 t -59.22 -46.29 88.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.792 0.837 . . . . 70.209999999999994 110.177 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.18 -43.48 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.898 0.879 . . . . 74.510000000000005 110.667 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -55.88 -49.08 74.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.172 0.589 . . . . 65.329999999999998 111.285 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.5 -45.73 92.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.653 0.781 . . . . 65.019999999999996 111.057 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.09 -52.26 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.894 0.877 . . . . 63.5 110.657 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -51.55 -54.03 31.74 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.557 1.143 . . . . 62.229999999999997 110.4 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.79 138.81 2.64 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.13 -0.788 . . . . 74.200000000000003 111.13 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -69.47 -42.15 75.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.548 -0.908 . . . . 63.350000000000001 108.548 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.95 -63.04 1.45 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.277 1.431 . . . . 74.239999999999995 109.128 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.49 -52.11 0.39 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.757 1.623 . . . . 64.349999999999994 107.36 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -101.73 -177.57 3.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.983 -1.117 . . . . 74.510000000000005 107.983 152.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -63.08 -52.7 61.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.546 0.738 . . . . 64.109999999999999 110.374 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.03 69.73 0.27 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.176 -1.169 . . . . 74.540000000000006 110.176 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 t -160.34 -175.54 5.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.475 1.11 . . . . 53.329999999999998 108.933 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 mt 63.79 65.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.787 1.635 . . . . 71.530000000000001 108.183 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -139.22 70.64 40.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.239 1.016 . . . . 75.329999999999998 109.851 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.24 89.4 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.386 2.724 . . . . 63.539999999999999 109.453 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.96 -170.78 46.48 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.013 0.816 . . . . 71.129999999999995 111.917 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.96 92.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.662 1.585 . . . . 60.140000000000001 109.177 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.37 134.46 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.691 -0.855 . . . . 72.430000000000007 108.691 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.1 44.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.655 -0.978 . . . . 74.239999999999995 110.655 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.05 -169.68 42.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.561 -1.016 . . . . 45.32 110.561 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.3 m -65.71 144.99 56.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.566 0.746 . . . . 70.319999999999993 110.757 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -123.27 80.31 52.67 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.59 1.156 . . . . 72.340000000000003 109.348 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.51 164.78 33.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 110.556 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -102.08 -157.25 0.6 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.249 1.019 . . . . 71.409999999999997 109.004 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.0 137.1 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.613 1.565 . . . . 74.129999999999995 108.126 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 157.24 28.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.709 0.804 . . . . 53.100000000000001 110.775 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.7 t -158.67 144.93 12.53 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.927 0.891 . . . . 72.430000000000007 108.966 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.65 -16.05 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.654 2.236 . . . . 75.230000000000004 111.842 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -60.24 -21.45 61.86 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 44.520000000000003 112.171 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.92 -42.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 65.519999999999996 110.979 169.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.62 -40.21 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.576 1.15 . . . . 71.140000000000001 111.534 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -58.55 -32.84 69.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.732 0.813 . . . . 63.210000000000001 111.995 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -67.53 -37.3 82.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.578 0.751 . . . . 74.030000000000001 111.153 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -64.47 -37.76 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.733 -0.839 . . . . 73.010000000000005 108.733 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.41 -46.84 79.01 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.032 0.825 . . . . 64.030000000000001 112.172 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -67.86 -43.06 80.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.198 0.999 . . . . 60.539999999999999 112.871 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -56.25 -36.44 68.54 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.205 1.187 . . . . 74.099999999999994 114.205 -167.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -32.38 69.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.574 1.534 . . . . 71.310000000000002 111.96 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -65.89 -36.44 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.3 0.5 . . . . 72.129999999999995 110.278 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -73.02 -52.55 13.98 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.596 0.358 . . . . 62.229999999999997 110.545 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.92 151.11 97.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.817 1.247 . . . . 75.219999999999999 110.308 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.21 -60.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.755 2.303 . . . . 65.349999999999994 111.888 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.5 p -134.91 62.6 1.64 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.008 0.923 . . . . 71.519999999999996 110.137 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 73.6 mtp -127.4 157.7 39.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.484 1.114 . . . . 73.349999999999994 108.701 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -140.76 173.24 11.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.289 1.436 . . . . 74.420000000000002 109.38 -167.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.41 -48.76 7.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 73.530000000000001 113.384 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -61.42 -47.4 85.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.412 1.085 . . . . 75.340000000000003 111.61 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.47 -46.94 74.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.608 1.163 . . . . 60.130000000000003 110.572 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.7 mm -58.58 -21.18 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.101 1.76 . . . . 53.100000000000001 113.148 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -44.55 -53.18 7.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.893 0.769 . . . . 73.319999999999993 109.823 167.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.96 -15.67 50.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.66 1.184 . . . . 71.319999999999993 112.727 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -58.57 -50.8 72.46 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 118.969 0.804 . . . . 73.209999999999994 109.116 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.1 -40.12 84.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.764 0.826 . . . . 71.310000000000002 111.466 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.53 -52.84 59.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.667 0.387 . . . . 71.230000000000004 110.014 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.75 74.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.957 . . . . 33.109999999999999 112.146 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.59 -28.37 61.8 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.171 0.988 . . . . 75.340000000000003 110.618 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.49 7.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.434 -1.066 . . . . 73.519999999999996 110.434 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.4 t -106.51 -51.21 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.328 1.451 . . . . 62.439999999999998 108.98 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 90.6 m -111.76 159.87 17.86 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.472 1.109 . . . . 64.329999999999998 109.88 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -97.46 162.16 13.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.922 1.289 . . . . 64.129999999999995 108.937 165.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -41.82 -46.65 3.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.813 2.045 . . . . 74.150000000000006 114.134 -171.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.68 -37.45 10.32 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.146 0.978 . . . . 75.099999999999994 111.515 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.0 p -58.95 -37.42 76.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.753 0.821 . . . . 73.349999999999994 112.17 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -40.83 127.06 1.95 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 126.012 1.725 . . . . 65.430000000000007 111.1 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 162.38 41.7 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.829 2.353 . . . . 70.420000000000002 112.619 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -59.19 135.24 57.58 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.977 1.311 . . . . 72.230000000000004 111.937 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.85 -33.94 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.822 0.849 . . . . 65.25 111.147 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -63.61 -34.95 78.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.638 0.775 . . . . 74.129999999999995 111.978 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -67.65 -63.1 1.13 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.002 0.521 . . . . 55.219999999999999 109.637 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.42 -41.52 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.552 0.741 . . . . 65.099999999999994 110.87 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.7 -60.71 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.7 -0.666 . . . . 62.32 111.34 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -62.86 -34.44 77.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.068 0.849 . . . . 73.209999999999994 112.238 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -52.39 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.261 0.624 . . . . 63.130000000000003 110.174 168.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.25 -42.18 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.981 0.912 . . . . 70.109999999999999 111.957 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -52.73 -39.13 61.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.994 0.918 . . . . 75.239999999999995 112.157 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.6 p -60.57 -24.5 65.47 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.469 0.577 . . . . 73.340000000000003 112.429 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.99 -43.51 11.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.082 0.953 . . . . 65.340000000000003 110.757 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.84 92.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.075 0.95 . . . . 60.310000000000002 110.348 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -145.95 167.64 22.81 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.789 1.235 . . . . 61.109999999999999 110.137 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.71 143.84 49.03 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.847 1.259 . . . . 74.230000000000004 108.483 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.03 172.78 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.366 2.711 . . . . 64.129999999999995 110.729 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -80.09 64.52 4.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.083 0.953 . . . . 63.43 109.94 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.39 148.94 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.546 1.139 . . . . 74.420000000000002 109.221 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.5 tp -112.56 91.66 17.67 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.942 1.297 . . . . 61.32 108.487 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.32 126.13 12.0 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.307 2.005 . . . . 72.450000000000003 109.236 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.5 tpt -154.44 106.48 2.75 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.737 0.815 . . . . 75.230000000000004 108.989 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.62 134.63 35.74 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.779 1.232 . . . . 63.210000000000001 108.535 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.7 m -164.17 165.11 22.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.373 1.469 . . . . 74.430000000000007 109.26 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.15 173.04 49.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.018 0.818 . . . . 73.439999999999998 112.231 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.8 73.58 6.49 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.384 1.073 . . . . 75.019999999999996 109.274 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.38 175.06 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.407 2.738 . . . . 74.310000000000002 111.213 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 97.47 98.33 1.98 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.067 -1.213 . . . . 51.130000000000003 110.067 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.95 173.88 42.25 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.214 -1.154 . . . . 71.319999999999993 110.214 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.39 -179.66 46.95 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.429 -1.068 . . . . 64.140000000000001 110.429 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 65.0 p -161.18 159.76 29.28 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.188 0.995 . . . . 71.510000000000005 109.647 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -160.38 106.58 1.53 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.506 -0.924 . . . . 72.329999999999998 108.506 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -132.99 62.36 1.66 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.931 0.892 . . . . 73.409999999999997 108.913 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -125.04 141.32 52.2 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.294 1.038 . . . . 73.450000000000003 109.725 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -166.2 167.5 16.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.631 1.172 . . . . 62.32 109.312 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -99.02 173.93 6.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.46 1.104 . . . . 72.299999999999997 109.435 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.549 -1.215 . . . . 52.240000000000002 109.76 174.15 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 117.914 -1.041 . . . . 62.450000000000003 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.82 159.82 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.929 1.753 . . . . 61.140000000000001 110.498 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -159.73 162.92 35.05 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.305 1.042 . . . . 63.329999999999998 109.516 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.71 173.4 12.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.366 0.666 . . . . 63.43 110.815 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -141.54 -64.45 0.44 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 108.827 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt 48.9 -161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.43 1.892 . . . . 74.299999999999997 112.208 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -160.98 143.51 12.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.22 -0.659 . . . . 75.0 109.22 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 p -165.07 120.76 1.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.912 0.885 . . . . 35.409999999999997 108.916 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.42 160.07 27.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.323 -1.111 . . . . 74.319999999999993 110.323 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -161.56 159.95 28.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.738 1.215 . . . . 73.430000000000007 108.89 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.45 38.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.415 -1.074 . . . . 45.329999999999998 110.415 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.26 53.96 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.206 -0.758 . . . . 63.100000000000001 111.206 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -157.88 -62.13 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.515 -0.92 . . . . 71.129999999999995 108.515 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -62.47 129.8 42.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.528 1.131 . . . . 54.329999999999998 110.343 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.67 159.96 37.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.829 1.251 . . . . 62.409999999999997 108.798 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.96 154.82 46.98 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.155 0.982 . . . . 72.299999999999997 110.293 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.31 163.2 33.83 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.752 -1.339 . . . . 65.519999999999996 109.752 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.88 39.26 77.47 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.737 0.684 . . . . 65.430000000000007 111.949 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.04 175.8 9.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.158 0.983 . . . . 74.099999999999994 110.304 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.45 149.38 42.84 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 110.059 -0.348 . . . . 65.150000000000006 110.059 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.1 t 69.54 -56.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.17 2.188 . . . . 72.129999999999995 111.667 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -60.93 -64.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.136 0.974 . . . . 71.219999999999999 110.579 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.78 -60.38 2.08 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.841 -1.704 . . . . 61.100000000000001 108.841 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 66.41 150.49 0.12 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.672 2.389 . . . . 74.349999999999994 113.381 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.91 86.01 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.33 2.686 . . . . 70.200000000000003 111.098 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.0 mt -124.83 -70.06 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.938 1.295 . . . . 55.409999999999997 109.782 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.03 -178.39 3.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.723 1.615 . . . . 41.210000000000001 108.842 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' VAL . 12.1 mt-10 -76.03 32.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.77 1.026 . . . . 71.439999999999998 113.77 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.26 -25.17 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.94 -0.552 . . . . 75.430000000000007 109.664 150.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 28' ' ' GLU . 6.4 p -52.42 -43.31 40.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 CA-C-N 118.822 0.737 . . . . 75.329999999999998 111.851 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -52.5 41.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 110.752 172.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -60.7 -45.71 93.17 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.534 0.733 . . . . 62.409999999999997 110.43 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -59.63 -43.44 93.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.336 0.655 . . . . 72.230000000000004 111.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.52 -48.2 88.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-O 118.688 -0.672 . . . . 70.109999999999999 111.314 172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.59 -56.12 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.841 0.746 . . . . 65.409999999999997 110.272 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.12 -45.87 79.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.477 1.511 . . . . 74.349999999999994 111.65 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.78 -48.01 41.82 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.344 0.658 . . . . 54.009999999999998 111.185 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.95 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.855 1.262 . . . . 62.210000000000001 112.273 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -52.9 -35.05 57.54 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.836 0.854 . . . . 73.25 112.276 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.51 -18.71 65.53 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.646 0.61 . . . . 72.510000000000005 112.646 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.93 73.25 1.26 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.714 -1.754 . . . . 33.310000000000002 108.714 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.27 140.77 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.79 0.836 . . . . 74.209999999999994 110.779 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -77.58 149.87 78.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.262 1.425 . . . . 73.439999999999998 109.993 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.88 -29.26 76.12 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.424 2.749 . . . . 64.319999999999993 112.194 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.32 -36.3 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.485 0.714 . . . . 62.43 111.633 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.13 -46.36 43.05 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 109.789 -0.448 . . . . 71.230000000000004 109.789 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -51.26 -39.75 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.737 0.415 . . . . 62.130000000000003 110.091 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 m -52.65 -49.36 65.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.421 0.688 . . . . 74.030000000000001 112.071 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -24.96 32.25 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.584 0.957 . . . . 72.540000000000006 113.584 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -58.08 -48.81 79.02 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.81 1.186 . . . . 62.439999999999998 110.546 166.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.66 -8.08 59.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.997 0.919 . . . . 75.340000000000003 111.471 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 46.83 68.22 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.833 2.053 . . . . 73.329999999999998 112.558 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 m -141.75 165.42 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.421 1.888 . . . . 71.239999999999995 109.584 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -78.19 141.67 38.49 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.191 0.996 . . . . 44.340000000000003 111.338 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -52.65 -39.18 61.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.767 1.227 . . . . 75.109999999999999 112.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.31 63.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.874 0.749 . . . . 60.109999999999999 111.426 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.72 -47.41 85.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.433 0.693 . . . . 74.25 110.381 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.4 t -54.71 -31.52 24.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 124.644 1.177 . . . . 53.219999999999999 112.367 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -48.95 -49.93 37.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.591 0.632 . . . . 74.219999999999999 111.052 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.21 -34.94 78.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.836 0.854 . . . . 73.209999999999994 111.878 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.64 -42.36 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.771 0.828 . . . . 74.140000000000001 110.062 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.67 -60.87 3.02 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.183 0.593 . . . . 25.43 109.538 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.88 148.27 15.49 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.37 -1.492 . . . . 54.210000000000001 109.37 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -46.77 -56.55 6.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.388 1.475 . . . . 75.310000000000002 110.391 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -104.62 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.746 2.018 . . . . 73.010000000000005 107.41 167.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -148.13 74.53 1.3 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.898 -0.778 . . . . 74.150000000000006 108.898 164.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 56.61 34.07 23.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.264 1.426 . . . . 52.039999999999999 113.219 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.5 p -84.43 -79.99 0.21 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.011 0.823 . . . . 61.420000000000002 109.477 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.23 17.41 18.35 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.019 -0.879 . . . . 64.319999999999993 113.517 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -163.8 174.42 11.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.645 1.222 . . . . 71.219999999999999 109.629 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mt 58.76 25.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.056 1.742 . . . . 73.329999999999998 112.185 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -152.77 148.7 20.85 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.393 1.477 . . . . 63.219999999999999 108.598 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.4 158.63 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.251 2.634 . . . . 75.409999999999997 110.483 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.91 56.68 0.43 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.271 -1.132 . . . . 74.530000000000001 110.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -84.06 60.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.335 1.054 . . . . 71.299999999999997 110.561 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.3 mt -71.59 -54.26 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.853 0.861 . . . . 62.409999999999997 110.1 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.05 -139.6 32.86 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.77 -0.932 . . . . 70.430000000000007 110.77 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.43 146.02 6.89 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.788 -0.925 . . . . 73.010000000000005 110.788 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -81.76 149.77 28.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.218 1.007 . . . . 74.25 110.225 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 131.3 23.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.499 1.12 . . . . 73.0 108.792 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.64 157.72 39.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.439 2.759 . . . . 72.230000000000004 111.654 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -86.66 67.46 9.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.81 1.244 . . . . 55.0 109.691 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.1 t -73.06 135.68 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.231 -0.655 . . . . 71.299999999999997 109.231 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.49 140.28 34.68 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.338 1.055 . . . . 74.129999999999995 109.641 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.41 144.26 11.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.759 0.824 . . . . 64.010000000000005 109.127 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.31 -5.3 16.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.591 2.86 . . . . 72.540000000000006 113.07 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -26.61 13.45 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.148 0.979 . . . . 73.129999999999995 112.617 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.8 t -47.81 -40.56 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.97 1.308 . . . . 71.519999999999996 111.266 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.67 -41.9 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.463 0.705 . . . . 73.340000000000003 111.18 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.34 -29.17 70.53 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.156 0.583 . . . . 74.310000000000002 111.589 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -75.21 -36.53 61.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.141 0.976 . . . . 62.43 111.51 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.14 -43.18 88.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-N 118.677 0.671 . . . . 73.109999999999999 109.287 166.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.7 -57.22 7.75 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.31 -0.716 . . . . 65.299999999999997 111.31 169.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -55.73 -46.85 77.68 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 117.902 0.851 . . . . 73.349999999999994 112.119 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -64.72 -34.39 78.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.094 0.861 . . . . 65.030000000000001 111.737 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -69.97 -25.75 63.77 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 71.150000000000006 113.052 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -78.11 -50.51 11.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.829 0.852 . . . . 73.329999999999998 110.434 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.82 -67.71 0.42 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.837 1.255 . . . . 75.25 110.251 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -79.37 150.28 73.51 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.47 -1.307 . . . . 75.510000000000005 107.47 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.37 85.81 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.11 2.54 . . . . 64.140000000000001 111.801 -170.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p 53.11 37.89 26.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.562 1.945 . . . . 73.439999999999998 113.485 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 23.7 ptm -57.85 164.45 2.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.688 1.195 . . . . 73.420000000000002 113.519 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.39 149.1 35.21 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 113.032 0.753 . . . . 71.140000000000001 113.032 -166.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.13 63.75 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.087 1.355 . . . . 73.099999999999994 111.318 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -52.33 -54.46 31.32 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.791 1.236 . . . . 73.120000000000005 111.241 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -58.45 -51.34 70.26 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.166 0.986 . . . . 75.430000000000007 110.101 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.47 -40.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.287 1.435 . . . . 73.209999999999994 112.8 -169.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -51.75 -51.21 57.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.524 0.602 . . . . 74.129999999999995 110.159 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.72 -35.74 75.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.85 0.86 . . . . 72.510000000000005 111.825 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -40.84 77.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.645 0.778 . . . . 73.010000000000005 111.032 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.8 mt -59.36 -39.71 84.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.121 0.568 . . . . 70.040000000000006 111.469 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.42 -44.57 67.63 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.89 0.476 . . . . 73.120000000000005 110.057 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.83 84.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.249 1.02 . . . . 75.549999999999997 111.311 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.25 -18.32 64.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.668 0.787 . . . . 73.010000000000005 112.029 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.28 34.18 58.15 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.939 0.78 . . . . 63.420000000000002 111.192 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.65 -36.64 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.556 1.542 . . . . 65.099999999999994 109.865 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.2 t -137.81 165.74 25.72 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.951 0.9 . . . . 73.109999999999999 110.374 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.8 152.67 22.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.295 1.438 . . . . 74.239999999999995 109.954 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -51.39 -31.07 21.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 73.540000000000006 114.71 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.2 -44.9 8.11 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.581 0.753 . . . . 71.019999999999996 109.997 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 54.8 p -62.37 -34.87 77.53 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.985 0.914 . . . . 72.329999999999998 112.099 -174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.0 135.26 73.76 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.756 1.223 . . . . 75.099999999999994 110.448 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.8 163.83 33.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.643 2.229 . . . . 73.510000000000005 111.093 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 151.16 47.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.746 0.818 . . . . 50.240000000000002 110.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -54.35 -45.73 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.687 0.795 . . . . 72.209999999999994 109.291 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 m -54.14 -41.68 68.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.528 1.131 . . . . 55.030000000000001 111.786 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.4 t -62.5 -74.54 0.09 Allowed 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.969 -0.752 . . . . 54.219999999999999 108.969 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.9 pt -45.48 -42.61 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.145 0.978 . . . . 74.010000000000005 112.73 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -54.09 -61.85 2.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.23 0.468 . . . . 75.129999999999995 110.304 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -58.43 -40.71 83.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.072 0.949 . . . . 73.200000000000003 112.253 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 mm -59.01 -53.53 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.141 -1.059 . . . . 73.510000000000005 108.141 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.7 mt -71.0 -30.63 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.842 1.257 . . . . 75.299999999999997 111.632 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -54.05 -44.41 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.04 0.836 . . . . 73.349999999999994 111.649 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -67.89 -14.14 62.72 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.547 0.573 . . . . 63.130000000000003 112.547 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -96.97 -111.92 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.45 -1.315 . . . . 72.239999999999995 107.45 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.41 84.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.293 -1.003 . . . . 72.239999999999995 108.293 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -79.48 91.48 5.14 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.285 1.034 . . . . 72.450000000000003 108.586 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -64.25 139.74 97.77 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.894 -0.78 . . . . 75.219999999999999 108.894 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.14 162.56 39.63 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.131 2.554 . . . . 74.349999999999994 111.488 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.38 60.68 4.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.496 1.118 . . . . 74.319999999999993 109.589 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -161.15 142.19 11.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.755 1.222 . . . . 54.229999999999997 109.583 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.0 pt? -87.8 149.76 46.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.819 1.248 . . . . 71.430000000000007 110.469 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.02 163.77 36.03 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.019 2.479 . . . . 74.040000000000006 110.734 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -121.04 156.88 31.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.824 1.25 . . . . 73.140000000000001 110.143 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.99 162.92 40.74 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.358 1.463 . . . . 72.0 109.097 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.0 m -158.62 143.0 15.8 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.061 1.344 . . . . 60.530000000000001 109.077 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.83 74.81 0.03 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.317 -1.113 . . . . 62.439999999999998 110.317 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.38 74.7 78.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 51.109999999999999 110.336 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.12 174.06 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.645 2.897 . . . . 71.329999999999998 111.165 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.04 179.13 48.1 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.045 -0.822 . . . . 70.319999999999993 111.045 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.93 47.66 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.767 -0.933 . . . . 63.43 110.767 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.32 47.91 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.196 -0.762 . . . . 65.040000000000006 111.196 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.8 t -162.72 169.79 19.43 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.76 1.224 . . . . 75.310000000000002 109.513 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -154.02 179.42 8.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.851 1.261 . . . . 72.140000000000001 109.822 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -150.43 108.23 3.69 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.515 1.126 . . . . 44.25 108.39 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -102.04 135.48 43.53 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.235 1.014 . . . . 73.540000000000006 109.09 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -168.25 167.44 12.18 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.037 1.335 . . . . 73.25 108.834 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -155.69 173.81 16.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.598 0.759 . . . . 71.329999999999998 110.544 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.436 -1.269 . . . . 73.540000000000006 109.225 173.499 . . . . . . . . 0 0 . 1 stop_ save_